[{"title":"The use of viscoelastic haemostatic assays in the management of major bleeding: a British Society for Haematology Guideline","googleId":"_WlGi6GMUGUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15524?af=R","googleCitationCount":86,"googleAuthor":"R Davenport","doi":"10.1111/bjh.15524","elsevierAuthor":"Curry N.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"56","altmetricAuthors":["Nicola S. Curry","Ross Davenport","Sue Pavord","Susan V. Mallett","Dianne Kitchen","Andrew A. Klein","Helena Maybury","Peter W. Collins","Mike Laffan"],"twitterCount":19,"altmetricId":46066907,"statusesArray":["1152180477924663296","1152135668191105024","1151929800002551808","1151823838956662784","1151813731917209601","1113066123480588288","1039178489906294784","1039173296665894912","1036545979338698752","1035515970939486213","1035455955511779329","1035271647530573824","1035268623852621830","1035193305754161152","1035191927342280704","1035190627867275265","1035189953922314240","1032517744951021569","1029367217719336966","1028376589392863233","1026034339346362368"]},{"title":"Cytokine release syndrome and neurotoxicity after CD 19 chimeric antigen receptor‐modified (CAR‐) T cell therapy","googleId":"VSDYNGLhYHgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15644","googleCitationCount":69,"googleAuthor":"","doi":"10.1111/bjh.15644","elsevierAuthor":"Hay K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"43","altmetricAuthors":["Kevin A. Hay"],"twitterCount":4,"altmetricId":51025485,"statusesArray":["1062339305220333568","1062135855178006528","1061995337219559425","1060876327400718337"]},{"title":"Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T …","googleId":"OF_PNdvK_hkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15547","googleCitationCount":73,"googleAuthor":"","doi":"10.1111/bjh.15547","elsevierAuthor":"Seto A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"59","altmetricAuthors":["Anita G. Seto","Xuan Beatty","Joshua M. Lynch","Melanie Hermreck","Michael Tetzlaff","Madeleine Duvic","Aimee L. Jackson"],"twitterCount":7,"altmetricId":46772457,"statusesArray":["1031988896190607361","1031987015963815936","1031985299272814592","1031972904273993729","1031934216265781249","1031850679525040128","1031844539164749824"]},{"title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis","googleId":"CtoAPxBdhwoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15790","googleCitationCount":55,"googleAuthor":"","doi":"10.1111/bjh.15790","elsevierAuthor":"Socié G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"43","altmetricAuthors":["Gérard Socié","Marie‐Pierre Caby‐Tosi","Jing L. Marantz","Alexander Cole","Camille L. Bedrosian","Christoph Gasteyger","Arshad Mujeebuddin","Peter Hillmen","Johan Vande Walle","Hermann Haller"],"twitterCount":5,"altmetricId":55593933,"statusesArray":["1147750089995296768","1097423121559310336","1097048263482638336","1096854462017273856","1096704816603115520"]},{"title":"A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma","googleId":"0emT511zQIUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15261","googleCitationCount":61,"googleAuthor":"","doi":"10.1111/bjh.15261","elsevierAuthor":"O'Donnell E.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"44","altmetricAuthors":["Elizabeth K. O'Donnell","Jacob P. Laubach","Andrew J. Yee","Tianqi Chen","Carol Ann Huff","Frank G. Basile","Philip M. Wade","Claudia E. Paba-Prada","Irene M. Ghobrial","Robert L. Schlossman","Jill N. Burke","Cynthia C. Harrington","Kathleen J. Lively","Hannah F. Lyons","Nikhil C. Munshi","Kenneth C. Anderson","Lorenzo Trippa","Paul G. Richardson","Noopur S. Raje"],"twitterCount":18,"altmetricId":40933869,"statusesArray":["1027772208150732800","1027770069256949760","1027769340513411072","1027298408921423872","995259001469358081","995058320733081600","995038910181990402","995001250700779520","994809390699044866","994742124649287682","994711076150415363","994683053954908160","994660101511372800","994619034023940096","994579904808308736","994571470314573824","994569055305654274","994568090452156416","994567426971979776"]},{"title":"How I manage patients with cold agglutinin disease","googleId":"W_dIMntF_n4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15109","googleCitationCount":63,"googleAuthor":"","doi":"10.1111/bjh.15109","elsevierAuthor":"Berentsen S.","publicationName":"Seminars in Hematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"13","altmetricAuthors":["Sigbjørn Berentsen"],"twitterCount":3,"altmetricId":32632168,"statusesArray":["1185674059381690369","1179630386684600320","992708270585450496"]},{"title":"The full spectrum of Castleman disease: 273 patients studied over 20 years","googleId":"f7KB_H5N3yAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15019","googleCitationCount":67,"googleAuthor":"","doi":"10.1111/bjh.15019","elsevierAuthor":"Oksenhendler E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"43","altmetricAuthors":["Eric Oksenhendler","David Boutboul","David Fajgenbaum","Adrien Mirouse","Claire Fieschi","Marion Malphettes","Laetitia Vercellino","Véronique Meignin","Laurence Gérard","Lionel Galicier"],"twitterCount":1,"altmetricId":40720049,"statusesArray":["1354936435929800715"]},{"title":"Haemostasis and innate immunity–a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","googleId":"JXHErXkr1dcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15062","googleCitationCount":62,"googleAuthor":"ZK McQuilten","doi":"10.1111/bjh.15062","elsevierAuthor":"Keragala C.B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"40","altmetricAuthors":["Charithani B. Keragala","Dominik F. Draxler","Zoe K. McQuilten","Robert L. Medcalf"],"twitterCount":22,"altmetricId":30682387,"statusesArray":["986120109918830593","986119687594393601","984118547038302210","984077226311372801","983954997892276224","983951598299656192","983880850994376704","983856689446293504","983823113631817728","983797513210736640","983751429574877184","983669340502478848","983659616138510338","983658453909504001","983633816651788289","983632593760542721","983624316217589760","983623514010869760","983613091119353857","983604927774773248","981285802310275073","943297043350675456"]},{"title":"Advances in understanding the pathogenesis of acquired aplastic anaemia","googleId":"msfP5AMI-QMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15443","googleCitationCount":47,"googleAuthor":"L Luzzatto","doi":"10.1111/bjh.15443","elsevierAuthor":"Luzzatto L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"37","altmetricAuthors":["Lucio Luzzatto","Antonio M. Risitano"],"twitterCount":31,"altmetricId":44584835,"statusesArray":["1121853297646886918","1121800199880396800","1116344966563934209","1114433798727438336","1114238256953139201","1114194349615611904","1114193172979232768","1114183235922165760","1114146808454963202","1114126033660383234","1114116736981393408","1095782410954960897","1048311657892524032","1046561745701982208","1046558101535510528","1046448922749796352","1046385311058669574","1046336642519314432","1046333487790399490","1046311173342162944","1046308003790688256","1046296184019668993","1046237363267985408","1046228630924394496","1046223192631791616","1040293685626318848","1040220586168016896","1040217184822349825","1040199641650872320","1040179925523812352","1040166706533081088","1017754678988193792","1015189132182601728","1015185353915764738"]},{"title":"How I manage patients with relapsed/refractory diffuse large B cell lymphoma","googleId":"7uWt_FdQ-hAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15412","googleCitationCount":55,"googleAuthor":"E Van Den Neste","doi":"10.1111/bjh.15412","elsevierAuthor":"Gisselbrecht C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"43","altmetricAuthors":["Christian Gisselbrecht","Eric Van Den Neste"],"twitterCount":19,"altmetricId":43045670,"statusesArray":["1138062236843479040","1138035240289624065","1138033077215776769","1061981980638629889","1040294887680352256","1040167588310011904","1034954257844162560","1034937768135348224","1031261736693899266","1015514578489405440","1015508240371552257","1004776814714159104","1004763550252969985","1004697364492414976","1004525613204504576","1004519190106124290","1004472965826777089","1004464726435385349","1004453569939066880","1002085501640282112"]},{"title":"Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus Conference","googleId":"Cv39QgGXlxAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15600","googleCitationCount":40,"googleAuthor":"","doi":"10.1111/bjh.15600","elsevierAuthor":"Lobitz S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"30","altmetricAuthors":["Stephan Lobitz","Paul Telfer","Elena Cela","Bichr Allaf","Michael Angastiniotis","Carolina Backman Johansson","Catherine Badens","Celeste Bento","Marelle J. Bouva","Duran Canatan","Matthew Charlton","Cathy Coppinger","Yvonne Daniel","Marianne de Montalembert","Patrick Ducoroy","Elena Dulin","Ralph Fingerhut","Claudia Frömmel","Marina García-Morin","Béatrice Gulbis","Ute Holtkamp","Baba Inusa","John James","Marina Kleanthous","Jeannette Klein","Joachim B. Kunz","Lisa Langabeer","Claudine Lapouméroulie","Ana Marcao","José L. Marín Soria","Corrina McMahon","Kwaku Ohene-Frempong","Jean-Marc Périni","Frédéric B. Piel","Giovanna Russo","Laura Sainati","Markus Schmugge","Allison Streetly","Leon Tshilolo","Charles Turner","Donatella Venturelli","Laura Vilarinho","Rachel Yahyaoui","Jacques Elion","Raffaella Colombatti"],"twitterCount":1,"altmetricId":56605642,"statusesArray":["1101165190463275009"]},{"title":"Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies","googleId":"x-onNfdPV_UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15038","googleCitationCount":54,"googleAuthor":"DS Vinjamur","doi":"10.1111/bjh.15038","elsevierAuthor":"Vinjamur D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"42","altmetricAuthors":["Divya S. Vinjamur","Daniel E. Bauer","Stuart H. Orkin"],"twitterCount":1,"altmetricId":40759223,"statusesArray":["992875409741156353"]},{"title":"Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: an integrated analysis","googleId":"gBQ5MV2IG_wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15690","googleCitationCount":38,"googleAuthor":"J Moslehi","doi":"10.1111/bjh.15690","elsevierAuthor":"Brown J.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"26","altmetricAuthors":["Jennifer R. Brown","Javid Moslehi","Michael S. Ewer","Susan M. O'Brien","Paolo Ghia","Florence Cymbalista","Tait D. Shanafelt","Graeme Fraser","Simon Rule","Steven E. Coutre","Marie‐Sarah Dilhuydy","Paula Cramer","Ulrich Jaeger","Martin Dreyling","John C. Byrd","Steven Treon","Emily Y. Liu","Stephen Chang","Amulya Bista","Rama Vempati","Lisa Boornazian","Rudolph Valentino","Vijay Reddy","Michelle Mahler","Huiying Yang","Thorsten Graef","Jan A. Burger"],"twitterCount":5,"altmetricId":52564728,"statusesArray":["1093633820513972224","1093461449538748416","1093398026578812928","1093310360495550464","1072899113316958210"]},{"title":"Advances in targeted therapy for acute myeloid leukaemia","googleId":"xLIgQ_dfxDoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15032","googleCitationCount":52,"googleAuthor":"MJ Levis","doi":"10.1111/bjh.15032","elsevierAuthor":"Kayser S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"36","altmetricAuthors":["Sabine Kayser","Mark J. Levis"],"twitterCount":1,"altmetricId":75003729,"statusesArray":["1224715507451998210"]},{"title":"Differentiation syndrome in acute promyelocytic leukaemia","googleId":"_3zLNnwaNLgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16151","googleCitationCount":23,"googleAuthor":"M Stahl","doi":"10.1111/bjh.16151","elsevierAuthor":"Stahl M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"16","altmetricAuthors":["Maximilian Stahl","Martin S. Tallman"],"twitterCount":21,"altmetricId":64959062,"statusesArray":["1201059677104001025","1190761365373431808","1190733641892192257","1190723090487087104","1190648517037088768","1190635046639677440","1190624536401711104","1190578309819748353","1190573918471544832","1186378607368835072","1186088640184758272","1186047782702014465","1186026205318963202","1185992073222283267","1185945293122129920","1185911647975739393","1185910597797535744","1185909809406730240","1185646328061333510","1185549188114857984","1161744983818493954","1161587622457827328"]},{"title":"Investigation and management of a raised serum ferritin","googleId":"PZklDkTwZI0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15166","googleCitationCount":44,"googleAuthor":"","doi":"10.1111/bjh.15166","elsevierAuthor":"Cullis J.O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"30","altmetricAuthors":["Jonathan O. Cullis","Edward J. Fitzsimons","William JH Griffiths","Emmanouil Tsochatzis","D. Wayne Thomas"],"twitterCount":21,"altmetricId":40742057,"statusesArray":["1156643704934948864","1155905523079942144","1155785632188370944","1155647106515947527","1155636715832389638","1155107340380753920","1154282178571845632","1153880632948416512","1153849269310222339","1153750670450798592","1153729198906859521","1153703985783685120","1153587738559549446","1140271723729891333","1137026997379637248","1006739635249270784","1003387173272293377","1003334628135063552","1001152833377505280","998899519570960386","998827033949081600","998502803717939200","997593707300958209","992708365523607552"]},{"title":"Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma","googleId":"UwUOeJPcDcUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15969","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15969","elsevierAuthor":"Jakubowiak A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"20","altmetricAuthors":["Andrzej J. Jakubowiak","Jagoda K. Jasielec","Cara A. Rosenbaum","Craig E. Cole","Ajai Chari","Joseph Mikhael","Jennifer Nam","Amanda McIver","Erica Severson","Leonor A. Stephens","Kathryn Tinari","Shaun Rosebeck","Todd M. Zimmerman","Tyler Hycner","Agata Turowski","Theodore Karrison","Jeffrey A. Zonder"],"twitterCount":6,"altmetricId":61990534,"statusesArray":["1139922959877824513","1139567381083238400","1139498435571343364","1139093747575263232","1138971448935161857","1138836767224815617"]},{"title":"Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome","googleId":"6EQobXvz4MYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15267","googleCitationCount":43,"googleAuthor":"S Grupp","doi":"10.1111/bjh.15267","elsevierAuthor":"Kernan N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"36","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A guideline for the diagnosis and management of polycythaemia vera","googleId":"DyZf7D4rOSoJ","googleLink":"http://orca.cf.ac.uk/115831/1/PV%20Guideline%20revision%20accepted%20changes%202018.pdf","googleCitationCount":36,"googleAuthor":"MF McMullin","statusesArray":[]},{"title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS‐III) database","googleId":"7030I404NIAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15182","googleCitationCount":42,"googleAuthor":"RG Hauser","doi":"10.1111/bjh.15182","elsevierAuthor":"Karafin M.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"30","altmetricAuthors":["Matthew S. Karafin","Matt Westlake","Ronald G. Hauser","Christopher A. Tormey","Philip J. Norris","Nareg H. Roubinian","Yanyun Wu","Darrell J. Triulzi","Steve Kleinman","Jeanne E. Hendrickson"],"twitterCount":2,"altmetricId":43657799,"statusesArray":["1150944773555073024","1006831121072566274"]},{"title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib","googleId":"Z3ZaZYzPa10J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16088","googleCitationCount":27,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.16088","elsevierAuthor":"Castillo J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"19","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: a British Society for Haematology Guideline","googleId":"n-KQcYiAmmMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519221/","googleCitationCount":31,"googleAuthor":"MFF McMullin","doi":"10.1111/bjh.15647","elsevierAuthor":"McMullin M.F.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"21","altmetricAuthors":["Mary F. F. McMullin","Adam J. Mead","Sahra Ali","Catherine Cargo","Frederick Chen","Joanne Ewing","Mamta Garg","Anna Godfrey","Steven Knapper","Donal P. McLornan","Jyoti Nangalia","Mallika Sekhar","Frances Wadelin","Claire N. Harrison"],"twitterCount":33,"altmetricId":51245074,"statusesArray":["1158859422430650368","1139547304745197569","1139480746194800640","1139473541127168000","1139461396146589701","1138418005417832448","1138409749941276672","1138160833421291521","1138111820412141568","1137602549731737601","1137377558939557888","1137335097047343104","1137228014381670400","1137162215230853121","1137075428135505925","1137046665339293696","1137032287407738885","1137030277266628608","1137021638925594624","1137021412286369792","1131402241427083264","1125913314872238080","1125776558843727874","1117757425942171648","1117636897776361472","1117606483695407104","1117569521538281472","1110242609157554177","1084471305401884673","1084213961690615809","1083681063837282304","1067109854903496705","1063753308521811968","1063604706113658881","1063428094218903552","1063422208796700673","1063201064760078338"]},{"title":"MYD88 wild‐type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival","googleId":"VAquLaccLzIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15049","googleCitationCount":50,"googleAuthor":"","doi":"10.1111/bjh.15049","elsevierAuthor":"Treon S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"35","altmetricAuthors":["Steven P. Treon","Joshua Gustine","Lian Xu","Robert J. Manning","Nicholas Tsakmaklis","Maria Demos","Kirsten Meid","Maria L. Guerrera","Manit Munshi","Gloria Chan","Jiaji Chen","Amanda Kofides","Christopher J. Patterson","Guang Yang","Xia Liu","Patricia Severns","Toni Dubeau","Zachary R. Hunter","Jorge J. Castillo"],"twitterCount":20,"altmetricId":29781451,"statusesArray":["962725022824480769","962112478778986496","961627532763287553","961513705077919744","961391874903814152","961355215810293760","961343729444491264","961277814296186886","961253460233605121","958464591754866689","958315614963150848","958130527256633350","958111713844518913","958111695536377856","958087774674006018","957993646048997376","957974048952250369","957973587373240320","936702727043862528","936597003022118912","935858460817805313","935828108359462912","935534491438895104"]},{"title":"Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia","googleId":"FXsrHhqxFIAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15573","googleCitationCount":36,"googleAuthor":"W Jurczak","doi":"10.1111/bjh.15573","elsevierAuthor":"Jurczak W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"23","altmetricAuthors":["Wojciech Jurczak","Krzysztof Chojnowski","Jiří Mayer","Katarzyna Krawczyk","Brian D. Jamieson","Wei Tian","Lee F. Allen"],"twitterCount":3,"altmetricId":49946538,"statusesArray":["1173945117411086336","1053412389066960896","1053335202779578370"]},{"title":"A tale of two antibodies: obinutuzumab versus rituximab","googleId":"q1WzAERlgv0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15232","googleCitationCount":35,"googleAuthor":"","doi":"10.1111/bjh.15232","elsevierAuthor":"Freeman C.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"26","altmetricAuthors":["Ciara L. Freeman","Laurie H. Sehn"],"twitterCount":13,"altmetricId":41511556,"statusesArray":["1328306394622173186","1252745260230488064","1252608081453887489","1252607053761216513","1015821795352403968","1015807493191041024","1015176705017819136","996863783418105857","996815500989681664","996728598202548225","996633826658054144","996438101772861442","996434911534944262","996393333709819906"]},{"title":"Resistance to proteasome inhibitors and other targeted therapies in myeloma","googleId":"-xsXj8Bl2DoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15210","googleCitationCount":35,"googleAuthor":"CT Wallington‐Beddoe","doi":"10.1111/bjh.15210","elsevierAuthor":"Wallington-Beddoe C.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"29","altmetricAuthors":["Craig T. Wallington-Beddoe","Magdalena Sobieraj-Teague","Bryone J. Kuss","Stuart M. Pitson"],"twitterCount":7,"altmetricId":38935463,"statusesArray":["1015179846622826496","1015176591515750400","992534461295325184","989685125205016576","988847212913483776","988820867630206976","988416422664720389"]},{"title":"How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults","googleId":"L2H_zwzLuBEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15409","googleCitationCount":30,"googleAuthor":"","doi":"10.1111/bjh.15409","elsevierAuthor":"Grainger J.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"17","altmetricAuthors":["John D. Grainger","Jecko Thachil","Andrew M. Will"],"twitterCount":14,"altmetricId":46703377,"statusesArray":["1078730993715027969","1041014516115546113","1040167514226024448","1039568736511033348","1039292280560148481","1039269487546003456","1039264594760531968","1039264400413208578","1039261191993020417","1039244608906113025","1039230547653009408","1032583228736061441","1031596767857520640","1031180091328528385","1031155534009909248","1031138460776718337"]},{"title":"Advances in understanding the pathogenesis of red cell membrane disorders","googleId":"KdQ7s2vJk2gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16126","googleCitationCount":19,"googleAuthor":"A Iolascon","doi":"10.1111/bjh.16126","elsevierAuthor":"Iolascon A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions","googleId":"swroaLQwxJAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15778","googleCitationCount":25,"googleAuthor":"C Keane","doi":"10.1111/bjh.15778","elsevierAuthor":"Lees C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"15","altmetricAuthors":["Charlotte Lees","Colm Keane","Maher K. Gandhi","Jay Gunawardana"],"twitterCount":19,"altmetricId":55616364,"statusesArray":["1339449166364352515","1337740442239119360","1166050484689334272","1156913672104697856","1156804515619856385","1156713097379364866","1156650743870476288","1156637322688921601","1156622856761069568","1156622556826353665","1156621735644602368","1156618253764087809","1156612569639129089","1156575161014988804","1156571759447027714","1156530555522965504","1156480932133527552","1156462059841892352","1156453864557678592","1156387442267574272","1095277515483041792"]},{"title":"von Willebrand factor clearance–biological mechanisms and clinical significance","googleId":"Eq5XtzcXkV0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15565","googleCitationCount":27,"googleAuthor":"JM O'Sullivan","doi":"10.1111/bjh.15565","elsevierAuthor":"O'Sullivan J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"21","altmetricAuthors":["Jamie M. O'Sullivan","Soracha Ward","Michelle Lavin","James S. O'Donnell"],"twitterCount":20,"altmetricId":51785223,"statusesArray":["1069215232424271873","1068165306907017216","1068014133961023488","1067773146013544448","1067548143653404672","1067538998397214721","1067532444868534278","1067507615285084160","1067496927397326849","1067484195537252353","1067396576329564160","1067365074526965761","1067351532205760512","1067329415292641280","1067323202005798912","1067319626906968064","1067305475115491328","1067229765529026560","1067223390954565632","1067204903125336065"]},{"title":"How we diagnose and treat systemic mastocytosis in adults","googleId":"_cIsLvs7WvwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14967","googleCitationCount":41,"googleAuthor":"RM Scherber","doi":"10.1111/bjh.14967","elsevierAuthor":"Scherber R.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"21","altmetricAuthors":["Robyn M. Scherber","Uma Borate"],"twitterCount":2,"altmetricId":27647182,"statusesArray":["1138002886561079296","920992311802200064"]},{"title":"Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice","googleId":"TBzB4_ol0fMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15080","googleCitationCount":39,"googleAuthor":"JG Gribben","doi":"10.1111/bjh.15080","elsevierAuthor":"Gribben J.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"19","altmetricAuthors":["John G. Gribben","Francesc Bosch","Florence Cymbalista","Christian H. Geisler","Paolo Ghia","Peter Hillmen","Carol Moreno","Stephan Stilgenbauer"],"twitterCount":12,"altmetricId":31488481,"statusesArray":["1080781040015339520","966773036555952128","966648406201511937","966557319059460096","966551272986955776","966551148172804096","966537483176603648","953740578801504256","953712856213704704","953251726848643072","951861370433056768","950986968074252288"]},{"title":"Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study","googleId":"W9FS2cE_V2cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15946?af=R","googleCitationCount":24,"googleAuthor":"MV Mateos","doi":"10.1111/bjh.15946","elsevierAuthor":"Mateos M.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"21","altmetricAuthors":["Maria‐Victoria Mateos","Robert Z. Orlowski","Enrique M. Ocio","Paula Rodríguez‐Otero","Donna Reece","Philippe Moreau","Nikhil Munshi","David E. Avigan","David S. Siegel","Razi Ghori","Mohammed Z. H. Farooqui","Patricia Marinello","Jesus San-Miguel"],"twitterCount":2,"altmetricId":60690246,"statusesArray":["1151990692261945344","1130321759301906432"]},{"title":"Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib","googleId":"HkYA9hljBQAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15567","googleCitationCount":32,"googleAuthor":"P Jain","doi":"10.1111/bjh.15567","elsevierAuthor":"Jain P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"26","altmetricAuthors":["Preetesh Jain","Rashmi Kanagal-Shamanna","Shaojun Zhang","Makhdum Ahmed","Ahmad Ghorab","Liang Zhang","Chi Young Ok","Shaoying Li","Frederick Hagemeister","Dongfeng Zeng","Tiejun Gong","Wendy Chen","Maria Badillo","Krystle Nomie","Luis Fayad","Leonard J. Medeiros","Sattva Neelapu","Nathan Fowler","Jorge Romaguera","Richard Champlin","Linghua Wang","Michael L. Wang"],"twitterCount":25,"altmetricId":47662181,"statusesArray":["1055909598526242816","1046401457413607425","1046382802818813952","1046173822511185921","1046140977981751298","1046075283940560896","1046015736471334913","1045867045643005952","1045866049353207809","1041373047196975106","1037810553442521089","1037608644249116672","1037573770041614336","1037546689643601920","1037232446402715649","1037216777229541377","1037214398232842241","1037204606755983362","1037147099668725760","1037138522749247488","1037132448910520320","1037097262818762752","1037057912928194561","1037057241268928512","1036917935942578177"]},{"title":"How we manage patients with pyruvate kinase deficiency","googleId":"0a0ByzznOMUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15758","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15758","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"0","altmetricAuthors":["Rachael F. Grace","D. Mark Layton","Wilma Barcellini"],"twitterCount":11,"altmetricId":54559159,"statusesArray":["1362107812680245249","1352771036195008512","1326899058242428933","1299964811351072769","1299855610196963328","1277299073486372870","1277296967492808704","1261720579352256512","1110805617881567232","1109980391107104768","1095757061630111749","1092870945319108608","1092311633517559809","1092014193950314496","1092008113908129793","1091971732737609728","1091843447093383168","1091278621388533760","1091245977036619777","1091133818029989888","1090947167865487360","1090880845156675584","1090756592792936449","1090740971493617664","1089447554994135040"]},{"title":"Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer","googleId":"I-4aHx3R4tUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15906","googleCitationCount":21,"googleAuthor":"F Posch","doi":"10.1111/bjh.15906","elsevierAuthor":"Grilz E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"17","altmetricAuthors":["Ella Grilz","Lisa‐Marie Mauracher","Florian Posch","Oliver Königsbrügge","Sabine Zöchbauer‐Müller","Christine Marosi","Irene Lang","Ingrid Pabinger","Cihan Ay"],"twitterCount":10,"altmetricId":58856937,"statusesArray":["1208493348639690753","1207888436239056897","1207778578651332612","1116582374911856640","1116495490252775430","1116477054638153728","1116310049255768065","1116299877653336067","1116299267298201601","1116240294289268737"]},{"title":"Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials","googleId":"G-SWBdlaIwQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15421","googleCitationCount":32,"googleAuthor":"A Mato","doi":"10.1111/bjh.15421","elsevierAuthor":"Jones J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"23","altmetricAuthors":["Jeffrey Jones","Anthony Mato","Steven Coutre","John C. Byrd","Richard R. Furman","Peter Hillmen","Anders Osterborg","Constantine Tam","Stephan Stilgenbauer","William G. Wierda","Nyla A. Heerema","Karl Eckert","Fong Clow","Cathy Zhou","Alvina D. Chu","Danelle F. James","Susan M. O'Brien"],"twitterCount":10,"altmetricId":43396002,"statusesArray":["1056033189544701953","1032541322413056000","1032185935931351041","1032183361132003328","1004867448766488577","1004844936058015744","1004587940624896000","1004502183411363840","1004495691920617478","1004487653448962060"]},{"title":"A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP","googleId":"yluWXxRlVsgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15090","googleCitationCount":34,"googleAuthor":"","doi":"10.1111/bjh.15090","elsevierAuthor":"Rodeghiero F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"22","altmetricAuthors":["Francesco Rodeghiero"],"twitterCount":13,"altmetricId":33739063,"statusesArray":["1015310166366064640","1015234083084029953","998913726794420225","998913620263174144","991611853359976448","991274899862904833","991141134851338245","991067390396936192","991065318259863554","991062930073509889","973261605222920197","973201950878691329","968548451305902080","968532732350468098","968451262026043392"]},{"title":"Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia–a matched pair analysis by the Acute Leukaemia Working Party …","googleId":"J8j5oE8LWSEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15691","googleCitationCount":27,"googleAuthor":"M Labopin","doi":"10.1111/bjh.15691","elsevierAuthor":"Schmid C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"15","altmetricAuthors":["Christoph Schmid","Myriam Labopin","Nicolaas Schaap","Hendrik Veelken","Michael Schleuning","Michael Stadler","Juergen Finke","Erin Hurst","Frederic Baron","Olle Ringden","Gesine Bug","Didier Blaise","Johanna Tischer","Adrian Bloor","Jordi Esteve","Sebastian Giebel","Bipin Savani","Norbert-Claude Gorin","Fabio Ciceri","Mohamad Mohty","Arnon Nagler"],"twitterCount":2,"altmetricId":51772667,"statusesArray":["1072057173188984832","1067108673443516419"]},{"title":"Daratumumab proves safe and highly effective in AL amyloidosis","googleId":"w_luDgUN8nEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15455?af=R","googleCitationCount":32,"googleAuthor":"J Khouri","doi":"10.1111/bjh.15455","elsevierAuthor":"Khouri J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"25","altmetricAuthors":["Jack Khouri","Andrew Kin","Bicky Thapa","Frederic J. Reu","Naresh Bumma","Christy J. Samaras","Hien D. Liu","Mary A. Karam","Janice Reed","Saveta Mathur","Beth M. Faiman","Georgia Devries","Jeffrey Zonder","Jason Valent"],"twitterCount":15,"altmetricId":44154978,"statusesArray":["1059259251393159174","1014330771753095169","1014137618760654849","1013897420332326912","1013880942245679105","1013787026276089857","1013735521510678530","1013720347399606273","1013720156818890752","1013708490601324544","1013693492227379200","1013663661095874560","1013451538415652864","1013306850777837568","1013238728939143169","1011603220349751296","1011585520042819585","1011579599472320513"]},{"title":"Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in …","googleId":"2D5y6eLDYxMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15797","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15797","elsevierAuthor":"Chiu H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"13","altmetricAuthors":["Hsiling Chiu","Preeti Trisal","Chad Bjorklund","Soraya Carrancio","Estela G. Toraño","Carla Guarinos","Despoina Papazoglou","Patrick R. Hagner","Asma Beldi‐Ferchiou","Karin Tarte","Marie‐Hélène Delfau‐Larue","Franck Morschhauser","Alan G. Ramsay","Anita K. Gandhi"],"twitterCount":10,"altmetricId":55597275,"statusesArray":["1115918141140406272","1115703320117686272","1115395006565691397","1100108572363550721","1097748452857995265","1096772068601806848","1096764773646053376","1096757375439159299","1096747987609546755","1096726360683352069","1096726289950490624"]},{"title":"Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study","googleId":"9K00xgyLkU0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15806","googleCitationCount":23,"googleAuthor":"","doi":"10.1111/bjh.15806","elsevierAuthor":"Yimer H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"17","altmetricAuthors":["Habte Yimer","Jason Melear","Edward Faber","William I. Bensinger","John M. Burke","Mohit Narang","Don Stevens","Sriya Gunawardena","Yana Lutska","Keqin Qi","Jon Ukropec","Ming Qi","Thomas S. Lin","Robert M. Rifkin"],"twitterCount":3,"altmetricId":56414214,"statusesArray":["1119268907167244288","1119213265177972737","1102447449422086150"]},{"title":"R‐CHOP versus dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis","googleId":"gRT2KypGGTgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15051","googleCitationCount":36,"googleAuthor":"NN Shah","doi":"10.1111/bjh.15051","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"0","altmetricAuthors":["Nirav N. Shah","Aniko Szabo","Scott F. Huntington","Narendranath Epperla","Nishitha Reddy","Siddhartha Ganguly","Julie Vose","Cynthia Obiozor","Fahad Faruqi","Alexandra E. Kovach","Luciano J. Costa","Ana C. Xavier","Ryan Okal","Abraham S. Kanate","Nilanjan Ghosh","Mohamed A. Kharfan-Dabaja","Lauren Strelec","Mehdi Hamadani","Timothy S. Fenske","Oscar Calzada","Jonathon B. Cohen","Julio Chavez","Jakub Svoboda"],"twitterCount":35,"altmetricId":30678782,"statusesArray":["1296461688397537280","1225622096761491457","1225621264846532608","1225401044437553154","1225283911166693376","1225077893333766145","1076882296630857735","1076864500324696065","1076864315083423745","967005112328773633","966970403594932224","966967689691435008","966803160470818821","966778635641384967","966778610463006732","966075940190212098","965969401907437568","965964368331661314","961229235162578944","949947485425868800","949330372940222464","946155095565131777","946147909183115264","946010662014156800","945942585213882368","945930306133069826","945814209278787584","945634649874817024","945160040163536896","944974222484484098","944959739024281600","944869780670042112","944857417686364160","944783725694418944","944747405815271425","944668908610494464","944652981286457345","944646528274255872","944645219303215104","944644289169985536","944625005165514753","944615286409433088","944614287242399744","944596881342124032","943486410245459969","943261900023803904"]},{"title":"Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis","googleId":"Zpd9EA-uQ94J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14879?af=R","googleCitationCount":42,"googleAuthor":"AS Kanate","doi":"10.1111/bjh.14879","elsevierAuthor":"Kanate A.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"24","altmetricAuthors":["Abraham S. Kanate","Alyssa DiGilio","Kwang W. Ahn","Monzr Al Malki","Eric Jacobsen","Amir Steinberg","Nelson Hamerschlak","Mohamed Kharfan-Dabaja","Rachel Salit","Edward Ball","Qaiser Bashir","Amanda Cashen","Daniel Couriel","Jose Diez-Martin","Emmanuel Katsanis","Yulia Linhares","Shahram Mori","Richard Nash","Attaphol Pawarode","Miguel-Angel Perales","Colin D. Phipps","Carol Richman","Bipin N. Savani","Michael Y. Shapira","Patrick Stiff","Roger Strair","Timothy S. Fenske","Sonali M. Smith","Anna Sureda","Horatiu Olteanu","Mehdi Hamadani"],"twitterCount":16,"altmetricId":23460123,"statusesArray":["1069985249868824578","1042221812925562883","1042183296006987776","894558186950230016","894272977310765057","894195016071081985","894186135332716544","894104905182359552","894087536209002496","893947893513691136","893925579011051520","893872644013133824","893855943712280578","893855265065500672","893840785896083456","893790043931901952","893774550856499200"]},{"title":"Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma","googleId":"L2URzApl1oIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30467845/","googleCitationCount":26,"googleAuthor":"J Smith","statusesArray":[]},{"title":"How do we manage iron deficiency after blood donation?","googleId":"0LLpJ3rX6r8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15136","googleCitationCount":30,"googleAuthor":"","doi":"10.1111/bjh.15136","elsevierAuthor":"Kiss J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"21","altmetricAuthors":["Joseph E. Kiss","Ralph R. Vassallo"],"twitterCount":2,"altmetricId":41721341,"statusesArray":["1185565604020928512","996865229194752000"]},{"title":"Treatment of acute lymphoblastic leukaemia with the second generation of CD 19 CAR‐T containing either CD 28 or 4‐1 BB","googleId":"Lj5NfejB7HkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15195","googleCitationCount":34,"googleAuthor":"","doi":"10.1111/bjh.15195","elsevierAuthor":"Li S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"26","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Therapeutic use of regulatory T cells for graft‐versus‐host disease","googleId":"ww3UhFDZmKsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16157","googleCitationCount":16,"googleAuthor":"AY Rudensky","doi":"10.1111/bjh.16157","elsevierAuthor":"Elias S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"11","altmetricAuthors":["Shlomo Elias","Alexander Y. Rudensky"],"twitterCount":1,"altmetricId":65085005,"statusesArray":["1162644994454433792"]},{"title":"Therapeutic gene editing in haematological disorders with CRISPR/Cas9","googleId":"BKSIip-KpugJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15851","googleCitationCount":19,"googleAuthor":"RO Bak","doi":"10.1111/bjh.15851","elsevierAuthor":"Jensen T.I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"10","altmetricAuthors":["Trine I. Jensen","Esben Axelgaard","Rasmus O. Bak"],"twitterCount":5,"altmetricId":57014791,"statusesArray":["1112208248621289472","1109194854003666944","1106493787377946624","1106479707195953153","1106214047660294144"]},{"title":"Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group","googleId":"XDCWQFLEexEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15919","googleCitationCount":19,"googleAuthor":"TM Horton","doi":"10.1111/bjh.15919","elsevierAuthor":"Horton T.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"12","altmetricAuthors":["Terzah M. Horton","James A. Whitlock","Xiaomin Lu","Maureen M. O'Brien","Michael J. Borowitz","Meenakshi Devidas","Elizabeth A. Raetz","Patrick A. Brown","William L. Carroll","Stephen P. Hunger"],"twitterCount":2,"altmetricId":58767506,"statusesArray":["1118915913259081729","1115555065178263555"]},{"title":"Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects","googleId":"pU6IDLjIKkwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15108","googleCitationCount":34,"googleAuthor":"O Hershkovitz‐Rokah","doi":"10.1111/bjh.15108","elsevierAuthor":"Hershkovitz-Rokah O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"31","altmetricAuthors":["Oshrat Hershkovitz-Rokah","Dana Pulver","Georg Lenz","Ofer Shpilberg"],"twitterCount":5,"altmetricId":32144772,"statusesArray":["994568000962531328","992708165354606592","956264517670985730","956040970780504064","956038015691952134"]},{"title":"Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.","googleId":"AEBs4BS4AVUJ","googleLink":"https://europepmc.org/article/med/29732531","googleCitationCount":35,"googleAuthor":"","statusesArray":[]},{"title":"Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia","googleId":"S7gvSgd4wpwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15777","googleCitationCount":21,"googleAuthor":"S Chattopadhyay","doi":"10.1111/bjh.15777","elsevierAuthor":"Zheng G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"16","altmetricAuthors":["Guoqiao Zheng","Subhayan Chattopadhyay","Amit Sud","Kristina Sundquist","Jan Sundquist","Asta Försti","Richard Houlston","Akseli Hemminki","Kari Hemminki"],"twitterCount":17,"altmetricId":54890257,"statusesArray":["1280750404679106561","1113052703830224896","1112870526282862592","1112866325028798464","1112044669586804737","1111960913576374272","1111907006401662976","1111814946252185601","1111646670553518080","1111630559300734976","1092828939821694976","1092497416761339905","1092473717882527750","1092387923876552704","1092358269870456832","1092158624842113025","1092023635936755713","1091790183731773441"]},{"title":"A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study …","googleId":"4zUex9II_JMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14987","googleCitationCount":38,"googleAuthor":"A Spencer","doi":"10.1111/bjh.14987","elsevierAuthor":"Spencer A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"30","altmetricAuthors":["Andrew Spencer","Simon Harrison","Jeffrey Zonder","Ashraf Badros","Jacob Laubach","Krystal Bergin","Amit Khot","Todd Zimmerman","Dharminder Chauhan","Nancy Levin","Ann MacLaren","Steven D. Reich","Mohit Trikha","Paul Richardson"],"twitterCount":5,"altmetricId":28084324,"statusesArray":["970492949585854465","970451681325576193","970448532451753984","924665616967008256","924624356529115136","924621844292030465"]},{"title":"Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations","googleId":"hB2oucpLjIgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15721","googleCitationCount":26,"googleAuthor":"RJ Lin","doi":"10.1111/bjh.15721","elsevierAuthor":"Lin R.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"17","altmetricAuthors":["Richard J. Lin","Caleb Ho","Patrick D. Hilden","Juliet N. Barker","Sergio A. Giralt","Paul A. Hamlin","Ann A. Jakubowski","Hugo R. Castro‐Malaspina","Kevin S. Robinson","Esperanza B. Papadopoulos","Miguel‐Angel Perales","Craig S. Sauter"],"twitterCount":21,"altmetricId":52515198,"statusesArray":["1303471187033382912","1303470266622803971","1300067894320156672","1300046654729605126","1299756630591049728","1299750581163241472","1073095814283698177","1072898301480067081","1072670163542118401","1072653639884382210","1072638708866842624","1072632779135946753","1072628566540648448","1072622097103495168","1072604037768454144","1072603863465758720","1072589657962135555","1072589082688151553","1072579071878545414","1072574888152571911","1072559699839672325","1072550465643126787","1072547968547479556","1072545870837633024"]},{"title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach","googleId":"hD9Z8nw2Kt8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15813","googleCitationCount":20,"googleAuthor":"L Lieberman","doi":"10.1111/bjh.15813","elsevierAuthor":"Lieberman L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"15","altmetricAuthors":["Lani Lieberman","Andreas Greinacher","Michael F. Murphy","James Bussel","Tamam Bakchoul","Stacy Corke","Mette Kjaer","Jens Kjeldsen‐Kragh","Gerald Bertrand","Dick Oepkes","Jillian M. Baker","Heather Hume","Edwin Massey","Cécile Kaplan","Donald M. Arnold","Shoma Baidya","Greg Ryan","Helen Savoia","Denise Landry","Nadine Shehata"],"twitterCount":13,"altmetricId":56608907,"statusesArray":["1105558578583293952","1105471110089342976","1105456489081106432","1105396373531303936","1105394652147052544","1105368235313115137","1105364529087541249","1105353956560121856","1105339113484533761","1105277104663527429","1105261623961374720","1105244177212850185","1103379873576439809"]},{"title":"Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years","googleId":"9kiEGAbC9yQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16081","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.16081","elsevierAuthor":"Matsue K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"11","altmetricAuthors":["Kosei Matsue","Yoshiaki Abe","Kentaro Narita","Hiroki Kobayashi","Akihiro Kitadate","Masami Takeuchi","Daisuke Miura","Kengo Takeuchi"],"twitterCount":19,"altmetricId":63119746,"statusesArray":["1204895873219645440","1204890124795940864","1204843875061370881","1204839292549255168","1204820603838095360","1189336762902073346","1189332017021886464","1189297334657662977","1189117765539553280","1147517522352181249","1147264141125701634","1147252785286508544","1147227186061107200","1147218831603130368","1147202073232138240","1147201471080992769","1147201147201044482","1147198365387505665","1147198238992322561","1147197501130313728","1147197227745579008","1146849744716800000","1146720819973935104"]},{"title":"Diagnosis of Hodgkin lymphoma in the modern era","googleId":"Eb4ux9WDmZsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15614","googleCitationCount":24,"googleAuthor":"JP Balakrishna","doi":"10.1111/bjh.15614","elsevierAuthor":"Wang H.W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"15","altmetricAuthors":["Hao-Wei Wang","Jayalakshmi P. Balakrishna","Stefania Pittaluga","Elaine S. Jaffe"],"twitterCount":4,"altmetricId":51025120,"statusesArray":["1349792591336902657","1323738308992737280","1060870389042036736","1060849857869594624"]},{"title":"The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I","googleId":"ZNYyTq681h4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15817","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15817","elsevierAuthor":"Roy N.B.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"10","altmetricAuthors":["Noémi B. A. Roy","Christian Babbs"],"twitterCount":1,"altmetricId":56669237,"statusesArray":["1132127683477942272"]},{"title":"How we manage Gaucher Disease in the era of choices","googleId":"yS1bHCbgGoQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15402","googleCitationCount":27,"googleAuthor":"","doi":"10.1111/bjh.15402","elsevierAuthor":"Revel-Vilk S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"19","altmetricAuthors":["Shoshana Revel-Vilk","Jeff Szer","Atul Mehta","Ari Zimran"],"twitterCount":5,"altmetricId":43389529,"statusesArray":["1011674866490200064","1011614845089800192","1011507441866027008","1011467406907240448","1004453633927368704"]},{"title":"Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study","googleId":"gYW4wk3DJugJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15826","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15826","elsevierAuthor":"de Bruijn C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"12","altmetricAuthors":["Clara M. A. de Bruijn","Frédéric Millot","Meinolf Suttorp","Marina Borisevich","Paul Brons","Birgitte Lausen","Eveline S. J. M. de Bont"],"twitterCount":1,"altmetricId":56650152,"statusesArray":["1103665021844930561"]},{"title":"Clinical and genetic ancestry profile of a large multi‐centre sickle cell disease cohort in Brazil","googleId":"97v1h4jpmOAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15462","googleCitationCount":26,"googleAuthor":"","doi":"10.1111/bjh.15462","elsevierAuthor":"Carneiro-Proietti A.B.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"21","altmetricAuthors":["Anna B. F. Carneiro-Proietti","Shannon Kelly","Carolina Miranda Teixeira","Ester C. Sabino","Cecilia S. Alencar","Ligia Capuani","Tassila P. Salomon Silva","Aderson Araujo","Paula Loureiro","Cláudia Máximo","Clarisse Lobo","Miriam V. Flor-Park","Daniela O. W. Rodrigues","Rosimere A. Mota","Thelma T. Gonçalez","Carolyn Hoppe","João E. Ferreira","Mina Ozahata","Grier P. Page","Yuelong Guo","Liliana R. Preiss","Donald Brambilla","Michael P. Busch","Brian Custer"],"twitterCount":1,"altmetricId":45491722,"statusesArray":["1021871080544317442"]},{"title":"Clinical effectiveness and safety of erythropoietin‐stimulating agents for the treatment of low‐and intermediate‐1− risk myelodysplastic syndrome: a systematic …","googleId":"88ytR8ofm1EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15707","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15707","elsevierAuthor":"Park S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"13","altmetricAuthors":["Sophie Park","Peter Greenberg","Aylin Yucel","Caroline Farmer","Frank O'Neill","Cisio De Oliveira Brandao","Pierre Fenaux"],"twitterCount":4,"altmetricId":52682947,"statusesArray":["1074897431064702978","1074668418073268224","1074505463163686912","1073804522139590661"]},{"title":"Overall survival of children and adolescents with mature B cell non‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB …","googleId":"1SeB-9chOK8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15491","googleCitationCount":26,"googleAuthor":"","doi":"10.1111/bjh.15491","elsevierAuthor":"Cairo M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"21","altmetricAuthors":["Mitchell Cairo","Anne Auperin","Sherrie L. Perkins","Ross Pinkerton","Lauren Harrison","Stanton Goldman","Catherine Patte"],"twitterCount":0,"altmetricId":44895625,"statusesArray":[]},{"title":"Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCR inhibitor setting: a UK wide analysis","googleId":"-hyfXbRBb14J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15802","googleCitationCount":24,"googleAuthor":"TA Eyre","doi":"10.1111/bjh.15802","elsevierAuthor":"Eyre T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"16","altmetricAuthors":["Toby A. Eyre","Amy A. Kirkwood","Sat Gohill","George Follows","Renata Walewska","Harriet Walter","Matthew Cross","Francesco Forconi","Nimish Shah","Richard Chasty","Alistair Hart","Angus Broom","Helen Marr","Piers E. M. Patten","Andy Dann","Arvind Arumainathan","Tal Munir","Paneesha Shankara","Adrian Bloor","Rosalynd Johnston","Kim Orchard","Anna H. Schuh","Christopher P. Fox"],"twitterCount":18,"altmetricId":55547745,"statusesArray":["1170609615622561792","1170030977575530497","1169990138979659776","1169928453421969413","1127629402433626113","1126956404672270336","1097639877091434497","1097424298296389632","1096761552923959296","1096761291119693824","1096707093158084609","1096644091369189376","1096624612513857537","1096609416504320003","1096509472686727169","1096504818510761985","1096504470891044865","1096503583363616769","1096491493223817216","1096450533626466306","1096432157793361921","1096420701320474626","1096389814012784640","1096389693598588929"]},{"title":"Fetal haemoglobin induction in sickle cell disease","googleId":"fpMhNeLVCR0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15021","googleCitationCount":33,"googleAuthor":"A Paikari","doi":"10.1111/bjh.15021","elsevierAuthor":"Paikari A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"22","altmetricAuthors":["Alireza Paikari","Vivien A. Sheehan"],"twitterCount":0,"altmetricId":29416216,"statusesArray":[]},{"title":"Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain …","googleId":"Hi8c9CfaXC0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15251","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15251","elsevierAuthor":"Chiaretti S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"15","altmetricAuthors":["Sabina Chiaretti","Monica Messina","Sara Grammatico","Alfonso Piciocchi","Anna L. Fedullo","Filomena Di Giacomo","Nadia Peragine","Valentina Gianfelici","Alessia Lauretti","Rohan Bareja","Maria P. Martelli","Marco Vignetti","Valerio Apicella","Antonella Vitale","Loretta S. Li","Cyril Salek","Olivier Elemento","Giorgio Inghirami","David M. Weinstock","Anna Guarini","Robin Foà"],"twitterCount":1,"altmetricId":38987980,"statusesArray":["988523533146972160"]},{"title":"The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP‐BFM …","googleId":"NP1P753FBNsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15449","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15449","elsevierAuthor":"Paganin M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"17","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma","googleId":"uA5lgnLdqYMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15552","googleCitationCount":23,"googleAuthor":"S Assouline","doi":"10.1111/bjh.15552","elsevierAuthor":"Andorsky D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"19","altmetricAuthors":["David J. Andorsky","Kathryn S. Kolibaba","Sarit Assouline","Andres Forero‐Torres","Vicky Jones","Leonard M. Klein","Dipti Patel‐Donnelly","Mitchell Smith","Wei Ye","Wen Shi","Christopher A. Yasenchak","Jeff P. Sharman"],"twitterCount":3,"altmetricId":47857720,"statusesArray":["1038407194931343360","1038336061678739456","1037641721113452545"]},{"title":"Advances in understanding the molecular mechanisms that maintain normal haemostasis","googleId":"69izreRNPW0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15872","googleCitationCount":19,"googleAuthor":"JM O'Sullivan","doi":"10.1111/bjh.15872","elsevierAuthor":"O'Donnell J.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"9","altmetricAuthors":["James S. O'Donnell","Jamie M. O'Sullivan","Roger J. S. Preston"],"twitterCount":26,"altmetricId":58351674,"statusesArray":["1114914048775217152","1114511633592868866","1114241053593354240","1114194822355718145","1114063219998515200","1114056122623774720","1114025350881841152","1113985289498787840","1113969105705549824","1113891760021876738","1113874982336122880","1113869545305980928","1113868679127666688","1113851215870173184","1113832512600584192","1113789176720318465","1113751342303019008","1113751254063374336","1113750558190505984","1113741360975220737","1113739334925131777","1113738760259239936","1113737349811322880","1113734071232995328","1113733261950423040","1113732201701695488","1113079064590454786"]},{"title":"Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern","googleId":"-i8N25WH-kIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16096","googleCitationCount":16,"googleAuthor":"E Muchtar","doi":"10.1111/bjh.16096","elsevierAuthor":"Muchtar E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"12","altmetricAuthors":["Eli Muchtar","Morie A. Gertz","Martha Q. Lacy","Ronald S. Go","Francis K. Buadi","David Dingli","Martha Grogan","Omar F. AbouEzzeddine","Suzanne R. Hayman","Prashant Kapoor","Nelson Leung","Amie Fonder","Miriam Hobbs","Yi Lisa Hwa","Wilson Gonsalves","Rahma Warsame","Taxiarchis V. Kourelis","Stephen Russell","John A. Lust","Yi Lin","Steven Zeldenrust","Robert A. Kyle","S. Vincent Rajkumar","Shaji K. Kumar","Angela Dispenzieri"],"twitterCount":26,"altmetricId":63472465,"statusesArray":["1208393560250355713","1207829742445051904","1202086805769793537","1200085494383751170","1200020870573543424","1199931824455028736","1199782348553891843","1199750064509460482","1199734987488210944","1199729348061880320","1199728813611143170","1199692202495995904","1199691528781864960","1199691215526146048","1199689260602994688","1199687521636159489","1199570094310866944","1199522528798089218","1199464841628524544","1199452530171895809","1199440749189836802","1199415499559329792","1199414140818927617","1199354434301628416","1198078892088549376","1150074174406139907","1149720511158472704"]},{"title":"Venous thromboembolism in multiple myeloma–choice of prophylaxis, role of direct oral anticoagulants and special considerations","googleId":"VkJts3bFN1UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15684","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15684","elsevierAuthor":"Swan D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"13","altmetricAuthors":["Dawn Swan","Alberto Rocci","Charlotte Bradbury","Jecko Thachil"],"twitterCount":2,"altmetricId":51424578,"statusesArray":["1074326486167875584","1064620096805576704"]},{"title":"Advances in understanding the pathogenesis of graft‐versus‐host disease","googleId":"f_HpgFh1tyUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16190","googleCitationCount":12,"googleAuthor":"R Zeiser","doi":"10.1111/bjh.16190","elsevierAuthor":"Zeiser R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"5","altmetricAuthors":["Robert Zeiser"],"twitterCount":21,"altmetricId":67959992,"statusesArray":["1275664860379054082","1211708808520720384","1208900328843812865","1208742462895874048","1208370110790021121","1208361011939565568","1208323677009403904","1208265339802456064","1208259273542774784","1208256751088390145","1208247365628579843","1208226539709403136","1208140254194085889","1208137128955265027","1208136609910181888","1208104666099322881","1208094181681508353","1207948478208520192","1207921963794141184","1207913364896264192","1207894022406193153","1207891834594299904","1207829637293850624","1181480179471925253"]},{"title":"Minimal residual disease in non‐Hodgkin lymphoma–current applications and future directions","googleId":"z-HNC-LLop0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14996","googleCitationCount":28,"googleAuthor":"","doi":"10.1111/bjh.14996","elsevierAuthor":"Chase M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"12","altmetricAuthors":["Matthew L. Chase","Philippe Armand"],"twitterCount":3,"altmetricId":28021433,"statusesArray":["1042545470252281857","924218316981354497","923982716021899264"]},{"title":"Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma","googleId":"wU_ifpGrlxwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16069","googleCitationCount":16,"googleAuthor":"RW Birkinshaw","doi":"10.1111/bjh.16069","elsevierAuthor":"Blombery P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"11","altmetricAuthors":["Piers Blombery","Richard W. Birkinshaw","Tamia Nguyen","Jia‐nan Gong","Ella R. Thompson","Zhen Xu","David A. Westerman","Peter E. Czabotar","Michael Dickinson","David C.S. Huang","John F. Seymour","Andrew W. Roberts"],"twitterCount":3,"altmetricId":62662056,"statusesArray":["1144435748478881794","1144427196032987136","1143459447563591680"]},{"title":"Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma","googleId":"65IzsSdM76sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15394","googleCitationCount":22,"googleAuthor":"CC Hofmeister","doi":"10.1111/bjh.15394","elsevierAuthor":"Richardson P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"18","altmetricAuthors":["Paul G. Richardson","Craig C. Hofmeister","Cara A. Rosenbaum","Myo Htut","David H. Vesole","Jesus G. Berdeja","Michaela Liedtke","Ajai Chari","Stephen D. Smith","Daniel Lebovic","Noopur Raje","Catriona Byrne","Eileen Liao","Neeraj Gupta","Alessandra Di Bacco","Jose Estevam","Deborah Berg","Rachid Baz"],"twitterCount":8,"altmetricId":44158155,"statusesArray":["1014001464770007040","1013817427619143682","1013653410745159680","1013637274289033216","1013475640933339137","1013473330303766528","1013467270423744512","1011601818705592321"]},{"title":"Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art","googleId":"bGCTw_KXWVAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15404","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15404","elsevierAuthor":"Porcelijn L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"14","altmetricAuthors":["Leendert Porcelijn","Elly Huiskes","Gonda Oldert","Martin Schipperus","Jaap J. Zwaginga","Masja de Haas"],"twitterCount":3,"altmetricId":46165986,"statusesArray":["1028224254175834112","1026858499953836032","1026595679660138503"]},{"title":"What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies","googleId":"ry0JxHbmmJQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15004","googleCitationCount":28,"googleAuthor":"","doi":"10.1111/bjh.15004","elsevierAuthor":"Trégouët D.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"14","altmetricAuthors":["David-Alexandre Trégouët","Pierre-Emmanuel Morange"],"twitterCount":10,"altmetricId":32219201,"statusesArray":["1003382852325691392","1002142903525953536","981161710840176641","976160068860334080","974851125215051776","974667508027445248","974652098443915269","974618694897754113","974576010825031680","956696154619764736"]},{"title":"The use of direct oral anticoagulants in chronic kidney disease","googleId":"dHnfl45GGzgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15564","googleCitationCount":21,"googleAuthor":"","doi":"10.1111/bjh.15564","elsevierAuthor":"Parker K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"15","altmetricAuthors":["Kathrine Parker","Jecko Thachil"],"twitterCount":4,"altmetricId":50533158,"statusesArray":["1068153615892676608","1057861192687865856","1057861078107869184","1057628961386057729","1057627391000895488"]},{"title":"Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a …","googleId":"pDwAdXkqiRAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15803","googleCitationCount":15,"googleAuthor":"A Newland","doi":"10.1111/bjh.15803","elsevierAuthor":"Kuter D.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"12","altmetricAuthors":["David J. Kuter","Adrian Newland","Beng H. Chong","Francesco Rodeghiero","Monica T. Romero","Ingrid Pabinger","Yuqi Chen","Kejia Wang","Bhakti Mehta","Melissa Eisen"],"twitterCount":3,"altmetricId":56842773,"statusesArray":["1225470672379367424","1169959958538051585","1169958767540277249"]},{"title":"Management of post‐transplant lymphoproliferative disorders","googleId":"YORkoJZ1cXYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15263","googleCitationCount":24,"googleAuthor":"CB DeStefano","doi":"10.1111/bjh.15263","elsevierAuthor":"DeStefano C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"20","altmetricAuthors":["Christin B. DeStefano","Sanjal H. Desai","Aarthi G. Shenoy","Joseph P. Catlett"],"twitterCount":8,"altmetricId":41458620,"statusesArray":["1023320102337490951","1022110997316882432","1022007307557855236","1021997435005140992","1021991724674174976","1021991615462813696","1021698134957862913","996269668607422464"]},{"title":"Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network","googleId":"EQJ4sJQs9SEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15258","googleCitationCount":25,"googleAuthor":"M Federico","doi":"10.1111/bjh.15258","elsevierAuthor":"Federico M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"17","altmetricAuthors":["Massimo Federico","Monica Bellei","Luigi Marcheselli","Marc Schwartz","Martina Manni","Vittoria Tarantino","Stefano Pileri","Young-Hyeh Ko","Maria E. Cabrera","Steven Horwitz","Won S. Kim","Andrei Shustov","Francine M. Foss","Arnon Nagler","Kenneth Carson","Lauren C. Pinter-Brown","Silvia Montoto","Michele Spina","Tatyana A. Feldman","Mary J. Lechowicz","Sonali M. Smith","Frederick Lansigan","Raul Gabus","Julie M. Vose","Ranjana H. Advani"],"twitterCount":13,"altmetricId":38989307,"statusesArray":["990196611304251393","989589412462854146","989400993484935174","989177967887765505","988930530614931456","988760573067386880","988667749525282817","988574142218694656","988559060889894914","988530464163016709","988526496699609090","988526442349842432","988522654918496256"]},{"title":"Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival","googleId":"XI8AaQ_Uq3AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15749","googleCitationCount":18,"googleAuthor":"A Galleu","doi":"10.1111/bjh.15749","elsevierAuthor":"Galleu A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"16","altmetricAuthors":["Antonio Galleu","Dragana Milojkovic","Simona Deplano","Richard Szydlo","Sandra Loaiza","Robert Wynn","David I. Marks","Deborah Richardson","Kim Orchard","Edward Kanfer","Eleni Tholouli","Muhammad Saif","Ponni Sivaprakasam","Sarah Lawson","Adrian Bloor","Antonio Pagliuca","Victoria Potter","Varun Mehra","John A. Snowden","Ajay Vora","Bhuvan Kishore","Hannah Hunter","Jane F. Apperley","Francesco Dazzi"],"twitterCount":6,"altmetricId":53903691,"statusesArray":["1090707108448911372","1086412505767968768","1085768519399071745","1084816805624008704","1084746530224041985","1084735918622289920"]},{"title":"Neonatal leukaemia","googleId":"cWakSjIjBbMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15246","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15246","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"0","altmetricAuthors":["Irene Roberts","Nicholas J. Fordham","Anupama Rao","Barbara J. Bain"],"twitterCount":4,"altmetricId":43584734,"statusesArray":["1019290492712955904","1006662881629429760","1006142157802090501","1006110793002348544"]},{"title":"Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease","googleId":"BS0mH8WBPvcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27711968/","googleCitationCount":38,"googleAuthor":"","statusesArray":[]},{"title":"SMAC mimetics as potential cancer therapeutics in myeloid malignancies","googleId":"LVa_8ECDQx4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15829","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15829","elsevierAuthor":"Boddu P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"11","altmetricAuthors":["Prajwal Boddu","Bing Z. Carter","Srdan Verstovsek","Naveen Pemmaraju"],"twitterCount":27,"altmetricId":56548242,"statusesArray":["1314956727037632513","1314953598426546176","1314916480195219456","1314915971291926529","1248068880939069440","1248051882175737857","1247942691016638467","1237952188456013824","1236532687109677056","1236430220456087552","1236355195887640587","1236350330855657472","1236350255983136768","1234490408773791746","1234481462013022209","1234479898300780544","1224944964829884416","1223306906288214018","1223297585412104192","1223256721889558528","1223080416787214337","1223078519640666114","1223077805338001408","1190672041143341070","1190602981600825345","1190597891162824704","1173579126575435778","1173579033696714757","1166492629959401472","1159277163222355969","1159243155566235649","1155269306646745089","1155250191886356480","1152194981014249472","1152184917029216256","1138095212637630465","1137197541991288832","1137098233375875077","1136828155447128070","1136826855380717569","1136793513922744325","1133217911978504192","1132782620344016897","1132617583058968577","1126187291485982720","1126187179628290049","1124285830309216257","1124119128783060992","1117790576974364679","1117766062618103808","1116118432850808833","1116065290016706561","1116064600187916289","1114220942648070145","1114175875002580992","1114170759646150656","1114148877098156032","1114133846566608896","1110739563708858373","1110561652880171010","1110484346505478145","1107418700003639296","1105907708144877569","1105127485052805121","1103744422523613184","1103744064443371520","1103743996940050432","1103694176313659393","1103404708809633802","1103403138055192578","1103396930900688896","1103393700921700361","1103382209266925568","1103382034163081216","1103362039286849537","1103327494613225472","1103320984843706368","1103316976087240704","1103310650879758336","1103306612402515968","1103306333141561350","1103282365256921088","1103257127399968768"]},{"title":"Current use of monoclonal antibodies in the treatment of multiple myeloma","googleId":"JZXbpjeiLFkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15121","googleCitationCount":25,"googleAuthor":"IM Ghobrial","doi":"10.1111/bjh.15121","elsevierAuthor":"Varga C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"20","altmetricAuthors":["Cindy Varga","Michelle Maglio","Irene M. Ghobrial","Paul G. Richardson"],"twitterCount":2,"altmetricId":42328799,"statusesArray":["999393758851616769","998870788517265409"]},{"title":"How I treat children with haemophilia and inhibitors","googleId":"HDPE2q3jZksJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15942","googleCitationCount":16,"googleAuthor":"","doi":"10.1111/bjh.15942","elsevierAuthor":"Young G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"11","altmetricAuthors":["Guy Young"],"twitterCount":4,"altmetricId":63872164,"statusesArray":["1153734569075589126","1153289951506812928","1153272039500865536","1153250587124928512"]},{"title":"Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)","googleId":"c2QB25_GhlkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15411","googleCitationCount":28,"googleAuthor":"P Jain","doi":"10.1111/bjh.15411","elsevierAuthor":"Jain P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"22","altmetricAuthors":["Preetesh Jain","Jorge Romaguera","Samer A. Srour","Hun J. Lee","Frederick Hagemeister","Jason Westin","Luis Fayad","Felipe Samaniego","Maria Badillo","Liang Zhang","Lorreta Nastoupil","Rashmi Kanagal-Shamanna","Nathan Fowler","Michael L. Wang"],"twitterCount":2,"altmetricId":43080607,"statusesArray":["1137298450750615552","1002276026385387520"]},{"title":"Molecular detection of minimal residual disease in multiple myeloma","googleId":"czjRW2DxfIMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15075","googleCitationCount":26,"googleAuthor":"Y Bai","doi":"10.1111/bjh.15075","elsevierAuthor":"Bai Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"13","altmetricAuthors":["Yinlei Bai","Alberto Orfao","Chor Sang Chim"],"twitterCount":2,"altmetricId":30678833,"statusesArray":["943296932029587456","943262266450960384"]},{"title":"Advances in understanding iron metabolism and its crosstalk with erythropoiesis","googleId":"SV5n734OkhQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15403","googleCitationCount":22,"googleAuthor":"","doi":"10.1111/bjh.15403","elsevierAuthor":"Camaschella C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"14","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Recent advances in developing specific therapies for haemophilia","googleId":"Qe0aqURrMgUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15084","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.15084","elsevierAuthor":"Ling G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"14","altmetricAuthors":["Gavin Ling","Amit C. Nathwani","Edward G. D. Tuddenham"],"twitterCount":2,"altmetricId":40229008,"statusesArray":["1088444793389146117","991055018789875712"]},{"title":"Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study","googleId":"76wlA8E8ay4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15384","googleCitationCount":23,"googleAuthor":"","doi":"10.1111/bjh.15384","elsevierAuthor":"Jagannath S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"17","altmetricAuthors":["Sundar Jagannath","Jacob Laubach","Ellice Wong","Keith Stockerl-Goldstein","Cara Rosenbaum","Madhav Dhodapkar","Ying-Ming Jou","Mark Lynch","Michael Robbins","Suresh Shelat","Kenneth C. Anderson","Paul G. Richardson"],"twitterCount":6,"altmetricId":43015133,"statusesArray":["1019700077361803271","1019699344952516608","1019688260912607232","1001944145827713024","1001944136059146242","1001939936319279104","1001939933131689984","1001939247824285700","1001938817333506049","1001803757850636290"]},{"title":"Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial","googleId":"nWGz5Smk-FcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15843","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15843","elsevierAuthor":"Becnel M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"13","altmetricAuthors":["Melody R. Becnel","Loretta J. Nastoupil","Felipe Samaniego","Richard E. Davis","M. J. You","Michael Green","Fredrick B. Hagemeister","Michelle A. Fanale","Luis E. Fayad","Jason R. Westin","Michael Wang","Yasuhiro Oki","Sheryl G. Forbes","Lei Feng","Sattva S. Neelapu","Nathan H. Fowler"],"twitterCount":14,"altmetricId":58039447,"statusesArray":["1271745039169810434","1173256590599831554","1173189867569893382","1112058705556766720","1111902679335358464","1111791760529936387","1111756184846061568","1111731264011292675","1111696247600173057","1111692441537531904","1111685491370295296","1111671120661528576","1111649150901407745","1111645773727522817","1111631082443718658","1111569200613654528"]},{"title":"How I manage children with Diamond‐Blackfan anaemia","googleId":"Dp3T8t5gzQ4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15701","googleCitationCount":16,"googleAuthor":"M Bierings","doi":"10.1111/bjh.15701","elsevierAuthor":"Bartels M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"7","altmetricAuthors":["Marije Bartels","Marc Bierings"],"twitterCount":1,"altmetricId":52310667,"statusesArray":["1070915723164299264"]},{"title":"A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders","googleId":"wGDyGkgGnCkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16111","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16111","elsevierAuthor":"Nogami K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Advances in understanding the molecular mechanisms of venous thrombosis","googleId":"VcYrWC2nozUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15869","googleCitationCount":13,"googleAuthor":"RJS Preston","doi":"10.1111/bjh.15869","elsevierAuthor":"Preston R.J.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"5","altmetricAuthors":["Roger J. S. Preston","Jamie M. O'Sullivan","James S. O'Donnell"],"twitterCount":21,"altmetricId":58031690,"statusesArray":["1273227908299907073","1111972449208291329","1111896761868537856","1111765344354553856","1111725624522084352","1111722792351784960","1111708461828575232","1111664436702523392","1111661865581662211","1111658451904663552","1111651557324587008","1111649989237882882","1111644693903917057","1111636060138860545","1111625778196824064","1111624235837984769","1111620803366395904","1111615397214781441","1111614245073051653","1111609247513669632","1111605463630655489"]},{"title":"Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery","googleId":"Fu6FQCFt0KkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15902","googleCitationCount":13,"googleAuthor":"VM Dominical","doi":"10.1111/bjh.15902","elsevierAuthor":"Leonard A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"7","altmetricAuthors":["Alexis Leonard","Aylin Bonifacino","Venina M. Dominical","Min Luo","Juan J. Haro‐Mora","Selami Demirci","Naoya Uchida","Francis J. Pierciey","John F. Tisdale"],"twitterCount":9,"altmetricId":58968363,"statusesArray":["1117064998696771585","1116834080451117057","1116746811832766465","1116710500849602571","1116686988848128000","1116685098500395008","1116679847764463616","1116679075391787008","1116677819105468416"]},{"title":"Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita","googleId":"ItRtOpoX4BQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15495","googleCitationCount":24,"googleAuthor":"S Iacobelli","doi":"10.1111/bjh.15495","elsevierAuthor":"Fioredda F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"17","altmetricAuthors":["Francesca Fioredda","Simona Iacobelli","Elisabeth T. Korthof","Cora Knol","Anja van Biezen","Dorine Bresters","Paul Veys","Ayami Yoshimi","Franca Fagioli","Brune Mats","Marco Zecca","Maura Faraci","Maurizio Miano","Luca Arcuri","Michael Maschan","Tracey O'Brien","Miguel A. Diaz","Julian Sevilla","Owen Smith","Regis Peffault de Latour","Josue de la Fuente","Reuven Or","Maria T. Van Lint","Jakub Tolar","Mahmoud Aljurf","Alain Fisher","Elena V. Skorobogatova","Cristina Diaz de Heredia","Antonio Risitano","Jean-Hugues Dalle","Petr Sedláček","Ardeshir Ghavamzadeh","Carlo Dufour"],"twitterCount":5,"altmetricId":44764274,"statusesArray":["1022480081116114945","1021845010592002054","1016785600186286083","1016634158758617088","1016624099404046336"]},{"title":"Romiplostim for the management of perioperative thrombocytopenia","googleId":"cYBkGj72ltAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15280","googleCitationCount":24,"googleAuthor":"H Al‐Samkari","doi":"10.1111/bjh.15280","elsevierAuthor":"Al-Samkari H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"16","altmetricAuthors":["Hanny Al-Samkari","Ariela L. Marshall","Katayoon Goodarzi","David J. Kuter"],"twitterCount":1,"altmetricId":42258165,"statusesArray":["998678131107024896"]},{"title":"Developing role of B cells in the pathogenesis and treatment of chronic GVHD","googleId":"ou9NVQKrkNMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15719","googleCitationCount":16,"googleAuthor":"","doi":"10.1111/bjh.15719","elsevierAuthor":"Li X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"9","altmetricAuthors":["Xiaoping Li","Qiangguo Gao","Yimei Feng","Xi Zhang"],"twitterCount":8,"altmetricId":53265288,"statusesArray":["1088225271801466882","1085542306424516608","1085454392155926529","1085453069838630913","1084987798304817152","1084546739892310017","1084436846388695041","1084397334300160000","1084236850997481479","1079012246544703488"]},{"title":"Venetoclax and hypomethylating agents in TP53‐mutated acute myeloid leukaemia","googleId":"R7P2EJ8jCgsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16166","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.16166","elsevierAuthor":"Aldoss I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"9","altmetricAuthors":["Ibrahim Aldoss","Jianying Zhang","Raju Pillai","Geoffrey Shouse","James F. Sanchez","Matthew Mei","Ryotaro Nakamura","Anthony S. Stein","Stephen J. Forman","Guido Marcucci","Vinod Pullarkat"],"twitterCount":1,"altmetricId":65368034,"statusesArray":["1164982332480204800"]},{"title":"The Di PEP (Diagnosis of PE in Pregnancy) biomarker study: An observational cohort study augmented with additional cases to determine the diagnostic utility of …","googleId":"jkA6YNIXUYwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15102","googleCitationCount":26,"googleAuthor":"","doi":"10.1111/bjh.15102","elsevierAuthor":"Hunt B.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"19","altmetricAuthors":["Beverley J Hunt","Kiran Parmar","Kimberley Horspool","Neil Shephard","Catherine Nelson-Piercy","Steve Goodacre"],"twitterCount":187,"altmetricId":32155012,"statusesArray":["1161192132406734848","1054857161908649985","1054178229253095424","1043061074050904064","1030350040143998976","1010661767083646977","999208738543341568","998422553428414464","997576479600005121","997363775505387520","996060678124376064","996059136960946176","996040638448664581","995969620535336961","995959380624510981","995935032924622848","995737808886222849","995708306890084352","995696015637405700","995636445942550529","995631153209073664","995601053872742405","995597017870229504","995596415438028805","995593087576616961","995583750519099393","995577962056638464","995570910299029504","995570908793397248","995564841313202177","995474652414857216","995445866185068544","995434494399270912","995420151305719811","995406289390927872","995405286683873286","995403258540756995","995394492751646720","995392452071690241","995383412390318081","995367843213475841","995366491171315718","995362901534937090","995346784527450113","995340845946671105","995328992013111296","995321863294410752","995312553369722881","995303804068352000","995297088425594880","995296439361261573","995295356010180608","995286338957119493","995285420635250689","995280322928500736","995198520796893184","980574320207409152","980426771064606720","980300065267855360","980290408868556800","980286477165764610","962041526074294272","962033746093293568","962032010377150464","962031809860067329","961584403930648577","960621473651154945","960239146089484288","960164542964817920","959709086404300800","959353831481135104","958750501612507140","958749426595622912","958425640742588416","958402202686586881","958401959442173954","958397210470862848","958396957004849152","958396221122600960","958396220824748039","958031275264225280","958029606778437632","957975074656673792","957754794617303045","957747164997828608","957714109482577920","957481377678544897","957446418775531520","957424259881754625","957353559280050178","957350183217565696","957325274194022402","957269672877051904","957244590087720960","957242773421395968","957239603353747457","957229918148014080","957214681713795072","957213406901260288","957209348710780929","957203354903433216","957194338869628928","957190270201815040","957190218272116738","957181742217035776","957181058801455104","957180985367515136","957173692370444288","957171837112332288","957170049458102273","957169831383568385","957167178004008966","957164688139317248","957150439010643968","957143601829462016","957135266254241793","957120218438029317","957120064435650560","957116699026776065","957100868167401472","957094721960079361","957088909233664000","957088899783843840","957074942759022592","957066420445065217","957043504546394113","957039626367262720","957036748680450049","957036477262819329","957034487115862018","957031786487341056","957030460252672001","957027182991368193","957026454616854528","957024015209680901","957022034273492992","957021990057017349","957021914341535744","957020827370827783","957020371110293504","957019726433210368","957019340628549632","957019244583161856","957018088578351105","957017620951248897","957016964152680454","957010795879018496","957009302883065856","957008939081719809","957006215141306373","957000629532217344","957000137322229762","956998405229875200","956997578670952448","956997095000629253","956996692972331008","956994649931083783","956994498961334272","956992205796859904","956987750418407424","956973539638292481","956969171073585164","956967357959888896","956964875707789313","956964407401164802","956963793019564040","956916745238908928","956907980099760128","956897466451869701","956885798254596102","956879488201011200","956832813663350786","956822250921037824","956812321908822016","956804132018577408","956797154730921984","956796393733095424","956796182008946688","956794001356738560","956793363382128640","956788318817128449","956784413773324288","956642578409062402","956637721312755713","956632045844881409","956601720766943232","956591689086496768","956584693511671808","956574260058906624","956573775763406848","956549973998530560","956547454450782208","956536095382081536","956528202163335168","956524435049246720","956524209013915648","956520304829980672","956519063835918336","956516963659976706","956516008692416512"]},{"title":"Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis","googleId":"zgvnW5_x7WoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15832","googleCitationCount":14,"googleAuthor":"S Sidana","doi":"10.1111/bjh.15832","elsevierAuthor":"Sidana S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7","altmetricAuthors":["Surbhi Sidana","Nidhi Tandon","Morie A. Gertz","Angela Dispenzieri","Marina Ramirez‐Alvarado","David L. Murray","Taxiarchis V. Kourelis","Francis K. Buadi","Prashant Kapoor","Wilson Gonsalves","Rahma Warsame","Martha Q. Lacy","Robert A. Kyle","S. Vincent Rajkumar","Shaji K. Kumar","Nelson Leung"],"twitterCount":3,"altmetricId":56548530,"statusesArray":["1111586891772633088","1111580604741627904","1103259062286704641"]},{"title":"Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities","googleId":"LbVoByk3EYUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15793","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15793","elsevierAuthor":"Burkhardt B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"9","altmetricAuthors":["Birgit Burkhardt","Michelle L. Hermiston"],"twitterCount":2,"altmetricId":56161491,"statusesArray":["1101075064726962177","1100987418021380096"]},{"title":"Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy","googleId":"ODEQOcplZKEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16122","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16122","elsevierAuthor":"Manwani R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"11","altmetricAuthors":["Richa Manwani","Shameem Mahmood","Sajitha Sachchithanantham","Helen J. Lachmann","Julian D. Gillmore","Kwee Yong","Neil Rabin","Rakesh Popat","Charalampia Kyriakou","Sarah Worthington","Faye Sharpley","Mark Smith","Raakhee Shah","Simon Cheesman","Philip N. Hawkins","Ashutosh D. Wechalekar"],"twitterCount":7,"altmetricId":64722347,"statusesArray":["1198094593452953600","1160704685113827328","1159789717313019904","1159758753169858560","1159633165377519616","1159593321976795136","1159457844393140227","1159453014673022976"]},{"title":"Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease","googleId":"UOWRdWmyk3sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15063?af=R","googleCitationCount":26,"googleAuthor":"","doi":"10.1111/bjh.15063","elsevierAuthor":"Małecka A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"18","altmetricAuthors":["Agnieszka Małecka","Gunhild Trøen","Anne Tierens","Ingunn Østlie","Jędrzej Małecki","Ulla Randen","Junbai Wang","Sigbjørn Berentsen","Geir E. Tjønnfjord","Jan M. A. Delabie"],"twitterCount":1,"altmetricId":30682370,"statusesArray":["943296902623358977"]},{"title":"Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study","googleId":"y88RW6nIpHYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15641","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15641","elsevierAuthor":"Iannitto E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"14","altmetricAuthors":["Emilio Iannitto","Monica Bellei","Sandy Amorim","Andrés J. M. Ferreri","Luigi Marcheselli","Marina Cesaretti","Corinne Haioun","Salvatrice Mancuso","Krimo Bouabdallah","Remy Gressin","Claudio Tripodo","Alexandra Traverse‐Glehen","Lucile Baseggio","Simonetta Zupo","Caterina Stelitano","Barbara Castagnari","Caterina Patti","Isabel Alvarez","Anna Marina Liberati","Michele Merli","Guido Gini","Maria Giuseppina Cabras","Jean Dupuis","Benoit Tessoulin","Aurore Perrot","Francesca Re","Francesca Palombi","Alessandro Gulino","Emanuele Zucca","Massimo Federico","Catherine Thieblemont"],"twitterCount":7,"altmetricId":51081990,"statusesArray":["1215487365235531779","1075008058827399168","1074968548177530882","1074965569743544320","1061868714994192385","1061864079709499392","1061863596739649537","1060890172349280257","1060849871559766016"]},{"title":"The absolute percent deviation of IGHV mutation rather than a 98% cut‐off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine …","googleId":"LUcKQVaJPPYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15018","googleCitationCount":26,"googleAuthor":"P Jain","doi":"10.1111/bjh.15018","elsevierAuthor":"Jain P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"17","altmetricAuthors":["Preetesh Jain","Graciela M. Nogueras González","Rashmi Kanagal-Shamanna","Uri Rozovski","Nawid Sarwari","Constantine Tam","William G. Wierda","Philip A. Thompson","Nitin Jain","Rajyalakshmi Luthra","Andres Quesada","Gabriela Sanchez-Petitto","Alessandra Ferrajoli","Jan Burger","Hagop Kantarjian","Jorge Cortes","Susan O'Brien","Michael J. Keating","Zeev Estrov"],"twitterCount":3,"altmetricId":29252969,"statusesArray":["933342806231474176","933219211706474498","933215425273282560"]},{"title":"How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy","googleId":"4rSvyBzQL-AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14973","googleCitationCount":25,"googleAuthor":"","doi":"10.1111/bjh.14973","elsevierAuthor":"Rea D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"20","altmetricAuthors":["Delphine Rea","François-Xavier Mahon"],"twitterCount":4,"altmetricId":27647099,"statusesArray":["926033679671087105","921721189785067521","921316329847635968","920991712578641920"]},{"title":"How I manage patients with Wiskott Aldrich syndrome","googleId":"yT8O409qjF8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15831","googleCitationCount":15,"googleAuthor":"A Worth","doi":"10.1111/bjh.15831","elsevierAuthor":"Rivers E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7","altmetricAuthors":["Elizabeth Rivers","Austen Worth","Adrian J. Thrasher","Siobhan O. Burns"],"twitterCount":4,"altmetricId":57352427,"statusesArray":["1258432628920692739","1127629665403920385","1126956219854405632","1108376851314036737"]},{"title":"Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding","googleId":"S5XUwpt-L0oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15705","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.15705","elsevierAuthor":"Arachchillage D.R.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"14","altmetricAuthors":["Deepa R. J. Arachchillage","Sharon Alavian","Jessica Griffin","Kamala Gurung","Richard Szydlo","Nilanthi Karawitage","Mike Laffan"],"twitterCount":73,"altmetricId":52693744,"statusesArray":["1221858885864239105","1221501921514618882","1220652160368697344","1219286554809720832","1219263821715595271","1219231393156231170","1219217727140913152","1219187631835308032","1219181963644325888","1219165971795128320","1219151573667811329","1219021249369780224","1219000791450759169","1218994867529048064","1218976625217458176","1218939644986957826","1218925250437689344","1218921532996628480","1113907136923357190","1096034794746589184","1079837059014148096","1079836940143390722","1075338888967798784","1075304354637336587","1075093022617100289","1074981068674088960","1074747542150176774","1074711053647470592","1074702192442007552","1074699179992248321","1074696120037752833","1074689573735854082","1074673069489356800","1074670491753988096","1074657830853066752","1074651834722250753","1074628852595482624","1074608755772407808","1074554875592220672","1074537285784354816","1074442187016949760","1074440508284514304","1074421211713564672","1074420068581294080","1074415700796678146","1074408948550328320","1074406468428926977","1074393314315517952","1074390632720990208","1074390127118561280","1074389308952461312","1074374696341262341","1074372477487341573","1074362271088996353","1074357621602336768","1074356779591524353","1074356577392484352","1074349439274369024","1074315357890830336","1074315299418185728","1074313608086065152","1074313518260912128","1074244204610633728","1074244062566330368","1074235073329803264","1074194868090650624","1074189592981581825","1074098128649777152","1074097872390508546","1074065254391402496","1074054779582799874","1074006810888151042","1073966906917437440","1073953029324464129","1073951951350587392","1073922390550372358","1073898423210991616","1073893217555369987","1073892766508142593","1073891820390809602"]},{"title":"How i treat primary haemophagocytic lymphohistiocytosis","googleId":"gw-qD14v5ZIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15274","googleCitationCount":24,"googleAuthor":"E Haddad","doi":"10.1111/bjh.15274","elsevierAuthor":"Marsh R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"14","altmetricAuthors":["Rebecca A. Marsh","Elie Haddad"],"twitterCount":4,"altmetricId":41785732,"statusesArray":["999459980418928640","997152146855522306","997073964034809856","997055176316989440"]},{"title":"Progress in the monitoring of direct oral anticoagulant therapy","googleId":"p1xKk7m7mHsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15756","googleCitationCount":14,"googleAuthor":"JP Patel","doi":"10.1111/bjh.15756","elsevierAuthor":"Patel J.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"11","altmetricAuthors":["Jignesh P. Patel","Rosalind A. Byrne","Raj K. Patel","Roopen Arya"],"twitterCount":34,"altmetricId":54702567,"statusesArray":["1106440063095853056","1103791555771551746","1092453910067974144","1092342069446746112","1091689647741300738","1091419414875066368","1091361657547358209","1091324123790364672","1091262511066873857","1091231691098783744","1091165602914463744","1091104036479225857","1091037217580027906","1091021768842756103","1091021239794188289","1090921714752647168","1090878093584203777","1090862448125661184","1090855072999841792","1090792436299939841","1090781500574814209","1090762691449368577","1090751482578780166","1090748713914564608","1090732429437009921","1090729950645309443","1090677434528223233","1090677098581278720","1090673328904380418","1090633461482905603","1090627607186599936","1090622606615764993","1090610282840367104","1090610133523152897"]},{"title":"Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome","googleId":"CQnxJBt3igkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16083","googleCitationCount":12,"googleAuthor":"P Rousselot","doi":"10.1111/bjh.16083","elsevierAuthor":"Berger M.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma","googleId":"HolC--MR0dMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15116","googleCitationCount":22,"googleAuthor":"","doi":"10.1111/bjh.15116","elsevierAuthor":"Varga C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"14","altmetricAuthors":["Cindy Varga","Jacob P. Laubach","Kenneth C. Anderson","Paul G. Richardson"],"twitterCount":2,"altmetricId":41610949,"statusesArray":["998870550478032896","996657549003943938"]},{"title":"Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the …","googleId":"KHvm1kqWYLkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15970","googleCitationCount":14,"googleAuthor":"DC Roy","doi":"10.1111/bjh.15970","elsevierAuthor":"Roy D.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"11","altmetricAuthors":["Denis Claude Roy","Sylvie Lachance","Sandra Cohen","Jean‐Sébastien Delisle","Thomas Kiss","Guy Sauvageau","Lambert Busque","Imran Ahmad","Lea Bernard","Nadia Bambace","Radia S. Boumédine","Marie‐Claude Guertin","Katayoun Rezvani","Stephan Mielke","Claude Perreault","Jean Roy"],"twitterCount":0,"altmetricId":66847881,"statusesArray":[]},{"title":"The treatment of older Hodgkin lymphoma patients","googleId":"KCyO48EdYjoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15652","googleCitationCount":16,"googleAuthor":"","doi":"10.1111/bjh.15652","elsevierAuthor":"Böll B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6","altmetricAuthors":["Boris Böll","Helen Görgen"],"twitterCount":2,"altmetricId":51025456,"statusesArray":["1060875804668764160","1060849868237869056"]},{"title":"Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL‐SCT 2003/2007 trial","googleId":"A_96B_Cw8OcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14965","googleCitationCount":23,"googleAuthor":"AM Willasch","doi":"10.1111/bjh.14965","elsevierAuthor":"Kuhlen M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"16","altmetricAuthors":["Michaela Kuhlen","Andre M. Willasch","Jean-Hugues Dalle","Jacek Wachowiak","Isaac Yaniv","Marianne Ifversen","Petr Sedlacek","Tayfun Guengoer","Peter Lang","Peter Bader","Sabina Sufliarska","Adriana Balduzzi","Brigitte Strahm","Irene von Luettichau","Jessica I. Hoell","Arndt Borkhardt","Thomas Klingebiel","Martin Schrappe","Arend von Stackelberg","Evgenia Glogova","Ulrike Poetschger","Roland Meisel","Christina Peters"],"twitterCount":0,"altmetricId":60320029,"statusesArray":[]},{"title":"How I manage patients with inherited haemophilia A and B and factor inhibitors","googleId":"b6BLrciDjj8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15053","googleCitationCount":23,"googleAuthor":"","doi":"10.1111/bjh.15053","elsevierAuthor":"Ljung R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"8","altmetricAuthors":["Rolf C. R. Ljung"],"twitterCount":8,"altmetricId":30929316,"statusesArray":["945982564128342016","945927145469210624","945832337295790080","945747174171795462","945677427501686785","945636345497649152","945631076873048069","945618580971966467"]},{"title":"Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome","googleId":"YSOejDwZCDMJ","googleLink":"https://ora.ox.ac.uk/objects/uuid:fffad324-2738-4cd9-8a1d-3fcc37598cc8","googleCitationCount":22,"googleAuthor":"","doi":"10.1111/bjh.15390","elsevierAuthor":"Tunstall O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"12","altmetricAuthors":["Oliver Tunstall","Neha Bhatnagar","Beki James","Alice Norton","Aengus S. O'Marcaigh","Tim Watts","Anne Greenough","Paresh Vyas","Irene Roberts","Michael Wright"],"twitterCount":29,"altmetricId":43904326,"statusesArray":["1204859633720053762","1202324263233040384","1137228149090070528","1137078336226832384","1137011076367900674","1136991211443707905","1026790193813225474","1026776616511385600","1023817029487403009","1023809598942334976","1021129447414685696","1011602259409620995","1009837002676727809","1009620417311436800","1009511918497869824","1009506698917081088","1009499449230585858","1009481418865405952","1009472511095042048","1009471246243942401","1009465344690413568","1009465153300193281","1009464732640833536","1009460654863011845","1009418585519919104","1009414337109340162","1009401816860196864","1009401137513017347","1009388311272656896","1009387747390476288","1009373361049391105","1009367308429430784","1009364418701004800","1009350894591229957","1009350389441941504","1009348328474202112","1009347643066249218"]},{"title":"Mesenchymal COX 2‐PG secretome engages NR 4A‐WNT signalling axis in haematopoietic progenitors to suppress anti‐leukaemia immunity","googleId":"mZBo2gltgAUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15548","googleCitationCount":16,"googleAuthor":"S Amarachintha","doi":"10.1111/bjh.15548","elsevierAuthor":"Wu L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"8","altmetricAuthors":["Limei Wu","Surya Amarachintha","Jian Xu","Frank Oley","Wei Du"],"twitterCount":3,"altmetricId":46537969,"statusesArray":["1029759924459384838","1029690972039520256","1029680246008598528"]},{"title":"Treatment of relapsed/refractory acute myeloid leukaemia in adults","googleId":"YCmlTBdITNIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15077","googleCitationCount":22,"googleAuthor":"DJ Weisdorf","doi":"10.1111/bjh.15077","elsevierAuthor":"Rashidi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"17","altmetricAuthors":["Armin Rashidi","Daniel J. Weisdorf","Nelli Bejanyan"],"twitterCount":4,"altmetricId":31488487,"statusesArray":["1093184811139850241","1093184095016898560","952276926655320064","950987019500564480"]},{"title":"Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma","googleId":"_l9_4S3B7JAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15203","googleCitationCount":23,"googleAuthor":"C Sun","doi":"10.1111/bjh.15203","elsevierAuthor":"McMaster M.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"17","altmetricAuthors":["Mary L. McMaster","Chongkui Sun","Maria  T. Landi","Sharon A. Savage","Melissa  Rotunno"," Xiaohong  R. Yang","Kristine Jones"," Aurélie Vogt","Amy Hutchinson","Bin Zhu","Mingyi Wang","Belynda Hicks","Anand Thirunavukarason"," Douglas R. Stewart","Stella Koutros","Alisa M. Goldstein","Stephen J. Chanock","Neil E. Caporaso"," Margaret A. Tucker","Lynn R. Goldin","Yie Liu"],"twitterCount":5,"altmetricId":41811666,"statusesArray":["1199478239665762305","1199424336085565440","997234123566604289","997093818863443968","997073080756289537"]},{"title":"Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline","googleId":"VfyvzQIJVm0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15460?af=R","googleCitationCount":18,"googleAuthor":"AH Schuh","doi":"10.1111/bjh.15460","elsevierAuthor":"Schuh A.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8","altmetricAuthors":["Anna H. Schuh","Nilima Parry-Jones","Niamh Appleby","Adrian Bloor","Claire E. Dearden","Christopher Fegan","George Follows","Christopher P. Fox","Sunil Iyengar","Ben Kennedy","Helen McCarthy","Helen M. Parry","Piers Patten","Andrew R. Pettitt","Ingo Ringshausen","Renata Walewska","Peter Hillmen"],"twitterCount":15,"altmetricId":45133985,"statusesArray":["1139534054032891904","1033405356913745920","1025485087788474368","1023884980177563648","1022112563721580544","1021698249567227904","1021104746801790977","1020996729225863170","1020937698457063424","1020719868201644034","1020717584893792256","1020589702141882368","1019829502116028416","1019584538291384322","1019550498272174081","1019511276718952449","1019507684939313153"]},{"title":"Prevalence and outcomes of uncommon BCR‐ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre","googleId":"myhhiHWGnm8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15453","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15453","elsevierAuthor":"Qin Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"14","altmetricAuthors":["Ya-Zhen Qin","Qian Jiang","Hao Jiang","Yue-Yun Lai","Hong-Xia Shi","Wen-Min Chen","Lu Yu","Xiao-Jun Huang"],"twitterCount":1,"altmetricId":47877174,"statusesArray":["1015174166603952128"]},{"title":"Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease","googleId":"c40LqlgHFkMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15277","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15277","elsevierAuthor":"Atiq F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"17","altmetricAuthors":["Ferdows Atiq","Karina Meijer","Jeroen Eikenboom","Karin Fijnvandraat","Eveline P. Mauser-Bunschoten","Karin P. M. van Galen","Marten R. Nijziel","Paula F. Ypma","Joke de Meris","Britta A. P. Laros-van Gorkom","Johanna G. van der Bom","Moniek P. de Maat","Marjon H. Cnossen","Frank W. G. Leebeek"],"twitterCount":8,"altmetricId":44491787,"statusesArray":["1014769001589825536","1014680691550969858","1014668858462834688","1014659719414177793","1014634950308614144","1014624369631514624","1014593449713131521","1014590068202393600"]},{"title":"Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma","googleId":"3kPJwvAzbyUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15720","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15720","elsevierAuthor":"Hill B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"10","altmetricAuthors":["Brian T. Hill","Loretta Nastoupil","Allison M. Winter","Melody R. Becnel","James R. Cerhan","Thomas M. Habermann","Brian K. Link","Matthew J. Maurer","Bita Fakhri","Prathima Reddy","Stephen D. Smith","Dhruvika Mukhija","Deepa Jagadeesh","Amrita Desai","Juan Pablo Alderuccio","Izidore S. Lossos","Pooja Mehra","Craig A. Portell","Max L. Goldman","Oscar Calzada","Jonathon B. Cohen","Mohammad J. Hussain","Nilanjan Ghosh","Paolo Caimi","Timothy Tiutan","Peter Martin","Abhigna Kodali","Andrew M. Evens","Brad S. Kahl"],"twitterCount":1,"altmetricId":53141552,"statusesArray":["1077768035321110528"]},{"title":"Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group","googleId":"QTSDVfQwm0cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16014","googleCitationCount":11,"googleAuthor":"PD Cole","doi":"10.1111/bjh.16014","elsevierAuthor":"Kelly K.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"5","altmetricAuthors":["Kara M. Kelly","Peter D. Cole","Qinglin Pei","Rizvan Bush","Kenneth B. Roberts","David C. Hodgson","Kathleen M. McCarten","Steve Y. Cho","Cindy Schwartz"],"twitterCount":3,"altmetricId":61881656,"statusesArray":["1270301141952155648","1140180270328537088","1138385752105127936"]},{"title":"Novel therapeutic agents for relapsed classical Hodgkin lymphoma","googleId":"og6xvfEMeEIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15695","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15695","elsevierAuthor":"von Keudell G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"11","altmetricAuthors":["Gottfried Keudell","Anas Younes"],"twitterCount":8,"altmetricId":53219647,"statusesArray":["1110242791131697154","1084920395038449679","1084891837737943040","1084824827574263809","1084811250650005504","1078644476820799488","1078593387761143809","1078591100473016320"]},{"title":"How we manage haemostasis during sepsis","googleId":"Vd0oSGwQBvIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15821","googleCitationCount":12,"googleAuthor":"M Levi","doi":"10.1111/bjh.15821","elsevierAuthor":"Scully M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"9","altmetricAuthors":["Marie Scully","Marcel Levi"],"twitterCount":9,"altmetricId":56546370,"statusesArray":["1142339569284554753","1142318740681482240","1142024657647951872","1142023418872827904","1142011740797972480","1115705100008415234","1115394502762561537","1103719139640832007","1103664905641693185","1103261410811887617","1103246228576440320"]},{"title":"SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation","googleId":"XTs33tklL8oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16044","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.16044","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines","googleId":"Vn3ez0EHpl8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15603","googleCitationCount":15,"googleAuthor":"J Baech","doi":"10.1111/bjh.15603","elsevierAuthor":"","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-03-01","elsevierCoverDisplayDate":"1 March 2020","elsevierCitationCount":"0","altmetricAuthors":["Joachim Baech","Steen M. Hansen","Peter E. Lund","Peter Soegaard","Peter de Nully Brown","Jacob Haaber","Judit Jørgensen","Jørn Starklint","Pär Josefsson","Christian B. Poulsen","Maja B. Juul","Christian Torp‐Pedersen","Tarec C. El‐Galaly"],"twitterCount":1,"altmetricId":51088915,"statusesArray":["1061991451150766080"]},{"title":"Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study","googleId":"WEtJleT6gvIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15577","googleCitationCount":14,"googleAuthor":"S Héritier","doi":"10.1111/bjh.15577","elsevierAuthor":"Héritier S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments","googleId":"avgUWlKVZCoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15877","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15877","elsevierAuthor":"Hu B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"7","altmetricAuthors":["Boyu Hu","Keyur P. Patel","Hsiang‐Chun Chen","Xuemei Wang","Feng Wang","Rajyalakshmi Luthra","Mark J. Routbort","Rashmi Kanagal‐Shamanna","Leonard J. Medeiros","Cheng C. Yin","Zhuang Zuo","Chi Y. Ok","Sanam Loghavi","Guilin Tang","Francesco P. Tambaro","Philip Thompson","Jan Burger","Nitin Jain","Alessandra Ferrajoli","Prithviraj Bose","Zeev Estrov","Michael J. Keating","William G. Wierda"],"twitterCount":9,"altmetricId":59834648,"statusesArray":["1174970800140455936","1174318787182682112","1174307117555232768","1173718326691999744","1133153837345312769","1133042896612016129","1133039667182485506","1133020760891637760","1112062950485848064"]},{"title":"Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre","googleId":"Hb4uXKVwOKsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15545","googleCitationCount":17,"googleAuthor":"PJ Hampel","doi":"10.1111/bjh.15545","elsevierAuthor":"Hampel P.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"13","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Azacitidine in the 'real‐world': an evaluation of 1101 higher‐risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada","googleId":"gfghWUBLjJYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15273","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15273","elsevierAuthor":"Mozessohn L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10","altmetricAuthors":["Lee Mozessohn","Matthew C. Cheung","Saber Fallahpour","Tripat Gill","Asmaa Maloul","Liying Zhang","Olivia Lau","Rena Buckstein"],"twitterCount":12,"altmetricId":41794584,"statusesArray":["998386898790830080","997814235026599941","997814033364541440","997652515742191616","997452016921100288","997450679693197312","997250831417298945","997152804203565056","997062138492538880","997062040249421824","997060775033225216","997056299505410048"]},{"title":"Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE-013","googleId":"U-Xrgu3VKYwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30937889/?from_term=Posada+J&from_pos=5","googleCitationCount":18,"googleAuthor":"","statusesArray":[]},{"title":"Immune checkpoint molecules in acute myeloid leukaemia: managing the double‐edged sword","googleId":"l7CzV0A8CCgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15078","googleCitationCount":21,"googleAuthor":"","doi":"10.1111/bjh.15078","elsevierAuthor":"Hobo W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"14","altmetricAuthors":["Willemijn Hobo","Tim J. A. Hutten","Nicolaas P. M. Schaap","Harry Dolstra"],"twitterCount":8,"altmetricId":31538313,"statusesArray":["1093103310226317312","955219728020180992","951861421633036288","951861360144433152","951791648987492352","951772890533330945","951410131555659776","951408757359235072"]},{"title":"Incidence and survival trends in mantle cell lymphoma","googleId":"tEd6QiqgWE4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14699?af=R","googleCitationCount":25,"googleAuthor":"N Epperla","doi":"10.1111/bjh.14699","elsevierAuthor":"Epperla N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"20","altmetricAuthors":["Narendranath Epperla","Mehdi Hamadani","Timothy S. Fenske","Luciano J. Costa"],"twitterCount":9,"altmetricId":19598213,"statusesArray":["897125329663381504","858720572544626688","858678222409433089","858664248863596545","858663353228697600","857618286640582656","857406233376116736","857222191087222784","857221337701654528"]},{"title":"A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC‐Remove","googleId":"shHAyeMjNbcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16091","googleCitationCount":11,"googleAuthor":"S MacDonald","doi":"10.1111/bjh.16091","elsevierAuthor":"Cox-Morton S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"10","altmetricAuthors":["Sally Cox‐Morton","Stephen MacDonald","Will Thomas"],"twitterCount":17,"altmetricId":63497613,"statusesArray":["1150331385900613633","1150314492619886592","1150305540901363717","1150284897631789057","1150278201740070919","1150256403338203136","1150184630261362690","1150164937358004224","1150134842115407874","1150120029544943617","1150118160281980928","1150116770814058496","1150003111702016000","1149999640831569920","1149985120067170306","1149971376301846528","1149952498037329920"]},{"title":"Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐and lenalidomide‐containing regimens","googleId":"x7w3vw5gJUEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15392?af=R","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15392","elsevierAuthor":"Storrar N.P.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"13","altmetricAuthors":["Neill P. F. Storrar","Abhinav Mathur","Peter R. E. Johnson","P. Huw Roddie"],"twitterCount":6,"altmetricId":42868376,"statusesArray":["1034459653395177477","1034436133122232320","1034293467126489088","1002936019988238337","1002930236999204864","1002540313515384838"]},{"title":"Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity","googleId":"9fuqcShBCmoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16013","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.16013","elsevierAuthor":"Jiménez-Solas T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"7","altmetricAuthors":["Tamara Jiménez‐Solas","Félix López‐Cadenas","Irene Aires‐Mejía","Juan Carlos Caballero‐Berrocal","Rebeca Ortega","Alba María Redondo","Fermín Sánchez‐Guijo","Sandra Muntión","Luís García‐Martín","Beatriz Albarrán","José María Alonso","Consuelo Del Cañizo","Ángel Hernández‐Hernández","María Díez‐Campelo"],"twitterCount":1,"altmetricId":70010147,"statusesArray":["1192838317844451329"]},{"title":"In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological …","googleId":"5RzAY8XZTB0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15174","googleCitationCount":23,"googleAuthor":"GM Rigolin","doi":"10.1111/bjh.15174","elsevierAuthor":"Rigolin G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"16","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Quantitative mass spectrometry of human reticulocytes reveal proteome‐wide modifications during maturation","googleId":"QpuwUwYTXasJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14976","googleCitationCount":23,"googleAuthor":"A Sinha","doi":"10.1111/bjh.14976","elsevierAuthor":"Chu T.T.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"15","altmetricAuthors":["Trang T. T. Chu","Ameya Sinha","Benoit Malleret","Rossarin Suwanarusk","Jung E. Park","Renugah Naidu","Rupambika Das","Bamaprasad Dutta","Seow Theng Ong","Navin K. Verma","Jerry K. Chan","François Nosten","Laurent Rénia","Siu K. Sze","Bruce Russell","Rajesh Chandramohanadas"],"twitterCount":5,"altmetricId":28306156,"statusesArray":["967302465782611968","967083149560659968","928094525754691585","928001660294778886","926506809044504576","926389465291087872"]},{"title":"Utilizing a PLASMIC score‐based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the …","googleId":"oNcS9U4nu3UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15932","googleCitationCount":11,"googleAuthor":"BP Geisler","doi":"10.1111/bjh.15932","elsevierAuthor":"Upadhyay V.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy","googleId":"UKi9aJQ-G_cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16155","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16155","elsevierAuthor":"Hashmi H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"8","altmetricAuthors":["Hamza Hashmi","Christina Bachmeier","Julio C. Chavez","Jinming Song","Mohammad Hussaini","Gabriel Krivenko","Taiga Nishihori","Hiroshi Kotani","Marco L. Davila","Frederick L. Locke","Michael D. Jain"],"twitterCount":7,"altmetricId":64982836,"statusesArray":["1163782348355321856","1163354186915954688","1163239247152910342","1163128632488935427","1162777469662978048","1162404483206455299","1161742893041758208"]},{"title":"How I manage severe von Willebrand disease","googleId":"uYjfDmcHJX4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16186","googleCitationCount":9,"googleAuthor":"FWG Leebeek","doi":"10.1111/bjh.16186","elsevierAuthor":"Leebeek F.W.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"6","altmetricAuthors":["Frank W. G. Leebeek","Ferdows Atiq"],"twitterCount":19,"altmetricId":66423930,"statusesArray":["1218088809142923270","1217979061730852865","1217920082258604032","1217895697594376192","1217890871821119490","1217890245942947840","1217890030804520962","1196195132221132800","1196189645647708160","1196038503206928384","1195268586081681413","1194702796106477569","1194611763423125506","1194609992474808320","1194571868826677251","1193837296665210880","1177966721161936896","1177958781705216000","1171824327785738240","1171750984948883457","1171724106225639424"]},{"title":"Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE …","googleId":"aPnFEgvRVowJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15533","googleCitationCount":18,"googleAuthor":"FA Klok","doi":"10.1111/bjh.15533","elsevierAuthor":"Klok F.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"10","altmetricAuthors":["Frederikus A. Klok","Stefano Barco","Alexander G. G. Turpie","Sylvia Haas","Reinhold Kreutz","Lorenzo G. Mantovani","Martin Gebel","Matthias Herpers","Joerg-Peter Bugge","Stavros V. Kostantinides","Walter Ageno"],"twitterCount":3,"altmetricId":47865284,"statusesArray":["1038154520621142017","1038131270906204160","1037691899656785920"]},{"title":"Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders","googleId":"06jCW5n2Bm8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15003","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15003","elsevierAuthor":"Foulk B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"15","altmetricAuthors":["Brad Foulk","Mike Schaffer","Steve Gross","Chandra Rao","Denis Smirnov","Mark C. Connelly","Shalini Chaturvedi","Manjula Reddy","Greg Brittingham","Marielena Mata","Madeline Repollet","Claudia Rojas","Daniel Auclair","Mary DeRome","Brendan Weiss","Amy K. Sasser"],"twitterCount":21,"altmetricId":28500621,"statusesArray":["979350456198713345","928720313818451972","928294845575200768","928070853664927746","928055315895119872","927931086730080256","927902682446204928","927872273570136065","927862631020589056","927763135930306560","927739880360370177","927726001685135360","927718643500306432","927705033596178432","927679912886112256","927628019778359296","927595835461914629","927582804036157440","927578804628926466","927549195569057792","927546678491668483"]},{"title":"Platelets at the crossroads of thrombosis, inflammation and haemolysis","googleId":"-CwgUnj1GpcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15117","googleCitationCount":21,"googleAuthor":"S Vogel","doi":"10.1111/bjh.15117","elsevierAuthor":"Vogel S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"10","altmetricAuthors":["Sebastian Vogel","Swee Lay Thein"],"twitterCount":2,"altmetricId":32506848,"statusesArray":["959020152602816512","959019511495131138","959013850480889856"]},{"title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","googleId":"XfcJSyYPZHAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15846","googleCitationCount":10,"googleAuthor":"M Fallaha","doi":"10.1111/bjh.15846","elsevierAuthor":"Oligbu G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"How we manage Bing–Neel syndrome","googleId":"EMhG_luSyfcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16167","googleCitationCount":8,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.16167","elsevierAuthor":"Castillo J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"5","altmetricAuthors":["Jorge J. Castillo","Steven P. Treon"],"twitterCount":4,"altmetricId":65572299,"statusesArray":["1197149092608167936","1195231470295625728","1194342906959556608","1166773000106119178"]},{"title":"Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia","googleId":"MQZMim2RwP0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15148","googleCitationCount":18,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.15148","elsevierAuthor":"Castillo J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"16","altmetricAuthors":["Jorge J. Castillo","Joshua N. Gustine","Kirsten Meid","Toni E. Dubeau","Patricia Severns","Lian Xu","Guang Yang","Zachary R. Hunter","Steven P. Treon"],"twitterCount":1,"altmetricId":33602428,"statusesArray":["967178814483845122"]},{"title":"The long and winding road to pathogen reduction of platelets, red blood cells and whole blood","googleId":"RUvYUUi0TiMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16093","googleCitationCount":10,"googleAuthor":"P Rebulla","doi":"10.1111/bjh.16093","elsevierAuthor":"Rebulla P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"7","altmetricAuthors":["Paolo Rebulla"],"twitterCount":3,"altmetricId":63724936,"statusesArray":["1187176702637756416","1187056000597184512","1186958460627406849"]},{"title":"Predictors of response to anti‐IL 6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial …","googleId":"oAhqspMV5I0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15588","googleCitationCount":14,"googleAuthor":"DE Morra","doi":"10.1111/bjh.15588","elsevierAuthor":"Morra D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"9","altmetricAuthors":["Deanna E. Morra","Sheila K. Pierson","Dustin Shilling","Sepideh Nemat","Carlos Appiani","Mary Guilfoyle","Craig Tendler","Frits Rhee","David C. Fajgenbaum"],"twitterCount":8,"altmetricId":49111855,"statusesArray":["1076638078071201793","1076523323914403841","1076291759909625861","1076274317531451393","1076261779683057666","1076258332665659394","1076258263866527745","1046925826187505665","1046453001240612864","1046450980911501312"]},{"title":"Treatment and outcome of Unicentric Castleman disease: a retrospective analysis of 71 cases","googleId":"RXLn8Tf2VAkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15921","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15921","elsevierAuthor":"Boutboul D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"6","altmetricAuthors":["David Boutboul","Jehane Fadlallah","Sylvain Chawki","Claire Fieschi","Marion Malphettes","Antoine Dossier","Laurence Gérard","Pierre Mordant","Véronique Meignin","Eric Oksenhendler","Lionel Galicier"],"twitterCount":1,"altmetricId":63595442,"statusesArray":["1150896712506052615"]},{"title":"Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era","googleId":"Svzagw3BjoQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15708","googleCitationCount":12,"googleAuthor":"A Rivas‐Delgado","doi":"10.1111/bjh.15708","elsevierAuthor":"Rivas-Delgado A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"10","altmetricAuthors":["Alfredo Rivas-Delgado","Laura Magnano","Miriam Moreno-Velázquez","Olga García","Ferran Nadeu","Pablo Mozas","Ivan Dlouhy","Tycho Baumann","Jordina Rovira","Blanca González-Farre","Antonio Martínez","Olga Balague","Julio Delgado","Neus Villamor","Eva Giné","Elías Campo","Juan M. Sancho-Cia","Armando López-Guillermo"],"twitterCount":11,"altmetricId":52264378,"statusesArray":["1104308382389944320","1074758790740877313","1071750202933932032","1071742093800996865","1071740756099039232","1071519654001152005","1071501286866972672","1071493960311422976","1071468177807298561","1071447080512708609","1070635015069986816"]},{"title":"CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation","googleId":"bJ_jnEEZQuwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15012","googleCitationCount":19,"googleAuthor":"","doi":"10.1111/bjh.15012","elsevierAuthor":"Mainardi C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"18","altmetricAuthors":["Chiara Mainardi","Martin Ebinger","Sigrid Enkel","Tobias Feuchtinger","Heiko-Manuel Teltschik","Matthias Eyrich","Michael Schumm","Armin Rabsteyn","Patrick Schlegel","Christian Seitz","Carl-Phillip Schwarze","Ingo Müller","Johann Greil","Peter Bader","Paul-Gerhardt Schlegel","David Martin","Ursula Holzer","Michaela Döring","Rupert Handgretinger","Peter Lang"],"twitterCount":3,"altmetricId":70353958,"statusesArray":["1356893638580711426","1356570812527083521","967074589636378624"]},{"title":"Transfusion strategies for major haemorrhage in trauma","googleId":"4fP0uLmSKwIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15737","googleCitationCount":15,"googleAuthor":"R Davenport","doi":"10.1111/bjh.15737","elsevierAuthor":"Curry N.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"10","altmetricAuthors":["Nicola S. Curry","Ross Davenport"],"twitterCount":23,"altmetricId":53234649,"statusesArray":["1089221428375883776","1088569353480650752","1088544375309778945","1081318320350134272","1080602125099458562","1080596864108351488","1079762904289853441","1079508247290277888","1079455586176192512","1079400974610059265","1079154386331492352","1079151983565582336","1079127913226752000","1079121702670553088","1079109941955383296","1079109200192724994","1079093829377114113","1079032589564997632","1079023989022969856","1078954527028625409","1078927601123512320","1078802094222655488","1078695083673903109","1078684081154650112"]},{"title":"Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine","googleId":"0hW7VJPvunEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15818","googleCitationCount":10,"googleAuthor":"MR Nahas","doi":"10.1111/bjh.15818","elsevierAuthor":"Nahas M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5","altmetricAuthors":["Myrna R. Nahas","Dina Stroopinsky","Jacalyn Rosenblatt","Leandra Cole","Athalia R. Pyzer","Eleni Anastasiadou","Anna Sergeeva","Adam Ephraim","Abigail Washington","Shira Orr","Malgorzata McMasters","Matthew Weinstock","Salvia Jain","Rebecca K. Leaf","Haider Ghiasuddin","Maryam Rahimian","Jessica Liegel","Jeffrey J. Molldrem","Frank Slack","Donald Kufe","David Avigan"],"twitterCount":4,"altmetricId":56510653,"statusesArray":["1256568504586612738","1171502377083363329","1102986850833174534","1102912910353784832"]},{"title":"A single‐institution retrospective cohort study of first‐line R‐EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic …","googleId":"9CiSix9OEw0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15035","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15035","elsevierAuthor":"Rogers K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"16","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients","googleId":"jWisfninbJMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16042","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16042","elsevierAuthor":"Hu B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"9","altmetricAuthors":["Boyu Hu","Keyur P. Patel","Hsiang‐Chun Chen","Xuemei Wang","Rajyalakshmi Luthra","Mark J. Routbort","Rashmi Kanagal‐Shamanna","L. Jeffrey Medeiros","C. Cameron Yin","Zhuang Zuo","Chi Y. Ok","Sanam Loghavi","Guilin Tang","Francesco P. Tambaro","Philip Thompson","Jan Burger","Nitin Jain","Alessandra Ferrajoli","Prithviraj Bose","Zeev Estrov","Michael Keating","William G. Wierda"],"twitterCount":3,"altmetricId":62867555,"statusesArray":["1200826876375289858","1151840529732296704","1144934169346215936","1144934071451230208"]},{"title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","googleId":"AHRof22W10AJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541482/","googleCitationCount":21,"googleAuthor":"","statusesArray":[]},{"title":"Pre‐and post‐transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia","googleId":"6P8UyA5QG2YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15086","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15086","elsevierAuthor":"Lovisa F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"14","altmetricAuthors":["Federica Lovisa","Marco Zecca","Bartolomeo Rossi","Mimma Campeggio","Elisa Magrin","Emanuela Giarin","Barbara Buldini","Simona Songia","Giovanni Cazzaniga","Tommaso Mina","Gloria Acquafredda","Paola Quarello","Franco Locatelli","Franca Fagioli","Giuseppe Basso"],"twitterCount":1,"altmetricId":32352898,"statusesArray":["957852425603506176"]},{"title":"Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the US population: a six‐year population‐based cohort …","googleId":"GdtVGHunpy0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15773","googleCitationCount":11,"googleAuthor":"J Zhou","doi":"10.1111/bjh.15773","elsevierAuthor":"Zhou J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death","googleId":"N5NqGX86vPsJ","googleLink":"https://moh-it.pure.elsevier.com/en/publications/time-to-progression-of-mantle-cell-lymphoma-after-high-dose-cytar-3","googleCitationCount":15,"googleAuthor":"C Visco","doi":"10.1111/bjh.15643","elsevierAuthor":"Visco C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"11","altmetricAuthors":["Carlo Visco","Maria C. Tisi","Andrea Evangelista","Alice Di Rocco","Anna‐Katharina Zoellner","Vittorio R. Zilioli","Stefan Hohaus","Roberta Sciarra","Alessandro Re","Cristina Tecchio","Annalisa Chiappella","Lucia Morello","Guido Gini","Luca Nassi","Tommasina Perrone","Anna L. Molinari","Alberto Fabbri","Maria C. Cox","Erica Finolezzi","Simone Ferrero","Benedetta Puccini","Isabel Alvarez De Celis","Annalisa Arcari","Dario Marino","Michele Merli","Francesco Piazza","Massimo Gentile","Matteo Pelosini","Giacomo Loseto","Olivier Hermine","Martin Dreyling","Marco Ruggeri","Maurizio Martelli","Eva Hoster","Umberto Vitolo"],"twitterCount":10,"altmetricId":51652416,"statusesArray":["1067414969921282048","1067106883541106688","1066903522153779200","1066879546996207617","1066810445904924672","1066798556646973441","1066798539378966529","1066797141614608384","1066569449564712960","1066346715387711490","1060849866744700928"]},{"title":"The Duffy antigen receptor for chemokines, ACKR1,– 'Jeanne DARC' of benign neutropenia","googleId":"ZcNdVE1qUNUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15730","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15730","elsevierAuthor":"Rappoport N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5","altmetricAuthors":["Naama Rappoport","Amos J. Simon","Ninette Amariglio","Gideon Rechavi"],"twitterCount":2,"altmetricId":54179954,"statusesArray":["1211188754729390080","1210885361167040512"]},{"title":"Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non‐Hodgkin and Hodgkin lymphoma","googleId":"ys59dGtjTv8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15789","googleCitationCount":11,"googleAuthor":"ML Metzger","doi":"10.1111/bjh.15789","elsevierAuthor":"Metzger M.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"9","altmetricAuthors":["Monika L. Metzger","Christine Mauz‐Körholz"],"twitterCount":1,"altmetricId":55180898,"statusesArray":["1093990527714951174"]},{"title":"A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children","googleId":"ZnL7uhUzcm8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15056","googleCitationCount":18,"googleAuthor":"","doi":"10.1111/bjh.15056","elsevierAuthor":"Sutton R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"14","altmetricAuthors":["Rosemary Sutton","Nicola C. Venn","Tamara Law","Judith M. Boer","Toby N. Trahair","Anthea Ng","Monique L. Den Boer","Anuruddhika Dissanayake","Jodie E. Giles","Pauline Dalzell","Chelsea Mayoh","Draga Barbaric","Tamas Revesz","Frank Alvaro","Rob Pieters","Michelle Haber","Murray D. Norris","Martin Schrappe","Luciano Dalla Pozza","Glenn M Marshall"],"twitterCount":4,"altmetricId":29758116,"statusesArray":["937696797572653057","937058512261304320","936913655504936962","936543005531656195"]},{"title":"Bortezomib and dexamethasone, an original approach for treating multi‐refractory warm autoimmune haemolytic anaemia","googleId":"en4v_85REuQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16009","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16009","elsevierAuthor":"Fadlallah J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"6","altmetricAuthors":["Jehane Fadlallah","Marc Michel","Etienne Crickx","Nicolas Limal","Nathalie Costedoat","Marion Malphettes","Claire Fieschi","Lionel Galicier","Eric Oksenhendler","Bertrand Godeau","Sylvain Audia","Matthieu Mahévas"],"twitterCount":8,"altmetricId":61943371,"statusesArray":["1178365368617684993","1177121000896548864","1177075586952564736","1176948259673313280","1147864433030553600","1143265363712454661","1140366849298878466","1140355977579048960","1137756490134118400"]},{"title":"Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results","googleId":"eOVtDo_1U4wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15058","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.15058","elsevierAuthor":"Richardson P.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"11","altmetricAuthors":["Paul G. Richardson","William I. Bensinger","Carol Ann Huff","Caitlin L. Costello","Nikoletta Lendvai","Jesus G. Berdeja","Larry D. Anderson","David S. Siegel","Daniel Lebovic","Sundar Jagannath","Jacob P. Laubach","Keith E. Stockerl-Goldstein","Long Kwei","Fong Clow","Laurence Elias","Zeena Salman","Thorsten Graef","Elizabeth Bilotti","Ravi Vij"],"twitterCount":6,"altmetricId":33181692,"statusesArray":["1337904041549045769","965122807226142722","964090895879540736","963907089340030976","963594290697064448","963465419607674881"]},{"title":"Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom","googleId":"Ligh34I8XecJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15566","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15566","elsevierAuthor":"Bröckelmann P.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"7","altmetricAuthors":["Paul J. Bröckelmann","Suzanne McMullen","J Ben Wilson","Kerstin Mueller","Sarah Goring","Aspasia Stamatoullas","Erin Zagadailov","Ashish Gautam","Dirk Huebner","Mehul Dalal","Tim Illidge"],"twitterCount":8,"altmetricId":48768578,"statusesArray":["1192714428602617856","1179355612804734976","1056113832534380545","1055403813316780032","1044703787611553797","1044677867865550850","1044665559445647362","1044658398967549953","1044224908589506560","1043440417398816768"]},{"title":"Haemophilia and ageing","googleId":"xTNcZh3-dpkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15745","googleCitationCount":11,"googleAuthor":"M Makris","doi":"10.1111/bjh.15745","elsevierAuthor":"Shapiro S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"9","altmetricAuthors":["Susan Shapiro","Mike Makris"],"twitterCount":15,"altmetricId":53240357,"statusesArray":["1081827398113464321","1080591083631988737","1080138911022804994","1079811055268839425","1079725738163662850","1079722863949697024","1079683636860018688","1079513003995873280","1079493518517854210","1079462008951656449","1078937154951303169","1078791124112867328","1078765557535727622","1078758201493991424","1078739648741031938"]},{"title":"Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism","googleId":"7hpzjKp1TOMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15857","googleCitationCount":12,"googleAuthor":"PL Lutsey","doi":"10.1111/bjh.15857","elsevierAuthor":"Lutsey P.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"7","altmetricAuthors":["Pamela L. Lutsey","Neil A. Zakai","Richard F. MacLehose","Faye L. Norby","Rob F. Walker","Nicholas S. Roetker","Terrence J. Adam","Alvaro Alonso"],"twitterCount":19,"altmetricId":57961246,"statusesArray":["1148037854049628160","1145761326813327360","1145728209964732417","1145721411236966401","1145659538839932928","1145624664846344192","1145582487722176513","1145578296517771264","1145540964276195329","1145501431958528001","1145440156712865794","1145434702209277952","1145419771418202115","1145396333085364224","1145392765095821312","1145389821050929159","1145388662152192001","1145385540004589571","1111351926497701894"]},{"title":"Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma","googleId":"fRbaLOQERTsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15054","googleCitationCount":18,"googleAuthor":"JP Reddy","doi":"10.1111/bjh.15054","elsevierAuthor":"Reddy J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"16","altmetricAuthors":["Jay P. Reddy","Mike Hernandez","Jillian R. Gunther","Bouthaina S. Dabaja","Geoffrey V. Martin","Wen Jiang","Mani Akhtari","Pamela K. Allen","Bradley J. Atkinson","Grace L. Smith","Chelsea C. Pinnix","Sarah A. Milgrom","Zeinab Abou Yehia","Eleanor M. Osborne","Yasuhiro Oki","Hun Lee","Fredrick Hagemeister","Michelle A. Fanale"],"twitterCount":18,"altmetricId":30931301,"statusesArray":["961229994809810945","949330357903675392","948398964277235712","948392004945416192","948389206199500800","948375835207225345","947272559535390721","946094363011989504","946092283312648193","945910791164723200","945827556326068225","945759767997440000","945742130047344641","945723288902406146","945722220470571009","945684438746370048","945683546974367744","945637629135081473","945634025124913153"]},{"title":"Human Pegivirus infection and lymphoma risk and prognosis: a North American study","googleId":"EZjr0wVIR_oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15416","googleCitationCount":15,"googleAuthor":"A Fama","doi":"10.1111/bjh.15416","elsevierAuthor":"Fama A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"14","altmetricAuthors":["Angelo Fama","Jinhua Xiang","Brian K. Link","Cristine Allmer","Donna Klinzman","Andrew L. Feldman","Grzegorz S. Nowakowski","Mark Liebow","Melissa C. Larson","Matthew J. Maurer","Stephen M. Ansell","Anne J. Novak","Yan W. Asmann","Susan L. Slager","Timothy G. Call","Thomas M. Habermann","James R. Cerhan","Jack T. Stapleton"],"twitterCount":2,"altmetricId":43079152,"statusesArray":["1004759542008287232","1002261205061423104"]},{"title":"Ticagrelor does not impact patient‐reported pain in young adults with sickle cell disease: a multicentre, randomised phase II b study","googleId":"Vo6btw8UIyAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15646","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.15646","elsevierAuthor":"Kanter J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"11","altmetricAuthors":["Julie Kanter","Miguel R. Abboud","Banu Kaya","Videlis Nduba","Carl Amilon","Christer Gottfridsson","Martin Rensfeldt","Maria Leonsson‐Zachrisson"],"twitterCount":1,"altmetricId":51379392,"statusesArray":["1064392535102169088"]},{"title":"Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party","googleId":"Ko1vlJvDHToJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15152","googleCitationCount":17,"googleAuthor":"A Bazarbachi","doi":"10.1111/bjh.15152","elsevierAuthor":"Bazarbachi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"13","altmetricAuthors":["Ali Bazarbachi","Ariane Boumendil","Hervé Finel","Mohamad Mohty","Luca Castagna","Karl S. Peggs","Didier Blaise","Boris Afanasyev","José L. Diez‐Martin","Jorge Sierra","Adrian Bloor","Carmen Martinez","Stephen Robinson","Ram Malladi","Jean El‐Cheikh","Paolo Corradini","Silvia Montoto","Peter Dreger","Anna Sureda"],"twitterCount":7,"altmetricId":33639731,"statusesArray":["1100011847560974336","980489321722589184","980483260684951553","980368237639725057","980263909788651520","970383103729512448","967555553206722560"]},{"title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.","googleId":"RGUOhacHz5sJ","googleLink":"https://europepmc.org/article/pmc/pmc7679007","googleCitationCount":14,"googleAuthor":"","statusesArray":[]},{"title":"Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas","googleId":"UCdb5_55TzEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15435","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15435","elsevierAuthor":"Goasguen J.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"14","altmetricAuthors":["Jean E. Goasguen","John M. Bennett","Barbara J. Bain","Richard Brunning","Maria-Teresa Vallespi","Masao Tomonaga","Gina Zini","Alain Renault"],"twitterCount":1,"altmetricId":44589674,"statusesArray":["1015212326222524417"]},{"title":"Diagnosis and therapy of genetic haemochromatosis (review and 2017 update)","googleId":"QBGrzkmJS00J","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10047172/","googleCitationCount":20,"googleAuthor":"","doi":"10.1111/bjh.15164","elsevierAuthor":"Fitzsimons E.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"9","altmetricAuthors":["Edward J. Fitzsimons","Jonathan O. Cullis","Derrick W. Thomas","Emmanouil Tsochatzis","William J. H. Griffiths"],"twitterCount":3,"altmetricId":37849803,"statusesArray":["1137253012915798016","1123622327521038338","986269298032369671"]},{"title":"Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review","googleId":"7-RAvRXVq6kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15410","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15410","elsevierAuthor":"van Westrhenen A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"11","altmetricAuthors":["Anouk van Westrhenen","Lisanne C. A. Smidt","Tatjana Seute","Stefan Nierkens","Abraham C. J. Stork","Monique C. Minnema","Tom J. Snijders"],"twitterCount":5,"altmetricId":43389835,"statusesArray":["1137298453787291649","1020516505744740352","1011672136786718720","1011554596353904640","1004453741511237633"]},{"title":"No evidence of increased cerebrovascular involvement in adult neurologically‐asymptomatic β‐Thalassaemia. A multicentre multimodal magnetic resonance study","googleId":"PozBt0cxs2oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15834","googleCitationCount":10,"googleAuthor":"I Tartaglione","doi":"10.1111/bjh.15834","elsevierAuthor":"Tartaglione I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The translational science of hodgkin lymphoma","googleId":"4xYNRtijNcgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15658","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15658","elsevierAuthor":"Cirillo M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6","altmetricAuthors":["Melita Cirillo","Sarah Reinke","Wolfram Klapper","Sven Borchmann"],"twitterCount":3,"altmetricId":51193676,"statusesArray":["1078593992525340673","1078590911246938113","1062301200236851200"]},{"title":"Venous thromboembolism and women's health","googleId":"x_Fqgl8XF3YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15608","googleCitationCount":12,"googleAuthor":"JP Patel","doi":"10.1111/bjh.15608","elsevierAuthor":"Speed V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"11","altmetricAuthors":["Victoria Speed","Lara N. Roberts","Jignesh P. Patel","Roopen Arya"],"twitterCount":24,"altmetricId":49966211,"statusesArray":["1110257699730661376","1103209275244064768","1103131397009670144","1103124224686858241","1103091634026283008","1103062022248267776","1103058924608147456","1103053342148886529","1103047426850480128","1071012456393334784","1069521623743717376","1066155505477922816","1054732113738715137","1054715784944070657","1054440501796130817","1054391496114348033","1054359274439229441","1054130578830827521","1053739136387997696","1053621236520153088","1053600747722485760","1053595788922834944","1053583446323445760","1053572804099104768","1053568367989284864","1053547169637167105"]},{"title":"Identification of novel diagnostic biomarkers for deep venous thrombosis","googleId":"5Y7FYi6x6PEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15206","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15206","elsevierAuthor":"Memon A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"7","altmetricAuthors":["Ashfaque A. Memon","Kristina Sundquist","Mirnabi PirouziFard","Johan L. Elf","Karin Strandberg","Peter J. Svensson","Jan Sundquist","Bengt Zöller"],"twitterCount":3,"altmetricId":39200793,"statusesArray":["1110850332102262784","988975071481024516","987377470843310080"]},{"title":"Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis","googleId":"Tvie5Y3iX00J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29265333/","googleCitationCount":18,"googleAuthor":"S Shah","doi":"10.1111/bjh.15061,","elsevierAuthor":"Tefferi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"16","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the …","googleId":"mxeUd3xMuWkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15540","googleCitationCount":13,"googleAuthor":"J Canaani","doi":"10.1111/bjh.15540","elsevierAuthor":"Canaani J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"14","altmetricAuthors":["Jonathan Canaani","Myriam Labopin","Xiao J. Huang","Fabio Ciceri","Maria T. Van Lint","Benedetto Bruno","Stella Santarone","José L. Diez-Martin","Didier Blaise","Patrizia Chiusolo","Depei Wu","Mohamad Mohty","Arnon Nagler"],"twitterCount":3,"altmetricId":46726834,"statusesArray":["1031859680358883328","1031789750175326208","1031435470432088064"]},{"title":"Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)","googleId":"vWEJt3OnZpQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15170","googleCitationCount":17,"googleAuthor":"A Smith","doi":"10.1111/bjh.15170","elsevierAuthor":"Smith A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"13","altmetricAuthors":["Alexandra Smith","Eve Roman","Simon Appleton","Debra Howell","Rod Johnson","Cathy Burton","Russell Patmore"],"twitterCount":9,"altmetricId":34277233,"statusesArray":["1044970501456756736","1044964630995636224","1044964595566342150","1013709625194090497","975390038325329920","973525984132689921","973502213388689408","973500519896535040","973499607685705731","973499301749026816","973499218743758848","973498890128379905"]},{"title":"Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis","googleId":"DaxwWB3Koc4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15722","googleCitationCount":10,"googleAuthor":"N Martínez‐Calle","doi":"10.1111/bjh.15722","elsevierAuthor":"Martínez-Calle N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"8","altmetricAuthors":["Nicolás Martínez‐Calle","Sarah Hartley","Matthew Ahearne","Benjamin Kasenda","Amy Beech","Helen Knight","Constantine Balotis","Ben Kennedy","Simon Wagner","Martin J. S. Dyer","Dean Smith","Andrew K. McMillan","Fiona Miall","Mark Bishton","Christopher P. Fox"],"twitterCount":2,"altmetricId":52694313,"statusesArray":["1073896093174374400","1073895639275184128"]},{"title":"Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy","googleId":"8lfuzq_s4tcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15861?af=R","googleCitationCount":11,"googleAuthor":"AJ Olszewski","doi":"10.1111/bjh.15861","elsevierAuthor":"Olszewski A.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"7","altmetricAuthors":["Adam J. Olszewski","Anna D. Chorzalska","Annette S. Kim","Peter J. Quesenberry","Mary L. Lopresti","Mary A. Fenton","John L. Reagan","James N. Butera","Ilyas Sahin","Celine Hamel","Jordan Robison","Max Petersen","Patrycja M. Dubielecka"],"twitterCount":2,"altmetricId":56982962,"statusesArray":["1105991300812283906","1105771000547950592"]},{"title":"Shwachman‐Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic …","googleId":"xPV__bOazukJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15729","googleCitationCount":11,"googleAuthor":"A Minelli","doi":"10.1111/bjh.15729","elsevierAuthor":"Valli R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"T‐cell receptor sequencing demonstrates persistence of virus‐specific T cells after antiviral immunotherapy","googleId":"Ox1yU72Fjd0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16053","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16053","elsevierAuthor":"Keller M.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"6","altmetricAuthors":["Michael D. Keller","Sam Darko","Haili Lang","Amy Ransier","Christopher A. Lazarski","Yunfei Wang","Patrick J. Hanley","Blachy J. Davila","Jennifer R. Heimall","Richard F. Ambinder","A. John Barrett","Cliona M. Rooney","Helen E Heslop","Daniel C. Douek","Catherine M. Bollard"],"twitterCount":1,"altmetricId":62454916,"statusesArray":["1141721597117685765"]},{"title":"Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL 2008 experience","googleId":"G9Q1BNJASR8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15761","googleCitationCount":10,"googleAuthor":"M Ifversen","doi":"10.1111/bjh.15761","elsevierAuthor":"Ifversen M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"7","altmetricAuthors":["Marianne Ifversen","Dominik Turkiewicz","Hanne V. Marquart","Jacek Winiarski","Jochen Buechner","Karin Mellgren","Johan Arvidson","Jelena Rascon","Lenne-Triin Körgvee","Hans O. Madsen","Jonas Abrahamsson","Bendik Lund","Olafur G. Jonsson","Carsten Heilmann","Mats Heyman","Kjeld Schmiegelow","Kim Vettenranta"],"twitterCount":1,"altmetricId":54601054,"statusesArray":["1089838339191123968"]},{"title":"Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma","googleId":"OQTTqQe-argJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16130","googleCitationCount":6,"googleAuthor":"S Bal","doi":"10.1111/bjh.16130","elsevierAuthor":"Bal S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"5","altmetricAuthors":["Susan Bal","Allison Weaver","Robert F. Cornell","Luciano J. Costa"],"twitterCount":21,"altmetricId":64355973,"statusesArray":["1337100215665377280","1337040424716931074","1222350460033601536","1222184243721330688","1222153411069730817","1217578615149416449","1217565554925621253","1217552213943488513","1217551042600218625","1217547018299760640","1217543369448095744","1217518606797459456","1217482896103170050","1217482405658886154","1217082736747388928","1217069378002456577","1216810952915652609","1216804781768966146","1216086148285632512","1216072491044605953","1215796517866373120","1215651319274516480","1215627013802938374","1215619509836488704","1215269160680349697","1215267278754930689","1214985307453624320","1214739083467071488","1214642012512833538","1213469255557173248","1213216557871980544","1213125636367237122","1213104273518743558","1213104101166342144","1213096294484467712","1213091809078980609","1206596131771342850","1205206776896868352","1205206741102673920","1205195528205549568","1205154221173010432","1205146245091725314","1205095523054735360","1205091671400169473","1167884982984929282","1167645024324075522","1167523813833265153","1167521711287193600","1167469582778556417","1163697168684859392","1163666268098052096","1163646839758962690","1156656604944748545","1156557177399783425","1156526326804865024","1156520050515501058","1156510107691311105","1156504798344220672"]},{"title":"Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL 2008","googleId":"yJbcLd8NV3IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15660","googleCitationCount":11,"googleAuthor":"BO Wolthers","doi":"10.1111/bjh.15660","elsevierAuthor":"Højfeldt S.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8","altmetricAuthors":["Sofie G. Højfeldt","Benjamin O. Wolthers","Morten Tulstrup","Jonas Abrahamsson","Ramneek Gupta","Arja Harila-Saari","Mats Heyman","Louise T. Henriksen","Òlafur G. Jónsson","Päivi M. Lähteenmäki","Bendik Lund","Kaie Pruunsild","Goda Vaitkeviciene","Kjeld Schmiegelow","Birgitte K. Albertsen"],"twitterCount":1,"altmetricId":70408151,"statusesArray":["1064849349341900801"]},{"title":"Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?","googleId":"C_MjIcs5DboJ","googleLink":"https://kyushu-u.pure.elsevier.com/en/publications/which-is-more-important-for-the-selection-of-cord-blood-units-for","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15418","elsevierAuthor":"Nakasone H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"11","altmetricAuthors":["Hideki Nakasone","Ken Tabuchi","Naoyuki Uchida","Yuju Ohno","Yoshiko Matsuhashi","Satoshi Takahashi","Yasushi Onishi","Makoto Onizuka","Hikaru Kobayashi","Takahiro Fukuda","Tatsuo Ichinohe","Minoko Takanashi","Koji Kato","Yoshiko Atsuta","Hiromasa Yabe","Yoshinobu Kanda"],"twitterCount":7,"altmetricId":43186672,"statusesArray":["1003615910387699712","1003595440288301057","1003490402874380288","1003458270466486272","1003456600986800128","1003455593942642688","1003452606646243329"]},{"title":"Methodological aspects of health‐related quality of life measurement and analysis in patients with multiple myeloma","googleId":"MkIxYKBB1M0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15759","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15759","elsevierAuthor":"Nielsen L.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":["Lene Kongsgaard Nielsen","Niels Abildgaard","Mary Jarden","Tobias Wirenfeld Klausen"],"twitterCount":3,"altmetricId":54200403,"statusesArray":["1088029057156087808","1088025572431810560","1087077301584506882"]},{"title":"How I manage red cell transfusions in patients with sickle cell disease","googleId":"VQ0BIBmssDwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15115","googleCitationCount":17,"googleAuthor":"DC Rees","doi":"10.1111/bjh.15115","elsevierAuthor":"Rees D.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"7","altmetricAuthors":["David C. Rees","Susan Robinson","Jo Howard"],"twitterCount":5,"altmetricId":32563771,"statusesArray":["1093684973108899840","959439019145908224","959434162284433409","959431220517105665","958332487507181569"]},{"title":"A journey through infectious risk associated with ruxolitinib","googleId":"qcoboy9BkGwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16174","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.16174","elsevierAuthor":"Sant’Antonio E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"12","altmetricAuthors":["Emanuela Sant’Antonio","Massimiliano Bonifacio","Massimo Breccia","Elisa Rumi"],"twitterCount":25,"altmetricId":65686417,"statusesArray":["1273497970466533378","1273222694855675912","1199772371231494144","1199759787036155904","1199759573252542464","1171367662749933568","1171235862350372864","1170850907170455552","1170850611413364737","1170839909642448897","1169650391371472897","1169498098399416320","1169490349951193088","1169485252240314368","1169454235580325893","1169415985230766081","1169413372372226053","1169393945035587585","1169348412191457280","1169257248012623874","1169242211302748163","1169234889444605954","1169144033983287296","1169135520238252034","1169051446169559041","1169051227298160641","1167561160608157696"]},{"title":"Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse","googleId":"BSZuy5p19WEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15770","googleCitationCount":9,"googleAuthor":"MP Schroeder","doi":"10.1111/bjh.15770","elsevierAuthor":"Groeneveld-Krentz S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases","googleId":"CqmYHoSmeqEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15000","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.15000","elsevierAuthor":"Yang J.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"11","altmetricAuthors":["Jin-Gang Yang","Li-Li Wang","Dong-Chu Ma"],"twitterCount":3,"altmetricId":28258911,"statusesArray":["967091706846838785","925887413871882246","925866314861867012"]},{"title":"Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in …","googleId":"PteQgO5QfWEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15146","googleCitationCount":18,"googleAuthor":"KR Crassini","doi":"10.1111/bjh.15146","elsevierAuthor":"Crassini K.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"17","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Pathogenesis, diagnosis and treatment of anaemia in immune‐mediated gastrointestinal disorders","googleId":"kQO-WLHGuOcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15254","googleCitationCount":13,"googleAuthor":"A Di Sabatino","doi":"10.1111/bjh.15254","elsevierAuthor":"Bergamaschi G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"9","altmetricAuthors":["Gaetano Bergamaschi","Antonio Di Sabatino","Gino R. Corazza"],"twitterCount":1,"altmetricId":45463942,"statusesArray":["1021698065001013248"]},{"title":"Low‐dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma","googleId":"96BCSWvK8GUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15787?af=R","googleCitationCount":14,"googleAuthor":"H Geng","doi":"10.1111/bjh.15787","elsevierAuthor":"Vu K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"8","altmetricAuthors":["Khoan Vu","Gabriel Mannis","Jimmy Hwang","Huimin Geng","James L. Rubenstein"],"twitterCount":4,"altmetricId":57695067,"statusesArray":["1337073536301752323","1336744273971122176","1325546513267888129","1144223896704638976","1143897521917517825","1143140062256861184","1142563244760084481","1110241312056528896","1092740129742077952"]},{"title":"Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization …","googleId":"th1M6HxfTKcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30548257/?from_term=Chaoui+D&from_pos=6","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15718,","elsevierAuthor":"Laribi K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL","googleId":"nVtjUxm735YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15406","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15406","elsevierAuthor":"Klintman J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8","altmetricAuthors":["Jenny Klintman","Katerina Barmpouti","Samantha J. L. Knight","Pauline Robbe","Hélène Dreau","Ruth Clifford","Kate Ridout","Adam Burns","Adele Timbs","David Bruce","Pavlos Antoniou","Alona Sosinsky","Jennifer Becq","David Bentley","Peter Hillmen","Jenny C. Taylor","Mark Caulfield","Anna H. Schuh"],"twitterCount":27,"altmetricId":42926266,"statusesArray":["1003950318252642304","1003642420096061442","1003593994172059648","1003584132037906433","1003578157029617664","1003568352890114048","1003543663581061120","1003528562354348032","1003490409866129411","1003419335212269569","1003404969989541888","1003385750719614976","1003366544762646530","1003360165427646464","1003315380901646336","1003290543529644033","1003290371034632192","1003286893205876736","1003285660906741760","1003285487178649600","1003285195339026432","1001775590649692161","1001718855343968256","1001580406804795392","1001564896314748929","1001542053799612417","1001514657130180609","1001508554669510657"]},{"title":"Infectious complications after post‐transplantation cyclophosphamide and anti‐thymocyte globulin‐based haploidentical stem cell transplantation","googleId":"gQAs7lQ7RZoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16189","googleCitationCount":7,"googleAuthor":"R Mohty","doi":"10.1111/bjh.16189","elsevierAuthor":"Mohty R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"6","altmetricAuthors":["Razan Mohty","Eolia Brissot","Giorgia Battipaglia","Annalisa Ruggeri","Rémy Dulery","Agnès Bonnin","Clémence Médiavilla","Simona Sestili","Ramdane Belhocine","Anne Vekhoff","Tounes Ledraa","Camelia Simona Lapusan","Rosa Adaeva","Françoise Isnard","Olivier Legrand","Mohamad Mohty","Florent Malard"],"twitterCount":43,"altmetricId":65998764,"statusesArray":["1255950327938981888","1255847979300409346","1255831032877776902","1255828285998727168","1183974894096261120","1175881486836359168","1175730291916333059","1175685840401567745","1175173585771663360","1175160729931960320","1175154703300202497","1175001964968632320","1170949823744356357","1170634615847116800","1170489401547329538","1170384716643463168","1170369229591175168","1170319511666483200","1170317172423450624","1170313718682529796","1170309767543349248","1170289904804388866","1170288410587742213","1170286158997336066","1170106216724328448","1170027636657184768","1169995045296058368","1169994645826355202","1169967809021054977","1169967608415703047","1169967523606851584","1169952077843501056","1169949588712767488","1169946015773941760","1169939670723104768","1169930409980940293","1169918025333706752","1169909021354024960","1169893636021964801","1169882103871262721","1169882064759341056","1169860954701488130","1169856839510417408","1169849508395507714","1169848428974624768","1169836268324147200","1169818584622649344","1169803549485731840","1169781688261648384","1169776571638571008","1169775123085312006","1169722968332754945","1169711108875309061","1169711000758738944"]},{"title":"The dual inhibitor of the phosphoinositol‐3 and PIM kinases, IBL‐202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic …","googleId":"UW_LNheq3ycJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15447","googleCitationCount":10,"googleAuthor":"K Crassini","doi":"10.1111/bjh.15447","elsevierAuthor":"Crassini K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"7","altmetricAuthors":["Kyle Crassini","Yandong Shen","Michael O'Dwyer","Michael O'Neill","Richard Christopherson","Stephen Mulligan","O. Giles Best"],"twitterCount":3,"altmetricId":44572011,"statusesArray":["1015537178770792448","1015305965854449664","1015137138990571521"]},{"title":"Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma","googleId":"Q1v9bk7mbyIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15679","googleCitationCount":10,"googleAuthor":"SK Kumar","doi":"10.1111/bjh.15679","elsevierAuthor":"Kumar S.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8","altmetricAuthors":["Shaji K. Kumar","Norbert Grzasko","Sosana Delimpasi","Wieslaw W. Jedrzejczak","Sebastian Grosicki","Marie‐Christine Kyrtsonis","Andrew Spencer","Neeraj Gupta","Zhaoyang Teng","Catriona Byrne","Richard Labotka","Meletios A. Dimopoulos"],"twitterCount":6,"altmetricId":51576072,"statusesArray":["1094176696918523905","1093945137259036673","1072559385338105856","1072552591492554753","1072551593680220160","1066430859308408832","1065773803010056192"]},{"title":"Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma","googleId":"yHVmguqkMycJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15723","googleCitationCount":13,"googleAuthor":"G Cook","doi":"10.1111/bjh.15723","elsevierAuthor":"Rule S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"9","altmetricAuthors":["Simon Rule","Gordon Cook","Nigel H. Russell","Ann Hunter","Stephen Robinson","Nick Morley","Anna Sureda","Pip Patrick","Laura Clifton-Hadley","Toyin Adedayo","Amy Kirkwood","Karl S. Peggs"],"twitterCount":8,"altmetricId":52879988,"statusesArray":["1103791876707176449","1084600387242524672","1075644130708086784","1075641940010565632","1075502163311427584","1075435684687740928","1075388981427220481","1075386966118588416","1075345685027921921"]},{"title":"Long term outcomes in monoclonal gammopathy of renal significance","googleId":"IyEnBtPvE-IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15987","googleCitationCount":9,"googleAuthor":"F Djebbari","doi":"10.1111/bjh.15987","elsevierAuthor":"Khera A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Efficacy of biological agents in the treatment of Erdheim-Chester disease","googleId":"pMv17GREoAQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29082516/","googleCitationCount":16,"googleAuthor":"G Goyal","doi":"10.1111/bjh.14997,","elsevierAuthor":"Goyal G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The impact of SOCS1 mutations in diffuse large B‐cell lymphoma","googleId":"0cq2EiNEoOIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16147","googleCitationCount":5,"googleAuthor":"JK Lennerz","doi":"10.1111/bjh.16147","elsevierAuthor":"Mellert K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"4","altmetricAuthors":["Kevin Mellert","Melanie Martin","Jochen K. Lennerz","Manuel Lüdeke","Annette M. Staiger","Markus Kreuz","Markus Löffler","Norbert Schmitz","Lorenz Trümper","Alfred C. Feller","Sylvia Hartmann","Martin‐Leo Hansmann","Wolfram Klapper","Harald Stein","Andreas Rosenwald","German Ott","Marita Ziepert","Peter Möller"],"twitterCount":8,"altmetricId":64920598,"statusesArray":["1275438725825048576","1216133555153178624","1215705278584381441","1209222200185671680","1209215901419163654","1205956904029212672","1205947508238770179","1161729333452558337","1161606650786009089","1161248365423792129"]},{"title":"The role of transplantation in Hodgkin lymphoma","googleId":"WiWXw-F7o9QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15639","googleCitationCount":13,"googleAuthor":"PL Zinzani","doi":"10.1111/bjh.15639","elsevierAuthor":"Broccoli A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6","altmetricAuthors":["Alessandro Broccoli","Pier Luigi Zinzani"],"twitterCount":1,"altmetricId":70403959,"statusesArray":["1060849860683972608"]},{"title":"CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity","googleId":"mKyJAp9Ide4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15725","googleCitationCount":12,"googleAuthor":"R Masetti","doi":"10.1111/bjh.15725","elsevierAuthor":"Masetti R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8","altmetricAuthors":["Riccardo Masetti","Salvatore N. Bertuccio","Andrea Pession","Franco Locatelli"],"twitterCount":0,"altmetricId":53475208,"statusesArray":[]},{"title":"Haematological management of major bleeding associated with direct oral anticoagulants–UK experience","googleId":"Ud2sqY53MaAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15808","googleCitationCount":10,"googleAuthor":"L Green","doi":"10.1111/bjh.15808","elsevierAuthor":"Green L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"8","altmetricAuthors":["Laura Green","Joachim Tan","Sotiris Antoniou","Raza Alikhan","Nicola Curry","Tamara Everington","Khalid Saja","Simon Stanworth","Campbell Tait","Joan K. Morris","Peter MacCallum"],"twitterCount":23,"altmetricId":55864367,"statusesArray":["1118577979024605185","1113754689621958657","1105134169536032769","1104744562428469248","1104367419181608960","1104344349431775232","1099932355458928640","1099694430204903424","1099299826418642944","1099285867724705799","1099013312694706176","1098998509498449921","1098938198888275971","1098893947290746880","1098860055561007105","1098826806038274048","1098821074278666242","1098776031006212099","1098727114986135552","1098709576080338950","1098705074363252736","1098704634254934016","1098703942467375111","1098701509267779587","1098690874291208192"]},{"title":"Advances in cellular and humoral immunotherapy–implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma","googleId":"LRnN55Oeeb4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15753","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15753","elsevierAuthor":"Chu Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"8","altmetricAuthors":["Yaya Chu","Aliza Gardenswartz","Amanda M. Termuhlen","Mitchell S. Cairo"],"twitterCount":3,"altmetricId":53631327,"statusesArray":["1082671281701412864","1082593393753112576","1082593042874417156"]},{"title":"Effect of renin‐angiotensin‐aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease","googleId":"ilBuyCepmQkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15651","googleCitationCount":11,"googleAuthor":"P Maitra","doi":"10.1111/bjh.15651","elsevierAuthor":"Thrower A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid …","googleId":"inJeh289jGQJ","googleLink":"http://orca.cf.ac.uk/123126/1/OTTMANN%2C%20Oliver%20-%20Phase%20I%20dose-escalation%20trial%20investi.pdf","googleCitationCount":14,"googleAuthor":"C Müller-Tidow","statusesArray":[]},{"title":"Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia","googleId":"XN1K16zCafIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15963","googleCitationCount":9,"googleAuthor":"A Piga","doi":"10.1111/bjh.15963","elsevierAuthor":"Aydinok Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4","altmetricAuthors":["Yesim Aydinok","Antonio Piga","Raffaella Origa","Nina Mufti","Anna Erickson","Anne North","Katie Waldhaus","Christine Ernst","Jin‐Sying Lin","Norman Huang","Richard J. Benjamin","Laurence Corash"],"twitterCount":1,"altmetricId":61460199,"statusesArray":["1135555754839150595"]},{"title":"Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6‐year population‐based cohort study","googleId":"PPn_uZsSA1UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15396","googleCitationCount":12,"googleAuthor":"J Zhou","doi":"10.1111/bjh.15396","elsevierAuthor":"Zhou J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"9","altmetricAuthors":["Jifang Zhou","Jin Han","Edith A. Nutescu","Victor R. Gordeuk","Santosh L. Saraf","Gregory S. Calip"],"twitterCount":4,"altmetricId":41724770,"statusesArray":["998198698520784897","997081979018412032","997081473655197697","996899877937451008"]},{"title":"An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell …","googleId":"zW7PRUJe6nkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15452","googleCitationCount":13,"googleAuthor":"ZS Lyu","doi":"10.1111/bjh.15452","elsevierAuthor":"Zhao H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"10","altmetricAuthors":["Hong-Yan Zhao","Zhong-Shi Lyu","Cai-Wen Duan","Yang Song","Ting-Ting Han","Xiao-Dong Mo","Yu Wang","Lan-Ping Xu","Xiao-Hui Zhang","Xiao-Jun Huang","Yuan Kong"],"twitterCount":2,"altmetricId":44593402,"statusesArray":["1015231353552547841","1015181082608582656"]},{"title":"New insights in Type I and II CD 20 antibody mechanisms‐of‐action with a panel of novel CD 20 antibodies","googleId":"Qj1cYY4RnDEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15132","googleCitationCount":15,"googleAuthor":"J Buijs","doi":"10.1111/bjh.15132","elsevierAuthor":"Meyer S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"12","altmetricAuthors":["Saskia Meyer","Mitchell Evers","Johannes H. M. Jansen","Jos Buijs","Blanca Broek","Stephanie E. Reitsma","Petra Moerer","Mojtaba Amini","Anna Kretschmer","Toine ten Broeke","Marcel T. den Hartog","Mark Rijke","Christian Klein","Thomas Valerius","Peter Boross","Jeanette H. W. Leusen"],"twitterCount":0,"altmetricId":81116088,"statusesArray":[]},{"title":"A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom","googleId":"vJnbHD5fPJUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16143","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.16143","elsevierAuthor":"Sharpley F.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"8","altmetricAuthors":["Faye A. Sharpley","Aviva Petrie","Shameem Mahmood","Sajitha Sachchithanantham","Helen J. Lachmann","Julian D. Gillmore","Carol J. Whelan","Marianna Fontana","Ana Martinez-Naharro","Cristina Quarta","Philip N. Hawkins","Ashutosh D. Wechalekar"],"twitterCount":6,"altmetricId":64986407,"statusesArray":["1322232534864928769","1162369172271247361","1162018689664897027","1161965341414576128","1161946899953270789","1161785040923254791","1161777837608755203"]},{"title":"Mesenchymal stem cells gene signature in high‐risk myeloma bone marrow linked to suppression of distinct IGFBP2‐expressing small adipocytes","googleId":"ErPM4yIwcBIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15669","googleCitationCount":10,"googleAuthor":"SJ Mehdi","doi":"10.1111/bjh.15669","elsevierAuthor":"Mehdi S.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"6","altmetricAuthors":["Syed J. Mehdi","Sarah K. Johnson","Joshua Epstein","Maurizio Zangari","Pingping Qu","Antje Hoering","Frits Rhee","Carolina Schinke","Sharmilan Thanendrarajan","Bart Barlogie","Faith E. Davies","Gareth J. Morgan","Shmuel Yaccoby"],"twitterCount":1,"altmetricId":51202033,"statusesArray":["1062900512239030272"]},{"title":"Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP 3/NF‐κB/SMAD pathway in patients with immune thrombocytopenia","googleId":"W73ujpMbkIUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15034","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15034","elsevierAuthor":"He Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"15","altmetricAuthors":["Yun He","Lin-Lin Xu","Fei-Er Feng","Qian-Ming Wang","Xiao-Lu Zhu","Chen-Cong Wang","Jia-Min Zhang","Hai-Xia Fu","Lan-Ping Xu","Kai-Yan Liu","Xiao-Jun Huang","Xiao-Hui Zhang"],"twitterCount":1,"altmetricId":33589341,"statusesArray":["967066300731109376"]},{"title":"Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population","googleId":"_4fRxyIuZ-EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15805","googleCitationCount":9,"googleAuthor":"L Magnano","doi":"10.1111/bjh.15805","elsevierAuthor":"Magnano L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7","altmetricAuthors":["Laura Magnano","Sara Alonso‐Alvarez","Miguel Alcoceba","Alfredo Rivas‐Delgado","Anna Muntañola","Ferran Nadeu","Xavier Setoain","Sonia Rodríguez","Marcio Andrade‐Campos","Natalia Espinosa‐Lara","Guillermo Rodríguez","Juan Manuel Sancho","Miriam Moreno","Santiago Mercadal","Itziar Carro","Antonio Salar","Francesc Garcia‐Pallarols","Reyes Arranz","Jimena Cannata","María J. Terol","Ana I. Teruel","Ana Jiménez‐Ubieto","Antonia Rodriguez","Sonia González de Villambrosía","José L. Bello","Lourdes López","Silvana Novelli","Erik Cabo","María E. Infante","Emilia Pardal","Silvia Monsalvo","Marcos González","Alejandro Martín","M. Dolores Caballero","Armando López‐Guillermo"],"twitterCount":13,"altmetricId":55945691,"statusesArray":["1118538070012366849","1118448408921092096","1118428354141728768","1100497016835268608","1100019780411633669","1099901561092927489","1099866773678112769","1099860366786351105","1099817679467225094","1099805351401213952","1099798474688815105","1099794147244982272","1099755753294966785","1099333376358662145","1099262711211483136"]},{"title":"Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon","googleId":"pqCWoQofMRgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15011","googleCitationCount":17,"googleAuthor":"A Wonkam","doi":"10.1111/bjh.15011","elsevierAuthor":"Wonkam A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"10","altmetricAuthors":["Ambroise Wonkam","Khuthala Mnika","Valentina J. Ngo Bitoungui","Bernard Chetcha Chemegni","Emile R. Chimusa","Collet Dandara","Andre P. Kengne"],"twitterCount":1,"altmetricId":53359510,"statusesArray":["1080320641985904641"]},{"title":"Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non …","googleId":"GhZvh8-JdBQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6200343/","googleCitationCount":29,"googleAuthor":"","statusesArray":[]},{"title":"Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study","googleId":"pKSrvfg3aXcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15513","googleCitationCount":13,"googleAuthor":"E Gyan","doi":"10.1111/bjh.15513","elsevierAuthor":"Gyan E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7","altmetricAuthors":["Emmanuel Gyan","Anne Sonet","Pauline Brice","Bruno Anglaret","Kamel Laribi","Christophe Fruchart","Hervé Tilly","Carla Araujo","Pierre Soubeyran","Hugo Gonzalez","Nadine Morineau","Emmanuelle Nicolas-Virelizier","Hervé Ghesquières","Bruno Salles","Réda Bouabdallah","Hubert Orfeuvre","Jonathan Fahri","Olivier Couturier","Luc Xerri","Pierre Feugier"],"twitterCount":24,"altmetricId":46630415,"statusesArray":["1041271532973170688","1040925332411482113","1040842778534506500","1040796785969487872","1040774319117197312","1040758468553039872","1040754312823988225","1040726505515569152","1040725439650652160","1040665456334569472","1040569563379912704","1040514066324889602","1040237911663431680","1039904991828422656","1039640976892080128","1039617808554962945","1039547240971415552","1039541063222996992","1039519884751908865","1039519403224657920","1039507598330945536","1039505796357283840","1030758275669782528","1030438122272763906","1030406436197679104"]},{"title":"Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin lymphoma","googleId":"PXh7WGi7uHwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15775","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15775","elsevierAuthor":"Ehrhardt M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"5","altmetricAuthors":["Matthew J. Ehrhardt","Jessica Hochberg","Kari L. Bjornard","Tara M. Brinkman"],"twitterCount":3,"altmetricId":54950959,"statusesArray":["1095320696463466497","1095318012834521088","1092519682370953216"]},{"title":"MEK 1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT‐737 under conditions that mimic the chronic …","googleId":"nkvcfDNuRuYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15282","googleCitationCount":12,"googleAuthor":"K Crassini","doi":"10.1111/bjh.15282","elsevierAuthor":"Crassini K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"11","altmetricAuthors":["Kyle Crassini","Yandong Shen","William S. Stevenson","Richard Christopherson","Chris Ward","Stephen P. Mulligan","O. Giles Best"],"twitterCount":0,"altmetricId":45505132,"statusesArray":[]},{"title":"The use of erythropoiesis‐stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib","googleId":"Q9vwXS-sQSAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15450","googleCitationCount":12,"googleAuthor":"EM Elli","doi":"10.1111/bjh.15450","elsevierAuthor":"Crisà E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8","altmetricAuthors":["Elena Crisà","Daniela Cilloni","Elena M. Elli","Vincenzo Martinelli","Giuseppe A. Palumbo","Novella Pugliese","Eloise Beggiato","Chiara Frairia","Marco Cerrano","Giuseppe Lanzarone","Monia Marchetti","Mauro Mezzabotta","Mario Boccadoro","Dario Ferrero"],"twitterCount":6,"altmetricId":44753153,"statusesArray":["1017100900614230023","1017041370853396481","1017041040715472896","1017028524048289792","1016982888351502336","1016544513190481920"]},{"title":"High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL …","googleId":"YIc5KSpurkgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15454","googleCitationCount":12,"googleAuthor":"L Arcaini","doi":"10.1111/bjh.15454","elsevierAuthor":"Avivi I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8","altmetricAuthors":["Irit Avivi","Luca Arcaini","Virginia V. Ferretti","Ariane Boumendil","Hervé Finel","Giuseppe Milone","Francesco Zaja","Devizzi Liliana","Maurizio Musso","Blaise Didier","Emmanuel Bachy","Mohammed Wattad","Emmanuelle Nicolas-Virelizier","Martin Gramatzki","Jean-Henri Bourhis","Denis Caillot","Anette Haenel","Gerhard Held","Catherine Thieblemont","Pavel Jindra","David Pohlreich","François Guilhot","Frank Kroschinsky","Björn Wahlin","Christof Scheid","Norbert Ifrah","Christian Berthou","Peter Dreger","Silvia Montoto","Annarita Conconi"],"twitterCount":9,"altmetricId":44751332,"statusesArray":["1110241923422478336","1043274900822216704","1042182211053805574","1040166960456192000","1031261607249235968","1017035634337374208","1016983036989198336","1016562370716372992","1016556047518007296","1016525798969208833"]},{"title":"Transplant results in adults with Fanconi anaemia","googleId":"nWHWYLpmsdEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15006","googleCitationCount":17,"googleAuthor":"M Bierings","doi":"10.1111/bjh.15006","elsevierAuthor":"Bierings M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"13","altmetricAuthors":["Marc Bierings","Carmem Bonfim","Regis Peffault De Latour","Mahmoud Aljurf","Parinda A. Mehta","Cora Knol","Farid Boulad","Abdelghani Tbakhi","Albert Esquirol","Grant McQuaker","Gulsan A. Sucak","Tarek B. Othman","Constantijn J. M. Halkes","Ben Carpenter","Dietger Niederwieser","Marco Zecca","Nicolaus Kröger","Mauricette Michallet","Antonio M. Risitano","Gerhard Ehninger","Raphael Porcher","Carlo Dufour"],"twitterCount":2,"altmetricId":29069246,"statusesArray":["934017533849559040","931616789620027393"]},{"title":"Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment","googleId":"zSX6W_5cSTcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15461","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15461","elsevierAuthor":"Stosch J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8","altmetricAuthors":["Juliane M. Stosch","Anezka Heumüller","Christoph Niemöller","Sabine Bleul","Maja Rothenberg-Thurley","Julian Riba","Nathalie Renz","Katarzyna Szarc vel Szic","Dietmar Pfeifer","Marie Follo","Heike L. Pahl","Stefan Zimmermann","Justus Duyster","Julius Wehrle","Michael Lübbert","Klaus H. Metzeler","Rainer Claus","Heiko Becker"],"twitterCount":6,"altmetricId":44531645,"statusesArray":["1040167228161884165","1015266633353318401","1015189630293983232","1015181088820346880","1015174162552197120","1014886950090788864"]},{"title":"Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological …","googleId":"S0bP3TyZtigJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16092","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.16092","elsevierAuthor":"Weisberg E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"6","altmetricAuthors":["Ellen Weisberg","Chengcheng Meng","Abigail E. Case","Martin Sattler","Hong L. Tiv","Prafulla C. Gokhale","Sara J. Buhrlage","Xiaoxi Liu","Jing Yang","Jinhua Wang","Nathanael Gray","Richard M. Stone","Sophia Adamia","Patrice Dubreuil","Sebastien Letard","James D. Griffin"],"twitterCount":4,"altmetricId":63656694,"statusesArray":["1219246081671946240","1152668560939872256","1151547890549981186","1151361415997005824"]},{"title":"Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V","googleId":"iz1pyzDhsPEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15525","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15525","elsevierAuthor":"Yada K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mature B‐NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","googleId":"2oCk6p00_UUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15734","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15734","elsevierAuthor":"Egan G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"8","altmetricAuthors":["Grace Egan","Stan Goldman","Sarah Alexander"],"twitterCount":4,"altmetricId":53563237,"statusesArray":["1082600839934550017","1082593047882420224","1082510428998168576","1082149600851566592"]},{"title":"Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas","googleId":"_K5xYSkdAXMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16118","googleCitationCount":5,"googleAuthor":"F Spriano","doi":"10.1111/bjh.16118","elsevierAuthor":"Spriano F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"3","altmetricAuthors":["Filippo Spriano","Chiara Tarantelli","Eugenio Gaudio","Magdalena M. Gerlach","Valdemar Priebe","Luciano Cascione","Elena Bernasconi","Altea Targa","Michele Mascia","Stefan Dirnhofer","Anastasios Stathis","Emanuele Zucca","Francesco Bertoni"],"twitterCount":4,"altmetricId":64286053,"statusesArray":["1156144497845100545","1156109013223923712","1156068799600349186","1155947538039500807"]},{"title":"Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta‐analysis of prospective studies","googleId":"O0qQInr_di0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15509","googleCitationCount":12,"googleAuthor":"A Welsher","doi":"10.1111/bjh.15509","elsevierAuthor":"Minhas H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"9","altmetricAuthors":["Hersimren Minhas","Arthur Welsher","Michelle Turcotte","Michelle Eventov","Suzanne Mason","Daniel K. Nishijima","Grégoire Versmée","Meirui Li","Kerstin de Wit"],"twitterCount":168,"altmetricId":45296961,"statusesArray":["1321968825005338624","1321968804147064832","1143620038454382594","1063846794612879360","1063845271510093826","1063844878747123712","1053076877777268736","1051897593758969857","1051828746179641350","1051739227761909760","1051723885366919168","1051712249226846208","1051597576858931200","1051568036522729472","1051531150869635072","1051529219891744768","1051507110540918785","1051506280647385088","1051416273622568960","1051415732830003200","1051410353572249601","1051393932838535169","1050121828541317121","1050121218622406656","1037406900772585472","1037400432535064577","1037361469837459456","1037360210225127425","1037261281366036480","1031647500778786816","1031644050766483456","1029463225614716928","1025504830671003648","1025488114217902080","1025479419790610433","1025419358716272640","1025355679085813761","1024636301084184578","1024430391938240512","1024380291551584256","1021813608936861697","1021668810447826944","1021628755368927232","1021586730674204673","1021586643873132544","1021475471588917249","1021464546907774976","1021378178995163136","1021360969937817600","1021360507083796483","1021332151432896513","1021324353772933120","1021287676215951360","1021252250117836800","1021174826197815296","1021149591184568322","1021147666980524033","1021140972795846658","1021124903330754560","1021123536088436737","1021117980875337728","1021109772836368384","1021107483400654848","1021092357092139008","1021078673510797313","1021068907254374401","1021027089745661952","1021026137785487360","1021025236542558208","1021013716907765760","1021003730198593537","1021002389325828097","1020996718962397185","1020994867969871872","1020993375909154816","1020989837757886466","1020982519041282049","1020980848273838082","1020980073648861184","1020979494352556035","1020978299483426816","1020978072265338880","1020967942723338240","1020963892619563009","1020963792052617216","1020963595583139845","1020962779019325440","1020959328025575424","1020956861313544192","1020956031600529413","1020954173154701312","1020953253058695175","1020952486415396864","1020952466085556225","1020950853753163776","1020950198598631430","1020949123854487552","1020947726702383104","1020945876792086530","1020944110448988160","1020941653778010112","1020941395614486528","1020939240518049792","1020932988262141954","1020931939358953472","1020926050191269894","1020925967546515456","1020925816325255168","1020922256090976258","1020918956524175361","1020912635905282054","1020910327695921152","1020897284626796555","1020873916989001728","1020858715279421442","1020852200161959936","1020845735196209154","1020845042594975744","1020843997835726849","1020831502282571776","1020830325855989760","1020824983881355264","1020823968113209347","1020822722849517568","1020817388114251776","1020813813740908546","1020791243612319744","1020779850062352385","1020763372558725121","1020763219114196993","1020722431273472002","1020673670199603202","1020667058466508800","1020648766032863233","1020647078408536064","1020644861417009152","1020627549184020481","1020625580864286720","1020613754558410752","1020613690054209536","1020611522966384640","1020607618442809344","1020606852298690560","1020597839875969024","1020593827076280320","1020587887841210368","1020575938029998085","1020571064798273536","1020555518333673472","1020553750061223936","1020552548149850112","1020551418330087424","1020510536050462720","1020496040326238208","1020490911501901824","1020473030764650496","1020468916848611328","1020467000571777026","1020460583068450817","1020457031508135937","1020453332085805056","1020452686100131841","1020452452296986624","1020452089028390913","1020447465030471682","1020445254019735552","1020444262666665985","1020442837735813120","1020441111255568386","1020417642123808768","1020403347969355777","1020392402098540546","1020390413797011456","1020390299351289857","1020387229661741056","1020383327486914562","1020380035251748864","1020376963293335553","1020376785941401604","1020376380050149376","1020375776540221441","1020375728137953281","1020371983098232832","1020363360158797826","1020362546300309506","1020358287500488704","1020357457011326977","1020350614285504512","1020350130443243520","1020349896266780679","1020349305629151232","1020348870931468291","1020348166938345473","1020347820782641153"]},{"title":"Transformed mucosa‐associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction‐based clonality analysis","googleId":"3ClPP8HH5NYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15953","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15953","elsevierAuthor":"Kiesewetter B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"What is pre‐fibrotic myelofibrosis and how should it be managed in 2018?","googleId":"UXyP15dxc10J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15562","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15562","elsevierAuthor":"Curto-Garcia N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"8","altmetricAuthors":["Natalia Curto-Garcia","Jean-Christophe Ianotto","Claire N. Harrison"],"twitterCount":0,"altmetricId":49974953,"statusesArray":[]},{"title":"Skewed megakaryopoiesis in human induced pluripotent stem cell‐derived haematopoietic progenitor cells harbouring calreticulin mutations","googleId":"0oxCRXUGQeQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15266","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15266","elsevierAuthor":"Takei H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"8","altmetricAuthors":["Hiraku Takei","Yoko Edahiro","Shuichi Mano","Nami Masubuchi","Yoshihisa Mizukami","Misa Imai","Soji Morishita","Kyohei Misawa","Tomonori Ochiai","Satoshi Tsuneda","Hiroshi Endo","Sou Nakamura","Koji Eto","Akimichi Ohsaka","Marito Araki","Norio Komatsu"],"twitterCount":1,"altmetricId":41455081,"statusesArray":["996218221656129536"]},{"title":"Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma …","googleId":"OEHdx-XSKc0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15504","googleCitationCount":11,"googleAuthor":"R Oostvogels","doi":"10.1111/bjh.15504","elsevierAuthor":"Oostvogels R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"8","altmetricAuthors":["Rimke Oostvogels","Margot Jak","Reinier Raymakers","Rogier Mous","Monique C. Minnema"],"twitterCount":4,"altmetricId":46215095,"statusesArray":["1026957850592137216","1026937798597718016","1026937115177824256","1026845426547191808","1026831824272510976"]},{"title":"Sustained treatment‐free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8 (+) T‐cells","googleId":"RvEekaP14gEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15858","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15858","elsevierAuthor":"Cayssials E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"6","altmetricAuthors":["Emilie Cayssials","Florence Jacomet","Nathalie Piccirilli","Lucie Lefèvre","Lydia Roy","François Guilhot","Jean‐Claude Chomel","Xavier Leleu","Jean‐Marc Gombert","André Herbelin","Alice Barbarin"],"twitterCount":4,"altmetricId":66963823,"statusesArray":["1273567620403429382","1175903208788697090","1175726609371979776","1106134065508503552"]},{"title":"Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease","googleId":"byEjdQDdtr4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15624","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15624","elsevierAuthor":"Carter M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"9","altmetricAuthors":["Melody C. Carter","Yun Bai","Karina N. Ruiz‐Esteves","Linda M. Scott","Daly Cantave","Hyejeong Bolan","Robin Eisch","Xiaoping Sun","Jamie Hahn","Irina Maric","Dean D. Metcalfe"],"twitterCount":7,"altmetricId":52230746,"statusesArray":["1080918095223353345","1080885175385497601","1080812200456044544","1080763947865788416","1080749734816555008","1070422637132820483","1070363965941788673"]},{"title":"Outcome of patients with myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT","googleId":"InO1EGkhUNsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15407","googleCitationCount":12,"googleAuthor":"R Szydlo","doi":"10.1111/bjh.15407","elsevierAuthor":"McLornan D.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"11","altmetricAuthors":["Donal P. McLornan","Richard Szydlo","Marie Robin","Anja van Biezen","Linda Koster","Henrik J. P. Blok","Maria T. Van Lint","Jürgen Finke","Antonin Vitek","Kristina Carlson","Laimonas Griskevicius","Ernst Holler","Maija Itälä-Remes","Michel Schaap","Gerard Socié","Jacques-Olivier Bay","Yves Beguin","Benedetto Bruno","Jan J. Cornelissen","Tobias Gedde-Dahl","Per Ljungman","Marie T. Rubio","Ibrahim Yakoub-Agha","Evgeny Klyuchnikov","Eduardo Olavarria","Yves Chalandon","Nicolaus Kröger"],"twitterCount":1,"altmetricId":45305126,"statusesArray":["1090206783694622720"]},{"title":"Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells","googleId":"ByNj04-U4wMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15515","googleCitationCount":9,"googleAuthor":"A Paulus","doi":"10.1111/bjh.15515","elsevierAuthor":"Paulus A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7","altmetricAuthors":["Aneel Paulus","Alak Manna","Sharoon Akhtar","Shumail M. Paulus","Mayank Sharma","Marie V. Coignet","Liuyan Jiang","Vivek Roy","Thomas E. Witzig","Stephen M. Ansell","John Allan","Richard Furman","Sonikpreet Aulakh","Rami Manochakian","Sikander Ailawadhi","Asher A. Chanan-Khan","Taimur Sher"],"twitterCount":6,"altmetricId":46331451,"statusesArray":["1040312337792675840","1036998326254792704","1027768856704688129","1027768101079842816","1027725697949806592","1027663421133778944","1027660797714096130"]},{"title":"Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro …","googleId":"HB9UoXEbZMYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15960","googleCitationCount":6,"googleAuthor":"N Jain","doi":"10.1111/bjh.15960","elsevierAuthor":"Khogeer H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"5","altmetricAuthors":["Haitham Khogeer","Haitham Rahman","Nitin Jain","Evgeniya A. Angelova","Hong Yang","Andres Quesada","Chi Y. Ok","Dawen Sui","Peng Wei","Areej Al Fattani","Sherry Pierce","Sanam Loghavi","Audrey Lamb","Peter Hu","Beenu Thakral","Rashmi Kanagal‐Shamanna","Jeffrey L. Jorgensen","Elias J. Jabbour","Hagop M. Kantarjian","L. Jeffrey Medeiros","Joseph D. Khoury"],"twitterCount":40,"altmetricId":60840010,"statusesArray":["1315318409890942976","1302355120273920006","1302330352745226240","1302308443060137987","1302308195344560130","1302308176163815426","1302301596794183680","1302287579946024961","1268486241210839040","1248392814687211522","1248378595719839746","1171460664172220418","1165427598396207106","1165304755876499456","1165285160620830721","1165249430662078464","1165210033212350464","1165196817916669953","1165094195801014272","1165084819530735617","1165076694446813184","1165054986302251008","1165047607342903296","1165047239972204544","1165046903400214534","1136965204531716096","1132792103745015809","1131750002366267400","1131542219549237248","1131534868997857281","1131523689751764992","1131508119790587904","1131500474455216130","1131499414537719808","1131472074508328960","1131461446913724421","1131461339371790336","1131436289339875328","1131415656006504448","1131405568160219136","1131403039951208448","1131400155939217408","1131397030063026179","1131388365964742662","1131388079535808518","1131384879965507591","1131263679297740800","1131238511246565376"]},{"title":"Outcome of CARE: a 6‐year national registry of acquired haemophilia A in China","googleId":"Zc9imEHb6fUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16128","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16128","elsevierAuthor":"Sun B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Infectious and immunological sequelae of daratumumab in multiple myeloma.","googleId":"rVZrBQhcuCkJ","googleLink":"https://europepmc.org/article/med/29974956","googleCitationCount":12,"googleAuthor":"","statusesArray":[]},{"title":"Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory …","googleId":"DLbwJeSGK_QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16097","googleCitationCount":7,"googleAuthor":"JMM Rondeel","doi":"10.1111/bjh.16097","elsevierAuthor":"Gooijer K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3","altmetricAuthors":["Koert Gooijer","Jan M. M. Rondeel","Fleur S. Dijk","Arjan G. J. Harsevoort","Guus J. M. Janus","Anton A. M. Franken"],"twitterCount":3,"altmetricId":64212535,"statusesArray":["1234489908296867841","1233773946887114754","1155377487679053824"]},{"title":"Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy …","googleId":"soGeHOisZtsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15520?","googleCitationCount":11,"googleAuthor":"JK Frazer","doi":"10.1111/bjh.15520","elsevierAuthor":"Frazer J.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"9","altmetricAuthors":["J. Kimble Frazer","Kevin J. Li","Paul J. Galardy","Sherrie L. Perkins","Anne Auperin","James R. Anderson","Ross Pinkerton","Allen Buxton","Thomas G. Gross","Jean Michon","Guy Leverger","Howard J. Weinstein","Lauren Harrison","Bruce Shiramizu","Mathew J. Barth","Stanton C. Goldman","Catherine Patte","Mitchell S. Cairo"],"twitterCount":3,"altmetricId":46670191,"statusesArray":["1032640815548456960","1032589562810380289","1030758272989638656"]},{"title":"Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER …","googleId":"VtLghtomYsoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15055","googleCitationCount":13,"googleAuthor":"MND Di Minno","doi":"10.1111/bjh.15055","elsevierAuthor":"Di Minno M.N.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"From bench to bedside: The past, present and future of therapy for systemic paediatric ALCL, ALK+","googleId":"8YRX6-hWIlUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15763","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15763","elsevierAuthor":"Larose H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple …","googleId":"-oZ_xw4Zi2YJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30931524/","googleCitationCount":8,"googleAuthor":"T Plesner","doi":"10.1111/bjh.15879,","elsevierAuthor":"Plesner T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients","googleId":"K8upFTM4pXoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15881","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15881","elsevierAuthor":"Schneidawind C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":["Corina Schneidawind","Simona Jahnke","Irmtraud Schober‐Melms","Michael Schumm","Rupert Handgretinger","Christoph Faul","Lothar Kanz","Wolfgang Bethge","Dominik Schneidawind"],"twitterCount":6,"altmetricId":57873229,"statusesArray":["1148310843748179968","1147963058003808256","1144349176035192833","1144225532017565697","1144193115709984768","1142892228215545856","1110997178259046403"]},{"title":"FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on CASP10 gene","googleId":"7BwThGR5bhcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16098","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16098","elsevierAuthor":"Miano M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study …","googleId":"P1orXyTp0xYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15799","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15799","elsevierAuthor":"Miyamura T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":["Takako Miyamura","Hiroshi Moritake","Hideki Nakayama","Shiro Tanaka","Daisuke Tomizawa","Norio Shiba","Akiko M. Saito","Akio Tawa","Akira Shimada","Shotaro Iwamoto","Yasuhide Hayashi","Takashi Koike","Keizo Horibe","Atsushi Manabe","Shuki Mizutani","Takashi Taga","Souichi Adachi"],"twitterCount":1,"altmetricId":55842017,"statusesArray":["1098538426532589568"]},{"title":"Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study-the FAIR Registry.","googleId":"IiW5Iiyjq2sJ","googleLink":"https://europepmc.org/article/med/29528100","googleCitationCount":15,"googleAuthor":"","statusesArray":[]},{"title":"Post‐partum haemorrhage and tranexamic acid: a global issue","googleId":"gcVaPcVApgoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15073","googleCitationCount":12,"googleAuthor":"I Roberts","doi":"10.1111/bjh.15073","elsevierAuthor":"Hibbs S.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"7","altmetricAuthors":["Stephen P. Hibbs","Ian Roberts","Haleema Shakur-Still","Beverley J. Hunt"],"twitterCount":33,"altmetricId":31689970,"statusesArray":["981417526570700800","981363574864986112","981288239926534144","972818298491621376","971757170764271616","971690843060015104","971669199113383941","971662594925891584","971395011102339073","954456962946813952","954445490950680579","954428388374171649","954365233790930944","954259713708802048","953237326322372608","953195051022209024","953194853806075904","953045124665237505","953032339134865409","953025765561552899","953018967836196865","953005352655687680","952994864022638593","952977372902559744","952931629621825536","952919846571749376","952918935933943810","952918118162190337","952908797831471105","952851496508493825","952840687682277376","952840364716675072","952832276802412544","952829295503773696","952828031353196544","952815728754741248","952812098668630016","952810268261838848"]},{"title":"Substratification of patients with newly diagnosed standard‐risk multiple myeloma","googleId":"3kcq3wec3QsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15800","googleCitationCount":6,"googleAuthor":"M Binder","doi":"10.1111/bjh.15800","elsevierAuthor":"Binder M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3","altmetricAuthors":["Moritz Binder","S. Vincent Rajkumar","Rhett P. Ketterling","Angela Dispenzieri","Martha Q. Lacy","Morie A. Gertz","Francis K. Buadi","Suzanne R. Hayman","Yi L. Hwa","Steven R. Zeldenrust","John A. Lust","Stephen J. Russell","Nelson Leung","Prashant Kapoor","Ronald S. Go","Wilson I. Gonsalves","Robert A. Kyle","Shaji K. Kumar"],"twitterCount":5,"altmetricId":55656750,"statusesArray":["1099329534527184897","1097744983375925254","1097688564811423746","1097685350317735936","1097316950655537152"]},{"title":"Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States","googleId":"yd5ZyYY_5B4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15923","googleCitationCount":6,"googleAuthor":"E Roberts","doi":"10.1111/bjh.15923","elsevierAuthor":"Geer M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"4","altmetricAuthors":["Marcus Geer","Emily Roberts","Maryann Shango","Brian G. Till","Stephen D. Smith","Hashim Abbas","Brian T. Hill","Jason Kaplan","Paul M. Barr","Paolo Caimi","Deborah M. Stephens","Emily Lin","Alex F. Herrera","Evan Rosenbaum","Jennifer E. Amengual","Philip S. Boonstra","Sumana Devata","Ryan A. Wilcox","Mark S. Kaminski","Tycel J. Phillips"],"twitterCount":4,"altmetricId":59881252,"statusesArray":["1125459773137330177","1125364484426616832","1125328184680099840","1124392148474970112"]},{"title":"Midostaurin abrogates CD 33‐directed Uni CAR and CD 33‐CD 3 bispecific antibody therapy in acute myeloid leukaemia","googleId":"jftqVoTJjCUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15975","googleCitationCount":7,"googleAuthor":"C Arndt","doi":"10.1111/bjh.15975","elsevierAuthor":"Fasslrinner F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"7","altmetricAuthors":["Frederick Fasslrinner","Claudia Arndt","Stefanie Koristka","Anja Feldmann","Heidi Altmann","Malte von Bonin","Marc Schmitz","Martin Bornhäuser","Michael Bachmann"],"twitterCount":1,"altmetricId":85972557,"statusesArray":["1284068938159095808"]},{"title":"Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units","googleId":"zx0BDySo1aEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15140","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15140","elsevierAuthor":"de Vries V.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"6","altmetricAuthors":["Vera A. Vries","Marcella C. A. Müller","M. Sesmu Arbous","Bart J. Biemond","Nicole M. A. Blijlevens","Nuray Kusadasi","Goda C. W. Choi","Alexander P. J. Vlaar","David J. Westerloo","Hanneke C. Kluin‐Nelemans","Walter M. Bergh","Marcella Müller","Alexander Vlaar","Bart Biemond","Pieter Roel Tuinman","Angelique Spoelstra","Marielle Wondergem","Sesmu Arbous","David v Westerloo","Erik Marijt","Nicole Blijlevens","Pieter Jobse","Murielle Hilkens","Jelle Epker","Annoek Broers","Walter van den Bergh","Hanneke Kluin‐Nelemans","Goda Choi","Vera de Vries","Astrid Demandt","Walther Mook","Anke Bruns"],"twitterCount":1,"altmetricId":36582897,"statusesArray":["984208333811961856"]},{"title":"Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study","googleId":"3IzQEavIj54J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16063","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16063","elsevierAuthor":"Kapustin D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX …","googleId":"oMU9_W2XAZUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15459","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15459","elsevierAuthor":"Royle K.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"11","altmetricAuthors":["Kara-Louise Royle","Walter M. Gregory","David A. Cairns","Sue E. Bell","Gordon Cook","Roger G. Owen","Mark T. Drayson","Faith E. Davies","Graham H. Jackson","Gareth J. Morgan","J. Anthony Child"],"twitterCount":5,"altmetricId":44740586,"statusesArray":["1018114914030899200","1017030749311127554","1016815629414928385","1016664079140839426","1016416627146067969"]},{"title":"Genotype/Phenotype correlations of childhood‐onset congenital sideroblastic anaemia in a European cohort","googleId":"jLpNrOcQTgEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16100","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16100","elsevierAuthor":"Fouquet C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3","altmetricAuthors":["Cyrielle Fouquet","Marie‐Amelyne Le Rouzic","Thierry Leblanc","Fanny Fouyssac","Guy Leverger","Laila Hessissen","Sandrine Marlin","Emmanuelle Bourrat","Mony Fahd","Emmanuel Raffoux","Jean‐Pierre Vannier","Nadja Jäkel","Ralf Knoefler","Valerie Triolo","Marlene Pasquet","Sophie Bayart","Isabelle Thuret","Patrick Lutz","Christiane Vermylen","Mohamed Touati","Christian Rose","Thomas Matthes","Bertrand Isidor","Caroline Kannengiesser","Stephane Ducassou"],"twitterCount":2,"altmetricId":76849543,"statusesArray":["1234505480107708417","1233780232219480066"]},{"title":"Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European …","googleId":"_QxBRem46t4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15973","googleCitationCount":5,"googleAuthor":"A Nagler","doi":"10.1111/bjh.15973","elsevierAuthor":"Nagler A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"5","altmetricAuthors":["Arnon Nagler","Myriam Labopin","Bhagirathbhai Dholaria","Jürgen Finke","Arne Brecht","Urs Schanz","Riitta Niittyvuopio","Andreas Neubauer","Martin Bornhäuser","Stella Santarone","Dietrich Beelen","Avichai Shimoni","Wolf Rösler","Sebastian Giebel","Bipin N. Savani","Mohamad Mohty"],"twitterCount":17,"altmetricId":60928777,"statusesArray":["1159812887260598272","1132497822367080448","1132369150188359691","1132048796983152643","1131964217454661632","1131916708510351361","1131838154946830341","1131827046835990528","1131816248722055168","1131812966905602049","1131681364070289408","1131661492649156609","1131627175222882305","1131608890519511040","1131602116076875776","1131580091992027136","1131565948224311296"]},{"title":"Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma","googleId":"i14qR3ZeikMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29411874/","googleCitationCount":13,"googleAuthor":"NWCJ van de Donk","doi":"10.1111/bjh.15122,","elsevierAuthor":"van de Donk N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mature outcomes and prognostic indices in diffuse large B‐cell lymphoma in Malawi: a prospective cohort","googleId":"dSWz578HvVsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15625","googleCitationCount":10,"googleAuthor":"MS Painschab","doi":"10.1111/bjh.15625","elsevierAuthor":"Painschab M.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"9","altmetricAuthors":["Matthew S. Painschab","Edwards Kasonkanji","Takondwa Zuze","Bongani Kaimila","Tamiwe Tomoka","Richard Nyasosela","Ruth Nyirenda","Bal M. Dhungel","Maurice Mulenga","Maria Chikasema","Blessings Tewete","Asekanadziwa Mtangwanika","Sarah Chiyoyola","Wilberforce Mhango","Fred Chimzimu","Coxcilly Kampani","Robert Krysiak","Thomas C. Shea","Nathan D. Montgomery","Yuri Fedoriw","Satish Gopal"],"twitterCount":2,"altmetricId":51653243,"statusesArray":["1066355110543011845","1064838163368161285"]},{"title":"TUBB 1 dysfunction in inherited thrombocytopenia causes genome instability","googleId":"74QUWoI4FKoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15835","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15835","elsevierAuthor":"Matsumura T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"5","altmetricAuthors":["Takayoshi Matsumura","Ayako Nakamura‐Ishizu","Kensuke Takaoka","Hiroaki Maki","Siva S. N. A. Muddineni","Chelsia Q. Wang","Hitoshi Suzushima","Makoto Kawakita","Norio Asou","Masao Matsuoka","Mineo Kurokawa","Motomi Osato","Toshio Suda"],"twitterCount":1,"altmetricId":62911407,"statusesArray":["1145383821220732929"]},{"title":"Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis","googleId":"zeE0I177R_0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14747?","googleCitationCount":15,"googleAuthor":"HJ Lachmann","doi":"10.1111/bjh.14747","elsevierAuthor":"Rezk T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"15","altmetricAuthors":["Tamer Rezk","Carol J. Whelan","Helen J. Lachmann","Marianna Fontana","Sajitha Sachchithanantham","Shameem Mahmood","Fakhar Khan","Raj Khiani","Joseph Tomson","Taryn Youngstein","Julian D. Gillmore","Philip N. Hawkins","Ashutosh D. Wechalekar"],"twitterCount":5,"altmetricId":20013267,"statusesArray":["994623836279754753","864724793223991296","864623389289447424","862307714415955969","862293651187171328"]},{"title":"Monitoring of post-transplant CBFB-MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell …","googleId":"V_FQRC2k-t8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27650511/","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.14340,","elsevierAuthor":"Tang F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Second primary malignancy after multiple myeloma‐population trends and cause‐specific mortality","googleId":"Kt2j6ncT7FYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15426","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15426","elsevierAuthor":"Costa L.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8","altmetricAuthors":["Luciano J. Costa","Kelly N. Godby","Saurabh Chhabra","Robert Frank Cornell","Parameswaran Hari","Smita Bhatia"],"twitterCount":19,"altmetricId":44547806,"statusesArray":["1016233393435095041","1016224432174632960","1016207552865021952","1016156953989582853","1016148012953845760","1016145987738439680","1015583013982343168","1015582485831454721","1015581204005969920","1015356801016107008","1015176376696045568","1015125592839204864","1015120563881304064","1015099054353571840","1015097430231126022","1015081941106819072","1015081367099658240","1015045667381698563","1015043259041796096","1015009639321219072","1014993107379769351","1014981369896849411"]},{"title":"Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity (ADCC), and complement …","googleId":"x_TiYaBKAw4J","googleLink":"https://eprints.soton.ac.uk/404348/","googleCitationCount":17,"googleAuthor":"","doi":"10.1111/bjh.14624","elsevierAuthor":"Lohse S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course","googleId":"CAtS5Y2xvhIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15672","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15672","elsevierAuthor":"Tang F.F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"6","altmetricAuthors":["Fei-Fei Tang","Xiao-Dong Mo","Yu Wang","Chen-Hua Yan","Yu-Hong Chen","Huan Chen","Wei Han","Ying-Jun Chang","Hai-Ying Zhang","Yan-Di Xie","Hui Ma","Lai Wei","Lan-Ping Xu","Xiao-Jun Huang","Xiao-Hui Zhang"],"twitterCount":1,"altmetricId":51219053,"statusesArray":["1063031874597998592"]},{"title":"Time to treatment is an independent prognostic factor in aggressive non‐Hodgkin lymphomas","googleId":"0kjXodv_mp8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15224","googleCitationCount":11,"googleAuthor":"AJ Olszewski","doi":"10.1111/bjh.15224","elsevierAuthor":"Olszewski A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10","altmetricAuthors":["Adam J. Olszewski","Thomas Ollila","John L. Reagan"],"twitterCount":11,"altmetricId":39306017,"statusesArray":["992734079534628866","992687066587820032","990665049780998145","990632979545444353","990629124468346882","990272029248118789","990265482140938240","989852921901801473","989849537241145344","989805852956782592","989443128154193920","989259547633217538","989215608859447296"]},{"title":"Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter …","googleId":"aeFUUgoNOioJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15816","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15816","elsevierAuthor":"Rusconi C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"6","altmetricAuthors":["Chiara Rusconi","Antonella Anastasia","Annalisa Chiarenza","Luigi Marcheselli","Federica Cavallo","Sara Rattotti","Barbara Botto","Angela Ferrari","Luca Nassi","Chiara Pagani","Erika Meli","Luca Arcaini","Massimo Federico","Giuseppe Rossi"],"twitterCount":8,"altmetricId":56054472,"statusesArray":["1256912584957198336","1256851769289818112","1101208331438436353","1100526362777899008","1100498416562569226","1100463042981171200","1100433082115596289","1100289313357479936","1100287742888550401","1099262716949217282"]},{"title":"Radiation exposure and longitudinal changes in peripheral monocytes over 50 years: the Adult Health Study of atomic‐bomb survivors","googleId":"nbXrtW0KU6MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15750","googleCitationCount":7,"googleAuthor":"B French","doi":"10.1111/bjh.15750","elsevierAuthor":"Yoshida K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":["Kengo Yoshida","Benjamin French","Noriaki Yoshida","Ayumi Hida","Waka Ohishi","Yoichiro Kusunoki"],"twitterCount":5,"altmetricId":53972038,"statusesArray":["1087511990849785856","1087329241253855232","1087270972766339072","1087269682594213889","1085296599205433344"]},{"title":"Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma","googleId":"l46yhqPJYowJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15889","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15889","elsevierAuthor":"Burkart M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"5","altmetricAuthors":["Madelyn Burkart","Michael Schieber","Sanjib Basu","Palmi Shah","Parameswaran Venugopal","Jeffrey A. Borgia","Leo Gordon","Reem Karmali"],"twitterCount":1,"altmetricId":62605542,"statusesArray":["1143006546630041601"]},{"title":"ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia","googleId":"3mJi2wnCNoEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15531","googleCitationCount":9,"googleAuthor":"C Marconi","doi":"10.1111/bjh.15531","elsevierAuthor":"Faleschini M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"6","altmetricAuthors":["Michela Faleschini","Federica Melazzini","Caterina Marconi","Tania Giangregorio","Tommaso Pippucci","Elena Cigalini","Alessandro Pecci","Roberta Bottega","Ugo Ramenghi","Timo Siitonen","Marco Seri","Annalisa Pastore","Anna Savoia","Patrizia Noris"],"twitterCount":2,"altmetricId":51784735,"statusesArray":["1067232447241187329","1067200067206094851"]},{"title":"Ibrutinib induces rapid down‐regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia‐related genes in blood and lymph nodes","googleId":"u6TpdIvNxb4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15516","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15516","elsevierAuthor":"Palma M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7","altmetricAuthors":["Marzia Palma","Aleksandra Krstic","Lucia Peña Perez","Anna Berglöf","Stephan Meinke","Qing Wang","K. Emelie M. Blomberg","Masood Kamali-Moghaddam","Qiujin Shen","Georg Jaremko","Jeanette Lundin","Ayla De Paepe","Petter Höglund","Eva Kimby","Anders Österborg","Robert Månsson","C. I. Edvard Smith"],"twitterCount":2,"altmetricId":46796450,"statusesArray":["1032990588759678978","1032898912372383745","1031972907717517312"]},{"title":"Cognitive impairment in hodgkin lymphoma survivors","googleId":"ul1GW_rb0_sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15448","googleCitationCount":10,"googleAuthor":"E Trachtenberg","doi":"10.1111/bjh.15448","elsevierAuthor":"Trachtenberg E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"10","altmetricAuthors":["Estherina Trachtenberg","Tatiana Mashiach","Rachel Ben Hayun","Tamar Tadmor","Tali Fisher","Judith Aharon-Peretz","Eldad J. Dann"],"twitterCount":21,"altmetricId":44851678,"statusesArray":["1018161788032987137","1017811396963205120","1017803045806202880","1017778908555460610","1017769603190198272","1017763607550054400","1017731871109722112","1017728094025801730","1017310158207291392","1017146204495450114","1017081945983987714","1017066035608944641","1017053590458904576","1017023164495355904","1016932942222909440","1016932049066737665","1016827820843196417","1016825697418072065","1016821786334425088","1016820836978823168","1016818731165634566","1016806609518022657"]},{"title":"Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation","googleId":"vWyhXbMHY1wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15244","googleCitationCount":12,"googleAuthor":"R Chakraborty","doi":"10.1111/bjh.15244","elsevierAuthor":"Chakraborty R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"6","altmetricAuthors":["Rajshekhar Chakraborty","Eli Muchtar","Shaji K. Kumar","Francis K. Buadi","David Dingli","Angela Dispenzieri","Suzanne R. Hayman","William J. Hogan","Prashant Kapoor","Martha Q. Lacy","Nelson Leung","Rahma Warsame","Taxiarchis Kourelis","Wilson Gonsalves","Morie A. Gertz"],"twitterCount":9,"altmetricId":40368849,"statusesArray":["1015812916858089474","1015812696715886592","1015177045557612544","991783531272704000","991774469957005312","991669719492112384","991669717336195073","991669214011383809","991668741049061376","991296251617579008","991295728717844484"]},{"title":"Anti‐αIIbβ3 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations","googleId":"gtltgr9OvkkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15087","googleCitationCount":10,"googleAuthor":"M Fiore","doi":"10.1111/bjh.15087","elsevierAuthor":"Fiore M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"3","altmetricAuthors":["Mathieu Fiore","Roseline d'Oiron","Xavier Pillois","Marie-Christine Alessi"],"twitterCount":14,"altmetricId":35765063,"statusesArray":["1005206889360166913","991611880073519105","991345379743535104","991275416718585861","991274396374458371","991239883359506432","991235483752718336","991217838110191616","991199045812215808","991101289684656128","991068262204092417","991067281596628992","991058130841882624","991056735082307585"]},{"title":"Saposin C is a frequent target of paraproteins in Gaucher disease‐associated MGUS/multiple myeloma","googleId":"XJFsgolWi0AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15659","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15659","elsevierAuthor":"Preuss K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"7","altmetricAuthors":["Klaus-Dieter Preuss","Carla E. M. Hollak","Natalie Fadle","Marinus van Oers","Evi Regitz","Michael Pfreundschuh"],"twitterCount":1,"altmetricId":53704148,"statusesArray":["1083091035394195456"]},{"title":"Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal …","googleId":"v6lZsBoavOEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15145","googleCitationCount":11,"googleAuthor":"KA Nguyen","doi":"10.1111/bjh.15145","elsevierAuthor":"Nguyen K.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"8","altmetricAuthors":["Kevin A. Nguyen","Chang Su","Harrison X. Bai","Zishu Zhang","Rong Xiao","Giorgos Karakousis","Paul J. Zhang","Guiying Zhang"],"twitterCount":4,"altmetricId":35139541,"statusesArray":["982976415086891008","982718154358083584","980876744810029061","980864111885025280"]},{"title":"Validation of the MCL 35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network","googleId":"RRrpLMx4jdMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15519","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15519","elsevierAuthor":"Rauert-Wunderlich H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5","altmetricAuthors":["Hilka Rauert‐Wunderlich","Anja Mottok","David W. Scott","Lisa M. Rimsza","German Ott","Wolfram Klapper","Michael Unterhalt","Hanneke C. Kluin‐Nelemans","Olivier Hermine","Sylvia Hartmann","Christoph Thorns","Grzegorz Rymkiewicz","Harald Holte","Martin Dreyling","Eva Hoster","Andreas Rosenwald"],"twitterCount":6,"altmetricId":46398563,"statusesArray":["1029133237292032001","1028801047207272448","1028756552675733507","1028753615647846400","1028342339281014784","1028220364105625600"]},{"title":"Renal protection by atorvastatin in a murine model of sickle cell nephropathy","googleId":"Lc9yuLcxSZgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15157","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15157","elsevierAuthor":"Zahr R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma","googleId":"yMYirMuUfMgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15801","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15801","elsevierAuthor":"Romano A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5","altmetricAuthors":["Alessandra Romano","Nunziatina L. Parrinello","Annalisa Chiarenza","Giovanna Motta","Daniele Tibullo","Cesarina Giallongo","Piera La Cava","Giuseppina Camiolo","Fabrizio Puglisi","Giuseppe A. Palumbo","Francesco Di Raimondo"],"twitterCount":3,"altmetricId":55593814,"statusesArray":["1096748005364039681","1096726387157856256","1096704200606736384"]},{"title":"Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm","googleId":"n4gp5cLez4EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15556","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15556","elsevierAuthor":"van der Pol L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"9","altmetricAuthors":["Liselotte M. van der Pol","Ingrid M. Bistervels","Thijs E. van Mens","Tom van der Hulle","Ludo F. M. Beenen","Paul L. den Exter","Lucia J. M. Kroft","Albert T. A. Mairuhu","Saskia Middeldorp","Jaap M. van Werkhoven","Marije ten Wolde","Menno V. Huisman","Frederikus A. Klok"],"twitterCount":36,"altmetricId":48137377,"statusesArray":["1052120037144883202","1052107890214010886","1047104133294149633","1046970560520032260","1046850582105837569","1046705532055310337","1046335499051372544","1046114450959474688","1045803506366631936","1045760427613986818","1045659522667286530","1045545039059804160","1045519765127794688","1045504980835344387","1045469203116052480","1045464614086029313","1045454864388632577","1045425810839142402","1045420237582225409","1045416972454940672","1045408195668307969","1045396987934314499","1045390571861409794","1045388121309937665","1045369806625615872","1045367024799674368","1045365629115555840","1045354655075700736","1045345072462614528","1045341051811241984","1045338673632296961","1045333770067480578","1045332671344381952","1045330220729937922","1045326462247743488","1040992531373326337","1040231154698412032","1039666133849190400"]},{"title":"MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma","googleId":"2e8vMF9S4gQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30408153/","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15674,","elsevierAuthor":"Hiemcke-Jiwa L.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia","googleId":"LCH0ZM96UlQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30203832/","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.15593,","elsevierAuthor":"Zwaan C.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Closing the survivorship gap in children and adolescents with Hodgkin lymphoma","googleId":"Sv2e9TxJjVwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16197","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16197","elsevierAuthor":"Castellino S.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"2","altmetricAuthors":["Sharon M. Castellino","Susan K. Parsons","Kara M. Kelly"],"twitterCount":1,"altmetricId":67518665,"statusesArray":["1178974243956150272"]},{"title":"Developments beyond blood group serology in the genomics era","googleId":"FgUI5LAC-HIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15747","googleCitationCount":7,"googleAuthor":"CA Hyland","doi":"10.1111/bjh.15747","elsevierAuthor":"Hyland C.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4","altmetricAuthors":["Catherine A. Hyland","Eileen V. Roulis","Elizna M. Schoeman"],"twitterCount":4,"altmetricId":54929662,"statusesArray":["1361080489281544196","1093171443138027521","1092958959114174465","1092390712887390208"]},{"title":"Recent advances in understanding the pathogenesis and management of reticular dysgenesis","googleId":"YzGYV_DEyf8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15045","googleCitationCount":13,"googleAuthor":"","doi":"10.1111/bjh.15045","elsevierAuthor":"Hoenig M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"9","altmetricAuthors":["Manfred Hoenig","Ulrich Pannicke","Hubert B. Gaspar","Klaus Schwarz"],"twitterCount":2,"altmetricId":30818834,"statusesArray":["1081194585773228032","944367209580769280"]},{"title":"Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients","googleId":"_wHkwDvUzVwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15092","googleCitationCount":13,"googleAuthor":"A Jurczyszyn","doi":"10.1111/bjh.15092","elsevierAuthor":"Jurczyszyn A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"10","altmetricAuthors":["Artur Jurczyszyn","Jakub Radocha","Julio Davila","Mark A. Fiala","Alessandro Gozzetti","Norbert Grząśko","Paweł Robak","Iwona Hus","Anna Waszczuk-Gajda","Renata Guzicka-Kazimierczak","Erden Atilla","Giuseppe Mele","Waldemar Sawicki","David S. Jayabalan","Grzegorz Charliński","Agoston G. Szabo","Roman Hajek","Michel Delforge","Agnieszka Kopacz","Dorotea Fantl","Anders Waage","Irit Avivi","Marek Rodzaj","Xavier Leleu","Valentine Richez","Wanda Knopińska-Posłuszny","Anna Masternak","Andrew J. Yee","Agnieszka Barchnicka","Agnieszka Druzd-Sitek","Thomas Guerrero-Garcia","Jieqi Liu","David H. Vesole","Jorge J. Castillo"],"twitterCount":10,"altmetricId":31390981,"statusesArray":["1363522370535849998","956135365257015298","951639290706104321","951464900920045569","951454825463648256","951453651792515072","951079449025376256","950250694816169985","950249839719337984","950239622684200960"]},{"title":"Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era","googleId":"y0KiSFXs0DwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16090","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16090","elsevierAuthor":"Prusila R.E.I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"4","altmetricAuthors":["Roosa E. I. Prusila","Marc Sorigue","Jyrki Jauhiainen","Santiago Mercadal","Aleksi Postila","Petteri Salmi","Taru Tanhua","Susanna Tikkanen","Sakari Kakko","Hanne Kuitunen","Marjukka Pollari","Ilja Nystrand","Milla E. L. Kuusisto","Kaija Vasala","Esa Jantunen","Eija Korkeila","Peeter Karihtala","Juan‐Manuel Sancho","Taina Turpeenniemi‐Hujanen","Outi Kuittinen"],"twitterCount":13,"altmetricId":63119745,"statusesArray":["1169282042439380992","1168966311592038403","1168757439627481088","1168665797063008256","1147092032730619906","1146952779824603137","1146870180204765185","1146848338953822209","1146848218061377536","1146836277527924736","1146827276614422528","1146819490866487296","1146816678719819778","1146803534370922497","1146780968554045440","1146720818195566592"]},{"title":"Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study","googleId":"-ngwROPNkr0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29611177/","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.15149,","elsevierAuthor":"Link B.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy","googleId":"nQ41Kz1s8QAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29363736/","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.15096,","elsevierAuthor":"Lapa C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"PML/RARA inhibits expression of HSP 90 and its target AKT","googleId":"HKWVJgN7Ol4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15715","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15715","elsevierAuthor":"Piredda M.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"5","altmetricAuthors":["Maria Liliana Piredda","Girish Gaur","Gianfranco Catalano","Mariadomenica Divona","Cristina Banella","Serena Travaglini","Maria Carmen Puzzangara","Maria Teresa Voso","Francesco Lo‐Coco","Nelida Ines Noguera"],"twitterCount":2,"altmetricId":66840925,"statusesArray":["1175001965497073664","1174715101443760128"]},{"title":"Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma","googleId":"xpMOyUP2exsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16105","googleCitationCount":4,"googleAuthor":"M Delforge","doi":"10.1111/bjh.16105","elsevierAuthor":"Hájek R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2","altmetricAuthors":["Roman Hájek","Michel Delforge","Marc S. Raab","Paul Schoen","Lucy DeCosta","Ivan Spicka","Jakub Radocha","Ludek Pour","Sebastian Gonzalez‐McQuire","Walter Bouwmeester"],"twitterCount":3,"altmetricId":64706441,"statusesArray":["1159433770891730945","1159371998360940544","1159344156868775936"]},{"title":"Identification of genetic biomarkers for alloimmunization in sickle cell disease","googleId":"m49pf4teTZEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15998","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15998","elsevierAuthor":"Meinderts S.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Haematology patients and the risk of transfusion transmitted infection","googleId":"Cj7n4Z3I-PwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15030","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.15030","elsevierAuthor":"Ainley L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B‐symptoms","googleId":"bmE9dhU0FnMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15703","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15703","elsevierAuthor":"Gholiha A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6","altmetricAuthors":["Alex R. Gholiha","Peter Hollander","Gustaf Hedstrom","Christer Sundstrom","Daniel Molin","Karin E. Smedby","Henrik Hjalgrim","Ingrid Glimelius","Rose‐Marie Amini","Gunilla Enblad"],"twitterCount":8,"altmetricId":52387015,"statusesArray":["1091739526903533568","1091689347554922497","1091391804929388546","1091387156742979590","1071971583441408000","1071833526184620034","1071833473101508611","1071684067739848707","1071462577568387081","1071419436555481091","1071405176613941250"]},{"title":"Energy metabolism and drug response in myeloid leukaemic stem cells","googleId":"WnxVlItF4wAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16074","googleCitationCount":3,"googleAuthor":"AE Bencomo‐Alvarez","doi":"10.1111/bjh.16074","elsevierAuthor":"Bencomo-Alvarez A.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"3","altmetricAuthors":["Alfonso E. Bencomo‐Alvarez","Andres J. Rubio","Mayra A. Gonzalez","Anna M. Eiring"],"twitterCount":1,"altmetricId":83454095,"statusesArray":["1268727501552930816"]},{"title":"Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia","googleId":"ik2qYMm5MJYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15776","googleCitationCount":8,"googleAuthor":"RM Ayling","doi":"10.1111/bjh.15776","elsevierAuthor":"Ayling R.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"7","altmetricAuthors":["Ruth M. Ayling","Stephen J. Lewis","Finbarr Cotter"],"twitterCount":1,"altmetricId":54940179,"statusesArray":["1092445646706098176"]},{"title":"Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial","googleId":"bfeMkjkRdbUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16059","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.16059","elsevierAuthor":"Boyle E.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"7","altmetricAuthors":["Eileen M. Boyle","Xavier Leleu","Marie‐Odile Petillon","Lionel Karlin","Chantal Doyen","Hélène Demarquette","Bruno Royer","Margaret Macro","Philippe Moreau","Karel Fostier","Chretien Marie‐Lorraine","Charles Zarnitsky","Aurore Perrot","Charles Herbaux","Stephanie Poulain","Salomon Manier","David Beauvais","Brian A. Walker","Christopher P. Wardell","Laure Vincent","Laurent Frenzel","Hélène Caillon","Schraen Susanna","Thomas Dejoie","Hervé Avet‐Loiseau","Mohamad Mohty","Thierry Facon","Bertrand Arnulf","Mamoun Dib","Sabine Brechignac‐Bureau","Pascal Godmer","Adrian Tempescul","Cecile Fohrer","Lotfi Benboubker","Laurent Voillat","Jean Valère Malfuson","Clara Mariette","Mourad Tiab","Sophie Rigaudeau","Arnaud Jaccard","Anne‐Marie Stoppa","Jean‐Claude Eisenmann","Philippe Rodon","Brigitte Kolb","Olivier Decaux","Brigitte Onraed","Michel Attal","Cyrille Hulin"],"twitterCount":4,"altmetricId":62605703,"statusesArray":["1200834678992842752","1193286593991327745","1143561058050826241","1143008242143903745"]},{"title":"Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients","googleId":"E43S3UW1hMIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15668","googleCitationCount":7,"googleAuthor":"L Catani","doi":"10.1111/bjh.15668","elsevierAuthor":"Palandri F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical relevance of pulmonary vasculature involvement in sickle cell disease","googleId":"pxtaUz1l6c4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15795","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15795","elsevierAuthor":"Carstens G.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types","googleId":"YoI5rG1hYyoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28699643/?dopt=Abstract","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.14843,","elsevierAuthor":"D'Agaro T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Risk factors for Burkitt lymphoma: a nested case‐control study in the UK Clinical Practice Research Datalink","googleId":"iI_Mrvth-ZwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15229","googleCitationCount":9,"googleAuthor":"P Karimi","doi":"10.1111/bjh.15229","elsevierAuthor":"Karimi P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"6","altmetricAuthors":["Parisa Karimi","Brenda M. Birmann","Lesley A. Anderson","Charlene M. McShane","Shahinaz M. Gadalla","Joshua N. Sampson","Sam M. Mbulaiteye"],"twitterCount":3,"altmetricId":38594170,"statusesArray":["988250512947589120","987695118164643840","987633545928622082"]},{"title":"How we manage patients with Waldenström macroglobulinaemia","googleId":"xKc1yaJ3VGgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15202","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15202","elsevierAuthor":"Simon L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"5","altmetricAuthors":["Laurence Simon","Marine Baron","Véronique Leblond"],"twitterCount":3,"altmetricId":36643211,"statusesArray":["1010102507312500736","984290296308649984","984288642762985472"]},{"title":"Requirement for etoposide in the initial treatment of Epstein‐Barr virus–associated haemophagocytic lymphohistiocytosis","googleId":"Lw2RnzirQqYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15988","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15988","elsevierAuthor":"Song Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"3","altmetricAuthors":["Yue Song","Yini Wang","Zhao Wang"],"twitterCount":1,"altmetricId":60855574,"statusesArray":["1131287622947622912"]},{"title":"Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosis","googleId":"_QkEM0DgmZoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15541","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15541","elsevierAuthor":"Sharpley F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"8","altmetricAuthors":["Faye A. Sharpley","Richa Manwani","Shameem Mahmood","Sajitha Sachchithanantham","Helen Lachmann","Julian Gilmore","Carol Whelan","Phillip Hawkins","Ashutosh Wechalekar"],"twitterCount":5,"altmetricId":46398983,"statusesArray":["1166738012358807558","1043170881781018624","1029751106929393664","1029714323784970241","1028223525838974977"]},{"title":"JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative …","googleId":"p98MGUiR4wkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15276","googleCitationCount":10,"googleAuthor":"R Manur","doi":"10.1111/bjh.15276","elsevierAuthor":"Aynardi J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"10","altmetricAuthors":["Jason Aynardi","Rashmi Manur","Paul R. Hess","Seble Chekol","Jennifer J. D. Morrissette","Daria Babushok","Elizabeth Hexner","Heesun J. Rogers","Eric D. Hsi","Elizabeth Margolskee","Attilio Orazi","Robert Hasserjian","Adam Bagg"],"twitterCount":3,"altmetricId":41819598,"statusesArray":["1001054424318513152","999677906837295104","997117134311342084"]},{"title":"Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non‐Hodgkin lymphoma","googleId":"uzwJPHJQls4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15702","googleCitationCount":9,"googleAuthor":"JM Umakanthan","doi":"10.1111/bjh.15702","elsevierAuthor":"Umakanthan J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"5","altmetricAuthors":["Jayadev M. Umakanthan","Javeed Iqbal","Connie L. Batlevi","Alyssa Bouska","Lynette M. Smith","Valerie Shostrom","Heather Nutsch","Basem M. William","R. Gregory Bociek","Matthew Lunning","Philip Bierman","Anas Younes","James O. Armitage","Julie M. Vose"],"twitterCount":2,"altmetricId":52343660,"statusesArray":["1072895446727704577","1071067570516705280"]},{"title":"Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma","googleId":"IbwuR14Qpl4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15676","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15676","elsevierAuthor":"Galati D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5","altmetricAuthors":["Domenico Galati","Serena Zanotta","Gaetano Corazzelli","Dario Bruzzese","Gaetana Capobianco","Emanuela Morelli","Manuela Arcamone","Rosaria De Filippi","Antonio Pinto"],"twitterCount":1,"altmetricId":51217241,"statusesArray":["1063024741236293632"]},{"title":"Wilms tumour 1 peptide vaccine as a cure‐oriented post‐chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse","googleId":"qOJAkGr_2CoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14768?af=R","googleCitationCount":15,"googleAuthor":"","doi":"10.1111/bjh.14768","elsevierAuthor":"Nakata J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"8","altmetricAuthors":["Jun Nakata","Yoshiki Nakae","Manabu Kawakami","Soyoko Morimoto","Daisuke Motooka","Naoki Hosen","Fumihiro Fujiki","Hiroko Nakajima","Kana Hasegawa","Sumiyuki Nishida","Akihiro Tsuboi","Yusuke Oji","Yoshihiro Oka","Atsushi Kumanogoh","Haruo Sugiyama"],"twitterCount":5,"altmetricId":20573647,"statusesArray":["1135849266759573510","876665023464169472","876160796811640832","868067587770392576","868052928052961281","868044708907495424"]},{"title":"MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine","googleId":"qW-v7izAJ-QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15595","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15595","elsevierAuthor":"Pepe A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"6","altmetricAuthors":["Alessia Pepe","Antonella Meloni","Laura Pistoia","Liana Cuccia","Maria R. Gamberini","Roberto Lisi","Domenico G. D'Ascola","Rosamaria Rosso","Massimo Allò","Anna Spasiano","Gennaro Restaino","Riccardo Righi","Maurizio Mangione","Vincenzo Positano","Paolo Ricchi"],"twitterCount":2,"altmetricId":49954090,"statusesArray":["1056775652001697793","1053411229580980224"]},{"title":"Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome","googleId":"PXvnUSJ3YuoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16106","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16106","elsevierAuthor":"Vannata B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3","altmetricAuthors":["Barbara Vannata","Annarita Conconi","Jonas Winkler","Luciano Cascione","Gloria Margiotta Casaluci","Luca Nassi","Riccardo Moia","Maria Cristina Pirosa","Alden A. Moccia","Anastasios Stathis","Davide Rossi","Gianluca Gaidano","Emanuele Zucca"],"twitterCount":9,"altmetricId":64646498,"statusesArray":["1166659171489468416","1166658576737296389","1166620792613945345","1166614772915343360","1166584639953264640","1166584616528089089","1159042544094912537","1158979659998158850","1158840732595228672"]},{"title":"The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long‐term follow‐up results from BSBMT/UKMF …","googleId":"cdWf1mJpyoEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15782","googleCitationCount":10,"googleAuthor":"G Cook","doi":"10.1111/bjh.15782","elsevierAuthor":"Cook G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5","altmetricAuthors":["Gordon Cook","Kara‐Louise Royle","Sheila O'Connor","David A. Cairns","A. John Ashcroft","Cathy D. Williams","Anna Hockaday","Jamie D. Cavenagh","John A. Snowden","Debo Ademokun","Eleni Tholouli","Vivienne E. Andrews","Matthew Jenner","Christopher Parrish","Kwee Yong","Jim Cavet","Hannah Hunter","Jenny M. Bird","Guy Pratt","Mark T. Drayson","Julia M. Brown","Treen C. M. Morris"],"twitterCount":16,"altmetricId":55071381,"statusesArray":["1174277198854967301","1131402898297053184","1119269220875948032","1119213815210696704","1098900376206622721","1095394156778831875","1094703405094846467","1094218802143875072","1093963356317278208","1093878239750176768","1093614207633891329","1093484904371941376","1093452142264885248","1093451816573042688","1093450679228739584","1093449334346211329"]},{"title":"Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry","googleId":"JxMZIzd0-QkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16139","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16139","elsevierAuthor":"Terebelo H.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1","altmetricAuthors":["Howard R. Terebelo","Rafat Abonour","Cristina J. Gasparetto","Kathleen Toomey","Brian G. M. Durie","James W. Hardin","Sundar Jagannath","Lynne Wagner","Mohit Narang","E. Dawn Flick","Shankar Srinivasan","Lihua Yue","Amani Kitali","Amit Agarwal","Robert M. Rifkin"],"twitterCount":11,"altmetricId":64629855,"statusesArray":["1216373273723908098","1216328152441597953","1216307251834753030","1216256308179062784","1215982624872763393","1198205457279533056","1198205444663070720","1198088549200846849","1198088086787215360","1163960079831502848","1163644688424951808","1158781596574605312","1158715943964594176"]},{"title":"Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia","googleId":"-lxP3kQLCdYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15441","googleCitationCount":9,"googleAuthor":"DC Rees","doi":"10.1111/bjh.15441","elsevierAuthor":"Hannemann A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"7","altmetricAuthors":["Anke Hannemann","David C. Rees","John N. Brewin","Andreas Noe","Ben Low","John S. Gibson"],"twitterCount":1,"altmetricId":44158287,"statusesArray":["1011602660045262855"]},{"title":"Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia …","googleId":"6KhdB-MxjQIJ","googleLink":"https://kyushu-u.pure.elsevier.com/en/publications/follow-up-of-a-randomised-phase-ii-study-of-chemotherapy-alone-or","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.15123","elsevierAuthor":"Ishida T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Modern principles in the management of nodular lymphocyte‐predominant Hodgkin lymphoma","googleId":"Wxk8fIAZ0poJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15616","googleCitationCount":8,"googleAuthor":"G Varma","doi":"10.1111/bjh.15616","elsevierAuthor":"Spinner M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6","altmetricAuthors":["Michael A. Spinner","Gaurav Varma","Ranjana H. Advani"],"twitterCount":2,"altmetricId":52011538,"statusesArray":["1068539644097298434","1068537978899873794"]},{"title":"Brain functional impairment in beta‐thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature","googleId":"l_tsZiCNodsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15959","googleCitationCount":6,"googleAuthor":"I Tartaglione","doi":"10.1111/bjh.15959","elsevierAuthor":"Tartaglione I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Molecular pathogenesis of chronic lymphocytic leukaemia","googleId":"jawohXKlIsYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16102","googleCitationCount":4,"googleAuthor":"K Crassini","doi":"10.1111/bjh.16102","elsevierAuthor":"Crassini K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"3","altmetricAuthors":["Kyle Crassini","William S. Stevenson","Stephen P. Mulligan","O. Giles Best"],"twitterCount":5,"altmetricId":64363260,"statusesArray":["1161077909370626051","1160970463474003968","1160732034190454784","1156609984484040704","1156546225895817217"]},{"title":"SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia","googleId":"d4H6rxuUHc8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15677","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15677","elsevierAuthor":"Brander D.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"7","altmetricAuthors":["Danielle M. Brander","Daphne R. Friedman","Alicia D. Volkheimer","Dale J. Christensen","Laura Z. Rassenti","Thomas J. Kipps","Eross Guadalupe","Youwei Chen","Dadong Zhang","Xi Wang","Carter Davis","Kouros Owzar","J. Brice Weinberg"],"twitterCount":3,"altmetricId":51308664,"statusesArray":["1090709167990587396","1065377054760361989","1063745921131995137","1063580410536493056"]},{"title":"Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective …","googleId":"T72tyeChzkAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15544?af=R","googleCitationCount":9,"googleAuthor":"L Castagna","doi":"10.1111/bjh.15544","elsevierAuthor":"Cauchois R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"6","altmetricAuthors":["Raphael Cauchois","Luca Castagna","Thomas Pagliardini","Samia Harbi","Boris Calmels","Stefania Bramanti","Angela Granata","Claude Lemarie","Valerio Maisano","Faezeh Legrand","Sabine Fürst","Catherine Faucher","Pierre‐Jean Weiller","Christian Chabannon","Didier Blaise","Raynier Devillier"],"twitterCount":21,"altmetricId":46815214,"statusesArray":["1041510439098769408","1032716052390715392","1032683876966166528","1032642574396403712","1032642438521937920","1032542013240094720","1032526683864281094","1032523955377262592","1032388987128692739","1032377632803835904","1032377491363491842","1032374379882004481","1032372845618245633","1032371830709862400","1032369095063158784","1032363316218343424","1032355027384455171","1032354337165651969","1032352983869054976","1032339621731082241","1032174942987714560","1032170782909231105"]},{"title":"NICE NG89 recommendations for extended pharmacological thromboprophylaxis-is it justified and is it cost effective: a rebuttal from the British Society for …","googleId":"RpfCY0THResJ","googleLink":"http://www.repository.uhblibrary.co.uk/id/eprint/3280","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16007","elsevierAuthor":"Lester W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":["Will Lester","Keith Gomez","Susie Shapiro","Keval Dabhi","Mike Laffan"],"twitterCount":23,"altmetricId":61583116,"statusesArray":["1170268496103649280","1157710195415506949","1137103701703888896","1137087346720038920","1137074307014811649","1137019757197168649","1136997441255989248","1136989031131041793","1136986648229634051","1136970373856157697","1136871873868963841","1136768374933991425","1136763389731049473","1136732883111092232","1136712427972812801","1136712330757234690","1136706603984572416","1136691224679784449","1136683141022781442","1136625430860054534","1136614030024552448","1136577437150732293","1136560320170909696","1136559884743446528"]},{"title":"Augmented NRF 2 activation protects adult sickle mice from lethal acute chest syndrome","googleId":"wvG83mj21b4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15401","googleCitationCount":10,"googleAuthor":"S Ghosh","doi":"10.1111/bjh.15401","elsevierAuthor":"Ghosh S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"6","altmetricAuthors":["Samit Ghosh","Rimi Hazra","Chibueze A. Ihunnah","Frances Weidert","Bethany Flage","Solomon F. Ofori-Acquah"],"twitterCount":5,"altmetricId":62094916,"statusesArray":["1174181224925093888","1161196966073786369","1153898580500983810","1153744215538589701","1139516702666964992"]},{"title":"Hepatitis E virus–key points for the clinical haematologist","googleId":"rvstYyQgGRwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15133","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15133","elsevierAuthor":"O'Gorman J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7","altmetricAuthors":["Joanne O'Gorman","Áine Burke","Niamh O'Flaherty"],"twitterCount":6,"altmetricId":33586034,"statusesArray":["1014680672592687105","1014634715037536256","1014626549218365442","1014592437858263041","1003938414880837633","967046276553428994"]},{"title":"Avatrombopag, an oral thrombopoietin receptor agonist: results of two double‐blind, dose‐rising, placebo‐controlled Phase 1 studies","googleId":"8-WFmKQlR28J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15574","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15574","elsevierAuthor":"Kuter D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7","altmetricAuthors":["David J. Kuter","Lee F. Allen"],"twitterCount":2,"altmetricId":51130100,"statusesArray":["1062335769082281984","1062327501274390528"]},{"title":"Guideline for the management of mantle cell lymphoma","googleId":"bnn7TIHF17wJ","googleLink":"http://cdn.biz.medsci.cn/ysi/clinical/2018/08/20/11c25d9e058edc76d9824e5e8fbcde1f.pdf","googleCitationCount":11,"googleAuthor":"","statusesArray":[]},{"title":"Intracranial 4D flow magnetic resonance imaging reveals altered haemodynamics in sickle cell disease","googleId":"g4MVwB4Q2g4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15043","googleCitationCount":10,"googleAuthor":"L Václavů","doi":"10.1111/bjh.15043","elsevierAuthor":"Václavů L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The MCL 35 gene expression proliferation assay predicts high‐risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy","googleId":"myB0vdnvAMUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15518","googleCitationCount":9,"googleAuthor":"H Holte","doi":"10.1111/bjh.15518","elsevierAuthor":"Holte H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7","altmetricAuthors":["Harald Holte","Klaus Beiske","Merrill Boyle","Gunhild Trøen","Yngvild N. Blaker","June Myklebust","Sunniva Kvaløy","Andreas Rosenwald","Ole C. Lingjaerde","Lisa M. Rimsza","Erlend B. Smeland","David W. Scott","Arne Kolstad"],"twitterCount":3,"altmetricId":46206100,"statusesArray":["1026962571474227206","1026784545402630144","1026774081021063168"]},{"title":"FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiency","googleId":"29LWjtecg3EJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10104696/1/Vandrovcova_FAS%20manuscript.pdf","googleCitationCount":5,"googleAuthor":"J Vandrovcova","statusesArray":[]},{"title":"Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma","googleId":"3L6L9xYxDw8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28369823/","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.14634,","elsevierAuthor":"Tokunaga M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"11","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies","googleId":"ekzO5NgXNEYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15990","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15990","elsevierAuthor":"Duarte B.K.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":["Bruno K. L. Duarte","Gabriela G. Yamaguti‐Hayakawa","Samuel S. Medina","Lúcia H. Siqueira","Brooke Snetsinger","Fernando F. Costa","Michael J. Rauh","Margareth C. Ozelo"],"twitterCount":2,"altmetricId":61046178,"statusesArray":["1133726793335222272","1132005691454119936"]},{"title":"Intracranial vasculopathy and infarct recurrence in children with sickle cell anemia, silent cerebral infarcts, and normal transcranial Doppler velocities","googleId":"I3vxlyYnZHQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133121/","googleCitationCount":14,"googleAuthor":"MR DeBaun","statusesArray":[]},{"title":"Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi‐agent chemotherapy","googleId":"JtZ8rw71vwMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15539","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15539","elsevierAuthor":"Walewski J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7","altmetricAuthors":["Jan Walewski","Andrzej Hellmann","Noppadol Siritanaratkul","Guner Hayri Ozsan","Muhit Ozcan","Suporn Chuncharunee","Ai Sim Goh","Wojciech Jurczak","Jan Koren","Ewa Paszkiewicz-Kozik","Bingxia Wang","Shalini Singh","Dirk Huebner","Andreas Engert","Bastian von Tresckow"],"twitterCount":4,"altmetricId":47551573,"statusesArray":["1062416789441859585","1062296612444213248","1038030453381455872","1036009873635528705","1035830787122388994"]},{"title":"Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm","googleId":"hnOLFWOUz20J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27650062/?report=xml&format=text","googleCitationCount":15,"googleAuthor":"LC Marti","doi":"10.1111/bjh.14327,","elsevierAuthor":"Helman R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The use of artificial neural network analysis can improve the risk‐stratification of patients presenting with suspected deep vein thrombosis","googleId":"B0ZdpkwWBFoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15780","googleCitationCount":6,"googleAuthor":"J Willan","doi":"10.1111/bjh.15780","elsevierAuthor":"Willan J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"4","altmetricAuthors":["John Willan","Harley Katz","David Keeling"],"twitterCount":1,"altmetricId":58939292,"statusesArray":["1149041911581179905"]},{"title":"Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second …","googleId":"-CeN-z6s0tgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15944","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15944","elsevierAuthor":"Maschan A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"3","altmetricAuthors":["Alexey Maschan","Natalia Myakova","Olga Aleinikova","Yulia Abugova","Natalia Ponomareva","Margarita Belogurova","Larisa Fechina","Alina Fedorova","Natalia Grigor'eva","Vladimir Lebedev","Olga Nikonova","Anastassia Shamardina","Guzel Sharapova","Nadezhda Smirnova","Anastassia Rudneva","Egor Volchkov","Elena Samochatova"],"twitterCount":2,"altmetricId":60219028,"statusesArray":["1128160583302418432","1126789865188753409"]},{"title":"Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma","googleId":"fe3kCGLLZHsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30255568/","googleCitationCount":8,"googleAuthor":"D D'Andrea","doi":"10.1111/bjh.15569,","elsevierAuthor":"Tornatore L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment","googleId":"caYWpgC1GHQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29740811/","googleCitationCount":9,"googleAuthor":"R Tarapore","doi":"10.1111/bjh.15271,","elsevierAuthor":"Romaguera J.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A new mutation of ANO6 in two familial cases of Scott syndrome","googleId":"oVdBt6i19TQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27879994/","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.14439,","elsevierAuthor":"Boisseau P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non‐Hodgkin lymphoma","googleId":"_44sBiwi4icJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15783","googleCitationCount":5,"googleAuthor":"MJ Barth","doi":"10.1111/bjh.15783","elsevierAuthor":"Barth M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4","altmetricAuthors":["Matthew J. Barth","Veronique Minard‐Colin"],"twitterCount":7,"altmetricId":54731353,"statusesArray":["1259231429864484864","1140180265165303809","1091290556423176192","1091201711509782531","1091030352649482241","1090961238958530560","1090841312268558336"]},{"title":"Concomitant Erdheim‐Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin","googleId":"jj7D1qLeWOQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16177","googleCitationCount":5,"googleAuthor":"G Goyal","doi":"10.1111/bjh.16177","elsevierAuthor":"Goyal G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"5","altmetricAuthors":["Gaurav Goyal","Yuanhang Liu","Aishwarya Ravindran","Aref Al‐Kali","Ronald S. Go","Mrinal M. Patnaik","Karen L. Rech"],"twitterCount":24,"altmetricId":65911426,"statusesArray":["1272846966574194688","1271162467205382145","1268090408686493697","1268014964331220993","1268001294289186820","1267994253466230784","1267959046231019523","1267928606593908741","1267911103729860608","1267874005794598912","1267866103000293381","1267859769081110537","1267859058347909121","1267856394046365699","1267849248126627840","1267849137220775939","1267846844836708354","1267845787326783488","1267845729457967104","1267843311068471296","1171019256588169216","1169648819060928512","1169585317676036100","1169426096594575361","1169424817658978304","1169423665399816192","1169344905996656641"]},{"title":"Attention, response inhibition and brain event‐related potential alterations in adults with beta‐thalassaemia major","googleId":"U8BWNwmnDpAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15957","googleCitationCount":3,"googleAuthor":"A Koren","doi":"10.1111/bjh.15957","elsevierAuthor":"Raz S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Comparing transfusion reaction risks for various plasma products–an analysis of 7 years of ISTARE haemovigilance data","googleId":"CCnl6UuiI14J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15082","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.15082","elsevierAuthor":"Saadah N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"8","altmetricAuthors":["Nicholas H. Saadah","Johanna G. van der Bom","Johanna C. Wiersum-Osselton","Clive Richardson","Rutger A. Middelburg","Constantina Politis","Philippe Renaudier","Pierre Robillard","Martin R. Schipperus"],"twitterCount":4,"altmetricId":31745730,"statusesArray":["954079273341472768","954077261082144768","953826546078302210","953169717899997184"]},{"title":"Results of successive EORTC‐CLG 58 881 and 58 951 trials in paediatric T‐cell acute lymphoblastic leukaemia (ALL)","googleId":"2YrwbEAOh6AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15983","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15983","elsevierAuthor":"Hofmans M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Optimizing outcomes for children with non‐Hodgkin lymphoma in low‐and middle‐income countries by early correct diagnosis, reducing toxic death and preventing …","googleId":"VxJVx6YFBxwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15785","googleCitationCount":5,"googleAuthor":"CG Lam","doi":"10.1111/bjh.15785","elsevierAuthor":"Chantada G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"3","altmetricAuthors":["Guillermo Chantada","Catherine G. Lam","Scott C. Howard"],"twitterCount":7,"altmetricId":55323678,"statusesArray":["1095297285062307841","1095277512593207296","1095270909190066176","1095187185396051969","1095171449260834817","1095151701525495808","1095148561384255490"]},{"title":"MYD 88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL","googleId":"XBeAmsdqtAcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15714","googleCitationCount":6,"googleAuthor":"JL Klitgaard","doi":"10.1111/bjh.15714","elsevierAuthor":"Improgo M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"6","altmetricAuthors":["Ma. Reina Improgo","Bethany Tesar","Josephine L. Klitgaard","Reuma Magori‐Cohen","Lijian Yu","Siddha Kasar","Divya Chaudhary","Wenyan Miao","Stacey M. Fernandes","Kevin Hoang","William F. Westlin","Haesook T. Kim","Jennifer R. Brown"],"twitterCount":12,"altmetricId":52602139,"statusesArray":["1174693822628028419","1174639575014281218","1073445226767937536","1073413603758362625","1073411259280838656","1073411070352596992","1073403616638193664","1073393150876676096","1073249986320760834","1073222737387184130","1073215130324926468","1073210723461931008","1073206941755817985"]},{"title":"Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma","googleId":"_DrI0L8xlMoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27984643/?dopt=Abstract","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.14449,","elsevierAuthor":"Kalac M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab","googleId":"ZkEoGvIqdl0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15262","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15262","elsevierAuthor":"Zhu K.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7","altmetricAuthors":["Katie Y. Zhu","Kevin W. Song","Joseph M. Connors","Heather Leitch","Michael J. Barnett","Khaled Ramadan","Graham W. Slack","Yasser Abou Mourad","Donna L. Forrest","Donna E. Hogge","Stephen H. Nantel","Sujaatha Narayanan","Thomas J. Nevill","Maryse M. Power","David S. Sanford","Heather J. Sutherland","Tracy Tucker","Cynthia L. Toze","Laurie H. Sehn","Raewyn Broady","Alina S. Gerrie"],"twitterCount":2,"altmetricId":41458615,"statusesArray":["1010102715060576257","996269577200906240"]},{"title":"Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives","googleId":"2FY4GYbiZhAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15764","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15764","elsevierAuthor":"Cairo M.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2","altmetricAuthors":["Mitchell S. Cairo","Auke Beishuizen"],"twitterCount":5,"altmetricId":55112908,"statusesArray":["1094178743034224640","1094083349826564099","1093990533830193158","1093990243836010496","1093614245839810562"]},{"title":"Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States","googleId":"2v1ZU-vR-hEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15532","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15532","elsevierAuthor":"Blum K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"8","altmetricAuthors":["Kristie A. Blum","Frank G. Keller","Sharon Castellino","Anh Phan","Christopher R. Flowers"],"twitterCount":3,"altmetricId":46398559,"statusesArray":["1028240625211080710","1028220504115634176","1028220360674689024"]},{"title":"Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population‐based setting: a report from the Swedish MDS register","googleId":"l1FnlPXw2eEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15243","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15243","elsevierAuthor":"Moreno Berggren D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"9","altmetricAuthors":["Daniel Moreno Berggren","Yasin Folkvaljon","Marie Engvall","Johan Sundberg","Mats Lambe","Petar Antunovic","Hege Garelius","Fryderyk Lorenz","Lars Nilsson","Bengt Rasmussen","Sören Lehmann","Eva Hellström-Lindberg","Martin Jädersten","Elisabeth Ejerblad"],"twitterCount":3,"altmetricId":40627518,"statusesArray":["992458277719027712","992243431484178433","991774443998531585"]},{"title":"Current considerations in AYA Hodgkin lymphoma","googleId":"RerGUA5NtqwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15640","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15640","elsevierAuthor":"Crombie J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"1","altmetricAuthors":["Jennifer L. Crombie","Ann S. LaCasce"],"twitterCount":1,"altmetricId":70408774,"statusesArray":["1065561678195101696"]},{"title":"How I manage patients with follicular lymphoma","googleId":"g6maO5ta1UwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16011","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16011","elsevierAuthor":"Casulo C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":["Carla Casulo"],"twitterCount":21,"altmetricId":61907358,"statusesArray":["1188506099885981696","1188506028167585792","1188407006211792897","1188247023146942465","1141351093181587458","1141156300627337217","1138557271510855681","1138180742184394752","1138168111499227136","1138100927502737410","1138075443670790144","1138073297810120705","1137970305673191425","1137967152483491840","1137964657740787712","1137951086285860865","1137747646284800006","1137740530400600064","1137661033886052354","1137647197829369856","1137622688753704960","1137339441209651200","1137298502084636673","1137012600850587648","1136972361692012545"]},{"title":"Essential thrombocythaemia treated with recombinant interferon:'real world'United Kingdom referral centre experience","googleId":"5RlnfZD2XTIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15968","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15968","elsevierAuthor":"Desterro J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":["Joana Desterro","Donal P. McLornan","Natalia Curto Garcia","Jennifer O'Sullivan","Samah Alimam","Clodagh Keohane","Claire Woodley","Yvonne Francis","Shahram Kordasti","Deepti H. Radia","Claire N. Harrison"],"twitterCount":3,"altmetricId":60555125,"statusesArray":["1188241008062021633","1134262179174076416","1129110211829149697"]},{"title":"Advances in predicting venous thromboembolism risk in children","googleId":"p4w2qU_ESx0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15060","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15060","elsevierAuthor":"Rühle F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"7","altmetricAuthors":["Frank Rühle","Monika Stoll"],"twitterCount":6,"altmetricId":33740293,"statusesArray":["968631366471569408","968567135885774851","968543768101048320","968482814973960192","968415654800969728","968415408981147648"]},{"title":"Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots","googleId":"YgjRNB3tLHAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31087331/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15954,","elsevierAuthor":"Beucher A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Headache: an important symptom possibly linked to white matter lesions in thalassaemia","googleId":"G0EHfPFWJ3kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15825","googleCitationCount":4,"googleAuthor":"A Premawardhena","doi":"10.1111/bjh.15825","elsevierAuthor":"Premawardhena A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population‐based case‐control study","googleId":"3vGfa90ZhuAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15163","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15163","elsevierAuthor":"Østgård L.S.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6","altmetricAuthors":["Lene S. G. Østgård","Mette Nørgaard","Lars Pedersen","René D. Østgård","Bruno C. Medeiros","Ulrik M. Overgaard","Claudia Schöllkopf","Marianne Severinsen","Claus W. Marcher","Morten K. Jensen"],"twitterCount":1,"altmetricId":33964024,"statusesArray":["970759241886814215"]},{"title":"Impairment of bone marrow endothelial progenitor cells in acute graft‐versus‐host disease patients after allotransplant","googleId":"2Ql28xoX6UQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15456","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15456","elsevierAuthor":"Cao X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"6","altmetricAuthors":["Xie-Na Cao","Yuan Kong","Yang Song","Min-Min Shi","Hong-Yan Zhao","Qi Wen","Zhong-Shi Lyu","Cai-Wen Duan","Yu Wang","Lan-Ping Xu","Xiao-Hui Zhang","Xiao-Jun Huang"],"twitterCount":1,"altmetricId":44762850,"statusesArray":["1016625985825828864"]},{"title":"Management of vaso‐occlusive episodes in the day hospital decreases admissions in children with sickle cell disease","googleId":"heSEecnLekgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16002","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16002","elsevierAuthor":"Karkoska K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1","altmetricAuthors":["Kristine Karkoska","Abena Appiah‐Kubi","Joshua Rocker","Guillaume Stoffels","Banu Aygun"],"twitterCount":0,"altmetricId":63435735,"statusesArray":[]},{"title":"Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic …","googleId":"hcEVjWCOdSQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30488420/","googleCitationCount":7,"googleAuthor":"C Vendramin","doi":"10.1111/bjh.15706,","elsevierAuthor":"Stubbs M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia","googleId":"U5NNnr_SO5oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15165","googleCitationCount":8,"googleAuthor":"I Nazy","doi":"10.1111/bjh.15165","elsevierAuthor":"Nazy I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6","altmetricAuthors":["Ishac Nazy","John G. Kelton","Jane C. Moore","Rumi Clare","Peter Horsewood","James W. Smith","Nikola Ivetic","Vanessa D'Souza","Na Li","Donald M. Arnold"],"twitterCount":2,"altmetricId":34290047,"statusesArray":["973682404270452737","973564812629331971"]},{"title":"Revisiting CLEC 12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy","googleId":"Kopzeiq1IAEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15711","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15711","elsevierAuthor":"Bill M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4","altmetricAuthors":["Marie Bill","Anni Aggerholm","Eigil Kjeldsen","Anne S. Roug","Peter Hokland","Line Nederby"],"twitterCount":1,"altmetricId":52564649,"statusesArray":["1072898564769148928"]},{"title":"Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies","googleId":"MbJNzlVMCvAJ","googleLink":"https://www.researchgate.net/profile/Thorsten_Graef/publication/331015534_Ibrutinib_provides_favourable_survival_outcomes_in_patients_with_comorbidities_versus_established_therapies/links/5d260cd4458515c11c23faaa/Ibrutinib-provides-favourable-survival-outcomes-in-patients-with-comorbidities-versus-established-therapies.pdf","googleCitationCount":5,"googleAuthor":"JA Burger","statusesArray":[]},{"title":"Prevalence and correlates of growth failure in young African patients with sickle cell disease","googleId":"nyuctskoEPkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15638","googleCitationCount":5,"googleAuthor":"L Alexandre‐Heymann","doi":"10.1111/bjh.15638","elsevierAuthor":"Alexandre-Heymann L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Long‐term survival after childhood acute lymphoblastic leukaemia: population‐based trends in cure and relapse by clinical characteristics","googleId":"50n9l8k1y-8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15424","googleCitationCount":9,"googleAuthor":"L Smith","doi":"10.1111/bjh.15424","elsevierAuthor":"Smith L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"6","altmetricAuthors":["Lesley Smith","Adam W. Glaser","Sally E. Kinsey","Darren C. Greenwood","Lucy Chilton","Anthony V. Moorman","Richard G. Feltbower"],"twitterCount":7,"altmetricId":43229441,"statusesArray":["1135460136015794176","1004089473565691905","1003938019668348929","1003915730230923264","1003471590959403008","1003382343334232064","1003355957458546690"]},{"title":"Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes","googleId":"XXbXKZB7KRQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15255","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15255","elsevierAuthor":"Parsons S.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"7","altmetricAuthors":["Susan K. Parsons","Michael J. Kelly","Joshua T. Cohen","Sharon M. Castellino","Tara O. Henderson","Kara M. Kelly","Frank G. Keller","Tobi J. Henzer","Anita J. Kumar","Peter Johnson","Ralph M. Meyer","John Radford","John Raemaekers","David C. Hodgson","Andrew M. Evens"],"twitterCount":6,"altmetricId":40158039,"statusesArray":["1095318776999043072","1016684198588018694","1016664244467707908","1006514111637868544","1002525673012039681","1002335994186747904","993477690798886912","991421342611275776","991262540217966592","991113555775811590","990942102568751104"]},{"title":"S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome …","googleId":"jBkYDYYrW20J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15878","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15878","elsevierAuthor":"Zhang J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2","altmetricAuthors":["Jing Zhang","Wen‐Yi Lu","Jia‐Min Zhang","Run‐Qing Lu","Li‐Xin Wu","Ya‐Zhen Qin","Yan‐Rong Liu","Yue‐Yun Lai","Hao Jiang","Qian Jiang","Bin Jiang","Lan‐Ping Xu","Xiao‐Hui Zhang","Xiao‐Jun Huang","Guo‐Rui Ruan","Kai‐Yan Liu"],"twitterCount":1,"altmetricId":70455540,"statusesArray":["1111164346447654912"]},{"title":"Risk factors for vitamin D deficiency in sickle cell disease","googleId":"rbwQB89FZPEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15270","googleCitationCount":9,"googleAuthor":"J Han","doi":"10.1111/bjh.15270","elsevierAuthor":"Han J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4","altmetricAuthors":["Jin Han","Xu Zhang","Santosh L. Saraf","Michel Gowhari","Robert E. Molokie","Johara Hassan","Shivi Jain","Binal N. Shah","Taimur Abbasi","Roberto F. Machado","Victor R. Gordeuk"],"twitterCount":2,"altmetricId":41813072,"statusesArray":["997087430590304257","997081951206019072"]},{"title":"Use of PD‐1 (PDCD 1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre","googleId":"20jON3PPk3wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15508?af=R","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15508","elsevierAuthor":"Rogers K.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"6","altmetricAuthors":["Kerry A. Rogers","Ying Huang","Emily Dotson","Jordan Lundberg","Leslie A. Andritsos","Farrukh T. Awan","Jennifer A. Woyach","John C. Byrd"],"twitterCount":3,"altmetricId":45429490,"statusesArray":["1021583586632163328","1021575843259138049","1021404618444738560"]},{"title":"BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy","googleId":"pmLXzVGfY0kJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29384193/","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15112,","elsevierAuthor":"Sibson K.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis‐like T‐cell lymphoma","googleId":"mmPrOiryhnwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14611?af=R","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.14611","elsevierAuthor":"Li Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia","googleId":"Nf7J8Ozr0EQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15819","googleCitationCount":4,"googleAuthor":"N Kröger","doi":"10.1111/bjh.15819","elsevierAuthor":"Kröger N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3","altmetricAuthors":["Nicolaus Kröger","Diderik‐Jan Eikema","Linda Köster","Dietrich Beelen","Liesbeth C. de Wreede","Jürgen Finke","Christian Koenecke","Dietger Niederwieser","Martin Bornhäuser","Stefan Schoenland","Victoria Potter","Christine Wolschke","Johan Maertens","Matthias Theobald","Guido Kobbe","Maija Itälä‐Remes","Gerald Wulf","Peter Kahls","Edouard Forcade","Hildegard Greinix","Tamás Masszi","Ibrahim Yakoub‐Agha","Yves Chalandon","Marie Robin"],"twitterCount":4,"altmetricId":56542649,"statusesArray":["1103457830865125377","1103386966589128704","1103386433535033349","1103225155789176832"]},{"title":"Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura","googleId":"mkQy5ex6p2oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15874","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15874","elsevierAuthor":"Stubbs M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4","altmetricAuthors":["Matthew J. Stubbs","Ryan Low","Siobhan McGuckin","Rosalind Newton","Mari Thomas","John P. Westwood","Raakhee Shah","Simon Cheesman","Marie A. Scully"],"twitterCount":20,"altmetricId":58001526,"statusesArray":["1147513204995698688","1145720493070323718","1145468965008920579","1145390813624578049","1145387271027339269","1140861274609397761","1140378875622567936","1140338944535597057","1140248079330959360","1140191477366235138","1140188376961884160","1140180141290729473","1138124998839869441","1138043736569667589","1138040451846553600","1114028530214625282","1113782619714535424","1111535557123940354","1111513836056690688","1111513830314688515","1111504746358194176"]},{"title":"Potentially inappropriate medication use in elderly non‐Hodgkin lymphoma patients is associated with reduced survival and increased toxicities","googleId":"SJ90Sh2wY2kJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15027","googleCitationCount":10,"googleAuthor":"RJ Lin","doi":"10.1111/bjh.15027","elsevierAuthor":"Lin R.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7","altmetricAuthors":["Richard J. Lin","Helen Ma","Robin Guo","Andrea B. Troxel","Catherine S. Diefenbach"],"twitterCount":18,"altmetricId":29019784,"statusesArray":["1323321334038818816","952910529642733568","935107020423860224","934624013275582465","934474630299078656","934438652096196608","934435453243191296","934426496344629248","933666693699850240","933339942708699136","933291488280166400","933017262944083969","933006983212478464","933001789888221184","931991545108148224","931459705561546752","931392491038957568","931310541687070720","931295945953722368","931277468190892032","931276760972431361","931272689192497152"]},{"title":"Sickle cell screening in Europe: the time has come.","googleId":"VG6DtIcNBhsJ","googleLink":"https://europepmc.org/article/med/30430539","googleCitationCount":7,"googleAuthor":"","statusesArray":[]},{"title":"A risk‐stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM …","googleId":"wpaTn_fYyHgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16086","googleCitationCount":5,"googleAuthor":"M Varettoni","doi":"10.1111/bjh.16086","elsevierAuthor":"Varettoni M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"5","altmetricAuthors":["Marzia Varettoni","Silvia Zibellini","Emanuela Boveri","Catherine Klersy","Chiara Candido","Sara Rattotti","Virginia V. Ferretti","Irene Defrancesco","Silvia Mangiacavalli","Maria E. Nizzoli","Elena Flospergher","Caterina Zerbi","Fabio Bergamini","Pietro Benvenuti","Marco Brociner","Gabriele Merati","Marco Paulli","Luca Arcaini"],"twitterCount":19,"altmetricId":63209385,"statusesArray":["1219198959257821186","1218940848001339394","1218891128713498624","1218816603774705664","1218806694228168705","1218794720199049217","1218792831608872960","1218780715522895873","1218735527135977472","1218624577041027073","1218572602890784768","1218532630280462336","1218532086799327233","1149409943109480448","1149375033288155136","1149348582035795968","1149179425050812417","1149131394809049091","1149056368814350336","1149055808602288128","1147445595419922432"]},{"title":"Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide …","googleId":"ATYvHMA8vXgJ","googleLink":"http://eprints.whiterose.ac.uk/134841/","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15551.","elsevierAuthor":"Popat R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Chronic lymphocytic leukaemia: the role of T cells in a B cell disease","googleId":"_1W1hhMQfWoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15918","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15918","elsevierAuthor":"Man S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":["Stephen Man","Peter Henley"],"twitterCount":7,"altmetricId":58613841,"statusesArray":["1147855183994609664","1141402629559529473","1116013571270430721","1116000945169620992","1116000235258634240","1115938214026543105","1114240674562314240"]},{"title":"Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest …","googleId":"G8GYytfg5DEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15884","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15884","elsevierAuthor":"Liu J.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":["Jia‐Hau Liu","Xiu‐Wen Liao","Chien‐Hung Chen","Ming Yao","Chi‐Cheng Li","Chien‐Ting Lin","Cheng‐Hong Tsai","Wen‐Chien Chou","Hsin‐An Hou","Shang‐Yi Huang","Shang‐Ju Wu","Yao‐Chang Chen","Hwei‐Fang Tien","Jih‐Luh Tang","Bor‐Sheng Ko"],"twitterCount":1,"altmetricId":84237265,"statusesArray":["1273563831827140608"]},{"title":"Long‐term overall‐and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma","googleId":"mPXI9PY9YUQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15814","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15814","elsevierAuthor":"Khashab T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2","altmetricAuthors":["Tamer Khashab","Fredrick Hagemeister","Jorge E. Romaguera","Michelle A. Fanale","Barbara Pro","Peter McLaughlin","M. Alma Rodriguez","Sattva S. Neelapu","Luis Fayad","Anas Younes","Lei Feng","Francisco Vega","Larry W. Kwak","Felipe Samaniego"],"twitterCount":4,"altmetricId":56522541,"statusesArray":["1256851771298807809","1256524970378723333","1103140467074629632","1103071917601419266","1101799466523348993"]},{"title":"The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of …","googleId":"O6ZqTSUGM7QJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31168834/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.16010,","elsevierAuthor":"Gee E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of Ruxolitinib on Myelofibrosis Patients Post Allogeneic Stem Cell Transplant---A Pilot Study","googleId":"eN7pX551tiMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706301/","googleCitationCount":4,"googleAuthor":"","statusesArray":[]},{"title":"Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma","googleId":"4TcRpmkzXIMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15997","googleCitationCount":3,"googleAuthor":"Y Wang","doi":"10.1111/bjh.15997","elsevierAuthor":"Wang Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2","altmetricAuthors":["Yucai Wang","Matthew J. Maurer","Melissa C. Larson","Cristine Allmer","Andrew L. Feldman","N. Nora Bennani","Carrie A. Thompson","Luis F. Porrata","Thomas M. Habermann","Thomas E. Witzig","Stephen M. Ansell","Susan L. Slager","Grzegorz S. Nowakowski","James R. Cerhan"],"twitterCount":21,"altmetricId":61212932,"statusesArray":["1170731176056639488","1135683886061457408","1133983320189100032","1133858418178056193","1133857597147222017","1133827578152792065","1133824681499402242","1133722197011288065","1133688365876822016","1133674782766043136","1133659486026108928","1133645832065044482","1133644422250487813","1133630413988159488","1133621551822245889","1133504783418122246","1133478650987388928","1133474382830080000","1133464486214545408","1133458731918856192","1133458316733165568"]},{"title":"Negative CD19 expression is associated with inferior relapse‐free survival in children with RUNX1‐RUNX1T1–positive acute myeloid leukaemia: results from the …","googleId":"6ajhmwCxRTkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16080","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16080","elsevierAuthor":"Sakamoto K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2","altmetricAuthors":["Kenichi Sakamoto","Norio Shiba","Takao Deguchi","Nobutaka Kiyokawa","Yoshiko Hashii","Akiko Moriya‐Saito","Daisuke Tomizawa","Takashi Taga","Soichi Adachi","Keizo Horibe","Toshihiko Imamura"],"twitterCount":1,"altmetricId":62810501,"statusesArray":["1144546794388557824"]},{"title":"Frontline management of nodular lymphocyte predominant Hodgkin lymphoma-a retrospective UK multicentre study","googleId":"oaWB84m0LB4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31344253/","googleCitationCount":4,"googleAuthor":"T Bagguley","doi":"10.1111/bjh.16109,","elsevierAuthor":"Wilson M.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia","googleId":"JExaoOfwmyEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15560","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.15560","elsevierAuthor":"Gustine J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"6","altmetricAuthors":["Joshua N. Gustine","Nicholas Tsakmaklis","Maria G. Demos","Amanda Kofides","Jiaji G. Chen","Xia Liu","Manit Munshi","Maria L. Guerrera","Gloria G. Chan","Christopher J. Patterson","Kirsten Meid","Toni Dubeau","Guang Yang","Zachary R. Hunter","Steven P. Treon","Jorge J. Castillo","Lian Xu"],"twitterCount":8,"altmetricId":47857718,"statusesArray":["1048081670115610624","1048031761047928832","1047863921506320385","1038527578632609793","1038489988575494144","1038459526901579776","1038453275673145344","1037641723185381376"]},{"title":"Prognostic factors and primary treatment for Waldenström macroglobulinemia–a Swedish Lymphoma Registry study","googleId":"ycOGeGRWP5EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15558","googleCitationCount":6,"googleAuthor":"B Melin","doi":"10.1111/bjh.15558","elsevierAuthor":"Brandefors L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2","altmetricAuthors":["Lena Brandefors","Beatrice Melin","Jack Lindh","Kristina Lundqvist","Eva Kimby"],"twitterCount":4,"altmetricId":48177479,"statusesArray":["1042868208783577094","1041856407379705856","1041721434895261697","1039921586139062272"]},{"title":"N‐acetyl‐L‐cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post‐allotransplant","googleId":"NGYiQJer4OwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15119","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15119","elsevierAuthor":"Kong Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"9","altmetricAuthors":["Yuan Kong","Yang Song","Fei-Fei Tang","Hong-Yan Zhao","Yu-Hong Chen","Wei Han","Chen-Hua Yan","Yu Wang","Xiao-Hui Zhang","Lan-Ping Xu","Xiao-Jun Huang"],"twitterCount":2,"altmetricId":32604196,"statusesArray":["960254839241416704","960254818597195776","959759388117426178"]},{"title":"Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma","googleId":"uvuYNJuCQLYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30536372/","googleCitationCount":6,"googleAuthor":"MJ Hussain","doi":"10.1111/bjh.15716,","elsevierAuthor":"Hussain M.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mesenchymal stromal cells from Shwachman‐Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis","googleId":"X_G8NhMgmHcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15388","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15388","elsevierAuthor":"Bardelli D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"6","altmetricAuthors":["Donatella Bardelli","Erica Dander","Cristina Bugarin","Claudia Cappuzzello","Alice Pievani","Grazia Fazio","Paolo Pierani","Paola Corti","Piero Farruggia","Carlo Dufour","Simone Cesaro","Marco Cipolli","Andrea Biondi","Giovanna D'Amico"],"twitterCount":1,"altmetricId":41810667,"statusesArray":["997066012951433216"]},{"title":"Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States","googleId":"73aV_ouaOwkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15201?af=R","googleCitationCount":10,"googleAuthor":"PA Pophali","doi":"10.1111/bjh.15201","elsevierAuthor":"Pophali P.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Emergency response to radiological and nuclear accidents and incidents","googleId":"ehoyVYaDjukJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16138","googleCitationCount":3,"googleAuthor":"RP Gale","doi":"10.1111/bjh.16138","elsevierAuthor":"Gale R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Cyclin D1 expression and novel mutational findings in Rosai‐Dorfman disease","googleId":"t0ZEDfMhr_wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16006","googleCitationCount":3,"googleAuthor":"E Baraban","doi":"10.1111/bjh.16006","elsevierAuthor":"Baraban E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2","altmetricAuthors":["Ezra Baraban","Sam Sadigh","Jason Rosenbaum","John Van Arnam","Agata M. Bogusz","Chelsea Mehr","Adam Bagg"],"twitterCount":6,"altmetricId":66352228,"statusesArray":["1281609945893371904","1281204151897198594","1171336034518544385","1171290478920249344","1171272232116449286","1171272033684115456"]},{"title":"Clinical value of automated fibrin generation markers in patients with septic shock: a SepsiCoag ancillary study","googleId":"2CV0u2D89H0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15576","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15576","elsevierAuthor":"Gris J.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: short report from a longitudinal study","googleId":"U5862DKtIgsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15993","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15993","elsevierAuthor":"Mitchell E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Potential involvement of ubiquitin‐proteasome system dysfunction associated with oxidative stress in the pathogenesis of sickle cell disease","googleId":"srYQwrNNWhoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15437","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15437","elsevierAuthor":"Warang P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions","googleId":"ulI_zEPVZUMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28466602/","googleCitationCount":11,"googleAuthor":"","doi":"10.1111/bjh.14623,","elsevierAuthor":"Al-Battat S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with …","googleId":"UjwMMm68XmcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15824","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15824","elsevierAuthor":"Gisslinger H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2","altmetricAuthors":["Heinz Gisslinger","Veronika Buxhofer‐Ausch","Juri Hodisch","Atanas Radinoff","Elena Karyagina","Slawomira Kyrcz‐Krzemień","Kudrat Abdulkadyrov","Rolandas Gerbutavicius","Anait Melikyan","Sonja Burgstaller","Marek Hus","Janusz Kłoczko","Vera Yablokova","Nikolay Tzvetkov","Malgorzata Całbecka","Tatyana Shneyder","Krzysztof Warzocha","Mindaugas Jurgutis","Kamil Kaplanov","Bernd Jilma","Christian Schoergenhofer","Christoph Klade"],"twitterCount":3,"altmetricId":58993522,"statusesArray":["1176843842462638081","1176813977202036740","1126957121294282757"]},{"title":"Unravelling the suboptimal response of TP53‐mutated chronic lymphocytic leukaemia to ibrutinib","googleId":"migqJdLWGuUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15613","googleCitationCount":6,"googleAuthor":"A Guarini","doi":"10.1111/bjh.15613","elsevierAuthor":"Guarini A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"3","altmetricAuthors":["Anna Guarini","Nadia Peragine","Monica Messina","Marilisa Marinelli","Caterina Ilari","Luciana Cafforio","Sara Raponi","Silvia Bonina","Paola Mariglia","Francesca R. Mauro","Gianluca Gaidano","Ilaria Del Giudice","Robin Foà"],"twitterCount":1,"altmetricId":54608199,"statusesArray":["1089885926824775681"]},{"title":"Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network","googleId":"x-6BIDvCbyIJ","googleLink":"http://eprints.whiterose.ac.uk/139582/","googleCitationCount":6,"googleAuthor":"S Lacy","doi":"10.1111/bjh.15619.","elsevierAuthor":"Painter D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R …","googleId":"vzngRw2iIcgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16070","googleCitationCount":6,"googleAuthor":"TA Eyre","doi":"10.1111/bjh.16070","elsevierAuthor":"Eyre T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"4","altmetricAuthors":["Toby A. Eyre","Amy A. Kirkwood","Julia Wolf","Catherine Hildyard","Carolyn Mercer","Hannah Plaschkes","John Griffith","Paul Fields","Arief Gunawan","Rebecca Oliver","Stephen Booth","Nicolas Martinez‐Calle","Andrew McMillan","Mark Bishton","Christopher P. Fox","Graham P. Collins","Chris S. R. Hatton"],"twitterCount":45,"altmetricId":62544698,"statusesArray":["1337106688835522561","1337071277777899520","1337068188551565312","1336744274986233857","1325546514136113158","1325367896885907456","1325256843720060929","1325122135321309185","1325116841770016771","1325092552379404291","1325092541893644290","1325091302019620864","1325081981546344448","1305543856147005440","1258817260023668736","1258816087287894017","1258809420236099585","1236005194082762752","1222192247740854272","1221922828565598210","1221904159819161600","1221815376461422593","1192223054170120195","1191861065862303744","1191195046785298433","1191194815440064513","1191168157685342209","1191109953580359681","1191096074833973248","1191096066315296773","1191061075535511552","1191005868172689409","1186139523996143617","1186049545605734405","1185992250830000129","1185908711925211137","1185838746274615296","1185834949582213120","1185805834946859008","1185803995081822208","1185667815451299841","1185645268693389319","1185644301843386371","1185637321036783619","1185616669223186433","1185614980412035073","1185613631960076288","1185599993899552768","1185581180038463488","1185576577859538945","1185563506252419074","1185557812543447040","1185549629796110342","1172066810323189760","1172009288266670080","1171940930129207296","1171875112296960000","1171800208382074880","1171477236966289409","1143984565381476352","1143897310272937989","1143291338013626368","1143149738834976769","1143140063284514816","1143132282410151937","1143007914950422531","1142458692354187264","1142395948829745152","1142391046720016384","1142390065232039936","1142382472971345920","1142372240291520513"]},{"title":"The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients","googleId":"FAxetC6t9TAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15887","googleCitationCount":4,"googleAuthor":"J Ribera","doi":"10.1111/bjh.15887","elsevierAuthor":"Ribera J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2","altmetricAuthors":["Jordi Ribera","Isabel Granada","Mireia Morgades","Susana Vives","Eulàlia Genescà","Celia González","Josep Nomdedeu","Lourdes Escoda","Pau Montesinos","Santiago Mercadal","Rosa Coll","José González‐Campos","Eugenia Abella","Pere Barba","Arancha Bermúdez","Cristina Gil","Mar Tormo","María Pedreño","Daniel Martínez‐Carballeira","Jesús‐María Hernández‐Rivas","Alberto Orfao","Joaquín Martínez‐López","Jordi Esteve","Pilar Bravo","Antoni Garcia‐Guiñon","Guillermo Debén","José M. Moraleda","José A. Queizán","Xavier Ortín","María J. Moreno","Evarist Feliu","Francesc Solé","Josep M. Ribera"],"twitterCount":8,"altmetricId":58014171,"statusesArray":["1266041559792959489","1265955117335040000","1265610787583918082","1137593313496838145","1136903538053996545","1136882983737221120","1112037041330708482","1111542232455233536","1111541652202622976"]},{"title":"The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis","googleId":"8faBT2UfZo4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15895","googleCitationCount":3,"googleAuthor":"AB Leichtle","doi":"10.1111/bjh.15895","elsevierAuthor":"Scholz G.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well‐controlled patients on VKA for atrial fibrillation: a …","googleId":"wQHtpJpDLosJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15856?af=R","googleCitationCount":5,"googleAuthor":"JHA van Miert","doi":"10.1111/bjh.15856","elsevierAuthor":"van Miert J.H.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"5","altmetricAuthors":["Jasper H. A. van Miert","Hilde A. M. Kooistra","Nic J. G. M. Veeger","Annelies Westerterp","Margriet Piersma-Wichers","Karina Meijer"],"twitterCount":4,"altmetricId":56719179,"statusesArray":["1108478885266710535","1105435524578398214","1105240320806141952","1104025574341857280","1103974589812621312"]},{"title":"Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma","googleId":"4dIOY8gxEC0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15249","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15249","elsevierAuthor":"Fridthjof K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F‐positive myeloproliferative neoplasms","googleId":"HNec0bfKgCEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15386?af=R","googleCitationCount":7,"googleAuthor":"M Al‐Kawaaz","doi":"10.1111/bjh.15386","elsevierAuthor":"Kucine N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":["Nicole Kucine","Mustafa Al‐Kawaaz","Daher Hajje","James Bussel","Attilio Orazi"],"twitterCount":0,"altmetricId":43445030,"statusesArray":[]},{"title":"Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma","googleId":"v0KgIT7hY7YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14970","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.14970","elsevierAuthor":"Fradley M.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8","altmetricAuthors":["Michael G. Fradley","John D. Groarke","Jacob Laubach","Melissa Alsina","Daniel J. Lenihan","Robert F. Cornell","Michelle Maglio","Kenneth H. Shain","Paul G. Richardson","Javid Moslehi"],"twitterCount":9,"altmetricId":27698994,"statusesArray":["924810562269310978","921924459224797185","921833294978789376","921632217541042176","921545381581860870","921538668745166848","921532390824136709","921517343452352512","921507412590383104","921390555493470209"]},{"title":"Acute myeloid leukaemia niche regulates response to L‐asparaginase","googleId":"B5utsY32FUIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15920","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15920","elsevierAuthor":"Michelozzi I.M.","publicationName":"British journal of haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"1 August 2019","elsevierCitationCount":"3","altmetricAuthors":["Ilaria M. Michelozzi","Valentina Granata","Giada De Ponti","Gaia Alberti","Chiara Tomasoni","Laura Antolini","Carlo Gambacorti‐Passerini","Bernhard Gentner","Francesco Dazzi","Andrea Biondi","Tiziana Coliva","Carmelo Rizzari","Alice Pievani","Marta Serafini"],"twitterCount":6,"altmetricId":65431506,"statusesArray":["1278362417525858312","1168996138034372609","1168879232682012672","1168592163753594880","1168552877981360129","1168540194393546756","1168535316107550725"]},{"title":"Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD‐driven …","googleId":"dC4gHdl7kNMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16116","googleCitationCount":3,"googleAuthor":"F Guolo","doi":"10.1111/bjh.16116","elsevierAuthor":"Guolo F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"T memory stem cells after allogeneic haematopoietic cell transplantation: unique long‐term kinetics and influence of chronic graft‐versus‐host disease","googleId":"wHMY78MrJf8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15995","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15995","elsevierAuthor":"Jimbo K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3","altmetricAuthors":["Koji Jimbo","Takaaki Konuma","Eri Watanabe","Chisato Kohara","Motoko Mizukami","Etsuko Nagai","Maki Oiwa‐Monna","Mai Mizusawa","Masamichi Isobe","Seiko Kato","Satoshi Takahashi","Arinobu Tojo"],"twitterCount":4,"altmetricId":61481292,"statusesArray":["1135870960060514305","1135799829987127296","1135790477863727104","1135742351563993089"]},{"title":"Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients","googleId":"R6LHxCx8b5EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15497","googleCitationCount":7,"googleAuthor":"L Catani","doi":"10.1111/bjh.15497","elsevierAuthor":"Palandri F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)","googleId":"EPeLXKk7J7QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15768","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15768","elsevierAuthor":"Rosenbaum C.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3","altmetricAuthors":["Cara A. Rosenbaum","Sin‐Ho Jung","Brandelyn Pitcher","Nancy L. Bartlett","Sonali M. Smith","Eric Hsi","Nina Wagner‐Johnston","Sachdev P. Thomas","John P. Leonard","Bruce D. Cheson"],"twitterCount":2,"altmetricId":56463165,"statusesArray":["1112013585872371712","1093464879292391424"]},{"title":"Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell …","googleId":"pdxhQPHkmaQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15025","googleCitationCount":9,"googleAuthor":"L Arcaini","doi":"10.1111/bjh.15025","elsevierAuthor":"Arcaini L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"6","altmetricAuthors":["Luca Arcaini","Thierry Lamy","Jan Walewski","David Belada","Jiri Mayer","John Radford","Wojciech Jurczak","Franck Morschhauser","Julia Alexeeva","Simon Rule","José Cabeçadas","Elias Campo","Stefano A. Pileri","Tsvetan Biyukov","Meera Patturajan","Marie-Laure Casadebaig Bravo","Marek Trnĕný"],"twitterCount":3,"altmetricId":32233886,"statusesArray":["956810149347430400","956810149276110848","956809935555309568"]},{"title":"DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia","googleId":"OwPu9UR8fZQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617782/","googleCitationCount":4,"googleAuthor":"HMH Qutob","doi":"10.1111/bjh.15823","elsevierAuthor":"Bailey G.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":["Graham D. Bailey","Haitham M. H. Qutob","Asma Akhtar","Nigel H. Russell","Claire H. Seedhouse"],"twitterCount":1,"altmetricId":66929637,"statusesArray":["1175364242343641088"]},{"title":"Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation","googleId":"ZJIEds5aSB4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15811","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15811","elsevierAuthor":"Barcellini W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3","altmetricAuthors":["Wilma Barcellini","Anna Zaninoni","Anna I. Gregorini","Giulia Soverini","Lorena Duca","Bruno Fattizzo","Juri A. Giannotta","Patrizia Pedrotti","Cristina Vercellati","Anna P. Marcello","Elisa Fermo","Paola Bianchi","Maria Domenica Cappellini"],"twitterCount":1,"altmetricId":60445065,"statusesArray":["1136966373085712388"]},{"title":"Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK","googleId":"hVS9gqlId0sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15542","googleCitationCount":8,"googleAuthor":"NCP Cross","doi":"10.1111/bjh.15542","elsevierAuthor":"Cross N.C.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"4","altmetricAuthors":["Nicholas C. P. Cross","Helen E. White","Paul A. S. Evans","Jeremy Hancock","Mhairi Copland","Dragana Milojkovic","Joanne Mason","Sandra Craine","Adam J. Mead"],"twitterCount":11,"altmetricId":47860750,"statusesArray":["1175756913780375552","1116952390207406081","1116344898821787648","1114146731434938369","1114124890024624128","1114119252276072448","1038586407403614208","1038158576374689793","1038108349277986816","1038091054535401472","1038090845243748353","1037661941613744130","1031972911416979456"]},{"title":"High‐dose melphalan‐based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or …","googleId":"FZvUKqI9BEQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15137","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15137","elsevierAuthor":"Steckel N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6","altmetricAuthors":["Nina K. Steckel","Christoph Groth","Jan-Henrik Mikesch","Rudolf Trenschel","Hellmut Ottinger","Lambros Kordelas","Carsten Mueller-Tidow","Christoph Schliemann","Christian Reicherts","Joern C. Albring","Gerda Silling","Eva Schmidt","Wolfgang E. Berdel","Georg Lenz","Markus Ditschkowski","Dietrich W. Beelen","Matthias Stelljes"],"twitterCount":5,"altmetricId":33545997,"statusesArray":["972359281109618693","967846024588025856","967558544731070464","967121840681504768","966785395433275394"]},{"title":"P-selectin plays a role in haem-induced acute lung injury in sickle mice.","googleId":"zlWMAHBKjIUJ","googleLink":"https://europepmc.org/articles/pmc6860014/bin/nihms1011173-supplement-supp_figs1.pdf","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15807","elsevierAuthor":"Ghosh S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia","googleId":"300SSCWuZp0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15996","googleCitationCount":4,"googleAuthor":"S Menzel","doi":"10.1111/bjh.15996","elsevierAuthor":"Brewin J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"PET‐adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH‐05 trial","googleId":"9-ik8yDISsYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15838","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15838","elsevierAuthor":"Pavlovsky A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"3","altmetricAuthors":["Astrid Pavlovsky","Isolda Fernandez","Nicolas Kurgansky","Virginia Prates","Lucia Zoppegno","Pedro Negri","Gustavo Milone","Ider Cerutti","Soledad Zabaljauregui","Romina Mariano","Horacio F. Grecco","Ana L. Basquiera","Silvia Saba","Silvia Rudoy","Federico Sackmann","Vanesa Castano","Guillermina Remaggi","Maria Cabrejo","Eriberto Roveri","Maria F. Casale","Vanina Cabane","Rossana Taus","Claudia Venturini","Francisco Sakamoto","Ana I. Varela","Maximiliano Riddick","Santiago Pavlovsky"],"twitterCount":42,"altmetricId":56977689,"statusesArray":["1156773164916940801","1156669548642390017","1156638046554591234","1156528336115576832","1156428197430530048","1156391732818395136","1156389070731264000","1156388947842523140","1156271293160816641","1156244242651582464","1156172845074001921","1156139611338362881","1156087490308124672","1155906060886188032","1155903967601352705","1155897388529278978","1155858889524555776","1155857551566807040","1155820431129100288","1137010600477954050","1136850977267392519","1136753876982517770","1108873481217699840","1107865401394892801","1107625857215070208","1107393238158184450","1107358113735368707","1106980871377248258","1106692029654818816","1106651816190771200","1106625899796070401","1106613145961984002","1106590241643741184","1106534475108892675","1106462799742537728","1106379514144264192","1106372174196211712","1106363028310638593","1106350676270088192","1106346936351764491","1106344286394740736","1106338903424987136","1106337627211530240","1106294610823909381","1106247569645203461","1106133304338776064","1106117046503383040","1106084082344181760","1106080156400173057","1105944298409869314"]},{"title":"A novel GFI1B mutation at the first zinc finger domain causes congenital macrothrombocytopenia","googleId":"TWYx4d77oMYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28439885/","googleCitationCount":12,"googleAuthor":"","doi":"10.1111/bjh.14710,","elsevierAuthor":"Uchiyama Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib","googleId":"tY0aNpuM4_UJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30460682/","googleCitationCount":7,"googleAuthor":"MP Cheng","doi":"10.1111/bjh.15627,","elsevierAuthor":"Cheng M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"An effective modestly intensive re‐induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia","googleId":"cMSXfZNKdIUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15233","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15233","elsevierAuthor":"Kaspers G.J.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Inverse correlation of Vδ2+ T‐cell recovery with EBV reactivation after haematopoietic stem cell transplantation","googleId":"IxWUCodSy3AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15037","googleCitationCount":10,"googleAuthor":"Z Bian","doi":"10.1111/bjh.15037","elsevierAuthor":"Liu J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Characterising the risk of hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study","googleId":"8yMc-0HHEzsJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10073858/1/Fox_Final%20draft%20HEV%20paper.pdf","googleCitationCount":6,"googleAuthor":"S Ijaz","statusesArray":[]},{"title":"A comprehensive analysis of Lymphoma‐associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis","googleId":"sr1jPQHoyLEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15506","googleCitationCount":6,"googleAuthor":"P Coppo","doi":"10.1111/bjh.15506","elsevierAuthor":"Bigenwald C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Beta thalassaemia intermedia due to co-inheritance of three unique alpha globin cluster duplications characterised by next generation sequencing analysis","googleId":"zYVGZ5_NslYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27469621/","googleCitationCount":13,"googleAuthor":"C Shooter","doi":"10.1111/bjh.14294,","elsevierAuthor":"Clark B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment","googleId":"fuq7YuL9grkJ","googleLink":"https://elibrary.ru/item.asp?id=41617308","googleCitationCount":3,"googleAuthor":"","statusesArray":[]},{"title":"Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib.","googleId":"-mFstFlkoaIJ","googleLink":"https://europepmc.org/article/pmc/pmc6819220","googleCitationCount":4,"googleAuthor":"SA Bhat","statusesArray":[]},{"title":"Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016","googleId":"DzOLN-DKGT4J","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10064984/1/Yong_Accepted_Patient%20chart%20audit%202014vs2016_letter_11Sept2018.pdf","googleCitationCount":5,"googleAuthor":"","statusesArray":[]},{"title":"The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the Ukall 2011 …","googleId":"MSTi3jx9XV8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15798?af=R","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15798","elsevierAuthor":"O'Reilly M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"4","altmetricAuthors":["Maeve A. O'Reilly","Dinisha Govender","Amy A. Kirkwood","Ajay Vora","Sujith Samarasinghe","Asim Khwaja","Victoria Grandage","Anupama Rao","Philip Ancliff","Vesna Pavasovic","Danny Cheng","Ben Carpenter","Stephen Daw","Rachael Hough","David O'Connor"],"twitterCount":1,"altmetricId":55597281,"statusesArray":["1096726389917712385"]},{"title":"Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults","googleId":"YYTNxJH34xAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30520018/","googleCitationCount":5,"googleAuthor":"RK Hills","doi":"10.1111/bjh.15698,","elsevierAuthor":"Freeman S.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Obesity negatively impacts outcome in elderly female patients with aggressive B‐cell lymphomas treated with R‐CHOP: results from prospective trials of the German …","googleId":"q5jL-ldWbHoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15029","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15029","elsevierAuthor":"Hohloch K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor","googleId":"lGxU6RdKnSEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6587980/","googleCitationCount":5,"googleAuthor":"JC Byrd","doi":"10.1111/bjh.15666","elsevierAuthor":"Wierda W.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"3","altmetricAuthors":["William G. Wierda","John C. Byrd","Matthew S. Davids","Richard R. Furman","Bruce D. Cheson","Paul M. Barr","Herbert Eradat","Leonard Heffner","Lang Zhou","Maria Verdugo","Jalaja Potluri","Michael Choi"],"twitterCount":2,"altmetricId":53040114,"statusesArray":["1171083603427676161","1171045910056513538"]},{"title":"Survival and specific outcome of sickle cell disease patients after renal transplantation","googleId":"dzq0Z6JaQkMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16113","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16113","elsevierAuthor":"Gérardin C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"2","altmetricAuthors":["Christel Gérardin","Anissa Moktefi","Cécile Couchoud","Alyette Duquesne","Nacera Ouali","Philippe Gataut","Alexandre Karras","Dany Anglicheau","Carmen Lefaucheur","Lucile Figueres","Laetitia Albano","Arnaud Lionet","Marine Novion","Marie‐Julia Ziliotis","Magali Louis","Arnaud Del Bello","Marie Matignon","Karine Dahan","Anoosha Habibi","Frederic Galacteros","Pablo Bartolucci","Philippe Grimbert","Vincent Audard"],"twitterCount":7,"altmetricId":64127230,"statusesArray":["1161002130137858049","1160998695426568193","1155168258166853632","1154818967770468352","1154811810178043904","1154804511917182976","1154800131243425793"]},{"title":"A risk stratification for systemic immunoglobulin light‐chain amyloidosis with renal involvement","googleId":"6T335kALoA0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16112","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16112","elsevierAuthor":"Li T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2","altmetricAuthors":["Ting Li","Xianghua Huang","Qingwen Wang","Liang Zhao","Guisheng Ren","Wencui Chen","Chunxia Zheng","Minlin Zhou","Qi Jiang","Ru Yin","Zhihong Liu"],"twitterCount":5,"altmetricId":64167018,"statusesArray":["1155445708994076672","1155388244600721408","1155028881050689542","1154950061681459200","1154878305692205056","1154867564880814080"]},{"title":"A Toll‐like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease","googleId":"M8ODKYfw0eAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15875","googleCitationCount":3,"googleAuthor":"V Rocha","doi":"10.1111/bjh.15875","elsevierAuthor":"Tozatto-Maio K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2","altmetricAuthors":["Karina Tozatto‐Maio","Robert Girot","Indou D. Ly","Vanderson Rocha","Ana C. Silva Pinto","Ibrahima Diagne","Yahia Benzerara","Carla L. Dinardo","Simone Kashima","Itauá Leston‐Araujo","Chantal Kenzey","Guilherme H. H. Fonseca","Evandra S. Rodrigues","Fernanda Volt","Luciana R. Jarduli","Annalisa Ruggeri","Christina M. Mariaselvam","Sandra F. M. Gualandro","Hanadi Elayoubi","Renato Cunha","Barbara Cappelli","Kelen C. R. Malmegrim","Belinda P. Simões","Eliane Gluckman","Ryad Tamouza"],"twitterCount":1,"altmetricId":83985296,"statusesArray":["1272023166781718528"]},{"title":"Knockout of von Willebrand factor in Zebrafish by CRISPR/Cas9 mutagenesis.","googleId":"puW9G_fmRRwJ","googleLink":"https://europepmc.org/articles/pmc6679758/bin/nihms1019648-supplement-supp_info.doc","googleCitationCount":4,"googleAuthor":"N Iyer","doi":"10.1111/bjh.15910","elsevierAuthor":"Iyer N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4","altmetricAuthors":["Neha Iyer","Vanina T. Tcheuyap","Sara Schneider","Vanessa Marshall","Pudur Jagadeeswaran"],"twitterCount":6,"altmetricId":92071479,"statusesArray":["1315009432539987968","1314955738389901312","1314951731663441921","1314951233568944129","1314611764382904320","1314592801892507649"]},{"title":"Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac …","googleId":"ntOGWYjDnOUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15125","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15125","elsevierAuthor":"Pepe A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Aeroallergen sensitization predicts acute chest syndrome in children with sickle cell anaemia","googleId":"7HZMqOgYqAkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15076","googleCitationCount":9,"googleAuthor":"","doi":"10.1111/bjh.15076","elsevierAuthor":"Willen S.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"5","altmetricAuthors":["Shaina M. Willen","Mark Rodeghier","Robert C. Strunk","Leonard B. Bacharier","Carol L. Rosen","Fenella J. Kirkham","Michael R. DeBaun","Robyn T. Cohen"],"twitterCount":1,"altmetricId":36855673,"statusesArray":["1089842146767761408"]},{"title":"Differential expression of long non‐coding RNA s are related to proliferation and histological diversity in follicular lymphomas","googleId":"vSCwDlmgnVYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15656","googleCitationCount":4,"googleAuthor":"A Roisman","doi":"10.1111/bjh.15656","elsevierAuthor":"Roisman A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"4","altmetricAuthors":["Alejandro Roisman","Giancarlo Castellano","Alba Navarro","Blanca Gonzalez-Farre","Patricia Pérez-Galan","Anna Esteve-Codina","Marc Dabad","Simon Heath","Marta Gut","Mattia Bosio","Pau Bellot","Philippe Salembier","Albert Oliveras","Irma Slavutsky","Laura Magnano","Heike Horn","Andreas Rosenwald","German Ott","Marta Aymerich","Armando López-Guillermo","Pedro Jares","José I. Martín-Subero","Elías Campo","Luis Hernández"],"twitterCount":1,"altmetricId":69507936,"statusesArray":["1189482966302580736","1075784777163292673"]},{"title":"11 C] Methionine emerges as a new biomarker for tracking active myeloma lesions","googleId":"VSdRBgnqHHIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28466502/?dopt=Abstract","googleCitationCount":10,"googleAuthor":"","doi":"10.1111/bjh.14696,","elsevierAuthor":"Lapa C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group","googleId":"YiBS6TWDI3wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15713","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15713","elsevierAuthor":"Redondo A.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"5","altmetricAuthors":["Alba M. Redondo","David Valcárcel","Ana P. González‐Rodríguez","María Suárez‐Lledó","José L. Bello","Miguel Canales","Jorge Gayoso","Mercedes Colorado","Isidro Jarque","Raquel Campo","Reyes Arranz","María J. Terol","José J. Rifón","María J. Rodríguez","María J Ramírez","Nerea Castro","Andrés Sánchez","Javier López‐Jiménez","Santiago Montes‐Moreno","Javier Briones","Aurelio López","Luis Palomera","Armando López‐Guillermo","Dolores Caballero","Alejandro Martín"],"twitterCount":24,"altmetricId":53374246,"statusesArray":["1212676300898545664","1098539328324681730","1095891988409393152","1095217925026328576","1095217190419292161","1095080580885217282","1095079492861739008","1095079121678405632","1095069017222639616","1095060606837764098","1095037453965107202","1095036405024256002","1094848959980412934","1094788085831864322","1094672988736286721","1094568695886761984","1094531865900474368","1094500377863614464","1094489562318061568","1094356975272583169","1094354091038425088","1094338714845761536","1094336365167341574","1080464081654562818","1073896091077226497"]},{"title":"Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia","googleId":"pRN3UF0l88YJ","googleLink":"https://www.researchgate.net/profile/Manuel_Perez-Encinas/publication/316176523_Clinical_characteristics_prognosis_and_treatment_of_myelofibrosis_patients_with_severe_thrombocytopenia/links/5cf41a72a6fdcc847500130a/Clinical-characteristics-prognosis-and-treatment-of-myelofibrosis-patients-with-severe-thrombocytopenia.pdf","googleCitationCount":11,"googleAuthor":"JG Correa","statusesArray":[]},{"title":"Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial","googleId":"_6rMv5d27YEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15741","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15741","elsevierAuthor":"Böll B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"6","altmetricAuthors":["Boris Böll","Annette Plütschow","Carolin Bürkle","Johannes Atta","Michael Pfreundschuh","Michaela Feuring‐Buske","Martin Vogelhuber","Martin Sökler","Dennis A. Eichenauer","Indra Thielen","Bastian Tresckow","Michael Fuchs","Andreas Engert","Peter Borchmann"],"twitterCount":2,"altmetricId":54571535,"statusesArray":["1089555231480926208","1079511547913875458","1079171088888881153"]},{"title":"The exomic landscape of t (14; 18)‐negative diffuse follicular lymphoma with 1p36 deletion","googleId":"mYz93HD3yOoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15041","googleCitationCount":7,"googleAuthor":"A Zamò","doi":"10.1111/bjh.15041","elsevierAuthor":"Zamò A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"6","altmetricAuthors":["Alberto Zamò","Jordan Pischimarov","Heike Horn","German Ott","Andreas Rosenwald","Ellen Leich"],"twitterCount":1,"altmetricId":29888678,"statusesArray":["976517828374392832"]},{"title":"Efficacy and safety of a bortezomib and reduced‐intensity cytarabine‐based protocol, TMC ALLR1, for relapsed childhood ALL in India","googleId":"vidDH_gmQxkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16005","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.16005","elsevierAuthor":"Roy P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genetic analysis of Diffuse Large B‐cell Lymphoma occurring in cases with antecedent Waldenström Macroglobulinaemia reveals different patterns of clonal evolution","googleId":"coca1OiNcUIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15610?","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15610","elsevierAuthor":"Talaulikar D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2","altmetricAuthors":["Dipti Talaulikar","Amber Biscoe","Jun H. Lim","John Gibson","Christopher Arthur","Naomi Mackinlay","Kartik Saxena","Yuen Y. Cheng","Vivien M. Chen"],"twitterCount":1,"altmetricId":49952138,"statusesArray":["1053390331356606464"]},{"title":"The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non‐transfusion‐dependent thalassaemia patients","googleId":"YwV-Y4r6lu4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15083","googleCitationCount":6,"googleAuthor":"P Ricchi","doi":"10.1111/bjh.15083","elsevierAuthor":"Ricchi P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6","altmetricAuthors":["Paolo Ricchi","Antonella Meloni","Anna Spasiano","Silvia Costantini","Alessia Pepe","Patrizia Cinque","Aldo Filosa"],"twitterCount":1,"altmetricId":33589058,"statusesArray":["966947744819630080"]},{"title":"Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure","googleId":"bA12dFNhL6oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15862","googleCitationCount":3,"googleAuthor":"CM Kerr","doi":"10.1111/bjh.15862","elsevierAuthor":"Shen W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Health‐related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study","googleId":"N4orzYgqdQIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15732","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15732","elsevierAuthor":"Grainger J.D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Rapid decline in estimated glomerular filtration rate is common in adults with sickle cell disease and associated with increased mortality","googleId":"oMIm95_S8dQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16003","googleCitationCount":4,"googleAuthor":"Q Zhou","doi":"10.1111/bjh.16003","elsevierAuthor":"Derebail V.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Expression of CD56 defines a distinct subgroup in childhood T‐ALL with inferior outcome. Results of the ALL‐BFM 2000 trial","googleId":"2ojKuevhRr4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15503","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15503","elsevierAuthor":"Fuhrmann S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":["Stephan Fuhrmann","Richard Schabath","Anja Möricke","Martin Zimmermann","Joachim B. Kunz","Andreas E. Kulozik","Wolf-Dieter Ludwig","Martin Schrappe","Leonid Karawajew","Richard Ratei"],"twitterCount":5,"altmetricId":45386220,"statusesArray":["1310682180570488834","1310680598873333760","1149415985369272320","1020988843556712448","1020972197328941058"]},{"title":"Tandem haematopoietic stem cell transplantation for high risk relapsed/refractory Hodgkin lymphoma: a LYSA study","googleId":"VsCryHSs9b8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15184","googleCitationCount":7,"googleAuthor":"A Perrot","doi":"10.1111/bjh.15184","elsevierAuthor":"Deau B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"6","altmetricAuthors":["Benedicte Deau","Sandy Amorim","Aurore Perrot","Philippe Quittet","Jerome Cornillon","Driss Chaoui","Jean P. Marolleau","Lucie Oberic","Katell Le Du","Luc-Matthieu Fornecker","Olivier Tournilhac","Anne S. Veillard","Isabelle Chaillol","Marie Robin","Jérôme Tamburini","Pauline Brice"],"twitterCount":4,"altmetricId":35726459,"statusesArray":["992110931604856832","991945832525123584","981868998521389057","981859458258268162"]},{"title":"The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis","googleId":"IMS-n4ZR-YIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15387","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.15387","elsevierAuthor":"Gatt M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"6","altmetricAuthors":["Moshe E. Gatt","Batia Kaplan","Dean Yogev","Elana Slyusarevsky","Galina Pogrebijski","Sizilia Golderman","Olga Kukuy","Avi Livneh"],"twitterCount":4,"altmetricId":41789679,"statusesArray":["999240219831521280","999004886619607041","997069914119716864","997057356566618112"]},{"title":"Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use …","googleId":"4eryAiC7-jYJ","googleLink":"http://heft-test.eprints-hosting.org/id/eprint/2777/","googleCitationCount":8,"googleAuthor":"TA Eyre","statusesArray":[]},{"title":"Antenatal screening for haemoglobinopathies: current status, barriers and ethics","googleId":"xUf69mf4Ew4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16188","googleCitationCount":2,"googleAuthor":"S Chakravorty","doi":"10.1111/bjh.16188","elsevierAuthor":"Chakravorty S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"0","altmetricAuthors":["Subarna Chakravorty","Moira C Dick"],"twitterCount":2,"altmetricId":66556206,"statusesArray":["1172527239344414720","1172491979315470336"]},{"title":"The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and …","googleId":"HcLqmFpo8AAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15650","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15650","elsevierAuthor":"Cabannes-Hamy A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"3","altmetricAuthors":["Aurélie Cabannes‐Hamy","Nicolas Boissel","Régis Peffault De Latour","Etienne Lengliné","Thierry Leblanc","Flore S. Fontbrune","Emmanuel Raffoux","Marie Robin","Aliénor Xhaard","André Baruchel","Gérard Socié","Nathalie Dhédin"],"twitterCount":1,"altmetricId":51102777,"statusesArray":["1062133458749808640"]},{"title":"A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple …","googleId":"9V7BzCdYCiIJ","googleLink":"https://kyushu-u.pure.elsevier.com/en/publications/a-comparison-of-minimal-residual-disease-detection-in-autografts-","googleCitationCount":7,"googleAuthor":"Y Zaimoku","doi":"10.1111/bjh.15002","elsevierAuthor":"Takamatsu H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4","altmetricAuthors":["Hiroyuki Takamatsu","Rachel K. Wee","Yoshitaka Zaimoku","Ryoichi Murata","Jianbiao Zheng","Martin Moorhead","Victoria E. H. Carlton","Katherine A. Kong","Naoki Takezako","Shigeki Ito","Toshihiro Miyamoto","Kenji Yokoyama","Kosei Matsue","Tsutomu Sato","Toshiro Kurokawa","Hideo Yagi","Yasushi Terasaki","Kinya Ohata","Morio Matsumoto","Takashi Yoshida","Malek Faham","Shinji Nakao"],"twitterCount":2,"altmetricId":30818821,"statusesArray":["945383652908830721","944367076730384384"]},{"title":"Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first‐line chemotherapy","googleId":"_-60H6LOl2IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15933","googleCitationCount":4,"googleAuthor":"LC Gormsen","doi":"10.1111/bjh.15933","elsevierAuthor":"Pedersen M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"3","altmetricAuthors":["Mette A. Pedersen","Lars C. Gormsen","Peter Kamper","Cecilia Wassberg","Maja D. Andersen","Alexander L. d'Amore","Sally F. Barrington","Peter Johnson","Stephen Hamilton‐Dutoit","Rose‐Marie Amini","Gunilla Enblad","Daniel Molin","Francesco d'Amore"],"twitterCount":10,"altmetricId":60910449,"statusesArray":["1152226846056099844","1131922435605901313","1131889286171779072","1131874444115349504","1131850186370748416","1131813849722695680","1131776337251844096","1131664945974792192","1131663272875307010","1131500443782270977"]},{"title":"Genome‐wide linkage analysis and whole‐exome sequencing identifies an ITGA2B mutation in a family with thrombocytopenia","googleId":"MnlvbRO3cR8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15961","googleCitationCount":2,"googleAuthor":"AB Ozel","doi":"10.1111/bjh.15961","elsevierAuthor":"Khoriaty R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":["Rami Khoriaty","Ayse B. Ozel","Shweta Ramdas","Charles Ross","Karl Desch","Jordan A. Shavit","Lesley Everett","David Siemieniak","Jun Z. Li","David Ginsburg"],"twitterCount":4,"altmetricId":62666329,"statusesArray":["1163343801206956033","1163332190182285313","1163286830214606848","1163174059133284353"]},{"title":"Histopathological evidence for macrophage activation driving post‐transfusion hyperhaemolysis syndrome","googleId":"f_xV429oxJkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15925","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15925","elsevierAuthor":"Win N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth","googleId":"-oa2B_bQAjkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15962","googleCitationCount":4,"googleAuthor":"RA Middelburg","doi":"10.1111/bjh.15962","elsevierAuthor":"Ree I.M.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome …","googleId":"RMCYSomfKUAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15208","googleCitationCount":6,"googleAuthor":"RS Sellar","doi":"10.1111/bjh.15208","elsevierAuthor":"Sellar R.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"6","altmetricAuthors":["Rob S. Sellar","Clare Rowntree","Ajay J. Vora","Caroline L. Furness","Nicholas Goulden","Chris Mitchell","Anthony V. Moorman","Rachael Hough"],"twitterCount":1,"altmetricId":39305398,"statusesArray":["989208320002043904"]},{"title":"Spontaneous regression of a plasmablastic lymphoma with MYC rearrangement","googleId":"U_Hlb6fJWQgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31257571/","googleCitationCount":4,"googleAuthor":"S Stilgenbauer","doi":"10.1111/bjh.16082,","elsevierAuthor":"Yordanova K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone …","googleId":"7R0xmMp1fFcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15490","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15490","elsevierAuthor":"Drevon L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"2","altmetricAuthors":["Louis Drevon","Alice Marceau","Odile Maarek","Wendy Cuccuini","Emmanuelle Clappier","Virginie Eclache","Thomas Cluzeau","Valentine Richez","Inès Berkaoui","Sophie Dimicoli-Salazar","Audrey Bidet","Jean-Philippe Vial","Sophie Park","Christina Vieira Dos Santos","Eléonore Kaphan","Céline Berthon","Aspasia Stamatoullas","François Delhommeau","Nassera Abermil","Thorsten Braun","Rosa Sapena","Daniel Lusina","Aline Renneville","Lionel Adès","Sophie Raynaud","Pierre Fenaux"],"twitterCount":2,"altmetricId":45093069,"statusesArray":["1019154975627202562","1018878755866140672"]},{"title":"Bendamustine with rituximab, etoposide and carboplatin (T (R) EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial","googleId":"RyGwWuvS-fgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15585","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15585","elsevierAuthor":"Budde L.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4","altmetricAuthors":["Lihua E. Budde","David Wu","Daniel B. Martin","Mary Philip","Andrei R. Shustov","Stephen D. Smith","Ted A. Gooley","Tara L. Chen","Edward N. Libby","Eric Y. Chen","Kiarash Kojouri","Alan Langerak","Jennifer E. Roden","Oliver W. Press","Ajay K. Gopal"],"twitterCount":7,"altmetricId":49412567,"statusesArray":["1082346457800142848","1080250090810421249","1080057193192476672","1050005662413946885","1049717747876331520","1049665434386018304","1049663218115899392"]},{"title":"Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.","googleId":"0s3Jvj_JHewJ","googleLink":"https://europepmc.org/article/pmc/pmc7046310","googleCitationCount":3,"googleAuthor":"MJ Maurer","statusesArray":[]},{"title":"Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia","googleId":"233FBgC4-tsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16060","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16060","elsevierAuthor":"Shigemura T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"2","altmetricAuthors":["Tomonari Shigemura","Kazuyuki Matsuda","Takashi Kurata","Kazuo Sakashita","Yusuke Okuno","Hideki Muramatsu","Fengming Yue","Yasuhiro Ebihara","Kohichiro Tsuji","Katsunori Sasaki","Tatsutoshi Nakahata","Yozo Nakazawa","Kenichi Koike"],"twitterCount":0,"altmetricId":62732934,"statusesArray":[]},{"title":"The role of plasma exchange in the management of autoimmune disorders","googleId":"9AEC3wXqLm0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15903","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15903","elsevierAuthor":"Zanatta E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":["Elisabetta Zanatta","Martina Cozzi","Piero Marson","Franco Cozzi"],"twitterCount":20,"altmetricId":58057756,"statusesArray":["1187341313848598529","1187074475646509059","1187067571306151939","1186903764810321920","1186871358506045440","1186752076245819394","1186742672054087680","1186680961972559872","1186670487549743105","1186661775225184256","1186658015019196418","1186657873218166784","1186657680842051585","1186657635925254144","1186657388390244352","1186655946472165377","1186653396574572544","1148184232163971072","1146525334025777152","1112031112849588224","1111694381680152576"]},{"title":"Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients","googleId":"Yk_P8dQNrtIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15259","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15259","elsevierAuthor":"Bram Ednersson S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4","altmetricAuthors":["Susanne Bram Ednersson","Martin Stenson","Mimmie Stern","Gunilla Enblad","Henrik Fagman","Herman Nilsson-Ehle","Sverker Hasselblom","Per-Ola Andersson"],"twitterCount":1,"altmetricId":41788744,"statusesArray":["997056852717326336"]},{"title":"STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice","googleId":"TryycfTvYQUJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484756/","googleCitationCount":11,"googleAuthor":"A Dutta","statusesArray":[]},{"title":"The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial","googleId":"OIwSOKu_3SQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30408160/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15629,","elsevierAuthor":"Austin G.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A retrospective study on the management of patients with rituximab refractory follicular lymphoma","googleId":"4XP8aXXbcVAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15023","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15023","elsevierAuthor":"Solal-Céligny P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition","googleId":"SDvjy72kivQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15162","googleCitationCount":6,"googleAuthor":"AE Rankine‐Mullings","doi":"10.1111/bjh.15162","elsevierAuthor":"Rankine-Mullings A.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical features and outcomes of secondary intraocular lymphoma","googleId":"9MSl7VHPdB4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29143310/","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15005,","elsevierAuthor":"Karakawa A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"SLC2A5 overexpression in childhood philadelphia chromosome‐positive acute lymphoblastic leukaemia","googleId":"dcJnMBHkkKUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15580","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15580","elsevierAuthor":"Zhao P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2)","googleId":"tPdpQ96BhwkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30924144/?from_term=Ghurye+R&from_pos=4","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15896,","elsevierAuthor":"Ghurye R.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information","googleId":"_cqPVgwYV7cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29359798/","googleCitationCount":9,"googleAuthor":"P Minetto","doi":"10.1111/bjh.15106,","elsevierAuthor":"Minetto P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Doubling rituximab in high‐risk patients with aggressive B‐cell lymphoma‐results of the DENSE‐R‐Mega CHOEP trial","googleId":"lqoRT0bf1g8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15710","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15710","elsevierAuthor":"Friedrichs B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3","altmetricAuthors":["Birte Friedrichs","Maike Nickelsen","Marita Ziepert","Bettina Altmann","Mathias Haenel","Andreas Viardot","Christian Schmidt","Christian Ruebe","Markus Loeffler","Michael Pfreundschuh","Andreas Rosenwald","Bertram Glass","Georg Lenz","Norbert Schmitz"],"twitterCount":5,"altmetricId":52310633,"statusesArray":["1098168217988710400","1097866412582993925","1072115715476520960","1071067568574738433","1070915292979740672"]},{"title":"Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenström macroglobulinaemia","googleId":"J5NbGGezn5gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15200?","googleCitationCount":7,"googleAuthor":"JJ Castillo","doi":"10.1111/bjh.15200","elsevierAuthor":"Castillo J.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"6","altmetricAuthors":["Jorge J. Castillo","Joshua N. Gustine","Kirsten Meid","Toni Dubeau","Patricia Severns","Lian Xu","Guang Yang","Zachary R. Hunter","Steven P. Treon"],"twitterCount":1,"altmetricId":97053806,"statusesArray":["1345883283763163138"]},{"title":"The miR-17~ 92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway","googleId":"20pxAgbgdZ0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30198569/","googleCitationCount":5,"googleAuthor":"C Jiang","doi":"10.1111/bjh.15591,","elsevierAuthor":"Jiang C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impaired immune responses to herpesviruses and microbial ligands in patients with Mono MAC","googleId":"A2JiKYqRgy4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15947","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15947","elsevierAuthor":"Mardahl M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2","altmetricAuthors":["Maibritt Mardahl","Sofie Eg Jørgensen","Alon Schneider","Klas Raaschou‐Jensen","Mette Holm","Jens Veirum","Thomas K. Kristensen","Isik S. Johansen","Mette Christiansen","Kristian Assing","Trine H. Mogensen"],"twitterCount":1,"altmetricId":62279144,"statusesArray":["1281089206673190918"]},{"title":"Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma","googleId":"-XpVK3ojW_YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16008","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16008","elsevierAuthor":"Spurgeon S.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"9","altmetricAuthors":["Stephen E. Spurgeon","Kamal Sharma","David F. Claxton","Christopher Ehmann","Jeffrey Pu","Sara Shimko","August Stewart","Nan Subbiah","Gundula Palmbach","Francis LeBlanc","Emile Latour","YiYi Chen","Motomi Mori","Zainul Hasanali","Elliot M. Epner"],"twitterCount":2,"altmetricId":61954913,"statusesArray":["1138167214400520192","1138023274959572992"]},{"title":"Challenges in managing parental expectations in paediatric care","googleId":"Ainnv_9iF2EJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15554","googleCitationCount":4,"googleAuthor":"J Brierley","doi":"10.1111/bjh.15554","elsevierAuthor":"du Pré P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Type 2 diabetes in adults with sickle cell disease: can we dive deeper?","googleId":"8fn3VD-tCMkJ","googleLink":"https://europepmc.org/article/med/31066026","googleCitationCount":3,"googleAuthor":"P Connes","statusesArray":[]},{"title":"Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP","googleId":"mxwYtEiNc_4J","googleLink":"https://ora.ox.ac.uk/objects/uuid:216010ed-9e4a-440f-bb4b-6ebf3255810f/download_file?file_format=pdf&safe_filename=Letter%2520to%2520BJH%2520Male%2520gender%2520is%2520an%2520independent%2520predictor%2520for%2520worse%2520progression%2520Revision.pdf&type_of_work=Journal+article","googleCitationCount":4,"googleAuthor":"T Eyre","statusesArray":[]},{"title":"Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)","googleId":"sPHfszjBC6gJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30407614/","googleCitationCount":5,"googleAuthor":"P Niscola","doi":"10.1111/bjh.15655,","elsevierAuthor":"Fabiani E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia–an updated meta‐analysis","googleId":"JsqyFp1DU68J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15901","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15901","elsevierAuthor":"Vidal L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":["Liat Vidal","Ronit Gurion","Liat Shargian","Martin Dreyling","Anat Gafter-Gvili"],"twitterCount":17,"altmetricId":58993797,"statusesArray":["1148225289828175874","1148185421186326529","1148184769815023617","1147850377422880768","1117871962922061825","1117837172084813830","1117736208635965440","1117667305079459840","1117658073152274432","1117657045384204288","1117638806558191616","1117617122459488256","1117601446021816322","1117523220209467393","1117458538006114309","1117399096673873921","1117382526341910528","1117381594124304387","1117371104836968448","1117367399647522816","1117325808803229696","1117322419751084037"]},{"title":"Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia","googleId":"yTxbSaWxGWgJ","googleLink":"https://elibrary.ru/item.asp?id=38922572","googleCitationCount":3,"googleAuthor":"JA Burger","statusesArray":[]},{"title":"Elevated fetal haemoglobin levels are associated with decreased incidence of retinopathy in adults with sickle cell disease","googleId":"YWBVAgaAe9gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15617","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15617","elsevierAuthor":"Mian U.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"4","altmetricAuthors":["Umar K. Mian","Joyce Tang","Ana P. M. Allende","Moonseong Heo","Nicole Bernstein","Leena Vattappally","Daniel Schoenfeld","Caterina P. Minniti"],"twitterCount":5,"altmetricId":51102835,"statusesArray":["1125399019688271873","1125367282841026561","1125362128200851456","1125310230987005952","1067111495782285314","1062134169587908609"]},{"title":"Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients","googleId":"Nl6uDSZQXesJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15521","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15521","elsevierAuthor":"Macauda A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"3","altmetricAuthors":["Angelica Macauda","Eleonora Castelli","Gabriele Buda","Matteo Pelosini","Aleksandra Butrym","Marzena Watek","Marcin Kruszewski","Annette Juul Vangsted","Marcin Rymko","Krzysztof Jamroziak","Niels Abildgaard","Eva Kannik Haastrup","Grzegorz Mazur","Rafael Ríos","Artur Jurczyszyn","Daria Zawirska","Marek Dudziński","Małgorzata Raźny","Magdalena Dutka","Waldemar Tomczak","Anna Suska","Agnieszka Druzd-Sitek","Herlander Marques","Mario Petrini","Miroslaw Markiewicz","Joaquin Martinez-Lopez","Lene Hyldahl Ebbesen","Elżbieta Iskierka-Jażdżewska","Juan Sainz","Federico Canzian","Daniele Campa"],"twitterCount":1,"altmetricId":46212583,"statusesArray":["1026815221304709121"]},{"title":"Identification of sphingosine kinase 1 as a therapeutic target in B‐lineage acute lymphoblastic leukaemia","googleId":"MiFUceB0gP8J","googleLink":"https://www.researchgate.net/profile/Alexander_Lewis6/publication/322664295_Identification_of_sphingosine_kinase_1_as_a_therapeutic_target_in_B-lineage_acute_lymphoblastic_leukaemia/links/5c859eeb458515831f9aa3af/Identification-of-sphingosine-kinase-1-as-a-therapeutic-target-in-B-lineage-acute-lymphoblastic-leukaemia.pdf","googleCitationCount":7,"googleAuthor":"CT Wallington‐Beddoe","statusesArray":[]},{"title":"Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective …","googleId":"amixVITLU24J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16145","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16145","elsevierAuthor":"Huguet F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1","altmetricAuthors":["Françoise Huguet","Jean‐Michel Cayuela","Nathalie Cambier","Nathalie Carpentier","Malka Tindel","Isabelle Violet","Patricia Zunic","Axelle Lascaux","Gabriel Etienne","ADIKO Didier Innocent","AME NATARAJAN Shanti","ARAUJO Carla","BENBRAHIM Omar","BOISSEAU Martial","BORDESSOULE Dominique","BOUDERBALA Azzedine","CAMBIER Nathalie","COITEUX Valerie","CONY MAKHOUL Pascale","COSTELLO Regis","DELAIN Martine","DUBRUILLE Viviane","EL YAMANI Abderrazak","ETIENNE Gabriel","FERNANDES Jose","GARIDI Reda","GUERCI BRESLER Agnes","GUYOTAT Denis","HACINI Maya","HERMET Eric","HUGUET Francoise","IANOTTO Jean Christophe","JOLY Bertrand","JOURDAN Eric","LAROSA Fabrice","LASCAUX Axelle","LEFORT Sophie","MARFAING Anne","MAROLLEAU Jean-Pierre","MICHEL Jessica","NICOLINI Franck","PLANTIER Isabelle","QUITTET Philippe","RODON Philippe","SANHES Laurence","VAIDA Ioana","VILLEMAGNE Bruno","VISANICA Sorin","VOILLAT Laurent","ZUNIC Patricia"],"twitterCount":2,"altmetricId":64771298,"statusesArray":["1165533520330153987","1159843888137326592"]},{"title":"Thalassaemia intermedia caused by coinheritance of a β‐thalassaemia mutation and a de novo duplication of α‐globin genes in the paternal allele","googleId":"Je6tDof07TAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15958","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15958","elsevierAuthor":"Pang D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":["Dejian Pang","Xuan Shang","Decheng Cai","Fei Zhu","Yi Cheng","Jianmei Zhong","Sheng Yi","Qianqian Zhang","Xiangmin Xu"],"twitterCount":1,"altmetricId":61210119,"statusesArray":["1268560147426635776","1133435151281606656"]},{"title":"Patient‐reported outcomes of multiple myeloma patients treated with panobinostat after≥ 2 lines of therapy based on the international phase 3, randomized, double …","googleId":"RIUC0AbVq2AJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15248","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15248","elsevierAuthor":"Richardson P.G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"5","altmetricAuthors":["Paul G. Richardson","Robert L. Schlossman","Anuja N. Roy","Ashok Panneerselvam","Suddhasatta Acharyya","Monika Sopala","Sagar Lonial"],"twitterCount":2,"altmetricId":42416875,"statusesArray":["1019360803785502721","1019295674230161408","999298219082383361","999297368649621504"]},{"title":"Sickle cell trait and renal disease among African American US Army soldiers","googleId":"yCXSx-l3EAAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15820","googleCitationCount":4,"googleAuthor":"J Hu","doi":"10.1111/bjh.15820","elsevierAuthor":"Hu J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls","googleId":"GP0Ek4lirxIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15965","googleCitationCount":2,"googleAuthor":"TC El‐Galaly","doi":"10.1111/bjh.15965","elsevierAuthor":"El-Galaly T.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"1","altmetricAuthors":["Tarec C. El‐Galaly","Chan Y. Cheah","Diego Villa"],"twitterCount":3,"altmetricId":61286645,"statusesArray":["1134492118766895106","1134296203267518464","1134037226462023680"]},{"title":"The impact of fertility preservation on treatment delay and progression-free survival in women with lymphoma: a single-centre experience","googleId":"6pRY2EcQrp0J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474218/","googleCitationCount":9,"googleAuthor":"","statusesArray":[]},{"title":"Acute myeloid/T‐lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy","googleId":"HDegzJKuxxMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15129","googleCitationCount":12,"googleAuthor":"A Kentsis","doi":"10.1111/bjh.15129","elsevierAuthor":"Gutierrez A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"10","altmetricAuthors":["Alejandro Gutierrez","Alex Kentsis"],"twitterCount":14,"altmetricId":33222663,"statusesArray":["1360923301669863425","1360794358023417856","1354424866099900417","1334699452519632897","1279172563042779137","1208205655095554048","1208131433690279942","1208003417597186053","1208000781485592576","1153002976216330242","1040219840496259072","1040209311308374016","1040069555291336705","1040011603733868544","1039979465416294400","1039963954376830983","1024478343457132544","967287711802552320","964581571218034688","964579676982272000","963955626492682240","963947279815200768"]},{"title":"Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making","googleId":"xIlK8qOCVXcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31617209/","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.16191,","elsevierAuthor":"Hofmans M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen","googleId":"ujUpklPEM9UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15438","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15438","elsevierAuthor":"Sun Q.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"3","altmetricAuthors":["Qixin Sun","Bingyi Wu","Hekui Lan","Fanyi Meng","Xiaoxiao Ma","Xinxin Chen","Zhiwei Huang","Qianqian Yao","Jianhui Xu","Yuxian Huang","Shaojie Wu","Zhigang Zhu"],"twitterCount":1,"altmetricId":44488465,"statusesArray":["1014552442095259650"]},{"title":"Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta‐analysis","googleId":"m-RZvtxyjIkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15904","googleCitationCount":1,"googleAuthor":"LR Teras","doi":"10.1111/bjh.15904","elsevierAuthor":"Teras L.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":["Lauren R. Teras","Alpa V. Patel","Brian D. Carter","Erika Rees‐Punia","Marjorie L. McCullough","Susan M. Gapstur"],"twitterCount":4,"altmetricId":58977678,"statusesArray":["1148799663492890624","1117144638631100421","1117144433571426304","1116963470866558976","1116962550254637057"]},{"title":"BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.","googleId":"GoEVnk7AcUIJ","googleLink":"https://europepmc.org/article/med/29974955","googleCitationCount":7,"googleAuthor":"A Visentin","statusesArray":[]},{"title":"CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy","googleId":"_aQHnwLdqGMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27604396/","googleCitationCount":9,"googleAuthor":"AE Bras","doi":"10.1111/bjh.14310,","elsevierAuthor":"Bras A.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients","googleId":"uc3RDcZIio8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15916","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15916","elsevierAuthor":"Folta A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2","altmetricAuthors":["Adam Folta","Martin Culen","Ivana Jeziskova","Zdenka Herudkova","Nikola Tom","Tereza Hlubinkova","Veronika Janeckova","Anna Durinikova","Jan Vydra","Lukas Semerad","Dana Dvorakova","Hana Remesova","Ela Cerovska","Petr Cetkovsky","Pavel Jindra","Tomas Szotkowski","Pavel Zak","Jiri Mayer","Zdenek Racil"],"twitterCount":1,"altmetricId":59157301,"statusesArray":["1118579031585304582","1118579015097507840"]},{"title":"Impaired cellular and humoral immunity is a feature of Diamond‐Blackfan anaemia; experience of 107 unselected cases in the United Kingdom","googleId":"9SXxvDakCOEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15915","googleCitationCount":3,"googleAuthor":"D Iskander","doi":"10.1111/bjh.15915","elsevierAuthor":"Iskander D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":["Deena Iskander","Irene Roberts","Clare Rees","Richard Szydlo","Mary Alikian","Michael Neale","Yvonne Harrington","Peter Kelleher","Anastasios Karadimitris","Josu Fuente"],"twitterCount":3,"altmetricId":58998385,"statusesArray":["1156249804625842176","1121862913201930240","1121398448769597441","1117367567600050177"]},{"title":"Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease‐could we strike while the liver is hard?","googleId":"GLqtZS17x3QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16047","googleCitationCount":2,"googleAuthor":"D Sharma","doi":"10.1111/bjh.16047","elsevierAuthor":"Ben Yakov G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"1","altmetricAuthors":["Gil Ben Yakov","Disha Sharma","Hawwa Alao","Pallavi Surana","Devika Kapuria","Ohad Etzion","Matthew M. Hsieh","John F. Tisdale","Courtney D. Fitzhugh","David E. Kleiner","Elliot B. Levy","Richard Chang","Elenita Rivera","Amy Huang","Christopher Koh","Theo Heller"],"twitterCount":6,"altmetricId":62499636,"statusesArray":["1142416247189061632","1142255930874183681","1142242159447330816","1142207816154828800","1142206438053298176","1142117036241252352","1142043463468240897"]},{"title":"Therapeutic recommendations for early stage Hodgkin lymphomas","googleId":"0QVJdnPEKlIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15623","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15623","elsevierAuthor":"Depaus J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"2","altmetricAuthors":["Julien Depaus","Anne Delcourt","Marc André"],"twitterCount":2,"altmetricId":51883503,"statusesArray":["1174624691115311105","1067884226081636353"]},{"title":"Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond …","googleId":"9kHXWWDIhkkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30198570/","googleCitationCount":5,"googleAuthor":"J Morini","doi":"10.1111/bjh.15594,","elsevierAuthor":"Morini J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Nilotinib after imatinib first‐line: a real‐life longitudinal cohort of patients with chronic myeloid leukaemia in chronic phase","googleId":"BlcELqwKZCEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15042","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15042","elsevierAuthor":"Cony-Makhoul P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene","googleId":"XVJUVLCQEEUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28466964/","googleCitationCount":8,"googleAuthor":"C Marconi","doi":"10.1111/bjh.14694,","elsevierAuthor":"Noris P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"8","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia","googleId":"uI5YbhcZceUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15085","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15085","elsevierAuthor":"Kasamatsu T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"7","altmetricAuthors":["Tetsuhiro Kasamatsu","Rumi Ino","Noriyuki Takahashi","Nanami Gotoh","Yusuke Minato","Makiko Takizawa","Akihiko Yokohama","Hiroshi Handa","Takayuki Saitoh","Norifumi Tsukamoto","Hirokazu Murakami"],"twitterCount":1,"altmetricId":32155011,"statusesArray":["956123490427404288"]},{"title":"The epidemiology of amyloidosis in Queensland, Australia","googleId":"B0EQcP9n70sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16000","googleCitationCount":2,"googleAuthor":"DSA McLeod","doi":"10.1111/bjh.16000","elsevierAuthor":"Wisniowski B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Venetoclax as a single agent and in combination with PI3K-MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma (MCL)","googleId":"kOVgSC44ML8J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066460/","googleCitationCount":6,"googleAuthor":"X Zhao","statusesArray":[]},{"title":"Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA","googleId":"ulULdYLErRoJ","googleLink":"https://okayama.pure.elsevier.com/en/publications/class-1-hdac-and-hdac6-inhibition-inversely-regulates-cd38-induct","googleCitationCount":4,"googleAuthor":"A Bat-Erdene","doi":"10.1111/bjh.15673","elsevierAuthor":"Bat-Erdene A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A new case of heterozygous variant of the GP1BB gene responsible for macrothrombocytopenia","googleId":"tq_SmBZud8UJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30609015/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15739,","elsevierAuthor":"Babuty A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.","googleId":"qXuVBpKjv4EJ","googleLink":"https://europepmc.org/article/med/30028005","googleCitationCount":5,"googleAuthor":"C Gurnari","statusesArray":[]},{"title":"Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge.","googleId":"sATSy0Z3jaYJ","googleLink":"https://europepmc.org/article/med/29363744","googleCitationCount":7,"googleAuthor":"A Shah","statusesArray":[]},{"title":"Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma","googleId":"YfATcjXgIcMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14992","googleCitationCount":8,"googleAuthor":"","doi":"10.1111/bjh.14992","elsevierAuthor":"Cohen A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7","altmetricAuthors":["Alexa Cohen","Tanya M. Spektor","Laura Stampleman","Alberto Bessudo","Peter J. Rosen","Leonard M. Klein","Thomas Woliver","Marshall Flam","Shahrooz Eshaghian","Youram Nassir","Tina Maluso","Regina A. Swift","Robert Vescio","James R. Berenson"],"twitterCount":1,"altmetricId":29472782,"statusesArray":["934844212582977537"]},{"title":"Interleukin‐12 and its procoagulant effect on erythrocytes, platelets and fibrin (ogen): the lesser known side of inflammation","googleId":"W2iKyblgp8IJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15020","googleCitationCount":7,"googleAuthor":"MJ Page","doi":"10.1111/bjh.15020","elsevierAuthor":"Page M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"6","altmetricAuthors":["Martin J. Page","Janette Bester","Etheresia Pretorius"],"twitterCount":3,"altmetricId":28997014,"statusesArray":["931214669548785664","931212749794959365","931104337169911808"]},{"title":"Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia","googleId":"WJFdPj9Vh_gJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29974954/","googleCitationCount":5,"googleAuthor":"ÉLM Vieira","doi":"10.1111/bjh.15439,","elsevierAuthor":"Belisário A.R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Novel mutations in SPTA1 and SPTB identified by whole exome sequencing in eight Thai families with hereditary pyropoikilocytosis presenting with severe fetal and …","googleId":"05tZTKZUSDoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30198572/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15559,","elsevierAuthor":"Ittiwut C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera","googleId":"sXWqe3L0tQ4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31418453/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16146,","elsevierAuthor":"Inano T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study","googleId":"NYzK9AGEFTAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16045","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16045","elsevierAuthor":"Mondesir J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Current treatment paradigms for advanced stage Hodgkin lymphoma","googleId":"tsLV9ZK9PpsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15622","googleCitationCount":3,"googleAuthor":"PWM Johnson","doi":"10.1111/bjh.15622","elsevierAuthor":"Longley J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"2","altmetricAuthors":["Jemma Longley","Peter W. M. Johnson"],"twitterCount":2,"altmetricId":51025407,"statusesArray":["1060874884014841856","1060849905722376192"]},{"title":"Haemolysis in sickle cell anaemia: effects of polymorphisms in α-globin gene regulatory elements","googleId":"X1tIpHvhMKoJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6606385/","googleCitationCount":3,"googleAuthor":"JN Milton","statusesArray":[]},{"title":"Cardiac expression of HMOX1 and PGF in sickle cell mice and haem‐treated wild type mice dominates organ expression profiles via Nrf2 (Nfe2l2)","googleId":"vSsgGy-tI9wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16129","googleCitationCount":2,"googleAuthor":"OT Gbotosho","doi":"10.1111/bjh.16129","elsevierAuthor":"Gbotosho O.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Angiogenin-mediated tRNA cleavage as a novel feature of stored red blood cells","googleId":"crFRFrTRwMwJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6472987/","googleCitationCount":3,"googleAuthor":"WH Yang","statusesArray":[]},{"title":"Clinical outcomes in chronic lymphocytic leukaemia associated with expression of CD5, a negative regulator of B‐cell receptor signalling","googleId":"Nq4S4IKAuBgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15632","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15632","elsevierAuthor":"Friedman D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"3","altmetricAuthors":["Daphne R. Friedman","Eross Guadalupe","Alicia Volkheimer","Joseph O. Moore","J. Brice Weinberg"],"twitterCount":3,"altmetricId":51023148,"statusesArray":["1060872909126881281","1060853401506979841","1060849863573884928"]},{"title":"Ventricular global longitudinal strain is altered in children with sickle cell disease","googleId":"bsTUJh69Il0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15607","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15607","elsevierAuthor":"Whipple N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy","googleId":"tEusX4iPOrAJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812827/","googleCitationCount":7,"googleAuthor":"T Bat","statusesArray":[]},{"title":"Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative …","googleId":"3fQArm2ZSPAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16064","googleCitationCount":3,"googleAuthor":"C Keane","doi":"10.1111/bjh.16064","elsevierAuthor":"Wight J.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"2","altmetricAuthors":["Joel C. Wight","Mimi Yue","Colm Keane","Anna Johnston","Kim Linton","Collin Chin","Shin Hnin Wai","Dipti Talaulikar","Robin Gasiorowski","Chan Yoon Cheah","Gareth P. Gregory","Michael Dickinson","Adrian Minson","Caitlin Coombes","Matthew Ku","Stephanie Lam","Eliza A. Hawkes"],"twitterCount":15,"altmetricId":63339200,"statusesArray":["1190716774213394433","1190656841438642178","1190656328601079808","1190632253677867015","1187051356344991744","1186878450411413504","1186840047753936896","1186800155325956096","1186732250504814592","1186704967463292928","1186696595393466369","1186688804259807232","1185563389059387392","1185557699620233216","1185549329488060417","1182875040074756096","1182860061246255104"]},{"title":"Novel findings from the multinational DOVE study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell …","googleId":"xIdtCzgQ2SUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15250?af=R","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15250","elsevierAuthor":"Kanter J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2","altmetricAuthors":["Julie Kanter","Lori E. Heath","Jack Knorr","E. Tsiri Agbenyega","Raffaella Colombatti","Carlton Dampier","Hoda Hassab","Deepa Manwani","Nancy Robitaille","Patricia B. Brown","Joseph A. Jakubowski","Suqin Yao","Carolyn Hoppe"],"twitterCount":0,"altmetricId":52153085,"statusesArray":[]},{"title":"New insights into red cell rheology and adhesion in patients with sickle cell anaemia during vaso-occlusive crises","googleId":"bYWh7yeDa3AJ","googleLink":"https://hal.univ-antilles.fr/hal-01968397","googleCitationCount":4,"googleAuthor":"P Connes","doi":"10.1111/bjh.15686","elsevierAuthor":"Lapoumeroulie C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia","googleId":"tGRyTWf2dUMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27649938/","googleCitationCount":9,"googleAuthor":"O Sartor","doi":"10.1111/bjh.14322,","elsevierAuthor":"Bennett C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy","googleId":"mJZANNCZR9QJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15899","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15899","elsevierAuthor":"Neave L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2","altmetricAuthors":["Lucy Neave","Daniel P. Gale","Simon Cheesman","Raakhee Shah","Marie Scully"],"twitterCount":1,"altmetricId":61914128,"statusesArray":["1263860182599315457"]},{"title":"Frontline treatment of elderly non transplant‐eligible multiple myeloma patients using CyBorD with or without thalidomide‐based consolidation: a retrospective multi …","googleId":"9njXR2idNnwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16095","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16095","elsevierAuthor":"Chan H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2","altmetricAuthors":["Henry Chan","Kern Chai","Steven Shih","Rebecca Lewsey","Kevin Chen","Bridgett McDiarmid","Sharon Jackson","David Simpson"],"twitterCount":5,"altmetricId":63471903,"statusesArray":["1157041449881370625","1156998606630600704","1156634732454715395","1150294032205012992","1149796958669873152","1149716845898846209"]},{"title":"Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma","googleId":"cmZsTJJaL6YJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15044","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.15044","elsevierAuthor":"Flinn I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"7","altmetricAuthors":["Ian W. Flinn","Dana S. Thompson","Ralph V. Boccia","Gerald Miletello","Andrew Lipman","Douglas Flora","Daniel Cuevas","Steven W. Papish","Jesus G. Berdeja"],"twitterCount":0,"altmetricId":56879364,"statusesArray":[]},{"title":"A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts","googleId":"iUXdAt7cDQkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5344766/","googleCitationCount":9,"googleAuthor":"","statusesArray":[]},{"title":"Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.","googleId":"4hip5XTSTGEJ","googleLink":"https://europepmc.org/article/med/29785734","googleCitationCount":5,"googleAuthor":"","statusesArray":[]},{"title":"Expression of the transcribed ultraconserved region 70 and the related long non‐coding RNA AC 092652.2‐202 has prognostic value in Chronic Lymphocytic …","googleId":"it0NZeUbjcIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15237?af=R","googleCitationCount":5,"googleAuthor":"A Roisman","doi":"10.1111/bjh.15237","elsevierAuthor":"Bomben R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4","altmetricAuthors":["Riccardo Bomben","Alejandro Roisman","Tiziana D'Agaro","Giancarlo Castellano","Tycho Baumann","Julio Delgado","Armando López-Guillermo","Antonella Zucchetto","Michele Dal-Bo","Vanessa Bravin","Irma Slavutsky","Anna Vlasova","Roderic Guigó","Jose I. Martin-Subero","Vicente Chapaprieta","Renee Beekman","David Martin-García","Sílvia Beà","Itziar Salaverria","Marta Aymerich","Elias Campo","Valter Gattei","Luis Hernández"],"twitterCount":2,"altmetricId":42238860,"statusesArray":["998626612584288261","989208323969830912"]},{"title":"Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts","googleId":"RHCFhXaRxFIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28198001/","googleCitationCount":7,"googleAuthor":"A Gill","doi":"10.1111/bjh.14556,","elsevierAuthor":"Gifford G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prospective randomized trial comparing two doses of rabbit anti‐thymocyte globulin in patients with severe aplastic anaemia","googleId":"43_SCA4fTREJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16055","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16055","elsevierAuthor":"Narita A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":["Atsushi Narita","Xiaofan Zhu","Hideki Muramatsu","Xiaojuan Chen","Ye Guo","Wenyu Yang","Jingliao Zhang","Fang Liu","Jun H. Jang","Hoon Kook","Hawk Kim","Kensuke Usuki","Hirohito Yamazaki","Yoshiyuki Takahashi","Shinji Nakao","Jong Wook Lee","Seiji Kojima"],"twitterCount":1,"altmetricId":62605732,"statusesArray":["1143008785314615298"]},{"title":"Acute myeloid leukaemia niche regulates response to L‐asparaginase","googleId":"eC4iUi7pL3YJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767544/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15924","elsevierAuthor":"Kaspers G.J.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Idiopathic pulmonary arterial hypertension–a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand …","googleId":"AewQwVwPSIoJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15530","googleCitationCount":3,"googleAuthor":"MC Pelland‐Marcotte","doi":"10.1111/bjh.15530","elsevierAuthor":"Pelland-Marcotte M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":["Marie-Claude Pelland-Marcotte","Tilman Humpl","Paula D. James","Margaret L. Rand","Vanessa Bouskill","Janette T. Reyes","Mackenzie L. Bowman","Manuel D. Carcao"],"twitterCount":1,"altmetricId":47071404,"statusesArray":["1033327386845097985"]},{"title":"Thrombophilia in non‐thrombotic chronic venous disease of the lower limb–a systematic review","googleId":"C3jp1_gGd_cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15692","googleCitationCount":3,"googleAuthor":"MKH Tan","doi":"10.1111/bjh.15692","elsevierAuthor":"Tan M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS).","googleId":"ngdXd2IZh7EJ","googleLink":"https://europepmc.org/article/med/29424433","googleCitationCount":6,"googleAuthor":"","statusesArray":[]},{"title":"CD 13 expression in B cell malignancies is a hallmark of plasmacytic differentiation","googleId":"aHrNU_Ej8OEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15584","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15584","elsevierAuthor":"Raimbault A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"4","altmetricAuthors":["Anna Raimbault","Sigrid Machherndl‐Spandl","Raphaël Itzykson","Sylvain Clauser","Nicolas Chapuis","Stéphanie Mathis","Jeroen Lauf","Anne‐Sophie Alary","Barbara Burroni","Olivier Kosmider","Michaela Fontenay","Marie C. Béné","Françoise Durrieu","Peter Bettelheim","Valérie Bardet"],"twitterCount":2,"altmetricId":48112453,"statusesArray":["1047833723549483008","1039891382557523969","1039454014838988800"]},{"title":"Incidence and outcomes of rare paediatric non‐Hodgkin lymphomas","googleId":"OkxqCUSXJvsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15194?af=R","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15194","elsevierAuthor":"Sorge C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting Partnership","googleId":"cce7Z_Q9iVAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31016727/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15928,","elsevierAuthor":"Shapiro S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft‐versus‐host disease: analysis of BMT CTN‐0201 and‐0901 …","googleId":"7KhF4QXFS8MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15492","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15492","elsevierAuthor":"Rashidi A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"3","altmetricAuthors":["Armin Rashidi","Ryan Shanley","Sophia L. Yohe","Bharat Thyagarajan","Julie Curtsinger","Claudio Anasetti","Edmund K. Waller","Bart L. Scott","Bruce R. Blazar","Daniel J. Weisdorf"],"twitterCount":3,"altmetricId":45007962,"statusesArray":["1021988513846321152","1021977605933805568","1018047228718518273"]},{"title":"Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma","googleId":"1i0t67124zoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29611184/","googleCitationCount":5,"googleAuthor":"F Spriano","doi":"10.1111/bjh.15212,","elsevierAuthor":"Spriano F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis","googleId":"cM7TrhAtWF0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15642","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15642","elsevierAuthor":"Furtado-Silva J.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5","altmetricAuthors":["Juliana Montibeller Furtado-Silva","Annalisa Paviglianiti","Annalisa Ruggeri","Jaap Jan Boelens","Paul Veys","Ali Abdallah Ahmari","Marco Zecca","Franco Locatelli","Gerard Michel","Fernanda Volt","Chantal Kenzey","Petr Sedlacek","Kanchan Rao","Arjan Lankester","Eliane Gluckman","Vanderson Rocha"],"twitterCount":11,"altmetricId":51539076,"statusesArray":["1077303951484248064","1074459185851580416","1073442503309836289","1073086633828864000","1073080377714069504","1070684509937524736","1070385284829855744","1070130534657908736","1069977282528325633","1069296954499305472","1069049951878029312","1069042728737091586","1065525366922649600"]},{"title":"Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki","googleId":"0xbRgEXZIusJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15050","googleCitationCount":6,"googleAuthor":"","doi":"10.1111/bjh.15050","elsevierAuthor":"Horai M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"2","altmetricAuthors":["Makiko Horai","Shinya Satoh","Masatoshi Matsuo","Masako Iwanaga","Kensuke Horio","Tatsuro Jo","Yumi Takasaki","Yasuhisa Kawaguchi","Hideki Tsushima","Shinichiro Yoshida","Masataka Taguchi","Hidehiro Itonaga","Yasushi Sawayama","Jun Taguchi","Yoshitaka Imaizumi","Tomoko Hata","Yukiyoshi Moriuchi","Detlef Haase","Koh-Ichiro Yoshiura","Yasushi Miyazaki"],"twitterCount":19,"altmetricId":30924641,"statusesArray":["1038700930529542144","1038662213030952960","1038657708625293312","1038650625771200513","1038631877362384896","1038628628626436097","1038623481536032768","1038620581283778566","1038506576867340289","1038360971679416321","1038353026870693888","1038350668224839680","1038348826447208448","1038345716618280960","1038344076897148928","945619834951294976","945586040894394369","945582394899234818","945575033333719040","945574327339982848","943296811258798080"]},{"title":"Haem Augments and Iron Chelation Decreases Toll-like Receptor 4-Mediated Inflammation in Monocytes from Sickle Cell Patients","googleId":"99lg7d9Xh10J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869174/","googleCitationCount":8,"googleAuthor":"PK Dagur","statusesArray":[]},{"title":"Expression of ELF 1, a lymphoid ETS domain‐containing transcription factor, is recurrently lost in classical Hodgkin lymphoma","googleId":"8nZ92zGWxCkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15757","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15757","elsevierAuthor":"Paczkowska J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2","altmetricAuthors":["Julia Paczkowska","Natalia Soloch","Magdalena Bodnar","Katarzyna Kiwerska","Joanna Janiszewska","Julia Vogt","Ewa Domanowska","José I. Martin‐Subero","Ole Ammerpohl","Wolfram Klapper","Andrzej Marszalek","Reiner Siebert","Maciej Giefing"],"twitterCount":2,"altmetricId":66726394,"statusesArray":["1174322771775643648","1173869364325572608"]},{"title":"Raman imaging highlights biochemical heterogeneity of human eosinophils versus human eosinophilic leukaemia cell line","googleId":"sIOyWrtCj8UJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15971","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15971","elsevierAuthor":"Rygula A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Durable graft‐versus‐leukaemia effects without donor lymphocyte infusions–results of a phase II study of sequential T‐replete allogeneic transplantation for high‐risk …","googleId":"LXLttjw-o-gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14980","googleCitationCount":5,"googleAuthor":"JK Davies","doi":"10.1111/bjh.14980","elsevierAuthor":"Davies J.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"4","altmetricAuthors":["Jeff K. Davies","Sandra Hassan","Shah-Jalal Sarker","Caroline Besley","Heather Oakervee","Matthew Smith","David Taussig","John G. Gribben","Jamie D. Cavenagh"],"twitterCount":1,"altmetricId":50923261,"statusesArray":["1060096344143093761"]},{"title":"Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins","googleId":"ZMnkn8qdM_kJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29076144/","googleCitationCount":5,"googleAuthor":"CA Di Buduo","doi":"10.1111/bjh.14977,","elsevierAuthor":"Grodzielski M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high‐risk or relapsed ALL–results of the ALL‐SCT 2003 trial","googleId":"UWJFfLtXqr4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15511","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15511","elsevierAuthor":"Kuhlen M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Gabapentin alleviates chronic spontaneous pain and acute hypoxia‐related pain in a mouse model of sickle cell disease","googleId":"8Qqlw0pdjfsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16067","googleCitationCount":1,"googleAuthor":"KE Sadler","doi":"10.1111/bjh.16067","elsevierAuthor":"Sadler K.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":["Katelyn E. Sadler","Sarah N. Langer","Anthony D. Menzel","Francie Moehring","Ashley N. Erb","Amanda M. Brandow","Cheryl L. Stucky"],"twitterCount":6,"altmetricId":66607560,"statusesArray":["1145442045395382273","1145065889617678336","1144790307973693440","1144764341146849280","1144623655302778880","1144619136787652610","1144619054390370304"]},{"title":"A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone‐releasing hormone","googleId":"S9wgsPKvLaUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15207","googleCitationCount":4,"googleAuthor":"P Popovics","doi":"10.1111/bjh.15207","elsevierAuthor":"Jimenez J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical features and therapeutic challenges of cytopenias belonging to alps and alps‐related (ARS) phenotype","googleId":"PRZ8FZlkzpIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15178?af=R","googleCitationCount":4,"googleAuthor":"C Micalizzi","doi":"10.1111/bjh.15178","elsevierAuthor":"Palmisani E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions","googleId":"2ahWv4H62TgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28905372/","googleCitationCount":8,"googleAuthor":"S Thota","doi":"10.1111/bjh.14907,","elsevierAuthor":"Thota S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome","googleId":"KF5LrH2wJ94J","googleLink":"https://moh-it.pure.elsevier.com/en/publications/chronic-myeloid-leukaemia-with-extreme-thrombocytosis-at-presenta-3","googleCitationCount":7,"googleAuthor":"S Sica","doi":"10.1111/bjh.14553","elsevierAuthor":"Sora F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute …","googleId":"6N8gNnm9KlcJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10080489/3/Morris_UCLHRFKCH%20-revisedBJH-240219-VM.pdf","googleCitationCount":2,"googleAuthor":"RS Sellar","statusesArray":[]},{"title":"Transcriptomic rationale for synthetic lethality‐targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia","googleId":"NdwRu_DQHWUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15408","googleCitationCount":3,"googleAuthor":"G Luengo‐Gil","doi":"10.1111/bjh.15408","elsevierAuthor":"Hurtado A.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"3","altmetricAuthors":["Ana M. Hurtado","Gines Luengo-Gil","Tzu H. Chen-Liang","Fabio Amaral","Kiran Batta","Laura Palomo","Eva Lumbreras","Bartlomiej Przychodzen","Eva Caparros","Marıa L. Amigo","Maria Dıez-Campelo","Lurdes Zamora","Eduardo J. Salido Fierrez","Jaroslaw P. Maciejewski","Francisco J. Ortuño","Vicente","Marıa del Canizo","Francesc Sole","Francisca Ferrer-Marin","Daniel H. Wiseman","Andres Jerez"],"twitterCount":12,"altmetricId":42930227,"statusesArray":["1306312274680913922","1306309603488137216","1191558462620102656","1139880545058525184","1137322646280916998","1002930082560774146","1002439060181389312","1002407116924182528","1002316071020498945","1002234944146563073","1002231798015938562","1002223795439128581","1001905290244079616","1001528815498113024"]},{"title":"Differential prognostic impact of GELTAMO‐IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm","googleId":"oHRb1anI1usJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15446","googleCitationCount":4,"googleAuthor":"A Díaz‐López","doi":"10.1111/bjh.15446","elsevierAuthor":"Montalbán C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"2","altmetricAuthors":["Carlos Montalbán","Antonio Díaz-López","Alejandro Martín","Mónica Baile","José M. Sanchez","Juan M. Sancho","Olga García","Silvana Novelli","Anna Monter-Rovira","Antonio Salar","Mariana Bastos","Antonio Gutiérrez","Leyre Bento","Raul Córdoba","Teresa Arquero","Sonia González de Villambrosia","Gilberto Barranco","Raquel De Oña","Armando López Guillermo","María J. Rodriguez Salazar","Juan F. Domínguez","Rubén Fernández","José A. Queizan","José Rodríguez","Victor Abraira","Juan F. García"],"twitterCount":8,"altmetricId":44639809,"statusesArray":["1061896212511682561","1061895882864508928","1060305474883649543","1060240220627574789","1060224871840522240","1060213534620037121","1060210476880138241","1059437671506952192","1059426608233242624","1053590614263164930","1015539682241679360"]},{"title":"Comments on pre‐fibrotic myelofibrosis and how should it be managed","googleId":"lyXtAZyi-_IJ","googleLink":"https://air.unimi.it/bitstream/2434/677709/2/Barbui_et_al-2019-British_Journal_of_Haematology.pdf","googleCitationCount":2,"googleAuthor":"T Barbui","statusesArray":[]},{"title":"A highly purified form of staphylococcal protein A alleviates murine immune thrombocytopenia (ITP)","googleId":"T9Qa44w_SuEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29048127/","googleCitationCount":6,"googleAuthor":"R Kapur","doi":"10.1111/bjh.14985,","elsevierAuthor":"Kapur R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Ethnic disparity in primary cutaneous CD30+ T‐cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer Database","googleId":"WHcefNiP8hgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15222","googleCitationCount":6,"googleAuthor":"KA Nguyen","doi":"10.1111/bjh.15222","elsevierAuthor":"Su C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"6","altmetricAuthors":["Chang Su","Kevin A. Nguyen","Harrison X. Bai","Cheryl K. Zogg","Ya Cao","Giorgos Karakousis","Paul J. Zhang","Guiying Zhang","Rong Xiao"],"twitterCount":1,"altmetricId":39995529,"statusesArray":["990694462388166656"]},{"title":"Mature (non‐anaplastic, non‐cutaneous) T‐/NK‐cell lymphomas in children, adolescents and young adults: state of the science","googleId":"BTQSaWbDt8wJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15767","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15767","elsevierAuthor":"Flower A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"2","altmetricAuthors":["Allyson Flower","Ana C. Xavier","Mitchell S. Cairo"],"twitterCount":4,"altmetricId":54991034,"statusesArray":["1092808377091215362","1091848625259311104","1091790177486471169","1091789762384588800"]},{"title":"Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients","googleId":"g9g7Z0zgzcYJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606327/","googleCitationCount":2,"googleAuthor":"P Mahale","statusesArray":[]},{"title":"Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous …","googleId":"FyHxF9iRhDcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31355916/","googleCitationCount":2,"googleAuthor":"E Kondo","doi":"10.1111/bjh.16115,","elsevierAuthor":"Kondo E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"TNFRSF 13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B‐cell precursor acute lymphoblastic leukaemia","googleId":"O4Vr7C1tX60J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14794?af=R","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.14794","elsevierAuthor":"Fazio G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma","googleId":"mZMPbiKuWBAJ","googleLink":"https://ueaeprints.uea.ac.uk/id/eprint/63139/","googleCitationCount":6,"googleAuthor":"TA Eyre","doi":"10.1111/bjh.14665","elsevierAuthor":"Eyre T.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3","altmetricAuthors":["Toby A. Eyre","Wendy L. Osborne","Eve Gallop-Evans","Kirit M. Ardeshna","Shireen Kassam","Shalal Sadullah","Gamal Sidra","Dominic Culligan","Arvind Arumainathan","Paneesha Shankara","Kristian M. Bowles","David W. Eyre","Ying Y. Peng","Ruth Pettengell","Adrian Bloor","Elisabeth Vandenberghe","Graham P. Collins"],"twitterCount":8,"altmetricId":18111838,"statusesArray":["1110613647510769664","1003546312283959297","849982630217097216","849970462461505536","846989977275842561","846746142037741572","846264768369430528","846047097656950784","845717748017717248","845709874692534272","845689323139874821","845689300398280706","845670725872762880","845585874188451841","845584950262935557"]},{"title":"Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in …","googleId":"IE-pwgWd7DsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15972","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15972","elsevierAuthor":"Mlak R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":["Radosław Mlak","Aneta Szudy‐Szczyrek","Marcin Mazurek","Michał Szczyrek","Iwona Homa‐Mlak","Michał Mielnik","Sylwia Chocholska","Olga Jankowska‐Łęcka","Teresa Małecka‐Massalska","Marek Hus"],"twitterCount":1,"altmetricId":60899954,"statusesArray":["1131463096436965376"]},{"title":"Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving …","googleId":"MmhmUY_b5z4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15582","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15582","elsevierAuthor":"Cencini E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"3","altmetricAuthors":["Emanuele Cencini","Anna Sicuranza","Alberto Fabbri","Ilaria Ferrigno","Luigi Rigacci","Maria C. Cox","Donatella Raspadori","Monica Bocchia"],"twitterCount":1,"altmetricId":48155029,"statusesArray":["1039817028465565697"]},{"title":"Large deletions of the 5'region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia","googleId":"s-xta5IdJZIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31148164/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15994,","elsevierAuthor":"Morel G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma.","googleId":"XqSENn5fCyUJ","googleLink":"https://europepmc.org/article/med/29527676","googleCitationCount":4,"googleAuthor":"","statusesArray":[]},{"title":"Cardiac manifestations in sickle cell disease varies with patient genotype","googleId":"GW5lObITxmgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15238","googleCitationCount":3,"googleAuthor":"P Guedeney","doi":"10.1111/bjh.15238","elsevierAuthor":"Guedeney P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"2","altmetricAuthors":["Paul Guedeney","François Lionnet","Alexandre Ceccaldi","Katia Stankovic Stojanovic","Ariel Cohen","Sarah Mattioni","Gilles Montalescot","Claude Bachmeyer","Richard Isnard","Jean-Philippe Haymann","Nadjib Hammoudi"],"twitterCount":1,"altmetricId":48210241,"statusesArray":["1040182098873733121"]},{"title":"The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype","googleId":"puZBP7mx6ZkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16117","googleCitationCount":1,"googleAuthor":"P Strati","doi":"10.1111/bjh.16117","elsevierAuthor":"Strati P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"1","altmetricAuthors":["Paolo Strati","Feng Wang","Francesco P. Tambaro","Philip A. Thompson","Jan A. Burger","Nitin Jain","Alessandra Ferrajoli","Prithviraj Bose","Zeev Estrov","Michael J. Keating","Andrew Futreal","Koichi Takahashi","William G. Wierda"],"twitterCount":2,"altmetricId":64066336,"statusesArray":["1154693423070425090","1154663738965929984"]},{"title":"Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities","googleId":"ffEflCCOaZIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15876","googleCitationCount":1,"googleAuthor":"SW Keith","doi":"10.1111/bjh.15876","elsevierAuthor":"Miller R.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1","altmetricAuthors":["Robin E. Miller","Dawn S. Brown","Scott W. Keith","Sarah E. Hegarty","Yamaja Setty","Claudia M. Campbell","Suzanne M. McCahan","Suhita Gayen‐Betal","Hal Byck","Marie Stuart"],"twitterCount":4,"altmetricId":58120029,"statusesArray":["1113043604199653377","1112019051272986624","1111958944883318785","1111951041757630464"]},{"title":"Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study","googleId":"gkyuOtccekkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28737236/","googleCitationCount":6,"googleAuthor":"L Cascione","doi":"10.1111/bjh.14817,","elsevierAuthor":"Cascione L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms","googleId":"RK61m8Dw5S4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28485484/","googleCitationCount":6,"googleAuthor":"JP Botero","doi":"10.1111/bjh.14746,","elsevierAuthor":"Perez Botero J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Is anticoagulating haemodialysis patients with non‐valvular atrial fibrillation too risky?","googleId":"FlcZ-RMp9lEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15144","googleCitationCount":4,"googleAuthor":"S Mitra","doi":"10.1111/bjh.15144","elsevierAuthor":"Parker K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4","altmetricAuthors":["Kathrine Parker","Sandip Mitra","Jecko Thachil"],"twitterCount":1,"altmetricId":34752119,"statusesArray":["1010102437879930881"]},{"title":"Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome","googleId":"bmdueDhJjdEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15898","googleCitationCount":1,"googleAuthor":"M Hara","doi":"10.1111/bjh.15898","elsevierAuthor":"Shimomura Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":["Yoshimitsu Shimomura","Masahiko Hara","Takayoshi Tachibana","Kazuteru Ohashi","Toru Sakura","Takahiro Fukuda","Hideyuki Nakazawa","Koji Iwato","Yoshinobu Kanda","Takashi Ikeda","Tetsuya Eto","Junya Kanda","Tatsuo Ichinohe","Yoshiko Atsuta","Takayuki Ishikawa","Ken Ishiyama"],"twitterCount":0,"altmetricId":63298894,"statusesArray":[]},{"title":"Thrombophilia screening and thromboprophylaxis may benefit specific ethnic subgroups with paediatric acute lymphoblastic leukaemia","googleId":"wFUZDXzmNfcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15752","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15752","elsevierAuthor":"Barzilai-Birenboim S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis","googleId":"AKRGe1rpEmMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15952","googleCitationCount":2,"googleAuthor":"D Mannina","doi":"10.1111/bjh.15952","elsevierAuthor":"Mannina D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"2","altmetricAuthors":["Daniele Mannina","Tatjana Zabelina","Christine Wolschke","Marion Heinzelmann","Ioanna Triviai","Maximilian Christopeit","Anita Badbaran","Stefan Bonmann","Ute‐Marie Pein","Dietlinde Janson","Francis Ayuk","Nicolaus Kröger"],"twitterCount":2,"altmetricId":61316684,"statusesArray":["1152131999810883584","1134262807354941440"]},{"title":"Aplastic anaemia in pregnancy–a single centre, North American series","googleId":"PIeEQufczQEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15654","googleCitationCount":2,"googleAuthor":"AK Malinowski","doi":"10.1111/bjh.15654","elsevierAuthor":"McGowan K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Mutation profiling by targeted sequencing of\" triple-negative\" essential thrombocythaemia patients","googleId":"NOf-C9jWTmEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28466600/","googleCitationCount":5,"googleAuthor":"X Liu","doi":"10.1111/bjh.14723,","elsevierAuthor":"Ju M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"MIR29B mediates epigenetic mechanisms of HBG gene activation","googleId":"ltFeqT9n0EAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15870","googleCitationCount":1,"googleAuthor":"A Starlard‐Davenport","doi":"10.1111/bjh.15870","elsevierAuthor":"Starlard-Davenport A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Possibility of a risk‐adapted treatment strategy for untreated aggressive adult T‐cell leukaemia‐lymphoma (ATL) based on the ATL prognostic index: a supplementary …","googleId":"k8IfmPIKIbAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15950","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15950","elsevierAuthor":"Toyoda K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"1","altmetricAuthors":["Kosuke Toyoda","Kunihiro Tsukasaki","Ryunosuke Machida","Tomohiro Kadota","Takuya Fukushima","Kenji Ishitsuka","Dai Maruyama","Hirokazu Nagai"],"twitterCount":3,"altmetricId":60627486,"statusesArray":["1280805883795124224","1129688738710343681","1129688282638508032","1129648643395457024"]},{"title":"Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow","googleId":"FRBTkZqyB-gJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15865","googleCitationCount":1,"googleAuthor":"AY Ali","doi":"10.1111/bjh.15865","elsevierAuthor":"Ali A.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"1","altmetricAuthors":["Ahmed Y. Ali","Qingdong Guan","Xun Wu","Sen Hou","Versha Banerji","James B. Johnston","Donna Wall","David Szwajcer","Spencer B. Gibson","Aaron J. Marshall"],"twitterCount":4,"altmetricId":57110311,"statusesArray":["1108628155709841409","1108616751636459520","1108465520557346816","1106858030489047047"]},{"title":"A significant proportion of children of African descent with HbSβ0 thalassaemia are inaccurately diagnosed based on phenotypic analyses alone.","googleId":"B12Ti1Xs1_EJ","googleLink":"https://europepmc.org/article/med/29797315","googleCitationCount":4,"googleAuthor":"ME Day","statusesArray":[]},{"title":"A novel complete blood count‐based score to screen for myelodysplastic syndrome in cytopenic patients","googleId":"9UQX1uEM3NwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15626","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15626","elsevierAuthor":"Boutault R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"3","altmetricAuthors":["Robin Boutault","Pierre Peterlin","Marouane Boubaya","Katja Sockel","Patrice Chevallier","Alice Garnier","Thierry Guillaume","Amandine Le Bourgeois","Camille Debord","Catherine Godon","Yannick Le Bris","Olivier Theisen","Frank Kroschinsky","Philippe Moreau","Marie C. Béné","Uwe Platzbecker","Marion Eveillard"],"twitterCount":7,"altmetricId":51078428,"statusesArray":["1074965425971191810","1062135315073298432","1061949932645556224","1061898654196359168","1061872986255511552","1061852351798087681","1061849244175343622"]},{"title":"CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis …","googleId":"qp9RNWMyhfAJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27984641/","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.14456,","elsevierAuthor":"Luo Q.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins","googleId":"Kt1kFU8065cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29048126/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.14971,","elsevierAuthor":"Gresch G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Erythropoiesis-stimulating agents in sickle cell anaemia","googleId":"p2Fe7xjg7MkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787037/","googleCitationCount":6,"googleAuthor":"J Han","statusesArray":[]},{"title":"Recurrent histone mutations in T‐cell acute lymphoblastic leukaemia","googleId":"9xeQ90nGXToJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766952/","googleCitationCount":4,"googleAuthor":"I Martincorena","doi":"10.1111/bjh.15155","elsevierAuthor":"Collord G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"1","altmetricAuthors":["Grace Collord","Inigo Martincorena","Matthew D. Young","Letizia Foroni","Niccolo Bolli","Michael R. Stratton","George S. Vassiliou","Peter J. Campbell","Sam Behjati"],"twitterCount":1,"altmetricId":35060266,"statusesArray":["1210886493725552641","980027300916822018"]},{"title":"Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial","googleId":"t0zG2_2vtxEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29528122/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15181,","elsevierAuthor":"Schetelig J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Targeted mutation screening of 292 candidate genes in 38 children with inborn haematological cytopenias efficiently identifies novel disease‐causing mutations","googleId":"nHg0AN4KgKgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15389","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15389","elsevierAuthor":"Kager L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"2","altmetricAuthors":["Leo Kager","Raúl Jimenez Heredia","Tatjana Hirschmugl","Jasmin Dmytrus","Ana Krolo","Heiko Müller","Christoph Bock","Petra Zeitlhofer","Michael Dworzak","Georg Mann","Wolfgang Holter","Oskar Haas","Kaan Boztug"],"twitterCount":1,"altmetricId":42929817,"statusesArray":["1001542155339423744"]},{"title":"Direct role of FLT 3 in regulation of early lymphoid progenitors","googleId":"cCCcUr9xkvsJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15578","googleCitationCount":2,"googleAuthor":"C Böiers","doi":"10.1111/bjh.15578","elsevierAuthor":"Zriwil A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"1","altmetricAuthors":["Alya Zriwil","Charlotta Böiers","Trine A. Kristiansen","Lilian Wittmann","Joan Yuan","Claus Nerlov","Ewa Sitnicka","Sten E. W. Jacobsen"],"twitterCount":1,"altmetricId":53346430,"statusesArray":["1080128297051115520"]},{"title":"Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age","googleId":"Wa4gTF4Jk0wJ","googleLink":"https://iwmf.com/wp-content/uploads/2020/12/bjh.15634.pdf","googleCitationCount":3,"googleAuthor":"","statusesArray":[]},{"title":"High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?","googleId":"NKrruIhhe58J","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10078196/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16057","elsevierAuthor":"Tomkins O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1","altmetricAuthors":["Oliver Tomkins","Stephen Keddie","Michael P. Lunn","Shirley D’Sa"],"twitterCount":2,"altmetricId":62442766,"statusesArray":["1305905358284697612","1141647846954950656"]},{"title":"Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma","googleId":"3wTZ6YjPyogJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28771659/","googleCitationCount":5,"googleAuthor":"I Oschlies","doi":"10.1111/bjh.14868,","elsevierAuthor":"Makarova O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis","googleId":"BSjRgfXaPVMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15751","googleCitationCount":4,"googleAuthor":"LA Thurgood","doi":"10.1111/bjh.15751","elsevierAuthor":"Thurgood L.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2","altmetricAuthors":["Lauren A. Thurgood","Eveline S. Dwyer","Karen M. Lower","Tim K. Chataway","Bryone J. Kuss"],"twitterCount":8,"altmetricId":54146635,"statusesArray":["1212485096474923008","1088728989840142337","1087767506436149249","1087670629631954944","1087072941966159872","1087072924442476545","1086776188314546177","1086631618935181313","1086579380497854464"]},{"title":"Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma","googleId":"9whj0L-WXmoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28493470/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.14735,","elsevierAuthor":"Li Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic impact of trisomy 21 in follicular lymphoma","googleId":"aKhJJqig0f0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15664","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15664","elsevierAuthor":"Mitsui T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"3","altmetricAuthors":["Takeki Mitsui","Akihiko Yokohama","Hiromi Koiso","Akio Saito","Kohtaro Toyama","Hiroaki Shimizu","Takuma Ishizaki","Hiroyuki Irisawa","Makiko Takizawa","Takayuki Saitoh","Kayoko Murayama","Morio Matsumoto","Hiroshi Handa","Junko Hirato","Masaru Kojima","Hirokazu Murakami","Norifumi Tsukamoto"],"twitterCount":4,"altmetricId":51146679,"statusesArray":["1062810107883462668","1062453266418728960","1062448018958548997","1062301197401538560"]},{"title":"Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8‐year follow‐up data of 281 patients from the …","googleId":"kke__AusVcUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15712","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15712","elsevierAuthor":"Hohloch K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"1","altmetricAuthors":["Karin Hohloch","Christiane Windemuth-Kieselbach","Julia Kolz","Pier Luigi Zinzani","Roberto Cacchione","Woijciech Jurczak","Angelika Bischof Delaloye","Lorenz Trümper","Christian W. Scholz"],"twitterCount":11,"altmetricId":52264377,"statusesArray":["1241315626880131072","1137137083099881473","1126794708313944064","1105372635154669568","1105371877076275200","1105234077312081922","1105182089941532674","1105180714037903361","1105178377873514497","1072306748839604225","1072147251911426048","1072144109513699329","1070635013056663552"]},{"title":"Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired …","googleId":"M_rSfpKwd14J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31612461/","googleCitationCount":1,"googleAuthor":"M Bacci","doi":"10.1111/bjh.16243,","elsevierAuthor":"Alberelli M.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome","googleId":"5Q0CsGti-NcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31177524/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15991,","elsevierAuthor":"Kim H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The cost‐effectiveness of immediate treatment or watch and wait with deferred chemotherapy for advanced asymptomatic follicular lymphoma","googleId":"M81cNdzBC80J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14990","googleCitationCount":4,"googleAuthor":"P Hoskin","doi":"10.1111/bjh.14990","elsevierAuthor":"Prettyjohns M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3","altmetricAuthors":["Matthew Prettyjohns","Peter Hoskin","Christopher McNamara","David Linch"],"twitterCount":5,"altmetricId":27992544,"statusesArray":["925465514893303808","925362727773724672","925354915953807360","925344995321831424","923835389089075200","923819218310660097","923770844928671744"]},{"title":"Erythropoietin and ferritin response in native highlanders aged 4–19 years from the Leh‐Ladakh region of India","googleId":"ynyVqAU__8MJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15553","googleCitationCount":2,"googleAuthor":"U Yanamandra","doi":"10.1111/bjh.15553","elsevierAuthor":"Yanamandra U.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Factor (F) VIII/VII a enhances global haemostatic function in the co‐presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor","googleId":"3CYxtAY4z-cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15209","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15209","elsevierAuthor":"Nogami K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA","googleId":"Zku26Gubhq0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30338508/","googleCitationCount":3,"googleAuthor":"A Desjonqueres","doi":"10.1111/bjh.15606,","elsevierAuthor":"Desjonqueres A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"CD 99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia","googleId":"CT_zxeHvZawJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15683","googleCitationCount":2,"googleAuthor":"A Camponeschi","doi":"10.1111/bjh.15683","elsevierAuthor":"Chen D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Autologous 111 In-labelled platelet scan as a predictor of splenectomy outcome in ITP","googleId":"EGdoNQBUK28J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29676450/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15236,","elsevierAuthor":"Kazi S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Azacitidine improves outcome in higher‐risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries","googleId":"cddNlLgOGnEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15190","googleCitationCount":4,"googleAuthor":"M Díez‐Campelo","doi":"10.1111/bjh.15190","elsevierAuthor":"Díez-Campelo M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3","altmetricAuthors":["María Díez-Campelo","Jose I. Lorenzo","Raphael Itzykson","Silvia M. Rojas","Céline Berthon","Elisa Luño","Odile Beyne-Rauzy","Jaime Perez-Oteyza","Norbert Vey","Joan Bargay","Sophie Park","Teresa Cedena","Dominique Bordessoule","Juan A. Muñoz","Emmanuel Gyan","Esperanza Such","Sorin Visanica","Félix López-Cadenas","Stéphane de Botton","Jesús M. Hernández-Rivas","Shanti Ame","Aspasia Stamatoullas","Jacques Delaunay","Celia Salanoubat","Françoise Isnard","Romain Guieze","Joan Pérez Guallar","Llorenc Badiella","Guillermo Sanz","Consuelo Cañizo","Pierre Fenaux"],"twitterCount":9,"altmetricId":35377703,"statusesArray":["1024917223293509633","1022902027641401344","1022772326503469056","1022720368769949696","1022527977966514176","1022442403880464385","1022439393645211650","981583371154403328","981540453496606720","981387265162272769"]},{"title":"A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis","googleId":"hlFAoorsN3wJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29411862/","googleCitationCount":4,"googleAuthor":"S Majumdar","doi":"10.1111/bjh.15124,","elsevierAuthor":"Majumdar S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate-or high-risk acute myeloid leukaemia undergoing reduced …","googleId":"h5ghIP961_gJ","googleLink":"https://orbi.uliege.be/bitstream/2268/224868/1/Ofran_et_al-2018-British_Journal_of_Haematology.pdf","googleCitationCount":4,"googleAuthor":"Y Ofran","statusesArray":[]},{"title":"Plasma histamine elevation in a large cohort of sickle cell disease patients","googleId":"M7YIBD6nQZIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15900","googleCitationCount":1,"googleAuthor":"J Callebert","doi":"10.1111/bjh.15900","elsevierAuthor":"Allali S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Acute deep vein thrombosis suppresses peripheral T cell effector function","googleId":"iGRR6UptutkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29574858/","googleCitationCount":4,"googleAuthor":"JH Prochaska","doi":"10.1111/bjh.15192,","elsevierAuthor":"Prochaska J.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Paediatric-type nodal follicular lymphoma in a child diagnosed with chronic myeloid leukaemia","googleId":"0Ho1mLIvylMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31286492/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16089,","elsevierAuthor":"Domínguez-Pinilla N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Paediatric-type nodal follicular lymphoma in a child diagnosed with chronic myeloid leukaemia","googleId":"0Ho1mLIvylMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31286492/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16089,","elsevierAuthor":"Domínguez-Pinilla N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived …","googleId":"mZHY64M0Bj8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28165136/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.14542,","elsevierAuthor":"Aslam R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell …","googleId":"IOmJBUhHA10J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28875547/","googleCitationCount":4,"googleAuthor":"F Posch","doi":"10.1111/bjh.14912,","elsevierAuthor":"Prochazka K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations","googleId":"vkJlWGF8IHIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31016714/","googleCitationCount":1,"googleAuthor":"C Gurnari","doi":"10.1111/bjh.15931,","elsevierAuthor":"Gurnari C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo‐glycosylation phenotype associated with …","googleId":"vXRYPti0HEIJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6491999/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.15189","elsevierAuthor":"Pellegrin S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2","altmetricAuthors":["Stéphanie Pellegrin","Katy L. Haydn-Smith","Lea A. Hampton-O'Neil","Bethan R. Hawley","Kate J. Heesom","Elisa Fermo","Paola Bianchi","Ashley M. Toye"],"twitterCount":1,"altmetricId":34343975,"statusesArray":["974046778545922048"]},{"title":"A new heterozygous mutation in GP1BA gene responsible for macrothrombocytopenia","googleId":"Avaj8S8dhYYJ","googleLink":"https://hal.archives-ouvertes.fr/hal-01744130/document","googleCitationCount":5,"googleAuthor":"","statusesArray":[]},{"title":"Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents","googleId":"r_YKGhb1dbkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31134622/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15977,","elsevierAuthor":"Wiegering V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Is the revised International staging system for myeloma valid in a real world population?","googleId":"tWa9eXhoq5EJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27734463/","googleCitationCount":7,"googleAuthor":"","doi":"10.1111/bjh.14341,","elsevierAuthor":"Walker I.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B‐cell lymphoma receiving rituximab‐chemotherapy combinations","googleId":"pm6LejqcjWAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16049","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.16049","elsevierAuthor":"Ong D.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"3","altmetricAuthors":["Doen Ming Ong","Michael Ashby","Andrew Grigg","Grace Gard","Zi Y. Ng","Huayi (Ellen) Huang","Yee Shuen Chong","Chan Yoon Cheah","Bianca Devitt","Geoffrey Chong","Zoe Loh","Allison Mo","Eliza A. Hawkes"],"twitterCount":20,"altmetricId":62345095,"statusesArray":["1146555362469961729","1146547453828698114","1146416988513808384","1146301119582355457","1143103412684382208","1141304594376679426","1141152602148810752","1141086215069995008","1141067985920176134","1141037137086881793","1140993276322955264","1140983473416491008","1140967178386268161","1140962432308981760","1140961330045837313","1140957520766226433","1140956444415660033","1140949033395077126","1140948718306451456","1140948170668675080","1140923318121447425"]},{"title":"Characterization of VWF gene conversions causing von Willebrand disease","googleId":"whDbnzAAGHMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15709","googleCitationCount":2,"googleAuthor":"F Ahmad","doi":"10.1111/bjh.15709","elsevierAuthor":"Ahmad F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Plasma metabolomics analysis in sickle cell disease patients with albuminuria-an exploratory study.","googleId":"dwhO-1bUSR8J","googleLink":"https://europepmc.org/articles/pmc6409098/bin/nihms986841-supplement-supp_tables1.docx","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15592","elsevierAuthor":"Elsherif L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Purification of zebrafish erythrocytes as a means of identifying a novel regulator of haematopoiesis","googleId":"WavC0hJMNeQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15048","googleCitationCount":4,"googleAuthor":"K Kulkeaw","doi":"10.1111/bjh.15048","elsevierAuthor":"Kulkeaw K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"3","altmetricAuthors":["Kasem Kulkeaw","Tomoko Inoue","Tohru Ishitani","Yoichi Nakanishi","Leonard I. Zon","Daisuke Sugiyama"],"twitterCount":1,"altmetricId":30798017,"statusesArray":["944168655171940352"]},{"title":"Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement","googleId":"NSdIkfItVW4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29676487/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15173,","elsevierAuthor":"Chin C.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clonal haematopoiesis is not prevalent in survivors of childhood cancer","googleId":"U7TqR6t1E0cJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001539/","googleCitationCount":4,"googleAuthor":"M Podestà","doi":"10.1111/bjh.14630","elsevierAuthor":"Collord G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3","altmetricAuthors":["Grace Collord","Naomi Park","Marina Podestà","Monica Dagnino","Daniela Cilloni","David Jones","Ignacio Varela","Francesco Frassoni","George S. Vassiliou"],"twitterCount":4,"altmetricId":18483539,"statusesArray":["1235610371974717441","1235385409229574152","849322935567474688","849226569247637505"]},{"title":"Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia.","googleId":"bBwThhvUbmIJ","googleLink":"https://europepmc.org/article/med/29315493","googleCitationCount":3,"googleAuthor":"A Artoni","statusesArray":[]},{"title":"Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study","googleId":"jntA-MhPJv0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15599","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15599","elsevierAuthor":"Li-Gao R.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"2","altmetricAuthors":["Ruifang Li-Gao","Vânia M. Morelli","Willem M. Lijfering","Suzanne C. Cannegieter","Frits R. Rosendaal","Astrid van Hylckama Vlieg"],"twitterCount":10,"altmetricId":52008136,"statusesArray":["1070419965898121216","1068871031446806531","1068609912224317445","1068557364058603522","1068557257183543296","1068557050781843458","1068556091716448256","1068514021249351681","1068513526292127747","1068512503989248001"]},{"title":"Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin–Frankfürt–Münster (I‐BFM) …","googleId":"4WKoeKyXaXcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15499","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15499","elsevierAuthor":"Klein K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":["Kim Klein","Henrik Hasle","Jonas Abrahamsson","Barbara De Moerloose","Gertjan J. L. Kaspers"],"twitterCount":1,"altmetricId":46149320,"statusesArray":["1026544109333274625"]},{"title":"Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation …","googleId":"MoilOngCFkUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28880377/","googleCitationCount":5,"googleAuthor":"J Markham","doi":"10.1111/bjh.14919,","elsevierAuthor":"Blombery P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid …","googleId":"rTUSIH_a3HYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30847896/","googleCitationCount":1,"googleAuthor":"P Kearns","doi":"10.1111/bjh.15847,","elsevierAuthor":"Kearns P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients …","googleId":"nBSTbJ4IBs0J","googleLink":"https://www.researchgate.net/profile/Liam_Smyth/publication/322796959_Autologous_stem_cell_transplant_and_combination_immunotherapy_of_rituximab_and_interferon-a_induces_prolonged_clinical_and_molecular_remissions_in_patients_with_follicular_lymphoma/links/5f23367e299bf1340494b783/Autologous-stem-cell-transplant-and-combination-immunotherapy-of-rituximab-and-interferon-a-induces-prolonged-clinical-and-molecular-remissions-in-patients-with-follicular-lymphoma.pdf","googleCitationCount":4,"googleAuthor":"R Buckstein","statusesArray":[]},{"title":"Immune thrombocytopenia–in defence of the platelet count","googleId":"J0aoWeRxXd0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14729?af=R","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.14729","elsevierAuthor":"Hill Q.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"2","altmetricAuthors":["Quentin A. Hill"],"twitterCount":2,"altmetricId":44680900,"statusesArray":["1015819143579238400","1015818716485857282"]},{"title":"Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases","googleId":"vOzxHYdbqjAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15436","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15436","elsevierAuthor":"Vega-García N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow‐up study","googleId":"fJLgD5GDCiAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16075","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16075","elsevierAuthor":"Hensen A.D.O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":["Annefleur D. O. Hensen","Willem M. Lijfering","Suzanne C. Cannegieter","Frits R. Rosendaal","Astrid van Hylckama Vlieg"],"twitterCount":41,"altmetricId":63272648,"statusesArray":["1157075394522226688","1156515543656124416","1156253037071147008","1155434822569009152","1155380970088017925","1155199134913220609","1155175240114331650","1155149614053543942","1155128197702410241","1155057653099454467","1155057389219045377","1154944199751548930","1154885693371555840","1154848874185576448","1154791986374815744","1154761503167393794","1154752047528513536","1154747904780840962","1154746548540137472","1154735857858949121","1154730078531661825","1154725648197476352","1154723111012450304","1154712259245072389","1154685403200401408","1154635443318734848","1154547067538161665","1154394955479224321","1154387887057723394","1154385963046572032","1154265595174690816","1154027392782032897","1154018401314123777","1148553228528836608","1148500964262813696","1148500904305238016","1148404942769541120","1148221264672317440","1148220499035664391","1148217605179637760","1148188774796599296","1148181782963130370","1148178658600869888","1148153704689754112","1148152548617940992"]},{"title":"A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.","googleId":"gRkutVdHe8UJ","googleLink":"https://europepmc.org/articles/pmc6589112/bin/nihms1002682-supplement-supp_tables1.pdf","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15742","elsevierAuthor":"Poston J.N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"3","altmetricAuthors":["Jacqueline N. Poston","Jonathan R. Fromm","Heather A. Rasmussen","Andrei R. Shustov","Edward N. Libby","Stephen D. Smith","Ted Gooley","Ajay K. Gopal"],"twitterCount":1,"altmetricId":70427377,"statusesArray":["1079171085906731009"]},{"title":"Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement","googleId":"vFKeHJk9rcoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29978452/","googleCitationCount":3,"googleAuthor":"D Chihara","doi":"10.1111/bjh.15444,","elsevierAuthor":"Chihara D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms","googleId":"E0w10eI_IzoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31525819/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16193,","elsevierAuthor":"Francis S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Long-term Sequential Deferiprone and Deferasirox Therapy in Transfusion-Dependent Thalassaemia Patients: A Prospective Clinical Trial","googleId":"rJNo3_HavhsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31344255/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16101,","elsevierAuthor":"Vitrano A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia","googleId":"l2Vt-orwaWAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15604","googleCitationCount":2,"googleAuthor":"O Al‐Sawaf","doi":"10.1111/bjh.15604","elsevierAuthor":"Al-Sawaf O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"1","altmetricAuthors":["Othman Al‐Sawaf","Jasmin Bahlo","Sandra Robrecht","Kirsten Fischer","Carmen D. Herling","Manuela Hoechstetter","Anna‐Maria Fink","Julia Tresckow","Petra Langerbeins","Paula Cramer","Stephan Stilgenbauer","Clemens M. Wendtner","Barbara Eichhorst","Michael Hallek","Valentin Goede"],"twitterCount":1,"altmetricId":63613637,"statusesArray":["1151070185891205121"]},{"title":"Overrepresentation of patients from HTLV‐1 endemic countries among T cell Non‐Hodgkin lymphomas in the Netherlands: an indication of under‐diagnosis of Adult T …","googleId":"g4QpviFYmsIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15160?af=R","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15160","elsevierAuthor":"van Tienen C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab","googleId":"tA6yR14U6G4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29363752/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.15110,","elsevierAuthor":"Chen L.Y.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prognostic impact of red blood cell distribution width in myelodysplastic syndromes","googleId":"E5RaztnCFr8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30836422/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15830,","elsevierAuthor":"Shi Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"G protein‐coupled receptor gpr34l mutation affects thrombocyte function in zebrafish","googleId":"0670C_r35CkJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15046","googleCitationCount":3,"googleAuthor":"A Alsrhani","doi":"10.1111/bjh.15046","elsevierAuthor":"Kim S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"2","altmetricAuthors":["Seongcheol Kim","Abdullah Alsrhani","Lala Zafreen","Gauri Khandekar","Florence L Marlow","Elliott W. Abrams","Mary C. Mullins","Pudur Jagadeeswaran"],"twitterCount":4,"altmetricId":30942898,"statusesArray":["945981095585173509","945756762199781377","945755286790270977","945755259342700544"]},{"title":"Ocular extramedullary myeloid leukaemia","googleId":"NxZlot-Srw4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27879987/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.14430,","elsevierAuthor":"Ohanian M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses","googleId":"xfzK5O7tVLQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15498","googleCitationCount":2,"googleAuthor":"C Vetro","doi":"10.1111/bjh.15498","elsevierAuthor":"Vetro C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"High prevalence of altered sudomotor function in homozygous sickle cell patients: influence of age and anaemia","googleId":"APACRRwYZYEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30937883/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15892,","elsevierAuthor":"Affes Z.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study","googleId":"5tY4tQfLreEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768906/","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"Pharmacogenetic association with neurotoxicity in Hispanic children with acute lymphoblastic leukaemia","googleId":"9lI1z7gpLoMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28419449/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.14678,","elsevierAuthor":"McClain C.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The concept of leukaemic stem cells in acute myeloid leukaemia 25 years on: hitting a moving target","googleId":"YBkDty3kYW8J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16104","googleCitationCount":0,"googleAuthor":"MC Hansen","doi":"10.1111/bjh.16104","elsevierAuthor":"Hokland P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Recurrently affected genes in juvenile myelomonocytic leukaemia","googleId":"BBYf6-dTlfEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28485469/","googleCitationCount":4,"googleAuthor":"","doi":"10.1111/bjh.14737,","elsevierAuthor":"Obenauer J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk …","googleId":"7vb9p8rLPbcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15546","googleCitationCount":2,"googleAuthor":"RF Schlenk","doi":"10.1111/bjh.15546","elsevierAuthor":"Krauter J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL)","googleId":"Gc-4cSC42IYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30255927/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15590,","elsevierAuthor":"Miller L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population‐based study","googleId":"1Wvt9nnBgfMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15883","googleCitationCount":0,"googleAuthor":"IS Sverrisdóttir","doi":"10.1111/bjh.15883","elsevierAuthor":"Sverrisdóttir I.S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"0","altmetricAuthors":["Ingigerður S. Sverrisdóttir","Sigrún H. Lund","Ingemar Turesson","Magnus Björkholm","Lynn R. Goldin","Ola Landgren","Sigurður Y. Kristinsson"],"twitterCount":1,"altmetricId":62605526,"statusesArray":["1143006245625876480"]},{"title":"Genetic characterization and therapeutic targeting of MYC‐rearranged T cell acute lymphoblastic leukaemia","googleId":"GWg0ioy7jUcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15425","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15425","elsevierAuthor":"Milani G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2","altmetricAuthors":["Gloria Milani","Filip Matthijssens","Wouter Van Loocke","Kaat Durinck","Juliette Roels","Sofie Peirs","Morgan Thénoz","Tim Pieters","Lindy Reunes","Beatrice Lintermans","Niels Vandamme","Tim Lammens","Nadine Van Roy","Filip Van Nieuwerburgh","Dieter Deforce","Claire Schwab","Susana Raimondi","Luciano Dalla Pozza","Andrew J. Carroll","Barbara De Moerloose","Yves Benoit","Steven Goossens","Geert Berx","Christine J. Harrison","Giuseppe Basso","Hélène Cavé","Rosemary Sutton","Vahid Asnafi","Jules Meijerink","Charles Mullighan","Mignon Loh","Pieter Van Vlierberghe"],"twitterCount":1,"altmetricId":44406164,"statusesArray":["1013803387383578625"]},{"title":"Inhibitor incidence in haemophilia A under exclusive use of a third-generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study","googleId":"L550XOoE_CEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30556277/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15728,","elsevierAuthor":"Jardim L.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.","googleId":"5p7PrQsxuZIJ","googleLink":"https://europepmc.org/article/med/29911350","googleCitationCount":3,"googleAuthor":"","statusesArray":[]},{"title":"Dissecting heterogeneous outcomes for paediatric Burkitt lymphoma in Malawi after anthracycline-based treatment","googleId":"QRG4ZZEhmz0J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771980/","googleCitationCount":3,"googleAuthor":"","statusesArray":[]},{"title":"Microdeletion of 7p12. 1p13, including IKZF1, causes intellectual impairment, overgrowth, and susceptibility to leukaemia","googleId":"BmwQ34k1eQQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30004112/","googleCitationCount":2,"googleAuthor":"V Zachariadis","doi":"10.1111/bjh.15494,","elsevierAuthor":"Järviaho T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma.","googleId":"DY3H5ulebJ4J","googleLink":"https://europepmc.org/article/med/29978498","googleCitationCount":2,"googleAuthor":"BR Dholaria","statusesArray":[]},{"title":"Expression of GNAZ, encoding the Gαz protein, predicts survival in mantle cell lymphoma","googleId":"b3BXaf_3zAYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15810","googleCitationCount":1,"googleAuthor":"F Mundt","doi":"10.1111/bjh.15810","elsevierAuthor":"Mundt F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"0","altmetricAuthors":["Filip Mundt","Magali Merrien","Lina Nygren","Lesley A. Sutton","Birger Christensson","Björn E. Wahlin","Richard Rosenquist","Birgitta Sander","Agata M. Wasik"],"twitterCount":1,"altmetricId":81263260,"statusesArray":["1256851765225574407"]},{"title":"Treatment and prognosis of mature (non‐anaplastic) T‐and NK‐cell lymphomas in childhood, adolescents, and young adults","googleId":"PWdV7iFwM_oJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15772","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15772","elsevierAuthor":"Xavier A.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"0","altmetricAuthors":["Ana C. Xavier","Ritsuro Suzuki"],"twitterCount":5,"altmetricId":54864137,"statusesArray":["1092808377091215362","1092162523057532930","1091893923813834752","1091790175326425099","1091789759310151680"]},{"title":"Megakaryocytes harbour the del (5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment","googleId":"tgFtk-UEoMgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15094","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15094","elsevierAuthor":"Scharenberg C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"2","altmetricAuthors":["Christian Scharenberg","Monika Jansson","Leonie Saft","Eva Hellström-Lindberg"],"twitterCount":1,"altmetricId":32419795,"statusesArray":["958293558401871872"]},{"title":"A rare complication of bone marrow aspiration and trephine biopsy: Staphylococcus aureus osteomyelitis and septicaemia.","googleId":"grcOqHFEKcgJ","googleLink":"https://europepmc.org/article/med/30408144","googleCitationCount":3,"googleAuthor":"","statusesArray":[]},{"title":"Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin","googleId":"LDjH7cPno8sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15586","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15586","elsevierAuthor":"Faulk K.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"1","altmetricAuthors":["Kelly E. Faulk","Jenna M. Sopfe","Kristen Campbell","Deborah R. Liptzin","Arthur K. Liu","Anna R. K. Franklin","Carrye R. Cost"],"twitterCount":0,"altmetricId":48225857,"statusesArray":[]},{"title":"The selectivity of Marinopyrrole A to induce apoptosis in MCL1 high BCL2 low expressing myeloma cells is related to its ability to impair protein translation","googleId":"1P7f_hbigmwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27523575/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.14293,","elsevierAuthor":"Gomez-Bougie P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma","googleId":"iMrvFTpq9w0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31090916/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15936,","elsevierAuthor":"Nijdam A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del (11q) in Taiwanese patients with chronic lymphocytic leukaemia","googleId":"b--ZTxkJowMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16051","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16051","elsevierAuthor":"Huang Y.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"HAX-1 overexpression in multiple myeloma is associated with poor survival","googleId":"ab3IHXpw7vIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29923187/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15430,","elsevierAuthor":"Feng X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia","googleId":"boiQ-U6l3KsJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511975/","googleCitationCount":4,"googleAuthor":"NJ Short","statusesArray":[]},{"title":"Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma","googleId":"dPXisjU0X8gJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29143308/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15026,","elsevierAuthor":"Dalla Palma B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant","googleId":"VkOv4FRL3lMJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31111479/","googleCitationCount":1,"googleAuthor":"A Nael","doi":"10.1111/bjh.15980,","elsevierAuthor":"Martynova A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers","googleId":"U4Q5A7A2g8cJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15955","googleCitationCount":0,"googleAuthor":"HJ Lachmann","doi":"10.1111/bjh.15955","elsevierAuthor":"Rezk T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"0","altmetricAuthors":["Tamer Rezk","Helen J. Lachmann","Marianna Fontana","Ana Martinez Naharro","Sajitha Sachchithanantham","Shameem Mahmood","Aviva Petrie","Carol J. Whelan","Jennifer H. Pinney","Darren Foard","Thirusha Lane","Taryn Youngstein","Ashutosh D. Wechalekar","Philip N. Hawkins","Julian D. Gillmore"],"twitterCount":2,"altmetricId":61214483,"statusesArray":["1285257042354212865","1133471332694482951"]},{"title":"Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit","googleId":"wR7T1kuTc-IJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29193017/","googleCitationCount":3,"googleAuthor":"MC Cox","doi":"10.1111/bjh.15039,","elsevierAuthor":"Cox M.C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Plasma cells in classical Hodgkin lymphoma: a new player in the microenvironment?","googleId":"HeRCQ9UY-wcJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587803/","googleCitationCount":2,"googleAuthor":"L Visser","doi":"10.1111/bjh.15704","elsevierAuthor":"Visser L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine","googleId":"uWeKS1-Yc8sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15091","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15091","elsevierAuthor":"Bianchini E.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"2","altmetricAuthors":["Elsa P. Bianchini","Alexandre Sebestyen","Toufik Abache","Yasmine Bourti","Alexandre Fontayne","Vincent Richard","Fabienne Tamion","Jean-Luc Plantier","Fabien Doguet","Delphine Borgel"],"twitterCount":13,"altmetricId":33744164,"statusesArray":["982960103849713664","982657935741464576","982611152034320384","980719203073347585","980545122306752513","980534676170399744","980525338278219782","980522201890910208","973116287428759553","969546060359196674","968982009782599680","968897519840382976","968804227534508033","968592811045085184","968582682165858306"]},{"title":"Global gene expression reveals an increase of HMGB1 and APEX1 proteins and their involvement in oxidative stress, apoptosis and inflammation pathways among …","googleId":"wdUEKcmgOuwJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16062","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16062","elsevierAuthor":"Maia de Oliveira da Silva J.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations","googleId":"nR55VDCCI-sJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29767408/","googleCitationCount":2,"googleAuthor":"E van den Berg","doi":"10.1111/bjh.15265,","elsevierAuthor":"Berger G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Lymphoma diagnostics: getting more from less","googleId":"8iybGxVEqewJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15788","googleCitationCount":0,"googleAuthor":"PJ Galardy","doi":"10.1111/bjh.15788","elsevierAuthor":"Galardy P.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"June 2019","elsevierCitationCount":"0","altmetricAuthors":["Paul J. Galardy","Tibor Bedekovics","Elizabeth Macintyre","Rodney R. Miles"],"twitterCount":2,"altmetricId":56241447,"statusesArray":["1259206513123450880","1098538424791957505"]},{"title":"Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study","googleId":"C8OyCk45JO4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29468641/","googleCitationCount":2,"googleAuthor":"AK Malinowski","doi":"10.1111/bjh.15142,","elsevierAuthor":"Malinowski A.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Development and validation of the Satisfaction with Treatment for Pain Questionnaire (STPQ) among patients with sickle cell disease","googleId":"aoaDQ5FEUBQJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16015","googleCitationCount":0,"googleAuthor":"J Elander","doi":"10.1111/bjh.16015","elsevierAuthor":"Elander J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Autologous adipose-derived stem cell for painful leg ulcers in patients with sickle cell disease. A preliminary study","googleId":"Hn9DK3pCIvIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30919931/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15891,","elsevierAuthor":"Farina Junior J.A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time‐series gene expression profiling","googleId":"dDr32AFgnhgJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15252","googleCitationCount":2,"googleAuthor":"AEJ Yeoh","doi":"10.1111/bjh.15252","elsevierAuthor":"Yeoh A.E.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation","googleId":"XoF7bThYPF8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29265180/","googleCitationCount":3,"googleAuthor":"MV Shah","doi":"10.1111/bjh.15059,","elsevierAuthor":"Shah M.V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis","googleId":"FUbSXDOUpksJ","googleLink":"https://discovery.ucl.ac.uk/id/eprint/10065004/1/Jones_Systematic%20review%20Teachers%20Knowledge%20and%20Attitudes%20submitted.pdf","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"The association of smartphone-based activity space measures with cognitive functioning and pain sickle cell disease","googleId":"uD10yCyXPH8J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771987/","googleCitationCount":3,"googleAuthor":"A Birenboim","statusesArray":[]},{"title":"LPL protein in chronic lymphocytic Leukaemia have different origins in mutated and Unmutated patients. Advances for a new prognostic marker in CLL","googleId":"lLasC9sIz1sJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15427","googleCitationCount":3,"googleAuthor":"D Prieto","doi":"10.1111/bjh.15427","elsevierAuthor":"Prieto D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"3","altmetricAuthors":["Daniel Prieto","Noé Seija","Angimar Uriepero","Thais Souto-Padron","Carolina Oliver","Victoria Irigoin","Cecilia Guillermo","Marcelo A. Navarrete","Ana Inés Landoni","Guillermo Dighiero","Raúl Gabus","Mirta Giordano","Pablo Oppezzo"],"twitterCount":0,"altmetricId":55860326,"statusesArray":[]},{"title":"Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia …","googleId":"UIjN_y39vN0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28677818/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.14836,","elsevierAuthor":"Winqvist M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impaired platelet activation in patients with hereditary deficiency of p47phox","googleId":"VtPMkxD8-KYJ","googleLink":"https://www.iris.unina.it/retrieve/handle/11588/697222/157140/Carnevale_et_al-2018-British_Journal_of_Haematology.pdf","googleCitationCount":4,"googleAuthor":"R Carnevale","statusesArray":[]},{"title":"Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?","googleId":"Eyy0xHNhLyIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28832940/","googleCitationCount":4,"googleAuthor":"V Ortiz-Maldonado","doi":"10.1111/bjh.14900,","elsevierAuthor":"Ortiz-Maldonado V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists","googleId":"K4C4I9ut1nQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27879997/","googleCitationCount":4,"googleAuthor":"C Bagot","doi":"10.1111/bjh.14395,","elsevierAuthor":"Thachil J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Effect of low‐dose bortezomib on bone formation in smouldering multiple myeloma","googleId":"4ojffRHdNtcJ","googleLink":"https://www.researchgate.net/profile/Meera_Mohan13/publication/323996960_Effect_of_low-dose_bortezomib_on_bone_formation_in_smouldering_multiple_myeloma/links/5d6aca40299bf1808d5cbabe/Effect-of-low-dose-bortezomib-on-bone-formation-in-smouldering-multiple-myeloma.pdf","googleCitationCount":2,"googleAuthor":"GC Hildebrandt","statusesArray":[]},{"title":"Development of a clinical prediction model for an international normalised ratio≥ 4· 5 in hospitalised patients using vitamin K antagonists","googleId":"sc7_pTdeHXAJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15161","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15161","elsevierAuthor":"Dreijer A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Combined somatic mutation and copy number analysis in the survival of familial CLL","googleId":"6bObPOA__i4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15239","googleCitationCount":1,"googleAuthor":"W Zhou","doi":"10.1111/bjh.15239","elsevierAuthor":"Zhou W.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"1","altmetricAuthors":["Weiyin Zhou","Lynn Goldin","Mingyi Wang","Mary L. McMaster","Kristine Jones","Laurie Burdett","Stephen J. Chanock","Meredith Yeager","Michael Dean","Neil E. Caporaso"],"twitterCount":1,"altmetricId":39305397,"statusesArray":["989208315946188800"]},{"title":"A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma","googleId":"IOd-TTas1AQJ","googleLink":"http://tbl12.com/sites/default/files/TBL12%20ASH%202011.pdf","googleCitationCount":4,"googleAuthor":"","statusesArray":[]},{"title":"Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era","googleId":"X5yYZDwOOkoJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107428/","googleCitationCount":3,"googleAuthor":"MJ Maurer","statusesArray":[]},{"title":"Autologous 111 indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists","googleId":"DBAL8bminCgJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30950041/?from_term=Chaoui+D&from_pos=8","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15890,","elsevierAuthor":"Mahevas M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid …","googleId":"W-LvbtXBJNkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30132795/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15538,","elsevierAuthor":"Wang H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study","googleId":"5dr22l3b5voJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15765","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15765","elsevierAuthor":"Nashashibi J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"0","altmetricAuthors":["Jeries Nashashibi","Gilat R. Avraham","Naama Schwartz","Youssef Awni","Mazen Elias"],"twitterCount":20,"altmetricId":54559165,"statusesArray":["1142414124015652864","1102229956774498310","1101974940239187969","1101973652696952834","1101968296335810571","1094153787223261185","1090017572769148928","1089996690038423552","1089990695459438592","1089988483442229248","1089975984307298305","1089957177819840512","1089954476256047104","1089950287996116992","1089582451171696641","1089511388589027328","1089453669832159232","1089451933318946817","1089448765440831488","1089447628264349696"]},{"title":"Ten‐year single‐centre experience in fertility preservation of 459 patients suffering from acute leukaemia","googleId":"VpvjVq_KSK4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15740","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15740","elsevierAuthor":"Noetzli J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"March 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Abdominal computed tomography angiography in post-transplantation sinusoidal obstruction syndrome associated with R-DHAOX/BEAM toxicity","googleId":"R_9H7d-dA-EJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29181839/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.15017,","elsevierAuthor":"Lavolé J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane","googleId":"fPx6Y_mXXt4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16084","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.16084","elsevierAuthor":"Andres O.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Serum alpha fetoprotein levels in Fanconi anaemia","googleId":"xOYEZbg1LlQJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383512/","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma","googleId":"W0mccqVlmZIJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168433/","googleCitationCount":1,"googleAuthor":"KD Getz","statusesArray":[]},{"title":"Low-level TP53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia","googleId":"UKZtvvW9110J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29460960/","googleCitationCount":2,"googleAuthor":"AM Pinto","doi":"10.1111/bjh.15147,","elsevierAuthor":"Pinto A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early-and long-term mortality.","googleId":"hHKypRuzkwwJ","googleLink":"https://livrepository.liverpool.ac.uk/3004787/2/bjh14454-sup-0001-Supinfo.docx","googleCitationCount":4,"googleAuthor":"A Patel","statusesArray":[]},{"title":"Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)","googleId":"QE2biv2khXkJ","googleLink":"https://moh-it.pure.elsevier.com/en/publications/deferasirox-in-the-management-of-iron-overload-in-patients-with-m","googleCitationCount":2,"googleAuthor":"EM Elli","doi":"10.1111/bjh.15964","elsevierAuthor":"Elli E.M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The impact of diagnostic wait time on the survival of patients with diffuse large B‐cell lymphoma: effect modification by the International Prognostic Index","googleId":"et77sOruG-0J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16078","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16078","elsevierAuthor":"Lee S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":["Shin Lee","Kei Fujita","Eiju Negoro","Tetsuji Morishita","Hideaki Yamauchi","Kana Oiwa","Takanori Ueda","Takahiro Yamauchi"],"twitterCount":12,"altmetricId":62810503,"statusesArray":["1160596695689957379","1149637882639872001","1149633803725332482","1148342364538359809","1147800977015226369","1147579046030540801","1147574351585251328","1147518051853774854","1147487165653426183","1147433745231876096","1146266460639125505","1146265701663068160","1144846720368599040","1144546797483896834"]},{"title":"Hypoalbuminaemia segregates different prognostic subgroups within the refined standard risk acute graft‐versus‐host disease score","googleId":"Mhv1AVEEHWYJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15105","googleCitationCount":2,"googleAuthor":"MA Kharfan‐Dabaja","doi":"10.1111/bjh.15105","elsevierAuthor":"Kharfan-Dabaja M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"2","altmetricAuthors":["Mohamed A. Kharfan-Dabaja","Kyle Sheets","Ambuj Kumar","Hemant S. Murthy","Taiga Nishihori","Athanasios Tsalatsanis","Alain Mina","John Mathews","Ernesto Ayala","Julio Chavez","Lia E. Perez","Brian C. Betts","Claudio Anasetti","Joseph Pidala"],"twitterCount":17,"altmetricId":31926808,"statusesArray":["955282910667558912","955254784071749632","955172411003023360","954586494601170944","954492617726754818","954396017729966080","954380193346543617","954326677362036736","954310815800266752","954244520429981696","954238362193448960","954237846101069824","954236202844147712","954224031665864704","954218454143430656","954205271936573440","954189667636797441","954184201582120960"]},{"title":"University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL","googleId":"4jwE3ujgyEgJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785463/","googleCitationCount":2,"googleAuthor":"N Galanina","statusesArray":[]},{"title":"Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome …","googleId":"RvPydgZzgN4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30407613/","googleCitationCount":1,"googleAuthor":"HS Sabnis","doi":"10.1111/bjh.15633,","elsevierAuthor":"Sabnis H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome","googleId":"aRrD33k95b8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28318026/","googleCitationCount":5,"googleAuthor":"","doi":"10.1111/bjh.14656,","elsevierAuthor":"Duarte F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B‐cell neoplasms","googleId":"GwOpeSDrDSMJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15762","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15762","elsevierAuthor":"Paterson A.L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma","googleId":"kMcgzf7d2g8J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772118/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16056","elsevierAuthor":"Guidez S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":["Stephanie Guidez","Laurence Lacotte‐Thierry","Cecile Tomowiak","Isabelle Princet","Brigitte Dreyfus","Gaelle Olivier","Emmanuel Fleck","Anne Corby","Carine Motard","Jocelyn Barrier","Antoine Machet","Katell Le Dû","Celine Debiais‐Delpech","Michele Chabin","Xavier Leleu","Joëlle Guilhot","Vincent Delwail"],"twitterCount":8,"altmetricId":63647708,"statusesArray":["1156623606270615552","1153272516103811073","1153250295213907969","1151431812285173761","1151381197559230464","1151381041405472768","1151267796992581632","1151266221519790082"]},{"title":"Early T-cell precursor lymphoblastic leukaemia: response to FLAG-IDA and high-dose cytarabine with sorafenib after initial refractoriness","googleId":"BN9X4m6amxEJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30334573/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15601,","elsevierAuthor":"Bataller A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Role of MFHAS1 in regulating hepcidin expression via the BMP/SMAD and MAPK/ERK1/2 signalling pathways.","googleId":"b5974BMpLjAJ","googleLink":"https://europepmc.org/article/pmc/pmc6679777","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia …","googleId":"bYK_5F7EdIUJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15399","googleCitationCount":1,"googleAuthor":"M Yanada","doi":"10.1111/bjh.15399","elsevierAuthor":"Konuma T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"1","altmetricAuthors":["Takaaki Konuma","Masamitsu Yanada","Satoshi Yamasaki","Yachiyo Kuwatsuka","Takahiro Fukuda","Takeshi Kobayashi","Yukiyasu Ozawa","Naoyuki Uchida","Shuichi Ota","Takumi Hoshino","Satoshi Takahashi","Yoshinobu Kanda","Yasunori Ueda","Minoko Takanashi","Junya Kanda","Tatsuo Ichinohe","Yoshiko Atsuta","Shingo Yano"],"twitterCount":1,"altmetricId":43567832,"statusesArray":["1005892383437926401"]},{"title":"A Novel Missense Mutation in a Leucine-Rich Repeat of GPIbα in a Bernard-Soulier Variant Reduces Shear-Dependent Adherence on Von Willebrand Factor","googleId":"Ck-5atr0WB4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31257572/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.16068,","elsevierAuthor":"Proulle V.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Whole genome MBD-seq reveals different CpG methylation patterns in azacytidine-treated juvenile myelomonocytic leukaemia (JMML) patients","googleId":"8nBbzvIDmYkJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28771681/","googleCitationCount":2,"googleAuthor":"PP Leoncini","doi":"10.1111/bjh.14876,","elsevierAuthor":"Leoncini P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Age-related heterogeneity of Burkitt lymphoma","googleId":"Sw4rEMm4DmsJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5276797/","googleCitationCount":3,"googleAuthor":"","statusesArray":[]},{"title":"Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical …","googleId":"Ko9OTiMUiKEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771337/","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"Gear and methodological considerations for deep diving","googleId":"a9pBWmnw2XcJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706311/","googleCitationCount":0,"googleAuthor":"J Zhou","statusesArray":[]},{"title":"Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptation","googleId":"qfvrhPUMj_cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28485070/","googleCitationCount":3,"googleAuthor":"","doi":"10.1111/bjh.14748,","elsevierAuthor":"Bidet A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"3","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma.","googleId":"wLqj6kKOiG0J","googleLink":"https://europepmc.org/article/med/30338523","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"Cancer specific survival in patients with sickle cell disease","googleId":"s854Y6uKeUIJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15687","googleCitationCount":1,"googleAuthor":"A Brunson","doi":"10.1111/bjh.15687","elsevierAuthor":"Brunson A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"1","altmetricAuthors":["Ann Brunson","Theresa H. M. Keegan","Anjlee Mahajan","Susan Paulukonis","Ted Wun"],"twitterCount":0,"altmetricId":77033689,"statusesArray":[]},{"title":"Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult …","googleId":"j0N2DEkihq0J","googleLink":"https://kyushu-u.pure.elsevier.com/en/publications/clinical-outcomes-of-hepatitis-b-or-c-virus-infections-in-patient","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16050","elsevierAuthor":"Kato H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":["Harumi Kato","Koji Kato","Sung‐Won Kim","Takahiro Fukuda","Takehiko Mori","Masashi Sawa","Yuju Ohno","Satoshi Yoshioka","Yasuharu Iwato","Hirofumi Taji","Makoto Onizuka","Shingo Kurahashi","Tatsuo Ichinohe","Junji Suzumiya","Ritsuro Suzuki"],"twitterCount":1,"altmetricId":62345094,"statusesArray":["1140923316393435137"]},{"title":"Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre","googleId":"2caHmjMhlWUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28106901/","googleCitationCount":2,"googleAuthor":"E Sinakos","doi":"10.1111/bjh.14509,","elsevierAuthor":"Sousos N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Molecular remissions are observed in chronic Adult T cell Leukaemia/Lymphoma in patients treated with mogamulizumab.","googleId":"fX2deJ-6MH0J","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_33_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"L Cook","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Expansion deficiency of CAR-T cells in patients with lymphoma and resolution by T cell purification","googleId":"UaTNIveEHZUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30834515/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15822,","elsevierAuthor":"Chen L.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-07-01","elsevierCoverDisplayDate":"July 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma","googleId":"Zn26qtORk8cJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31364154/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16114,","elsevierAuthor":"Ferretti A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation","googleId":"sqKgJZoXSZkJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021206/","googleCitationCount":3,"googleAuthor":"M Sivina","statusesArray":[]},{"title":"Prenatal origin of KRAS mutation in a child with an acute myelomonocytic leukaemia bearing the KMT2A/MLL-AFDN/MLLT4/AF6 fusion transcript.","googleId":"-8lYm3ArC3oJ","googleLink":"https://europepmc.org/article/med/30132801","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"Venetoclax Monotherapy and Combined with Dexamethasone as Targeted Therapy for Relapsed/Refractory t (11; 14) Multiple Myeloma","googleId":"fPCYSAJbPBgJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_50_A_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"J Kaufman","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Early detection of differentiation syndrome by chest ultrasound in acute promyelocytic leukaemia.","googleId":"nn1bTTN3sZAJ","googleLink":"https://europepmc.org/article/med/29607485","googleCitationCount":1,"googleAuthor":"P Karunakaran","statusesArray":[]},{"title":"UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN","googleId":"WBfRos7ogSkJ","googleLink":"https://ora.ox.ac.uk/objects/uuid:dc28a1e9-5f8a-49a7-b5e3-f360920dab0e/download_file?file_format=pdf&safe_filename=Mead-2019-myeloproliferative-neoplasms-landmark-survey.pdf&type_of_work=Journal+article","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group","googleId":"aNNSz47XgVwJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31115898/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15966,","elsevierAuthor":"Nudel M.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line","googleId":"Ct04bJfUY88J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29048125/","googleCitationCount":2,"googleAuthor":"E Gaudio","doi":"10.1111/bjh.14989,","elsevierAuthor":"Gaudio E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel …","googleId":"rrVP8ZCpC18J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31282989/?from_term=Kahr+WH%5BAuthor%5D&from_pos=9","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16077,","elsevierAuthor":"Egan G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al.","googleId":"Z9b2RhD5fVsJ","googleLink":"https://europepmc.org/article/pmc/pmc6706311","googleCitationCount":0,"googleAuthor":"J Zhou","statusesArray":[]},{"title":"Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients","googleId":"HLyoC3gh5bAJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811806/","googleCitationCount":3,"googleAuthor":"L Marcheselli","doi":"10.1111/bjh.14406","elsevierAuthor":"Bari A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"Februaryy 2018","elsevierCitationCount":"1","altmetricAuthors":["Alessia Bari","Luigi Marcheselli","Raffaella Marcheselli","Samantha Pozzi","Maria Christina Cox","Cinzia Baldessari","Paola Ferri","Paolo Gobbi","Luca Baldini","Tamar Tadmor","Pellegrino Musto","Massimo Federico","Stefano Sacchi"],"twitterCount":1,"altmetricId":32787269,"statusesArray":["961230644763295745"]},{"title":"Clonality and clonal evolution analysis of paediatric ALL based on B-cell receptor/T-cell receptor rearrangement.","googleId":"pCFTfkFoXRMJ","googleLink":"https://europepmc.org/article/med/29532914","googleCitationCount":2,"googleAuthor":"LW Ding","statusesArray":[]},{"title":"Successful treatment of primary cutaneous diffuse large B cell lymphoma leg type with single agent venetoclax","googleId":"j8FUFbSgBgUJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_24_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"CS Trethewey","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Detection by a simple and cheaper methodology of Ik6 and Ik10 isoforms of the IKZF1 gene is highly associated with a poor prognosis in B-lineage paediatric acute …","googleId":"IftZAmsokFoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31483479/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16172,","elsevierAuthor":"Moreira L.B.P.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Single centre outcome of patients with secondary central nervous system lymphoma","googleId":"s6Ns3MpwZjYJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_26_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Reduced regulatory T cells (Treg) in bone marrow preferentially associate with the expansion of cytotoxic T lymphocytes in low risk MDS patients","googleId":"D0BfBsnEFNcJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30010189/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15496,","elsevierAuthor":"Giovazzino A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"April 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"In field relapses following involved site radiotherapy to limited stage or localised residual double hit high grade B cell lymphoma: a review of 4 consecutive …","googleId":"1fZS18Xd8QcJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_38_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Importance of sequential analysis of TP53 variation in patients with Waldenström Macroglobulinaemia","googleId":"68gJxqJBMlUJ","googleLink":"https://www.researchgate.net/profile/Amy_Christian6/publication/332325087_Importance_of_sequential_analysis_of_TP_53_variation_in_patients_with_Waldenstrom_Macroglobulinaemia/links/5e3036c1299bf1cdb9f69406/Importance-of-sequential-analysis-of-TP-53-variation-in-patients-with-Waldenstroem-Macroglobulinaemia.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Identification of the first large intronic deletion responsible of type I antithrombin deficiency not detected by routine molecular diagnostic methods","googleId":"rJmaDPfv9ycJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30941754/","googleCitationCount":0,"googleAuthor":"B De la Morena-Barrio","doi":"10.1111/bjh.15913,","elsevierAuthor":"De la Morena-Barrio B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"HHV-6 as a cause of Fever and Delayed Platelet Engraftment in patients undergoing Autologous Stem Cell Transplant","googleId":"-eD_MF0xaAoJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_83_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Focal bone lesions in Hairy Cell Leukaemia","googleId":"ZH5RmykkPo8J","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_29_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"B Sharma","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study","googleId":"P4-Ac_G2lHoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30854624/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15849,","elsevierAuthor":"Barilà G.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"August 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Wilms tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish group for molecular biology in …","googleId":"i6zWckavI_UJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28369773/","googleCitationCount":2,"googleAuthor":"C Martínez-Laperche","doi":"10.1111/bjh.14635,","elsevierAuthor":"Martínez-Laperche C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?","googleId":"m30dY3RMQ7sJ","googleLink":"https://www.researchgate.net/profile/Tim_Illidge2/publication/325294676_How_do_we_move_towards_a_personalised_approach_in_the_treatment_of_Early_Hodgkin_lymphoma/links/5f4e2637a6fdcc14c50609ac/How-do-we-move-towards-a-personalised-approach-in-the-treatment-of-Early-Hodgkin-lymphoma.pdf","googleCitationCount":1,"googleAuthor":"TM Illidge","statusesArray":[]},{"title":"Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma","googleId":"Sel0TuWOnHYJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31222716/","googleCitationCount":0,"googleAuthor":"F Djebbari","doi":"10.1111/bjh.16071,","elsevierAuthor":"Djebbari F.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Adult-onset Beta-Thalassaemia Intermedia Caused by a 5-Mb Somatic Clonal Segmental Deletion in Haemopoietic Stem Cells Involving the β-globin Locus","googleId":"iDzF-mb-9hIJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31206601/","googleCitationCount":0,"googleAuthor":"J Traeger-Synodinos","doi":"10.1111/bjh.16043,","elsevierAuthor":"Traeger-Synodinos J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis","googleId":"Ujt173xb_b4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31240709/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16072,","elsevierAuthor":"Shinohara A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The diagnostic value of Neutrophil Gelatinase–Associated Lipocalin (NGAL) for detecting early phase sepsis in patients with suspected bacterial infection.","googleId":"bOnZMW6mPUoJ","googleLink":"https://www.researchgate.net/profile/Muttuswamy_Sivakumaran/publication/332850022_The_diagnostic_value_of_Neutrophil_Gelatinase_-Associated_Lipocalin_NGAL_for_detecting_early_phase_sepsis_in_patients_with_suspected_bacterial_infection/links/5cccca34a6fdccc9dd8b3d9d/The-diagnostic-value-of-Neutrophil-Gelatinase-Associated-Lipocalin-NGAL-for-detecting-early-phase-sepsis-in-patients-with-suspected-bacterial-infection.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Long‐term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib","googleId":"19PIccHV0_wJ","googleLink":"https://www.researchgate.net/profile/Matteo_Molica/publication/313830940_Long-term_impact_of_molecular_response_fluctuations_in_chronic_myeloid_leukaemia_patients_treated_with_imatinib/links/5c103f8b92851c39ebe6aa26/Long-term-impact-of-molecular-response-fluctuations-in-chronic-myeloid-leukaemia-patients-treated-with-imatinib.pdf","googleCitationCount":2,"googleAuthor":"M Breccia","statusesArray":[]},{"title":"ALL and AML","googleId":"JtBo5bOHcqEJ","googleLink":"https://www.researchgate.net/profile/Deepali_Bij/publication/332817920_Development_and_validation_of_the_Satisfaction_with_Treatment_for_Pain_Questionnaire_STPQ_among_people_with_sickle_cell_disease/links/5ccb0f4ca6fdcc4719835f88/Development-and-validation-of-the-Satisfaction-with-Treatment-for-Pain-Questionnaire-STPQ-among-people-with-sickle-cell-disease.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"Treatment with bortezomib in dense deposit disease associated with monoclonal gammopathy of undetermined significance","googleId":"W8FWrvzooB4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29363742/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15081,","elsevierAuthor":"Pampa-Saico S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"January 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Novel three-way fusions among ZNF384, EWSR1 and EHMT1 genes in paediatric B cell precursor acute lymphoblastic leukaemia with translocations resembling …","googleId":"LARhLLZ40pQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31531845/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16199,","elsevierAuthor":"Chen X.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-11-01","elsevierCoverDisplayDate":"1 November 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction","googleId":"0rmMEZEUPtsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30924125/","googleCitationCount":0,"googleAuthor":"S Sanikommu","doi":"10.1111/bjh.15897,","elsevierAuthor":"Ghosh N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Negative MR 4· 0 Chronic Myeloid Leukaemia and Its Possible Implications for Treatment-Free Remission","googleId":"87ryODaOWk8J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31218669/","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.16058,","elsevierAuthor":"Cerveira N.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Cognition in thalassaemia: the next milestone","googleId":"EQXSQT7tJyEJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15956","googleCitationCount":1,"googleAuthor":"D Rund","doi":"10.1111/bjh.15956","elsevierAuthor":"Rund D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":["Deborah Rund"],"twitterCount":1,"altmetricId":82312446,"statusesArray":["1262685314910269443"]},{"title":"Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study","googleId":"ZhSlA6Tx5UoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/31368111/","googleCitationCount":0,"googleAuthor":"EJ Choi","doi":"10.1111/bjh.16121,","elsevierAuthor":"Choi E.J.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Use of extended half-life Factor VIII and IX concentrates in Haemophilia: a clinical audit","googleId":"Deo8ouETQdQJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_66_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Unique anti‐myeloma activity by thiazolidine‐2, 4‐dione compounds with Pim inhibiting activity","googleId":"xyk6oU4B_GcJ","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15033","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.15033","elsevierAuthor":"Fujii S.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"0","altmetricAuthors":["Shiro Fujii","Shingen Nakamura","Asuka Oda","Hirokazu Miki","Hirofumi Tenshin","Jumpei Teramachi","Masahiro Hiasa","Ariunzaya Bat-Erdene","Yusaku Maeda","Masahiro Oura","Mamiko Takahashi","Masami Iwasa","Itsuro Endo","Sumiko Yoshida","Ken-ichi Aihara","Kiyoe Kurahashi","Takeshi Harada","Kumiko Kagawa","Michiyasu Nakao","Shigeki Sano","Masahiro Abe"],"twitterCount":2,"altmetricId":31642090,"statusesArray":["952308186698182657","952299216570732544"]},{"title":"High HFE mutation incidence in idiopathic erythrocytosis","googleId":"fq4zvHH0ECoJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30407617/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.15631,","elsevierAuthor":"Burlet B.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-05-01","elsevierCoverDisplayDate":"May 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Induction therapy for multiple myeloma: more is not necessarily better!","googleId":"Pg7ev8fl7_YJ","googleLink":"https://europepmc.org/article/med/29676443","googleCitationCount":1,"googleAuthor":"","statusesArray":[]},{"title":"Abnormal bone marrow signal on MRI heralding oncologic diagnoses","googleId":"MZL-IEhQLOUJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_51_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia-results of two cohort studies involving 215 patients and 3759 controls","googleId":"G34fTGJr2RUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28106906/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.14527,","elsevierAuthor":"Schulz E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Paediatric thrombosis: A single centre 8-month experience","googleId":"6KU8FeK6J88J","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_71_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Lipopolysaccharide (LPS)-responsive and beige-like anchor protein deficiency: Unifying diagnosis of multiple autoimmune conditions and immunedeficiency","googleId":"wK2AWmc1lq4J","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_53_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Prophylactic FFP transfusion: are we complying with National guidance?","googleId":"uIwSNRTYILQJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_79_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Fatal Acute Haemolytic Transfusion Reaction due to Anti-Wright (a) Antibody","googleId":"HO18VJ5dYRkJ","googleLink":"https://www.researchgate.net/profile/Muttuswamy_Sivakumaran/publication/332471910_Fatal_Acute_Haemolytic_Transfusion_Reaction_due_to_ant-Wright_a_antibody/links/5cb78f254585156cd79f9549/Fatal-Acute-Haemolytic-Transfusion-Reaction-due-to-ant-Wright-a-antibody.pdf","googleCitationCount":0,"googleAuthor":"","statusesArray":[]},{"title":"When is chronic myeloid leukaemia'cured'? Relapse post allogeneic bone marrow transplantation after 32 years","googleId":"UWL5AwTErLAJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_86_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"A Patel","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Impact of graft‐versus‐lymphoma effect on outcomes after reduced intensity conditioned‐alemtuzumab allogeneic haematopoietic stem cell transplantation for …","googleId":"GgSRBrmK0o4J","googleLink":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15685","googleCitationCount":0,"googleAuthor":"","doi":"10.1111/bjh.15685","elsevierAuthor":"Brierley C.K.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2019-02-01","elsevierCoverDisplayDate":"Februaryy 2019","elsevierCitationCount":"0","altmetricAuthors":["Charlotte K. Brierley","Francesca M. Jones","Katharine Hanlon","Andy J. Peniket","Chris Hatton","Graham P. Collins","Anna Schuh","Patrick Medd","Andrew Clark","Janice Ward","Sridar Chaganti","Ram Malladi","Anne Parker","Charles Craddock","Robert Danby","Vanderson Rocha"],"twitterCount":13,"altmetricId":51645431,"statusesArray":["1070450092220522498","1067109283458895872","1067077834890534912","1066799265454936064","1066788061525303298","1066747165479981056","1066698923643990016","1066674471233310720","1066391110510149632","1066364401761091584","1066321333322166272","1066289563746865158","1066286465959768064"]},{"title":"Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?","googleId":"BH7CCv9MGMsJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/27662562/","googleCitationCount":2,"googleAuthor":"","doi":"10.1111/bjh.14323,","elsevierAuthor":"Bigenwald C.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis","googleId":"1fxOEJb_YDAJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6282794/","googleCitationCount":0,"googleAuthor":"UT Khan","doi":"10.1111/bjh.15489","elsevierAuthor":"Khan U.T.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Clinical utility of bone marrow biopsy pre-autograft in myeloma.","googleId":"YqW-GL8cPGQJ","googleLink":"https://www.postersessiononline.eu/173580348_eu/congresos/BSH2019/aula/-EP_45_BSH2019.pdf","googleCitationCount":0,"googleAuthor":"","doi":"10.3252/pso.eu.BSH2019.2019","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma","googleId":"j4jbGLWCbk4J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28857117/","googleCitationCount":1,"googleAuthor":"","doi":"10.1111/bjh.14871,","elsevierAuthor":"Chee A.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Validation of clinical-grade whole genome sequencing reproduces cytogenetic analysis and identifies mutational landscape in newly-diagnosed multiple myeloma …","googleId":"vOV5Hi1MStgJ","googleLink":"https://www.researchgate.net/profile/Oliver_Lomas/publication/337246894_Clinical-Grade_Whole_Genome_Sequencing_Reproduces_FISH_Cytogenetics_and_Provides_Actionable_Data_in_Newly_Diagnosed_Myeloma_-_a_Pilot_Study_from_the_UK_100000_Genomes_Project/links/5e3773d0458515072d7a0c1b/Clinical-Grade-Whole-Genome-Sequencing-Reproduces-FISH-Cytogenetics-and-Provides-Actionable-Data-in-Newly-Diagnosed-Myeloma-a-Pilot-Study-from-the-UK-100-000-Genomes-Project.pdf","googleCitationCount":0,"googleAuthor":"O Lomas","statusesArray":[]},{"title":"Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients","googleId":"4OTiujPxDpcJ","googleLink":"https://biblio.ugent.be/publication/8550793","googleCitationCount":14,"googleAuthor":"","doi":"10.1111/bjh.14991","elsevierAuthor":"Hanekamp D.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"9","altmetricAuthors":[],"twitterCount":0,"statusesArray":[]},{"title":"Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia","googleId":"n6ubE9vDdMEJ","googleLink":"http://eprints.uanl.mx/15810/1/12.pdf","googleCitationCount":9,"googleAuthor":"D Gómez Almaguer","statusesArray":[]}]